data_2jxo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jxo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.11 142.63 42.47 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.548 2.165 . . . . 0.0 111.976 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -107.48 141.22 39.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.085 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.3 tp -98.6 134.26 41.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.544 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 41.4 t -129.92 139.99 51.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 19.0 m -131.86 101.99 5.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.157 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.427 ' HE2' ' CE2' ' A' ' 166' ' ' PHE . 6.6 ptp -109.99 137.53 47.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 111.219 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -100.59 119.09 38.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.657 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.29 -82.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.48 -156.42 26.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.23 -0.0 10.38 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.603 2.202 . . . . 0.0 112.841 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.7 p -108.43 -30.03 8.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.724 0.297 . . . . 0.0 111.119 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.92 -131.11 10.17 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.423 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CZ ' ' CG2' ' A' ' 219' ' ' ILE . 32.5 m-85 -110.2 -46.56 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.05 17.41 63.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.809 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.427 ' CE2' ' HE2' ' A' ' 157' ' ' MET . 0.1 OUTLIER -124.93 -178.62 4.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.092 0.472 . . . . 0.0 111.845 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.404 ' CB ' ' CG ' ' A' ' 180' ' ' ARG . 9.9 m120 -134.83 160.73 37.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.393 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -138.54 137.25 36.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.313 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 0.7 OUTLIER -134.76 141.53 46.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.62 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 t -155.09 150.14 26.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.25 -72.95 0.56 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.033 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -64.34 163.97 12.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.044 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.0 m -110.05 20.3 18.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.606 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 23.1 mttp -112.47 -50.56 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.873 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 25.2 Cg_exo -63.15 -64.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.143 1.895 . . . . 0.0 112.248 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 142.58 -148.34 20.04 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.5 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -114.93 129.09 56.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 0.0 110.973 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.476 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 1.6 m-85 -117.34 165.27 13.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.349 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 5.0 mt -90.18 136.3 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.939 0.399 . . . . 0.0 110.358 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.409 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 9.4 ptm180 -102.38 -34.55 9.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.818 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.9 t -150.36 149.4 30.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 0.0 111.909 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 81.9 t -135.32 134.1 52.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.548 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 186' ' ' SER . 47.4 t0 -84.37 122.5 75.33 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.971 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.01 130.22 30.1 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.229 1.953 . . . . 0.0 112.193 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 75.93 18.18 2.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.736 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.6 m -98.23 164.93 16.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.56 0.219 . . . . 0.0 110.632 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 97.5 Cg_exo -43.45 -40.1 9.84 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.607 2.205 . . . . 0.0 112.768 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.77 91.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.039 0.447 . . . . 0.0 110.373 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.03 -50.86 37.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.755 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -47.91 -32.96 6.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.333 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -79.32 -30.0 42.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.04 32.58 1.51 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.241 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -97.59 149.17 22.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.854 0.359 . . . . 0.0 110.995 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.405 ' N ' ' CD2' ' A' ' 193' ' ' LEU . 76.5 mtt180 -142.51 133.77 26.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -46.59 161.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.576 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 56.4 mt-30 82.73 -13.92 0.79 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.042 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.496 ' HB2' ' HB ' ' A' ' 230' ' ' VAL . 7.9 p-10 -68.18 146.45 53.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.749 0.309 . . . . 0.0 110.566 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.476 ' HD2' ' CE1' ' A' ' 178' ' ' PHE . 15.8 mmt85 -93.1 123.13 36.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.387 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.406 ' CD1' HG13 ' A' ' 230' ' ' VAL . 22.1 mm -66.52 128.96 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.976 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.81 -42.97 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.785 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 10.9 pt-20 -144.87 172.63 12.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.024 0.44 . . . . 0.0 111.649 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 16.5 t -149.42 105.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.017 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 35.7 t30 70.27 26.39 4.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.538 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.06 -21.85 32.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.486 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.0 m -80.32 97.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.985 0.422 . . . . 0.0 111.158 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.446 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 42.3 t -89.98 98.78 11.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.114 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.403 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 21.7 mmt -130.24 99.68 5.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.817 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -74.48 106.56 6.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.121 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.04 11.93 8.72 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.858 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.403 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 12.3 mmtt -55.76 161.91 1.97 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.887 0.375 . . . . 0.0 111.217 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -88.25 160.33 17.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.909 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -49.89 -57.28 7.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.577 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.97 -34.21 82.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.814 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -44.75 80.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 35.5 t -70.65 -37.32 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.342 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.96 -41.77 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.418 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.8 m -66.24 -40.05 89.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.537 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.39 -39.01 69.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.469 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 25.2 mm -69.75 -32.28 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.716 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -71.57 -36.49 70.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.86 5.16 29.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.619 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.33 14.03 60.43 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.009 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.03 -135.55 26.19 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.906 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.96 -25.13 24.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.793 0.33 . . . . 0.0 111.184 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -108.75 114.93 29.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 24.6 m -109.82 101.56 10.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.715 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -81.19 98.12 7.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.893 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 32.8 mt -108.19 129.87 55.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.045 0.45 . . . . 0.0 112.17 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.417 ' CB ' ' HG2' ' A' ' 201' ' ' GLU . 11.8 tp -110.7 109.74 20.12 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 197' ' ' ASP . 33.9 m -110.91 -179.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.563 . . . . 0.0 112.305 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.7 t -119.52 165.66 14.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.116 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -99.8 109.75 22.15 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 196' ' ' GLN . 25.2 ttm180 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.472 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.777 0.322 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.87 151.46 85.11 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.742 2.295 . . . . 0.0 112.786 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -130.67 145.91 52.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.709 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 21.9 tp -93.08 137.93 31.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.189 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 42.1 t -130.17 140.05 50.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.814 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.1 m -130.17 107.35 9.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.826 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 9.5 ptp -109.98 143.11 40.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.812 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -105.87 127.36 53.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -60.2 -80.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.824 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.68 -156.86 9.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.442 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.77 -1.51 11.68 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.571 2.181 . . . . 0.0 112.671 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.8 p -101.37 -30.15 11.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.126 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.3 -127.93 8.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.433 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.466 ' CZ ' ' CG2' ' A' ' 219' ' ' ILE . 9.7 m-85 -110.08 -50.21 3.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.863 0.364 . . . . 0.0 110.814 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.24 13.96 69.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.99 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.414 ' CE1' ' CB ' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -124.86 178.39 5.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.223 0.535 . . . . 0.0 111.963 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -134.35 157.76 45.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.256 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.406 ' CD1' ' HA ' ' A' ' 179' ' ' ILE . 2.3 mm? -133.07 148.32 52.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.965 0.412 . . . . 0.0 111.599 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -134.53 149.18 50.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.103 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 148.02 33.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.011 0.434 . . . . 0.0 111.423 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -130.19 -74.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.612 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -90.08 174.73 7.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.714 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.2 m -110.02 20.22 18.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.252 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.562 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 25.2 mtpt -108.66 -49.25 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.684 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 21.6 Cg_exo -65.28 -56.75 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.269 1.98 . . . . 0.0 112.19 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.73 -156.76 21.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.492 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -102.5 136.16 42.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.849 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -132.31 152.16 51.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.406 ' HA ' ' CD1' ' A' ' 168' ' ' LEU . 57.3 mt -74.4 138.08 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -103.61 -33.09 9.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.63 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.8 t -149.73 154.66 38.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.95 0.405 . . . . 0.0 111.441 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 37.4 t -135.01 134.99 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 186' ' ' SER . 56.8 t0 -84.37 125.54 71.69 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.24 131.05 30.67 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.341 2.027 . . . . 0.0 112.224 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 73.69 18.71 3.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.78 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.428 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.6 m -97.75 164.36 17.65 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.6 0.238 . . . . 0.0 110.69 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 88.4 Cg_exo -44.4 -40.13 13.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.563 2.175 . . . . 0.0 112.739 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.67 -42.99 98.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 110.639 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.92 -50.89 37.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.966 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -49.1 -30.22 6.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.551 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.5 t -84.97 -26.1 27.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.71 27.89 3.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.175 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 tt -75.96 149.85 37.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.832 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -134.66 129.86 35.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.794 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -57.8 150.58 19.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.163 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 73.75 3.07 4.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.766 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -66.86 154.84 39.94 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.274 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -89.84 110.25 21.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.767 0.318 . . . . 0.0 111.453 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.4 ' CD1' HG11 ' A' ' 230' ' ' VAL . 24.5 mm -61.99 123.79 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.939 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.88 -45.94 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.448 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 9.6 pt-20 -143.31 174.16 10.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 111.363 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 40.4 t -152.91 106.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 18.8 t30 70.3 25.97 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.482 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.81 -21.02 35.15 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.372 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.7 m -81.45 97.27 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.998 0.428 . . . . 0.0 111.232 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.46 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 42.4 t -87.84 98.26 11.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.7 mmt -130.17 99.83 5.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -68.58 101.9 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 113.34 25.37 4.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.543 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.86 164.04 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.843 0.354 . . . . 0.0 111.169 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -99.59 160.21 14.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.037 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -48.76 -62.56 1.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.87 -32.6 59.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.043 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.37 -44.95 74.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.153 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.64 -40.01 76.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 44.1 t -64.0 -42.83 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.336 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 58.8 m -71.57 -39.04 70.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.575 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.02 81.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.466 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 32.3 mm -61.82 -31.7 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.597 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -73.1 -38.15 66.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.727 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.03 5.32 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.66 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -82.12 9.24 58.08 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.21 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -139.2 20.2 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.017 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -25.12 34.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.663 0.268 . . . . 0.0 111.252 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -116.01 115.34 25.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 110.782 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.9 m -107.32 99.23 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -76.32 98.52 4.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.149 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 34.5 mt -107.36 128.06 54.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.715 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.429 ' CB ' ' HG2' ' A' ' 201' ' ' GLU . 13.5 tp -107.6 109.66 21.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.337 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.4 HG11 ' CD1' ' A' ' 199' ' ' ILE . 29.4 m -123.62 169.93 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 112.187 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.6 t -120.01 138.89 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.393 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -69.85 112.7 6.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.33 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 179.557 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.603 0.24 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 137.87 20.6 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.439 2.093 . . . . 0.0 112.172 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 230' ' ' VAL . 0.8 OUTLIER -93.7 139.37 30.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.786 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.62 123.0 32.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 50.5 t -122.33 127.55 49.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.9 m -127.28 103.7 7.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.502 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.459 ' HE3' ' CE2' ' A' ' 166' ' ' PHE . 2.0 ptt? -110.64 145.04 38.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.02 0.438 . . . . 0.0 111.259 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -104.32 119.36 38.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.578 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.403 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 1.5 tppt? -47.83 -78.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.88 -159.85 26.78 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.228 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.56 0.16 10.24 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.582 2.188 . . . . 0.0 112.91 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.3 p -104.0 -30.27 10.39 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.403 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 93.12 -140.3 15.0 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.079 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.525 ' HB3' ' CE2' ' A' ' 166' ' ' PHE . 7.8 m-85 -110.38 -47.17 3.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.931 0.396 . . . . 0.0 110.762 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.52 24.13 51.54 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.646 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 164' ' ' TYR . 8.5 p90 -124.81 172.87 8.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.216 0.532 . . . . 0.0 111.827 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 166' ' ' PHE . 10.0 m120 -137.95 152.5 49.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.96 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.487 HD21 ' CE1' ' A' ' 166' ' ' PHE . 4.2 mm? -129.78 146.13 51.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.246 0.546 . . . . 0.0 112.299 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 2.8 p80 -143.59 133.72 24.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.721 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.5 t -129.46 155.5 45.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.033 0.444 . . . . 0.0 111.605 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -130.05 -64.39 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.474 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -90.06 162.52 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -110.12 22.5 15.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.348 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.606 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 52.8 mttm -105.56 -50.22 0.11 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.608 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 9.0 Cg_exo -72.13 -57.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.426 2.084 . . . . 0.0 112.144 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 145.06 -144.22 12.87 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.369 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -100.76 150.29 22.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.753 0.311 . . . . 0.0 110.857 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.452 ' CZ ' ' NH1' ' A' ' 198' ' ' ARG . 3.6 m-85 -131.06 138.12 49.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.781 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.9 mt -71.7 133.57 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 110.271 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.479 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 4.5 ptm180 -101.54 -30.88 11.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.723 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.2 t -152.78 145.43 24.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.469 . . . . 0.0 111.731 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.0 t -128.64 132.31 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.434 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 186' ' ' SER . 53.9 t0 -84.1 120.23 74.44 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.106 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.45 133.44 49.01 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.415 2.076 . . . . 0.0 112.359 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 71.81 15.25 5.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.814 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.412 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 44.8 m -97.43 161.8 24.75 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.623 0.249 . . . . 0.0 110.64 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 99.6 Cg_exo -43.99 -40.32 11.78 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.571 2.18 . . . . 0.0 112.753 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.41 -44.3 96.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.444 . . . . 0.0 110.518 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -70.37 -52.27 23.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.027 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.51 -29.39 1.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.609 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.5 t -83.78 -31.98 25.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.959 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.49 7.38 6.32 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.984 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.17 146.45 27.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.744 0.306 . . . . 0.0 110.85 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -136.54 137.99 40.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -63.46 149.64 45.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.299 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 75.31 2.61 3.91 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.099 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -73.1 153.98 40.58 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.435 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.452 ' NH1' ' CZ ' ' A' ' 178' ' ' PHE . 1.3 mmp_? -89.6 115.26 26.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 0.0 111.154 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 33.8 mm -65.01 125.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 229' ' ' LEU . 21.4 t -106.15 -44.29 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.492 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 6.2 pt-20 -144.34 173.35 11.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.024 0.44 . . . . 0.0 111.623 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.412 ' HA ' ' CD2' ' A' ' 228' ' ' LEU . 43.4 t -151.52 107.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.861 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.1 t30 70.27 24.35 4.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.322 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.76 -20.14 37.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.343 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.48 99.19 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.99 0.424 . . . . 0.0 111.335 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.436 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 45.3 t -84.92 100.62 11.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.986 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 20.4 mmt -130.13 99.81 5.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -69.73 102.42 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.761 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.81 20.93 4.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.729 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.547 ' HA ' ' CE ' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -54.82 150.67 9.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.918 0.389 . . . . 0.0 111.076 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -94.56 160.25 14.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.1 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -47.15 -61.64 1.79 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.12 -30.55 60.9 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.151 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -44.26 67.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.407 . . . . 0.0 110.331 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.96 -38.95 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.312 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.4 -41.2 88.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.592 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 64.6 m -72.55 -34.64 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.696 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.1 83.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.057 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 32.0 mm -59.55 -41.98 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 ttp-105 -64.21 -41.68 96.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.724 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.06 5.32 30.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.712 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.64 19.21 38.1 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.046 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -145.08 9.61 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.941 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.63 -25.15 28.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.725 0.298 . . . . 0.0 111.158 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -103.98 114.99 29.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.59 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 4.5 m -111.09 108.05 17.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.345 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -91.12 99.89 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.403 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.416 ' CD1' ' CE ' ' A' ' 157' ' ' MET . 12.4 mt -107.06 132.21 53.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.044 0.45 . . . . 0.0 111.717 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 200' ' ' VAL . 13.3 tp -116.46 109.41 17.26 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 153' ' ' ARG . 34.3 m -113.86 177.69 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.021 0.439 . . . . 0.0 112.061 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 198' ' ' ARG . 5.2 t -124.48 144.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.778 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -74.1 110.91 8.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.375 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.665 179.364 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.64 142.53 14.44 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -110.38 153.92 24.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.708 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.5 tp -104.15 133.1 49.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.028 0.442 . . . . 0.0 111.114 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 228' ' ' LEU . 38.4 t -129.99 138.55 50.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.736 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.0 m -140.09 101.21 4.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.781 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.433 ' HE3' ' CG ' ' A' ' 164' ' ' TYR . 3.3 ptt? -109.91 135.8 50.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.954 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -95.12 135.61 36.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.011 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.446 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 18.3 tptp -73.97 -78.03 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.82 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.421 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.89 -159.94 5.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.198 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.02 0.17 10.22 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.614 2.209 . . . . 0.0 112.519 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.8 p -103.07 -30.12 10.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.592 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.446 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 95.46 -148.56 19.03 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.398 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.461 ' CZ ' ' CG2' ' A' ' 219' ' ' ILE . 31.7 m-85 -97.73 -44.16 6.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.922 0.392 . . . . 0.0 110.77 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 183' ' ' ASP . . . 88.68 14.83 60.73 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.95 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.405 ' C ' ' CD1' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -124.86 -177.46 3.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.139 0.495 . . . . 0.0 111.879 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.435 ' CB ' ' CG ' ' A' ' 180' ' ' ARG . 9.8 m120 -129.7 161.76 29.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.888 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -135.67 134.63 39.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.22 0.533 . . . . 0.0 112.276 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 6.6 p-80 -134.8 165.29 25.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.808 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.1 t -128.2 142.13 51.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.513 0.673 . . . . 0.0 112.504 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 178' ' ' PHE . 16.1 t0 -105.6 -40.22 5.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.386 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 14.3 mmtm -82.97 175.02 10.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.854 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.7 m -104.4 -26.97 12.22 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.912 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.756 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 32.0 mtmm -122.21 -58.64 0.03 OUTLIER Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.756 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 7.0 Cg_exo -81.28 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.837 2.358 . . . . 0.0 115.702 -175.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -39.07 145.0 0.24 Allowed Glycine 0 N--CA 1.453 -0.21 0 N-CA-C 116.532 1.373 . . . . 0.0 116.532 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.468 ' HG2' ' CG1' ' A' ' 215' ' ' VAL . 2.0 tp-100 -138.35 127.13 23.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 112.867 -1.667 . . . . 0.0 107.159 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.638 ' CD2' ' NH2' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -134.93 135.65 41.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.4 mt -80.88 129.91 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 169' ' ' HIS . 19.6 ptt180 -95.99 -33.27 12.21 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.0 t -154.74 157.69 38.4 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.9 139.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.503 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 186' ' ' SER . 47.1 t0 -87.35 122.44 70.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.176 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.4 133.87 48.55 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.28 1.987 . . . . 0.0 111.973 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 75.26 14.85 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.625 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.427 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 46.6 m -100.62 162.97 19.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.637 0.255 . . . . 0.0 110.532 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 82.4 Cg_exo -45.87 -40.21 19.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.469 2.112 . . . . 0.0 112.797 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.53 94.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.07 0.462 . . . . 0.0 110.475 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -70.42 -51.58 28.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.022 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.2 -24.76 11.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.497 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.8 t -85.06 -29.14 25.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 0.0 110.969 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.13 8.72 11.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.506 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -60.41 150.86 29.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.694 0.283 . . . . 0.0 110.557 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.427 ' N ' ' CD2' ' A' ' 193' ' ' LEU . 48.1 mtt180 -142.87 129.69 20.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.712 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -55.19 152.26 8.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 35.6 mt-30 78.31 6.73 2.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.851 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 40.7 p30 -78.11 152.62 32.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.636 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.9 mmp_? -85.78 109.1 18.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.652 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.43 HG13 ' HG3' ' A' ' 177' ' ' GLN . 39.1 mm -68.64 113.14 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.809 0.337 . . . . 0.0 110.441 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.0 t -105.72 -46.09 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.45 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 6.2 pt-20 -136.69 171.68 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 0.0 111.912 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' A' ' 205' ' ' VAL . 17.9 t -147.84 113.09 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.553 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 50.6 t30 70.04 20.66 6.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.934 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 102.53 -15.41 55.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.559 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 202' ' ' VAL . 27.1 m -83.61 91.31 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 117.229 0.514 . . . . 0.0 111.537 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.45 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 51.6 t -82.89 109.59 17.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.737 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.425 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 20.5 mmt -130.5 99.89 5.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -74.9 103.57 5.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.77 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 175' ' ' PRO . . . 122.16 10.38 6.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.939 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.425 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 9.1 mmtt -56.82 147.61 22.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.9 0.381 . . . . 0.0 111.258 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.53 160.51 26.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -47.84 -54.3 12.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.668 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.2 -33.02 85.77 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.802 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.52 -47.21 82.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.849 0.357 . . . . 0.0 110.281 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.468 ' CG1' ' HG2' ' A' ' 177' ' ' GLN . 28.2 t -66.55 -38.41 81.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.181 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.24 -43.3 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.496 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 52.4 m -64.58 -37.64 88.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.409 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.0 -44.3 78.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.898 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.461 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 34.0 mm -61.57 -36.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.696 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 47.7 ttp85 -72.4 -33.98 67.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.04 5.39 29.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.67 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -84.55 12.61 55.49 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.187 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -140.77 17.35 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.88 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.49 -25.18 36.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 111.154 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -115.62 114.87 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.9 m -107.82 94.97 5.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -81.27 94.76 6.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.464 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 155' ' ' CYS . 19.2 mt -101.27 141.51 34.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.657 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.41 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 13.1 tp -117.18 109.66 17.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 26.8 m -116.96 178.35 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.3 t -119.69 165.77 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.495 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -93.91 109.22 20.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.992 0.425 . . . . 0.0 112.016 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.457 ' HD3' ' NH1' ' A' ' 198' ' ' ARG . 24.9 ttp180 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.424 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.403 ' HB2' ' HD2' ' A' ' 152' ' ' PRO . 9.9 ptm180 . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.899 0.38 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HB3' ' CG2' ' A' ' 231' ' ' VAL . 19.7 Cg_endo -60.78 140.9 93.08 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.692 2.261 . . . . 0.0 112.422 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -108.41 141.68 39.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.991 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.433 ' HA ' HD11 ' A' ' 229' ' ' LEU . 37.2 tp -76.27 132.61 39.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.222 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 6.1 t -126.93 140.16 52.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.265 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.428 ' N ' ' OG ' ' A' ' 191' ' ' SER . 4.3 m -130.03 104.61 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.655 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -109.88 141.49 42.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.007 0.432 . . . . 0.0 111.379 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -113.09 115.93 29.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.401 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.416 ' HD3' ' CE1' ' A' ' 164' ' ' TYR . 7.6 tptp -61.76 -88.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.804 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.68 -150.15 18.16 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.341 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.9 0.06 10.3 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.68 2.253 . . . . 0.0 112.627 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.7 p -92.31 -30.33 15.89 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.321 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.04 -158.65 21.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.471 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.444 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 30.4 m-85 -87.93 -50.71 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.967 0.413 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.53 14.91 33.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.968 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 164' ' ' TYR . 7.5 p90 -163.72 -179.42 6.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.168 0.509 . . . . 0.0 111.585 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -127.72 165.06 20.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.551 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 166' ' ' PHE . 3.2 mm? -134.37 137.65 44.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -134.82 153.43 52.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.042 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.0 t -155.25 158.09 38.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.768 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -130.09 -77.23 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -81.05 175.14 10.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.666 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -90.41 12.25 19.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.369 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.464 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 26.7 mtmm -105.65 -47.17 0.13 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.904 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.464 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 76.9 Cg_exo -51.27 -63.56 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.145 1.897 . . . . 0.0 112.462 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.08 -141.15 16.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.434 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -105.31 104.88 14.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.681 0.277 . . . . 0.0 110.972 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.492 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 10.3 m-30 -115.64 148.82 39.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.717 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.0 mt -76.08 133.73 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.583 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.434 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 8.1 ptt180 -104.97 -31.07 9.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.363 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.2 t -150.32 155.67 40.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 111.241 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 24.5 t -132.89 141.65 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -94.4 120.92 64.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.915 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.55 134.17 49.7 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.36 2.04 . . . . 0.0 112.362 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 73.09 14.89 4.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.839 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 36.4 m -94.78 162.51 25.15 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.565 0.221 . . . . 0.0 110.503 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.22 -40.16 34.82 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.367 2.045 . . . . 0.0 112.4 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.61 96.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.495 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -65.28 -55.41 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.017 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.19 -25.47 61.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 156' ' ' THR . 26.4 t -78.73 -22.53 46.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 106.89 28.63 4.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.016 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.437 HD11 ' CG ' ' A' ' 166' ' ' PHE . 7.3 tt -85.4 145.18 27.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 0.0 110.935 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -131.53 131.64 43.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -57.37 145.64 31.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.319 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 233' ' ' ARG . 56.5 mt-30 74.81 -0.22 3.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.979 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 49.2 p30 -63.63 158.2 21.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.765 0.317 . . . . 0.0 110.672 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.492 ' HD2' ' CE1' ' A' ' 178' ' ' PHE . 1.8 mmm180 -94.95 112.84 24.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.344 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.7 mm -65.08 117.21 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.853 0.359 . . . . 0.0 110.586 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.61 -46.64 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.61 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 5.2 pt-20 -139.68 176.03 9.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.069 0.461 . . . . 0.0 111.425 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 33.8 t -153.18 105.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.773 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.7 t30 70.35 25.09 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.395 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.47 -19.85 38.56 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.451 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.0 m -82.8 98.16 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.992 0.425 . . . . 0.0 111.319 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 45.8 t -84.93 102.47 13.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.034 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 16.2 mmt -130.14 99.86 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.938 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -69.55 102.61 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.48 22.43 4.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.71 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.93 157.79 3.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.87 160.12 14.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.12 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -50.09 -60.72 2.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.9 -33.58 84.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.236 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.64 -48.62 80.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 110.26 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 23.0 t -68.01 -40.42 83.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.089 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 47.0 t -62.4 -44.81 99.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.281 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 75.0 m -66.84 -39.05 87.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.29 80.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.874 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.5 mm -62.68 -36.43 75.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.653 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -46.93 84.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.536 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.0 5.08 30.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.534 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -92.37 20.18 45.52 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.837 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.26 -143.33 12.47 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.893 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -88.71 -22.9 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.674 0.273 . . . . 0.0 111.342 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -108.42 115.73 30.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 28.0 m -120.19 114.19 21.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.452 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -86.04 99.04 11.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.171 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 23.0 mt -105.39 140.75 38.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.046 0.451 . . . . 0.0 111.961 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.495 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 13.7 tp -115.55 109.47 17.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.467 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 33.3 m -116.63 169.23 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.999 0.428 . . . . 0.0 111.736 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 152' ' ' PRO . 2.6 t -135.62 152.94 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -69.86 109.66 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.77 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 196' ' ' GLN . 26.8 ttp180 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.247 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.415 ' HB3' ' CG2' ' A' ' 231' ' ' VAL . 7.6 Cg_endo -50.45 151.95 9.39 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.063 2.509 . . . . 0.0 112.957 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -127.71 140.94 51.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.575 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 16.6 tp -87.16 132.93 33.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.278 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 39.4 t -130.08 140.1 50.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.757 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -135.1 106.39 6.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.707 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 12.3 ptp -113.78 143.93 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 0.0 111.171 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -102.22 124.3 47.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.792 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 224' ' ' ASP . 6.6 tptm -55.76 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.37 -150.66 40.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.403 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.74 -16.68 14.54 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.72 2.28 . . . . 0.0 112.596 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.5 p -93.12 -30.15 15.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.174 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.418 ' HA2' ' HD2' ' A' ' 159' ' ' LYS . . . 80.05 -131.68 10.73 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.471 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CB ' ' CE1' ' A' ' 166' ' ' PHE . 3.6 m-85 -105.94 -50.36 3.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 110.433 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.06 20.83 52.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.29 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.497 ' CE1' ' CB ' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -124.86 179.11 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.125 0.488 . . . . 0.0 111.728 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.417 ' CB ' ' HG2' ' A' ' 180' ' ' ARG . 8.7 m120 -129.87 159.2 37.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.877 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -136.32 136.02 39.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.191 0.52 . . . . 0.0 112.066 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.426 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -134.53 165.26 25.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.5 178.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.5 t -140.69 148.0 40.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.073 0.463 . . . . 0.0 111.789 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -130.33 -67.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.527 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -90.05 164.63 14.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.733 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 67.0 m -110.15 22.33 15.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.472 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.688 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 25.1 mtpp -116.96 -56.25 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.838 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.688 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 57.4 Cg_exo -53.62 -56.23 2.85 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.139 1.892 . . . . 0.0 112.536 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 137.92 -143.7 14.78 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.358 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -84.22 142.48 30.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 110.776 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.532 ' CD2' ' CZ ' ' A' ' 198' ' ' ARG . 1.7 m-85 -120.98 149.67 42.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.427 ' CG2' ' HA ' ' A' ' 195' ' ' ALA . 9.9 mt -98.46 130.91 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.1 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.426 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 24.2 ptt180 -100.77 -30.57 11.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.5 t -157.73 151.24 23.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.1 0.476 . . . . 0.0 112.009 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 54.6 t -131.85 141.09 46.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.456 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 186' ' ' SER . 56.8 t0 -84.95 125.33 70.92 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.111 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.18 127.53 19.47 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.392 2.061 . . . . 0.0 112.161 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 185' ' ' ASP . 13.7 t0 74.4 23.49 1.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.429 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.5 m -102.56 164.63 15.27 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.606 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 81.1 Cg_exo -44.85 -40.28 14.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.612 2.208 . . . . 0.0 112.747 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -43.01 92.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.077 0.465 . . . . 0.0 110.407 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.56 -51.81 25.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.038 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -49.28 -27.4 3.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.644 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.3 t -85.03 -31.54 23.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 111.056 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 121.19 21.33 3.13 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.991 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.435 ' CD2' ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -83.09 151.59 25.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.613 0.244 . . . . 0.0 110.573 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.435 ' N ' ' CD2' ' A' ' 193' ' ' LEU . 30.5 mtp180 -145.57 129.72 17.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.266 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -52.15 160.78 0.71 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.703 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 54.9 mt-30 82.43 -4.82 1.4 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.092 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.414 ' OD1' ' CD1' ' A' ' 179' ' ' ILE . 38.3 p30 -86.13 165.2 16.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 110.593 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.532 ' CZ ' ' CD2' ' A' ' 178' ' ' PHE . 15.5 mmp_? -101.55 125.12 48.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 111.682 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 26.0 mm -69.43 108.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.854 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.18 -50.11 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.367 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 11.2 pt-20 -136.22 173.92 11.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.98 0.419 . . . . 0.0 111.139 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 40.1 t -151.48 107.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.929 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 53.5 t30 70.25 25.22 4.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.437 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.55 -18.67 43.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.5 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 36.0 m -83.74 97.87 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.008 0.432 . . . . 0.0 111.191 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.436 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 48.5 t -85.91 101.66 13.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.061 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 96.6 mmm -130.11 99.66 5.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.856 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -70.89 105.34 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.27 17.85 5.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.743 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.94 150.15 10.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.952 0.406 . . . . 0.0 111.123 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -91.53 160.43 15.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.058 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -47.81 -64.58 0.75 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.67 -33.79 59.9 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.108 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.27 -47.13 83.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.191 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 23.3 t -71.94 -38.95 66.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.116 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.44 -41.63 92.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.193 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 32.4 m -75.05 -40.82 60.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.419 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.26 -46.79 87.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.694 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.479 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 23.3 mm -61.23 -34.08 59.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.534 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -73.89 -36.89 64.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.382 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.75 5.53 28.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.674 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -83.29 16.34 29.65 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.171 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.29 -135.89 26.96 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.055 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.2 m-20 -92.21 -25.08 18.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.668 0.27 . . . . 0.0 111.38 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -102.34 117.94 35.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.592 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 5.7 m -114.69 98.45 6.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.485 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -88.73 97.71 11.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.056 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 54.3 mt -105.38 138.89 40.85 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.418 ' CB ' ' HG2' ' A' ' 201' ' ' GLU . 13.6 tp -117.8 109.91 17.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.082 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 35.4 m -124.43 170.76 14.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 152' ' ' PRO . 2.6 t -141.33 135.44 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.484 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -72.55 119.87 17.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.401 . . . . 0.0 111.408 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 198' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.81 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.706 0.288 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.24 170.77 19.62 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.674 2.249 . . . . 0.0 112.869 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 15.5 mtm105 -135.39 145.13 47.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.611 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.414 ' HA ' ' CD1' ' A' ' 229' ' ' LEU . 59.4 tp -85.76 135.02 33.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.37 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.7 t -130.01 140.07 50.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.814 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -131.53 108.34 9.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 6.7 ptp -119.85 142.1 48.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -102.73 135.63 44.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.085 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.452 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 18.2 tptt -70.14 -78.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.785 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.419 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.87 -159.89 5.62 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.266 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.62 0.21 10.2 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.597 2.198 . . . . 0.0 112.654 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.0 p -101.03 -30.24 11.72 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 89.41 -147.79 19.7 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.26 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.493 ' HB3' ' CE2' ' A' ' 166' ' ' PHE . 13.8 m-85 -110.19 -43.93 3.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.991 0.424 . . . . 0.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.94 40.49 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.507 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.501 ' CE1' HD22 ' A' ' 168' ' ' LEU . 4.2 p90 -124.6 174.08 8.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 117.219 0.509 . . . . 0.0 111.714 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -134.98 152.84 52.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.319 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.501 HD22 ' CE1' ' A' ' 166' ' ' PHE . 4.1 mm? -127.49 142.8 51.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.011 0.434 . . . . 0.0 111.838 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.464 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 1.5 p80 -142.62 144.39 32.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.235 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.9 t -144.05 160.48 40.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.924 0.392 . . . . 0.0 111.273 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -126.39 -71.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -90.09 168.54 11.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.7 m -110.0 21.19 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.233 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.552 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 30.7 mtmm -104.79 -49.1 0.13 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.492 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 13.8 Cg_exo -69.39 -66.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.402 2.068 . . . . 0.0 112.154 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.48 -159.45 28.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -105.52 144.32 32.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.419 ' CG ' ' CZ ' ' A' ' 198' ' ' ARG . 8.7 m-85 -135.8 151.29 49.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.804 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.0 mt -72.96 138.98 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.549 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.464 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 5.8 ptt180 -99.31 -34.13 10.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.583 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.0 t -151.73 152.86 33.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.051 0.453 . . . . 0.0 111.512 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.407 ' CG2' ' CD2' ' A' ' 193' ' ' LEU . 26.8 t -131.17 135.48 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.665 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 186' ' ' SER . 59.0 t0 -81.66 120.72 78.56 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.949 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.94 126.94 20.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.351 2.034 . . . . 0.0 112.38 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 t70 74.25 22.94 2.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.741 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 183' ' ' ASP . 5.6 m -100.86 162.61 20.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.594 0.235 . . . . 0.0 110.638 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -43.49 -40.34 10.16 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.673 2.249 . . . . 0.0 112.721 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.61 89.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.471 . . . . 0.0 110.31 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.54 -51.68 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.887 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -48.12 -29.68 3.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.541 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.6 t -83.5 -30.05 27.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 120.7 29.5 1.54 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.53 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.407 ' CD2' ' CG2' ' A' ' 182' ' ' VAL . 8.2 tt -84.2 149.22 26.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.74 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -141.43 135.93 30.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.08 153.37 9.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.343 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 70.97 7.87 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.774 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -74.02 150.05 40.9 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.419 ' CZ ' ' CG ' ' A' ' 178' ' ' PHE . 1.4 mmp_? -89.87 113.43 25.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 111.231 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 27.8 mm -68.27 125.73 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.75 -44.52 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.499 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.461 ' HG2' ' CB ' ' A' ' 229' ' ' LEU . 10.1 pt-20 -143.61 176.85 8.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 111.389 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 36.0 t -155.65 107.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.946 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 12.5 t30 70.19 24.27 4.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.45 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.79 -19.16 39.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.369 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.7 m -81.87 95.69 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.015 0.436 . . . . 0.0 111.272 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.429 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 50.2 t -86.42 99.17 11.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.938 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 17.6 mmt -130.14 99.83 5.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -68.24 103.91 1.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.748 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.61 21.02 4.83 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.583 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.557 ' HA ' ' HE3' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -54.78 142.18 29.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.972 0.415 . . . . 0.0 111.138 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -85.84 160.39 19.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -45.55 -60.91 1.92 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.02 -31.14 64.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.981 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -43.71 67.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.939 0.4 . . . . 0.0 110.249 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 40.5 t -72.14 -39.13 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.286 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.92 -41.25 89.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.48 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 73.1 m -70.06 -38.47 75.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.566 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.49 -45.15 77.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.004 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.456 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 30.1 mm -63.84 -36.43 76.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.752 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -65.43 -41.32 93.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.649 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.51 5.2 28.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -81.89 5.56 70.08 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.073 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -140.13 18.53 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.852 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.21 -25.18 34.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.71 0.291 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -115.6 114.86 25.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.524 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 17.3 m -111.6 96.48 6.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.445 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -73.58 97.07 2.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.009 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 73.6 mt -105.33 131.59 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.978 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.461 ' CB ' ' HG2' ' A' ' 201' ' ' GLU . 12.2 tp -109.58 109.48 20.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.315 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.19 169.82 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.031 0.443 . . . . 0.0 111.907 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 15.9 t -119.82 156.32 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.697 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -92.41 112.31 24.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.304 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.804 179.586 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 120.79 0.329 . . . . 0.0 111.587 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.12 -179.91 5.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.794 2.329 . . . . 0.0 112.783 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -137.79 141.47 40.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.735 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 35.1 tp -99.4 131.36 45.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.962 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.9 t -130.01 138.54 50.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.035 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -131.49 104.4 6.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.486 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.7 ptm -119.73 140.49 50.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.216 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -96.28 129.42 43.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.41 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 18.9 tptp -59.78 -80.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.802 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.82 -156.7 17.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.262 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.69 0.02 10.33 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.615 2.21 . . . . 0.0 112.798 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.4 p -92.89 -30.36 15.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.574 0.226 . . . . 0.0 111.469 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 159' ' ' LYS . . . 91.33 -124.9 7.79 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.378 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.471 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 2.4 m-85 -108.21 -55.07 2.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 0.0 110.488 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.71 -5.04 61.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.457 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 164' ' ' TYR . 45.1 p90 -128.74 177.45 7.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.403 0.602 . . . . 0.0 111.762 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.43 ' CB ' ' HG2' ' A' ' 180' ' ' ARG . 5.7 m120 -125.5 165.19 18.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.426 HD21 ' CD2' ' A' ' 166' ' ' PHE . 2.4 mm? -133.55 147.66 51.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.011 0.434 . . . . 0.0 112.003 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 2.2 p-80 -134.47 146.23 49.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.708 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.6 t -155.21 150.04 26.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 111.65 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -114.96 -68.93 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.231 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 155.2 19.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.464 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.1 m -96.34 20.27 10.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.177 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.546 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 31.7 mttp -110.9 -49.71 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.994 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 38.2 Cg_exo -57.63 -63.38 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.109 1.873 . . . . 0.0 112.391 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.9 -162.02 29.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.579 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -108.3 136.47 47.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 0.0 110.886 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.432 ' CD1' ' HD2' ' A' ' 198' ' ' ARG . 2.3 m-85 -124.08 158.05 33.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.608 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 15.0 mt -87.14 139.6 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.875 0.369 . . . . 0.0 110.743 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 169' ' ' HIS . 10.2 ptm180 -105.16 -37.79 6.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.516 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.6 t -148.49 154.95 40.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.013 0.435 . . . . 0.0 111.716 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.6 t -132.34 143.04 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.739 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 57.2 t0 -95.03 125.33 51.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.081 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 23.5 Cg_exo -63.96 134.42 43.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.275 1.984 . . . . 0.0 112.084 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 74.24 14.9 3.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.728 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 21.2 m -97.26 163.37 20.0 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.515 0.198 . . . . 0.0 110.537 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.66 -40.35 18.67 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.473 2.115 . . . . 0.0 112.548 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.13 -41.62 94.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 110.687 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -70.13 -50.6 38.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.82 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -47.59 -31.49 4.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.474 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.2 t -81.23 -31.45 33.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.049 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 113.1 31.54 2.42 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.063 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.59 151.37 26.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.733 0.302 . . . . 0.0 110.905 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -137.78 130.02 29.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.645 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -52.82 157.59 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.497 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 47.5 mt-30 82.46 -17.04 0.55 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.326 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.483 ' HB2' ' HB ' ' A' ' 230' ' ' VAL . 20.1 p-10 -61.13 149.58 36.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.727 0.299 . . . . 0.0 110.662 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 4.6 mmm-85 -90.63 118.31 29.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.335 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 24.3 mm -65.28 128.6 28.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.799 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.412 ' CG2' ' CG2' ' A' ' 231' ' ' VAL . 11.8 t -111.23 -43.73 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.636 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.4 pt-20 -142.81 173.74 11.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.477 . . . . 0.0 111.433 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 47.0 t -153.4 107.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.983 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.5 t30 70.37 25.27 4.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.508 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.48 -20.46 37.14 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.452 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.9 m -80.4 95.28 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.09 0.445 . . . . 0.0 111.161 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 44.9 t -89.93 99.73 12.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.012 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 45.6 mmm -130.16 101.38 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -67.1 100.04 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.625 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.23 26.49 3.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.392 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -54.9 156.27 3.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 111.119 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -92.11 160.28 15.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -47.71 -62.69 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.49 -30.3 64.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.284 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.86 -45.78 73.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 110.484 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 28.7 t -70.92 -37.04 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.458 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.2 -42.03 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.658 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 70.3 m -72.15 -33.18 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.78 80.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.139 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.457 ' CG2' ' CE1' ' A' ' 164' ' ' TYR . 26.8 mm -62.24 -38.08 80.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.944 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -68.47 -36.84 79.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.734 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.14 5.2 30.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.645 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -85.1 10.18 64.1 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.039 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.17 -128.68 27.07 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.806 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.33 -25.09 18.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.717 0.294 . . . . 0.0 111.125 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -107.98 117.37 33.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.788 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.0 m -113.24 96.11 5.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -78.5 98.55 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.097 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 28.7 mt -106.46 131.01 54.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.035 0.445 . . . . 0.0 111.906 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.427 ' CB ' ' HG2' ' A' ' 201' ' ' GLU . 11.9 tp -115.98 109.7 17.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.572 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 197' ' ' ASP . 32.0 m -109.77 176.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 112.068 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.412 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 5.4 t -126.49 162.89 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.074 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -80.61 112.9 18.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.252 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.572 179.446 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.537 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 3.7 ptm85 . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.4 139.13 12.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.567 2.178 . . . . 0.0 112.556 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -94.51 139.89 30.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.383 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.421 ' HA ' ' CD1' ' A' ' 229' ' ' LEU . 18.1 tp -95.99 119.84 35.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.989 0.423 . . . . 0.0 111.026 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 228' ' ' LEU . 45.3 t -116.21 126.94 54.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.53 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.448 ' N ' ' OG ' ' A' ' 191' ' ' SER . 3.0 m -135.48 99.91 4.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.192 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.4 ptp -112.38 142.91 44.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.195 0.522 . . . . 0.0 111.88 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -104.44 119.65 39.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.895 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 224' ' ' ASP . 16.5 tptp -58.08 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.057 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.01 -152.86 12.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.385 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.02 0.17 10.22 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.747 2.298 . . . . 0.0 112.885 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.7 p -87.16 -30.41 21.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.575 0.226 . . . . 0.0 111.544 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 97.27 -146.66 18.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.179 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 7.7 m-85 -109.33 -46.83 3.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.167 0.508 . . . . 0.0 110.259 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 183' ' ' ASP . . . 70.71 28.34 71.01 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.626 -0.715 . . . . 0.0 113.813 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.475 ' CZ ' ' HB3' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -140.84 175.68 9.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.576 0.688 . . . . 0.0 112.163 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.43 ' HB3' ' CG ' ' A' ' 180' ' ' ARG . 10.0 m120 -135.65 155.98 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.66 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 168' ' ' LEU . 2.3 mm? -133.42 143.06 48.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.046 0.451 . . . . 0.0 111.9 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.466 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 2.5 p80 -141.03 136.86 32.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.298 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.6 t -137.15 163.95 29.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.379 . . . . 0.0 111.28 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -130.04 -78.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.665 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -90.14 175.05 7.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.761 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.0 m -109.22 19.65 19.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.208 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.615 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 2.6 mtmp? -110.87 -51.36 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.752 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 38.8 Cg_exo -61.2 -63.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.238 1.959 . . . . 0.0 112.229 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 144.35 -176.4 23.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.53 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.406 ' HB3' ' CG1' ' A' ' 215' ' ' VAL . 9.8 tp-100 -89.27 140.28 29.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.445 ' CD1' ' HD3' ' A' ' 198' ' ' ARG . 3.0 m-85 -127.73 147.84 50.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.654 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.0 mt -78.38 135.03 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.209 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.466 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 10.2 ptm180 -98.71 -35.04 10.3 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.9 t -151.58 156.76 41.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 112.076 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.413 ' CG2' ' CD2' ' A' ' 193' ' ' LEU . 23.3 t -132.69 140.6 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.524 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 165' ' ' GLY . 40.7 t0 -95.11 117.1 66.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.199 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.86 140.76 96.56 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.502 2.135 . . . . 0.0 112.185 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.1 t70 66.0 14.87 9.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.511 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.486 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 9.2 m -105.03 166.36 11.58 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.447 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 98.4 Cg_exo -43.98 -40.15 11.63 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.438 2.092 . . . . 0.0 112.437 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.94 93.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.684 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.18 -54.5 12.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -52.79 -26.63 14.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.533 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 156' ' ' THR . 4.4 t -85.09 -24.71 27.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.991 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.09 26.07 6.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.121 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.413 ' CD2' ' CG2' ' A' ' 182' ' ' VAL . 8.3 tt -79.82 149.39 31.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 111.009 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.4 ' N ' ' CD2' ' A' ' 193' ' ' LEU . 50.6 mtt-85 -140.72 129.9 23.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.706 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -58.42 151.1 20.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.324 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 41.5 mt-30 77.55 -3.05 2.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.163 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -67.71 151.83 46.59 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.567 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.445 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 68.1 mmt-85 -90.61 115.67 27.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.25 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.51 124.55 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.117 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.02 -45.19 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.492 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.503 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.9 pt-20 -144.27 173.97 11.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 111.449 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 26.4 t -155.43 112.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.817 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 44.2 t30 70.21 22.93 5.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.385 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.54 -15.96 48.88 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.581 -0.818 . . . . 0.0 113.589 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.59 93.75 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.25 0.525 . . . . 0.0 111.539 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.503 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 50.8 t -92.18 100.92 13.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.668 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.1 mmt -130.63 101.61 5.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.353 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -68.36 99.25 0.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.643 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.5 25.55 3.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.609 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 175.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.767 0.318 . . . . 0.0 110.916 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -91.11 157.23 17.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.986 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -52.44 -64.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.692 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.05 -25.04 61.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.283 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.01 -44.02 55.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.323 . . . . 0.0 110.712 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 177' ' ' GLN . 4.6 t -74.81 -36.82 40.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.565 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 40.7 t -70.13 -38.22 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.71 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.3 m -74.56 -33.51 62.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.627 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.34 82.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.0 mm -61.86 -42.16 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 54.2 ttp85 -75.16 -28.4 60.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.21 5.78 28.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.737 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -66.53 -0.65 8.57 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.564 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 47.43 -132.23 15.16 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.987 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.506 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.1 m-20 -83.86 -25.17 30.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.308 . . . . 0.0 111.217 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -125.48 114.82 19.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.814 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 4.6 m -112.42 96.84 6.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.369 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -84.08 94.8 8.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.031 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 155' ' ' CYS . 8.1 mt -110.07 140.1 44.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.145 0.498 . . . . 0.0 112.283 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.427 ' CB ' ' HG2' ' A' ' 201' ' ' GLU . 10.4 tp -120.0 109.58 15.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.313 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 27.5 m -114.87 179.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 111.766 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 198' ' ' ARG . 2.6 t -119.95 166.08 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.726 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -90.26 111.0 22.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.209 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.617 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 29.2 ptt85 . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.19 176.88 5.76 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.671 2.247 . . . . 0.0 113.075 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.44 158.11 43.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.699 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.418 ' HA ' HD13 ' A' ' 229' ' ' LEU . 36.2 tp -90.01 125.74 35.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.005 0.431 . . . . 0.0 111.369 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 47.7 t -120.52 140.2 51.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.374 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.4 m -134.11 104.1 6.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -109.81 127.02 54.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -90.39 125.53 35.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.981 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.419 ' HE2' ' CZ ' ' A' ' 164' ' ' TYR . 1.7 tppp? -59.66 -80.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.703 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.38 -156.19 12.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.498 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.76 0.02 10.35 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.704 2.269 . . . . 0.0 112.782 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 p -96.85 -30.15 13.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.734 0.302 . . . . 0.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.93 -142.12 15.84 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.439 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.452 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 14.7 m-85 -96.41 -51.33 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.34 30.49 24.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.627 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -151.49 178.65 9.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.238 0.542 . . . . 0.0 112.152 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -135.22 154.63 51.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.054 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 168' ' ' LEU . 0.4 OUTLIER -132.19 148.33 52.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.398 . . . . 0.0 111.655 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -134.21 141.33 46.99 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.314 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.6 t -155.14 149.61 26.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.179 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -121.44 -67.97 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.561 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -90.16 159.73 16.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.6 m -100.8 21.41 13.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.166 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 5.0 mttp -108.73 -48.59 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.792 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 25.5 Cg_exo -63.02 -65.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.216 1.944 . . . . 0.0 112.298 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.09 -152.25 23.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.411 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -125.88 133.96 51.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 111.097 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 2.8 m-85 -122.53 165.11 16.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.412 ' CD1' ' OD1' ' A' ' 197' ' ' ASP . 57.0 mt -91.9 135.91 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 110.66 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.78 -35.63 10.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.879 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.0 t -153.21 158.51 41.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 111.63 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 195' ' ' ALA . 49.0 t -135.29 141.15 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.789 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.4 ' HB3' ' OG ' ' A' ' 186' ' ' SER . 48.7 t0 -90.72 117.28 67.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.799 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.91 136.61 74.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.448 2.099 . . . . 0.0 112.408 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.7 t70 71.21 14.78 6.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.58 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.488 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 48.0 m -99.99 164.78 15.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.583 0.23 . . . . 0.0 110.778 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 99.9 Cg_exo -44.04 -40.25 11.91 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.584 2.19 . . . . 0.0 112.912 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.95 97.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -70.33 -51.65 28.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.007 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.96 -32.19 3.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.574 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.1 t -83.99 -27.5 28.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.063 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 115.11 25.51 3.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.464 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -83.44 149.21 26.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.731 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.406 ' N ' ' CD2' ' A' ' 193' ' ' LEU . 1.4 mtt85 -143.15 138.31 29.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.798 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.404 ' N ' ' CG2' ' A' ' 182' ' ' VAL . . . -55.69 153.97 7.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.573 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 71.39 9.14 6.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.065 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 231' ' ' VAL . 38.9 p30 -75.77 149.53 37.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.029 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 17.4 mmt85 -85.67 112.49 21.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.691 0.281 . . . . 0.0 111.548 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.401 ' CD1' HG12 ' A' ' 230' ' ' VAL . 12.8 mm -68.09 123.9 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.366 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.3 t -110.18 -43.86 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.126 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 10.6 pt-20 -143.19 176.64 8.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.317 0.58 . . . . 0.0 111.936 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.7 t -150.81 107.77 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.517 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.45 23.86 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.368 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.65 -17.01 51.01 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.633 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.43 90.2 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.191 0.495 . . . . 0.0 111.569 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.475 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 53.0 t -80.31 100.57 8.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.754 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.441 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 17.0 mmt -130.74 99.43 4.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.18 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -75.03 115.5 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.2 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 104.21 12.85 28.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.112 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.441 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 0.5 OUTLIER -54.93 166.16 0.54 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.06 0.457 . . . . 0.0 111.398 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -94.46 160.4 14.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -47.49 -56.42 7.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.026 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.05 -29.12 70.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.17 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.94 -44.5 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.55 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 32.9 t -71.84 -35.04 53.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.449 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.25 -41.61 74.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.458 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.8 m -67.14 -38.13 84.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.67 -45.64 77.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.053 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.8 mm -65.45 -33.33 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.793 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -67.68 -41.35 83.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.86 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.09 5.03 31.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.613 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -87.6 10.03 71.33 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.975 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.12 -136.32 25.56 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.854 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.79 -25.13 23.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.74 0.305 . . . . 0.0 111.079 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -104.22 114.89 29.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.682 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 19.9 m -110.55 101.12 9.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.287 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -85.35 94.86 9.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.192 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.6 mt -103.67 137.62 41.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.026 0.441 . . . . 0.0 111.858 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.511 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 13.9 tp -110.56 109.41 19.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 23.8 m -124.62 177.04 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.475 0.655 . . . . 0.0 112.243 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 197' ' ' ASP . 39.9 t -119.2 145.11 25.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.776 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -96.41 112.81 24.42 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.581 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 . . . . . 0 CA--C 1.531 0.245 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.946 -179.829 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.581 ' HB2' ' HD2' ' A' ' 152' ' ' PRO . 5.7 ptm180 . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.931 0.396 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 151' ' ' ARG . 7.1 Cg_endo -51.52 143.71 35.04 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.979 2.453 . . . . 0.0 112.439 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -125.2 171.81 10.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.354 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.409 ' HA ' HD12 ' A' ' 229' ' ' LEU . 25.2 tp -108.21 139.35 43.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.046 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.453 ' N ' ' O ' ' A' ' 228' ' ' LEU . 54.1 t -126.56 135.83 51.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.51 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 191' ' ' SER . 3.0 m -137.24 99.9 4.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.744 0.307 . . . . 0.0 110.689 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -114.43 141.12 48.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 111.266 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -96.22 121.6 38.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.552 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -46.41 -76.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.126 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.36 -158.05 7.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.314 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.01 0.03 10.32 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.676 2.25 . . . . 0.0 112.69 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.2 p -100.56 -30.19 11.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.517 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.95 -124.79 6.57 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.71 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 8.2 m-85 -91.63 -60.41 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.084 0.469 . . . . 0.0 111.099 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 183' ' ' ASP . . . 96.71 -0.74 61.22 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.555 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 164' ' ' TYR . 1.4 p90 -124.8 -176.89 3.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.06 0.457 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.412 ' CB ' ' HG2' ' A' ' 180' ' ' ARG . 3.3 m120 -124.72 161.96 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.685 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.417 ' CD2' ' N ' ' A' ' 168' ' ' LEU . 0.9 OUTLIER -132.71 135.27 45.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.076 0.465 . . . . 0.0 111.976 -179.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.456 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 0.7 OUTLIER -134.86 143.31 46.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.948 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 t -155.06 166.84 32.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 111.442 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -130.14 -59.5 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.739 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -90.01 167.34 12.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 m -110.08 22.21 15.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.278 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.533 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 14.2 mttt -102.93 -48.6 0.17 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.563 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 14.2 Cg_exo -69.3 -58.0 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.359 2.039 . . . . 0.0 112.331 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 140.33 -146.75 18.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.41 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -103.97 131.58 51.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.765 0.317 . . . . 0.0 110.865 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.535 ' CD1' ' HD3' ' A' ' 198' ' ' ARG . 1.2 m-30 -109.76 165.19 11.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.416 ' CG1' ' OD1' ' A' ' 197' ' ' ASP . 4.0 mt -100.37 131.75 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.166 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.456 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 10.9 ptm180 -104.33 -33.53 8.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.709 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.4 t -150.82 152.53 33.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 111.868 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.67 140.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.761 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 165' ' ' GLY . 47.3 t0 -89.0 123.1 68.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 23.7 Cg_exo -63.59 133.07 37.95 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.233 1.955 . . . . 0.0 112.195 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 185' ' ' ASP . 13.6 t0 76.88 14.84 2.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.26 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.423 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 37.0 m -98.69 163.21 19.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 84.1 Cg_exo -45.56 -40.2 18.05 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.36 2.04 . . . . 0.0 112.345 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.61 -44.85 95.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.764 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -66.64 -54.52 22.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.917 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -55.84 -26.49 46.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.279 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 156' ' ' THR . 11.3 t -82.52 -20.3 36.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.22 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 100.8 36.95 3.81 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.914 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.445 HD12 ' CD2' ' A' ' 166' ' ' PHE . 8.3 tt -100.18 148.68 24.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.83 0.347 . . . . 0.0 111.153 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -147.79 138.78 23.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.758 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -47.69 166.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.613 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.685 ' O ' ' HB2' ' A' ' 233' ' ' ARG . 67.1 mt-30 80.27 -24.36 0.2 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.237 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.713 ' HA ' ' O ' ' A' ' 231' ' ' VAL . 27.2 p-10 -66.92 138.17 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.452 0.644 . . . . 0.0 112.266 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.535 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 0.2 OUTLIER -92.19 130.12 37.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.373 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.2 mm -69.78 116.45 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.764 0.316 . . . . 0.0 110.58 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.21 -46.48 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.736 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 10.2 pt-20 -138.45 174.11 10.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.962 0.41 . . . . 0.0 111.164 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 205' ' ' VAL . 23.7 t -152.74 109.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.144 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 13.0 t30 70.01 24.32 5.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.306 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.33 49.38 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.469 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 202' ' ' VAL . 28.5 m -80.95 95.29 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.205 0.502 . . . . 0.0 111.093 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.42 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 26.5 t -86.8 103.6 15.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.176 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 84.7 mmm -130.16 99.92 5.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.69 103.66 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.705 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 113.95 23.71 4.84 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.337 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -54.9 158.47 2.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.918 0.389 . . . . 0.0 111.157 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.08 160.28 14.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.151 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -48.05 -60.99 2.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.92 -31.15 67.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.212 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -46.15 78.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.261 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.05 -35.41 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.438 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 41.5 t -70.36 -42.69 78.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.649 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 71.6 m -73.46 -33.44 64.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.735 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.04 80.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.143 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.408 ' CG2' ' CE2' ' A' ' 164' ' ' TYR . 17.6 mm -63.81 -40.35 88.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -43.37 89.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.675 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.95 5.06 30.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.526 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -90.81 19.71 43.61 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.895 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.05 -137.7 22.77 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.963 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.85 -24.83 20.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -100.38 117.96 35.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.393 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.0 m -111.38 99.49 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.6 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -87.42 94.93 9.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.947 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 155' ' ' CYS . 18.4 mt -109.12 139.8 43.53 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.446 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 14.2 tp -109.54 111.42 22.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 197' ' ' ASP . 34.8 m -125.39 152.49 32.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 197' ' ' ASP . 2.6 t -119.98 137.79 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 197' ' ' ASP . 20.4 t0 -67.94 143.5 55.62 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.856 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.685 ' HB2' ' O ' ' A' ' 196' ' ' GLN . 38.6 ttp180 . . . . . 0 CA--C 1.511 -0.534 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.658 0.266 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.68 165.9 30.49 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.621 2.214 . . . . 0.0 112.913 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -129.71 158.43 39.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.774 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.414 ' HA ' HD11 ' A' ' 229' ' ' LEU . 26.3 tp -96.48 129.37 43.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.376 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.4 t -128.25 135.63 49.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.504 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.2 m -131.47 111.26 11.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.03 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 3.6 ptp -118.18 133.11 56.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -92.97 130.54 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' A' ' 160' ' ' GLY . 10.7 tptm -61.56 -80.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.754 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.73 -157.2 6.98 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.299 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.77 0.21 10.19 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.681 2.254 . . . . 0.0 112.686 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.3 p -95.23 -30.14 14.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.428 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.45 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 93.01 -161.2 25.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.46 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.463 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 31.8 m-85 -81.67 -43.29 18.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.336 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.18 27.67 32.91 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.927 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.464 ' CE2' ' CD1' ' A' ' 168' ' ' LEU . 0.0 OUTLIER -164.83 -177.32 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.256 0.55 . . . . 0.0 111.882 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.439 ' CB ' ' HG2' ' A' ' 180' ' ' ARG . 9.8 m120 -136.6 157.29 47.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.028 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.464 ' CD1' ' CE2' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -133.35 130.64 39.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.166 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.528 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.3 OUTLIER -136.04 135.58 39.55 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.018 178.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.0 t -155.32 144.26 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.152 0.501 . . . . 0.0 111.498 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -130.26 -6.45 4.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.309 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.443 ' CB ' ' HD2' ' A' ' 175' ' ' PRO . 0.1 OUTLIER -89.16 146.58 24.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.555 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.1 m -110.21 8.95 23.86 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.707 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 50.4 mtmt -120.68 -58.27 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.707 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 37.1 Cg_exo -56.89 -64.48 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.138 1.892 . . . . 0.0 112.302 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.81 -145.44 12.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.686 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -108.68 151.12 26.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 110.838 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -130.29 151.45 50.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.854 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.418 ' CD1' ' OD1' ' A' ' 197' ' ' ASP . 69.6 mt -82.53 140.79 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.528 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 2.8 ptm180 -103.21 -36.32 8.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.225 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 40.8 t -151.0 153.8 35.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.034 0.445 . . . . 0.0 111.681 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 32.5 t -133.5 141.82 43.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.575 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -91.89 121.23 67.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.973 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.41 132.67 39.38 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.345 2.03 . . . . 0.0 112.33 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.7 t0 69.87 22.62 5.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.259 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 58.6 m -104.9 164.69 14.65 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.725 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 94.5 Cg_exo -43.47 -40.12 9.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.628 2.218 . . . . 0.0 112.792 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.2 96.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 110.293 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -70.02 -52.63 22.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.894 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.6 -31.14 2.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.655 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.2 t -81.97 -30.61 31.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 116.96 25.61 3.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.45 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 166' ' ' PHE . 7.8 tt -78.29 150.32 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.739 0.304 . . . . 0.0 110.743 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -139.6 130.01 25.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -55.05 152.7 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 75.22 2.9 4.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.08 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.418 ' OD1' ' CD1' ' A' ' 179' ' ' ILE . 41.2 p30 -73.74 155.58 38.76 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.307 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.426 ' HB2' ' HB ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -87.72 112.76 22.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.458 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 24.8 mm -66.97 124.17 21.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.913 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 19.3 t -106.78 -44.0 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.912 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.4 pt-20 -145.2 175.15 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.102 0.477 . . . . 0.0 111.688 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 40.1 t -150.56 109.36 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.65 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 49.8 t30 70.38 23.43 4.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.299 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.17 -16.28 53.73 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.564 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.7 m -85.45 96.76 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 117.181 0.49 . . . . 0.0 111.432 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' CYS . . . . . 0.442 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 52.5 t -81.8 103.2 11.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.661 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' MET . . . . . 0.43 ' HB2' ' CG ' ' A' ' 210' ' ' LYS . 21.9 mmt -130.23 99.47 5.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -78.7 101.73 7.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.1 5.34 6.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.135 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.43 ' CG ' ' HB2' ' A' ' 207' ' ' MET . 0.9 OUTLIER -54.85 156.81 3.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.096 0.448 . . . . 0.0 110.97 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -89.34 160.28 16.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.999 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -47.26 -60.92 2.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.91 -31.41 64.65 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.114 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.23 -44.02 69.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.473 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 16.8 t -72.38 -38.9 62.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 49.2 t -65.06 -42.29 94.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.186 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 45.4 m -67.24 -39.67 86.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.411 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.06 73.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.959 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.433 HG21 ' CE1' ' A' ' 164' ' ' TYR . 25.9 mm -61.35 -37.53 77.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -70.48 -33.91 71.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.509 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.15 5.33 30.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.591 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -83.99 13.99 46.08 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.149 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.12 -134.78 27.56 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.868 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.46 -25.18 23.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.722 0.296 . . . . 0.0 111.239 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -112.72 117.5 32.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.706 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 5.8 m -112.85 95.06 5.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.31 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -78.84 97.97 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.251 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 46.3 mt -105.02 135.72 45.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 112.259 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' A' ' 154' ' ' LEU . 14.3 tp -112.06 109.45 19.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.117 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 31.9 m -120.78 169.44 12.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.137 0.494 . . . . 0.0 112.114 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 198' ' ' ARG . 39.8 t -119.92 137.54 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.74 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -71.21 110.73 6.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.257 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.812 179.511 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -94.64 133.9 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.837 0.351 . . . . 0.0 110.922 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.434 ' O ' ' CD1' ' A' ' 144' ' ' ILE . 14.2 t70 -75.21 136.09 72.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.388 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.41 -57.6 1.02 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.545 2.163 . . . . 0.0 112.314 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.668 ' O ' ' CG2' ' A' ' 148' ' ' THR . 14.1 t80 -86.25 -60.61 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.104 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.668 ' CG2' ' O ' ' A' ' 147' ' ' PHE . 2.3 p 159.86 157.96 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.428 0.691 . . . . 0.0 110.567 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.412 ' HG3' ' CB ' ' A' ' 145' ' ' ASP . 45.0 mtm -125.56 -55.21 1.54 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.822 0.344 . . . . 0.0 111.798 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 151' ' ' ARG . 20.7 tp -124.11 -4.61 7.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.239 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.44 ' CD ' ' CG2' ' A' ' 148' ' ' THR . 1.0 OUTLIER -29.34 143.42 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.11 142.63 42.47 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.548 2.165 . . . . 0.0 111.976 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -107.48 141.22 39.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.085 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.3 tp -98.6 134.26 41.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.544 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 41.4 t -129.92 139.99 51.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 19.0 m -131.86 101.99 5.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.157 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.427 ' HE2' ' CE2' ' A' ' 166' ' ' PHE . 6.6 ptp -109.99 137.53 47.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 111.219 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -100.59 119.09 38.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.657 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.29 -82.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.48 -156.42 26.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.23 -0.0 10.38 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.603 2.202 . . . . 0.0 112.841 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.7 p -108.43 -30.03 8.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.724 0.297 . . . . 0.0 111.119 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.92 -131.11 10.17 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.423 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CZ ' ' CG2' ' A' ' 219' ' ' ILE . 32.5 m-85 -110.2 -46.56 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.05 17.41 63.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.809 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.427 ' CE2' ' HE2' ' A' ' 157' ' ' MET . 0.1 OUTLIER -124.93 -178.62 4.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.092 0.472 . . . . 0.0 111.845 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.404 ' CB ' ' CG ' ' A' ' 180' ' ' ARG . 9.9 m120 -134.83 160.73 37.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.393 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -138.54 137.25 36.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.313 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 0.7 OUTLIER -134.76 141.53 46.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.62 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 t -155.09 150.14 26.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.25 -72.95 0.56 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.033 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -64.34 163.97 12.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.044 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.0 m -110.05 20.3 18.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.606 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 23.1 mttp -112.47 -50.56 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.873 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 25.2 Cg_exo -63.15 -64.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.143 1.895 . . . . 0.0 112.248 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 142.58 -148.34 20.04 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.5 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -114.93 129.09 56.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 0.0 110.973 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.476 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 1.6 m-85 -117.34 165.27 13.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.349 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 5.0 mt -90.18 136.3 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.939 0.399 . . . . 0.0 110.358 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.409 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 9.4 ptm180 -102.38 -34.55 9.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.818 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.9 t -150.36 149.4 30.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 0.0 111.909 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 81.9 t -135.32 134.1 52.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.548 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 186' ' ' SER . 47.4 t0 -84.37 122.5 75.33 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.971 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.01 130.22 30.1 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.229 1.953 . . . . 0.0 112.193 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 75.93 18.18 2.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.736 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.6 m -98.23 164.93 16.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.56 0.219 . . . . 0.0 110.632 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 97.5 Cg_exo -43.45 -40.1 9.84 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.607 2.205 . . . . 0.0 112.768 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.77 91.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.039 0.447 . . . . 0.0 110.373 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.03 -50.86 37.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.755 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -47.91 -32.96 6.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.333 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -79.32 -30.0 42.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.04 32.58 1.51 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.241 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -97.59 149.17 22.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.854 0.359 . . . . 0.0 110.995 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.405 ' N ' ' CD2' ' A' ' 193' ' ' LEU . 76.5 mtt180 -142.51 133.77 26.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -46.59 161.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.576 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 56.4 mt-30 82.73 -13.92 0.79 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.042 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.496 ' HB2' ' HB ' ' A' ' 230' ' ' VAL . 7.9 p-10 -68.18 146.45 53.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.749 0.309 . . . . 0.0 110.566 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.476 ' HD2' ' CE1' ' A' ' 178' ' ' PHE . 15.8 mmt85 -93.1 123.13 36.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.387 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.406 ' CD1' HG13 ' A' ' 230' ' ' VAL . 22.1 mm -66.52 128.96 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.976 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.81 -42.97 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.785 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 10.9 pt-20 -144.87 172.63 12.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.024 0.44 . . . . 0.0 111.649 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 16.5 t -149.42 105.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.017 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 35.7 t30 70.27 26.39 4.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.538 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.06 -21.85 32.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.486 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.0 m -80.32 97.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.985 0.422 . . . . 0.0 111.158 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.446 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 42.3 t -89.98 98.78 11.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.114 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.403 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 21.7 mmt -130.24 99.68 5.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.817 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -74.48 106.56 6.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.121 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.04 11.93 8.72 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.858 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.403 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 12.3 mmtt -55.76 161.91 1.97 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.887 0.375 . . . . 0.0 111.217 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -88.25 160.33 17.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.909 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -49.89 -57.28 7.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.577 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.97 -34.21 82.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.814 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -44.75 80.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 35.5 t -70.65 -37.32 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.342 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.96 -41.77 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.418 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.8 m -66.24 -40.05 89.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.537 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.39 -39.01 69.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.469 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 25.2 mm -69.75 -32.28 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.716 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -71.57 -36.49 70.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.86 5.16 29.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.619 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.33 14.03 60.43 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.009 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.03 -135.55 26.19 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.906 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.96 -25.13 24.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.793 0.33 . . . . 0.0 111.184 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -108.75 114.93 29.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 24.6 m -109.82 101.56 10.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.715 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -81.19 98.12 7.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.893 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 32.8 mt -108.19 129.87 55.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.045 0.45 . . . . 0.0 112.17 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.417 ' CB ' ' HG2' ' A' ' 201' ' ' GLU . 11.8 tp -110.7 109.74 20.12 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 197' ' ' ASP . 33.9 m -110.91 -179.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.563 . . . . 0.0 112.305 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.7 t -119.52 165.66 14.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.116 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -99.8 109.75 22.15 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 196' ' ' GLN . 25.2 ttm180 -82.23 -20.08 38.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.472 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -46.51 -37.34 7.78 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.797 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 54.0 m -85.14 -34.46 22.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.553 -0.748 . . . . 0.0 108.986 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 233' ' ' ARG . 10.3 t70 -53.04 -35.71 59.77 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.008 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.07 -31.65 39.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.992 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -59.37 -52.03 67.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.142 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -59.79 -21.05 60.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.823 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.925 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.639 -0.185 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.478 HG21 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -122.6 121.1 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.043 0.449 . . . . 0.0 111.018 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -105.27 138.13 19.46 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.65 -54.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.551 2.167 . . . . 0.0 112.891 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.438 ' O ' ' CD1' ' A' ' 147' ' ' PHE . 1.0 OUTLIER -54.59 -25.72 28.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.24 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.6 p -119.11 129.54 55.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.66 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 38.5 mtp -122.87 -14.74 7.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.086 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.9 tp -64.54 -18.4 64.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -36.83 152.31 0.11 Allowed Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.465 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.87 151.46 85.11 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.742 2.295 . . . . 0.0 112.786 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -130.67 145.91 52.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.709 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 21.9 tp -93.08 137.93 31.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.189 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 42.1 t -130.17 140.05 50.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.814 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.1 m -130.17 107.35 9.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.826 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 9.5 ptp -109.98 143.11 40.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.812 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -105.87 127.36 53.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -60.2 -80.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.824 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.68 -156.86 9.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.442 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.77 -1.51 11.68 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.571 2.181 . . . . 0.0 112.671 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.8 p -101.37 -30.15 11.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.126 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.3 -127.93 8.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.433 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.466 ' CZ ' ' CG2' ' A' ' 219' ' ' ILE . 9.7 m-85 -110.08 -50.21 3.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.863 0.364 . . . . 0.0 110.814 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.24 13.96 69.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.99 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.414 ' CE1' ' CB ' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -124.86 178.39 5.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.223 0.535 . . . . 0.0 111.963 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -134.35 157.76 45.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.256 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.406 ' CD1' ' HA ' ' A' ' 179' ' ' ILE . 2.3 mm? -133.07 148.32 52.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.965 0.412 . . . . 0.0 111.599 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -134.53 149.18 50.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.103 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 148.02 33.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.011 0.434 . . . . 0.0 111.423 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -130.19 -74.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.612 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -90.08 174.73 7.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.714 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.2 m -110.02 20.22 18.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.252 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.562 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 25.2 mtpt -108.66 -49.25 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.684 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 21.6 Cg_exo -65.28 -56.75 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.269 1.98 . . . . 0.0 112.19 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.73 -156.76 21.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.492 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -102.5 136.16 42.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.849 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -132.31 152.16 51.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.406 ' HA ' ' CD1' ' A' ' 168' ' ' LEU . 57.3 mt -74.4 138.08 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -103.61 -33.09 9.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.63 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.8 t -149.73 154.66 38.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.95 0.405 . . . . 0.0 111.441 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 37.4 t -135.01 134.99 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 186' ' ' SER . 56.8 t0 -84.37 125.54 71.69 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.24 131.05 30.67 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.341 2.027 . . . . 0.0 112.224 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 73.69 18.71 3.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.78 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.428 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.6 m -97.75 164.36 17.65 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.6 0.238 . . . . 0.0 110.69 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 88.4 Cg_exo -44.4 -40.13 13.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.563 2.175 . . . . 0.0 112.739 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.67 -42.99 98.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 110.639 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.92 -50.89 37.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.966 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -49.1 -30.22 6.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.551 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.5 t -84.97 -26.1 27.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.71 27.89 3.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.175 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 tt -75.96 149.85 37.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.832 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -134.66 129.86 35.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.794 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -57.8 150.58 19.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.163 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 73.75 3.07 4.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.766 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -66.86 154.84 39.94 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.274 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -89.84 110.25 21.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.767 0.318 . . . . 0.0 111.453 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.4 ' CD1' HG11 ' A' ' 230' ' ' VAL . 24.5 mm -61.99 123.79 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.939 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.88 -45.94 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.448 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 9.6 pt-20 -143.31 174.16 10.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 111.363 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 40.4 t -152.91 106.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 18.8 t30 70.3 25.97 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.482 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.81 -21.02 35.15 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.372 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.7 m -81.45 97.27 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.998 0.428 . . . . 0.0 111.232 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.46 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 42.4 t -87.84 98.26 11.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.7 mmt -130.17 99.83 5.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -68.58 101.9 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 113.34 25.37 4.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.543 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.86 164.04 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.843 0.354 . . . . 0.0 111.169 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -99.59 160.21 14.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.037 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -48.76 -62.56 1.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.87 -32.6 59.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.043 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.37 -44.95 74.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.153 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.64 -40.01 76.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 44.1 t -64.0 -42.83 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.336 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 58.8 m -71.57 -39.04 70.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.575 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.02 81.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.466 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 32.3 mm -61.82 -31.7 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.597 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -73.1 -38.15 66.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.727 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.03 5.32 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.66 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -82.12 9.24 58.08 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.21 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -139.2 20.2 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.017 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -25.12 34.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.663 0.268 . . . . 0.0 111.252 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -116.01 115.34 25.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 110.782 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.9 m -107.32 99.23 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -76.32 98.52 4.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.149 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 34.5 mt -107.36 128.06 54.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.715 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.429 ' CB ' ' HG2' ' A' ' 201' ' ' GLU . 13.5 tp -107.6 109.66 21.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.337 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.4 HG11 ' CD1' ' A' ' 199' ' ' ILE . 29.4 m -123.62 169.93 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 112.187 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.6 t -120.01 138.89 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.393 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -69.85 112.7 6.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.33 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -100.16 -24.75 14.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.03 -60.1 3.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.841 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.3 m -66.53 -28.15 68.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -66.96 -22.09 65.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.149 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -102.6 -33.08 9.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.829 0.347 . . . . 0.0 111.103 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -63.43 -62.48 1.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -28.46 67.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.491 HG23 HD13 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -120.5 131.8 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.396 . . . . 0.0 110.989 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.434 ' CB ' ' HG3' ' A' ' 149' ' ' MET . 24.8 t70 -45.0 139.25 3.98 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.67 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.85 -56.27 2.76 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.74 2.293 . . . . 0.0 112.223 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.628 ' O ' HG23 ' A' ' 148' ' ' THR . 39.6 t80 -82.55 -61.13 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.857 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.0 p 158.32 150.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.827 0.851 . . . . 0.0 110.649 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.434 ' HG3' ' CB ' ' A' ' 145' ' ' ASP . 8.4 mtt -125.7 -52.86 1.57 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.4 tp -122.31 -10.02 8.53 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.497 ' CD ' HG21 ' A' ' 148' ' ' THR . 5.5 ptm180 -51.53 145.64 14.63 Favored Pre-proline 0 N--CA 1.465 0.288 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.856 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 137.87 20.6 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.439 2.093 . . . . 0.0 112.172 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 230' ' ' VAL . 0.8 OUTLIER -93.7 139.37 30.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.786 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.62 123.0 32.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 50.5 t -122.33 127.55 49.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.9 m -127.28 103.7 7.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.502 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.459 ' HE3' ' CE2' ' A' ' 166' ' ' PHE . 2.0 ptt? -110.64 145.04 38.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.02 0.438 . . . . 0.0 111.259 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -104.32 119.36 38.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.578 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.403 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 1.5 tppt? -47.83 -78.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.88 -159.85 26.78 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.228 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.56 0.16 10.24 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.582 2.188 . . . . 0.0 112.91 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.3 p -104.0 -30.27 10.39 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.403 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 93.12 -140.3 15.0 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.079 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.525 ' HB3' ' CE2' ' A' ' 166' ' ' PHE . 7.8 m-85 -110.38 -47.17 3.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.931 0.396 . . . . 0.0 110.762 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.52 24.13 51.54 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.646 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 164' ' ' TYR . 8.5 p90 -124.81 172.87 8.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.216 0.532 . . . . 0.0 111.827 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 166' ' ' PHE . 10.0 m120 -137.95 152.5 49.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.96 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.487 HD21 ' CE1' ' A' ' 166' ' ' PHE . 4.2 mm? -129.78 146.13 51.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.246 0.546 . . . . 0.0 112.299 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 2.8 p80 -143.59 133.72 24.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.721 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.5 t -129.46 155.5 45.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.033 0.444 . . . . 0.0 111.605 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -130.05 -64.39 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.474 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -90.06 162.52 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -110.12 22.5 15.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.348 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.606 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 52.8 mttm -105.56 -50.22 0.11 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.608 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 9.0 Cg_exo -72.13 -57.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.426 2.084 . . . . 0.0 112.144 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 145.06 -144.22 12.87 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.369 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -100.76 150.29 22.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.753 0.311 . . . . 0.0 110.857 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.452 ' CZ ' ' NH1' ' A' ' 198' ' ' ARG . 3.6 m-85 -131.06 138.12 49.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.781 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.9 mt -71.7 133.57 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 110.271 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.479 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 4.5 ptm180 -101.54 -30.88 11.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.723 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.2 t -152.78 145.43 24.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.469 . . . . 0.0 111.731 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.0 t -128.64 132.31 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.434 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 186' ' ' SER . 53.9 t0 -84.1 120.23 74.44 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.106 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.45 133.44 49.01 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.415 2.076 . . . . 0.0 112.359 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 71.81 15.25 5.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.814 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.412 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 44.8 m -97.43 161.8 24.75 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.623 0.249 . . . . 0.0 110.64 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 99.6 Cg_exo -43.99 -40.32 11.78 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.571 2.18 . . . . 0.0 112.753 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.41 -44.3 96.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.444 . . . . 0.0 110.518 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -70.37 -52.27 23.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.027 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.51 -29.39 1.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.609 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.5 t -83.78 -31.98 25.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.959 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.49 7.38 6.32 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.984 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.17 146.45 27.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.744 0.306 . . . . 0.0 110.85 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -136.54 137.99 40.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -63.46 149.64 45.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.299 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 75.31 2.61 3.91 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.099 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -73.1 153.98 40.58 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.435 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.452 ' NH1' ' CZ ' ' A' ' 178' ' ' PHE . 1.3 mmp_? -89.6 115.26 26.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 0.0 111.154 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 33.8 mm -65.01 125.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 229' ' ' LEU . 21.4 t -106.15 -44.29 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.492 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 6.2 pt-20 -144.34 173.35 11.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.024 0.44 . . . . 0.0 111.623 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.412 ' HA ' ' CD2' ' A' ' 228' ' ' LEU . 43.4 t -151.52 107.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.861 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.1 t30 70.27 24.35 4.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.322 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.76 -20.14 37.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.343 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.48 99.19 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.99 0.424 . . . . 0.0 111.335 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.436 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 45.3 t -84.92 100.62 11.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.986 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 20.4 mmt -130.13 99.81 5.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -69.73 102.42 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.761 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.81 20.93 4.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.729 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.547 ' HA ' ' CE ' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -54.82 150.67 9.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.918 0.389 . . . . 0.0 111.076 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -94.56 160.25 14.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.1 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -47.15 -61.64 1.79 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.12 -30.55 60.9 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.151 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -44.26 67.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.407 . . . . 0.0 110.331 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.96 -38.95 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.312 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.4 -41.2 88.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.592 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 64.6 m -72.55 -34.64 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.696 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.1 83.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.057 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 32.0 mm -59.55 -41.98 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 ttp-105 -64.21 -41.68 96.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.724 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.06 5.32 30.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.712 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.64 19.21 38.1 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.046 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -145.08 9.61 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.941 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.63 -25.15 28.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.725 0.298 . . . . 0.0 111.158 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -103.98 114.99 29.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.59 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 4.5 m -111.09 108.05 17.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.345 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -91.12 99.89 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.403 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.416 ' CD1' ' CE ' ' A' ' 157' ' ' MET . 12.4 mt -107.06 132.21 53.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.044 0.45 . . . . 0.0 111.717 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 200' ' ' VAL . 13.3 tp -116.46 109.41 17.26 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 153' ' ' ARG . 34.3 m -113.86 177.69 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.021 0.439 . . . . 0.0 112.061 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 198' ' ' ARG . 5.2 t -124.48 144.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.778 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -74.1 110.91 8.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.375 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 -100.07 -25.28 14.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.665 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -56.63 -60.02 4.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.738 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 23.0 m -58.35 -32.47 68.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.455 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.84 -31.89 68.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.874 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.84 -30.14 11.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -57.65 -58.9 6.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.02 -29.97 68.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.917 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.576 -0.209 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.437 ' CD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -135.11 147.76 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.986 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.437 ' N ' ' CD1' ' A' ' 144' ' ' ILE . 25.7 t70 -44.73 140.84 3.14 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.382 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.5 -63.79 0.26 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.911 2.407 . . . . 0.0 112.172 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.65 ' O ' ' CG2' ' A' ' 148' ' ' THR . 19.3 t80 -88.03 -61.81 1.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.949 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.65 ' CG2' ' O ' ' A' ' 147' ' ' PHE . 2.2 p 158.37 132.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.338 0.655 . . . . 0.0 110.818 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.5 mtm -125.39 -57.42 1.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.966 0.413 . . . . 0.0 111.159 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.461 ' O ' ' C ' ' A' ' 151' ' ' ARG . 20.8 tp -109.88 -4.12 16.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.563 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.461 ' C ' ' O ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -24.73 119.34 0.21 Allowed Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.301 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.64 142.53 14.44 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.1 mtm105 -110.38 153.92 24.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.708 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.5 tp -104.15 133.1 49.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.028 0.442 . . . . 0.0 111.114 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 228' ' ' LEU . 38.4 t -129.99 138.55 50.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.736 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.0 m -140.09 101.21 4.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.781 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.433 ' HE3' ' CG ' ' A' ' 164' ' ' TYR . 3.3 ptt? -109.91 135.8 50.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.954 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -95.12 135.61 36.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.011 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.446 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 18.3 tptp -73.97 -78.03 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.82 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.421 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.89 -159.94 5.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.198 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.02 0.17 10.22 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.614 2.209 . . . . 0.0 112.519 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.8 p -103.07 -30.12 10.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.592 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.446 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 95.46 -148.56 19.03 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.398 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.461 ' CZ ' ' CG2' ' A' ' 219' ' ' ILE . 31.7 m-85 -97.73 -44.16 6.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.922 0.392 . . . . 0.0 110.77 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 183' ' ' ASP . . . 88.68 14.83 60.73 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.95 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.405 ' C ' ' CD1' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -124.86 -177.46 3.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.139 0.495 . . . . 0.0 111.879 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.435 ' CB ' ' CG ' ' A' ' 180' ' ' ARG . 9.8 m120 -129.7 161.76 29.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.888 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -135.67 134.63 39.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.22 0.533 . . . . 0.0 112.276 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 6.6 p-80 -134.8 165.29 25.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.808 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.1 t -128.2 142.13 51.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.513 0.673 . . . . 0.0 112.504 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 178' ' ' PHE . 16.1 t0 -105.6 -40.22 5.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.386 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 14.3 mmtm -82.97 175.02 10.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.854 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.7 m -104.4 -26.97 12.22 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.912 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.756 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 32.0 mtmm -122.21 -58.64 0.03 OUTLIER Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.756 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 7.0 Cg_exo -81.28 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.837 2.358 . . . . 0.0 115.702 -175.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -39.07 145.0 0.24 Allowed Glycine 0 N--CA 1.453 -0.21 0 N-CA-C 116.532 1.373 . . . . 0.0 116.532 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.468 ' HG2' ' CG1' ' A' ' 215' ' ' VAL . 2.0 tp-100 -138.35 127.13 23.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 112.867 -1.667 . . . . 0.0 107.159 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.638 ' CD2' ' NH2' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -134.93 135.65 41.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.4 mt -80.88 129.91 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 169' ' ' HIS . 19.6 ptt180 -95.99 -33.27 12.21 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.0 t -154.74 157.69 38.4 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.9 139.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.503 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 186' ' ' SER . 47.1 t0 -87.35 122.44 70.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.176 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.4 133.87 48.55 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.28 1.987 . . . . 0.0 111.973 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 75.26 14.85 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.625 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.427 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 46.6 m -100.62 162.97 19.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.637 0.255 . . . . 0.0 110.532 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 82.4 Cg_exo -45.87 -40.21 19.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.469 2.112 . . . . 0.0 112.797 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.53 94.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.07 0.462 . . . . 0.0 110.475 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -70.42 -51.58 28.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.022 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.2 -24.76 11.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.497 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.8 t -85.06 -29.14 25.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 0.0 110.969 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.13 8.72 11.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.506 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -60.41 150.86 29.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.694 0.283 . . . . 0.0 110.557 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.427 ' N ' ' CD2' ' A' ' 193' ' ' LEU . 48.1 mtt180 -142.87 129.69 20.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.712 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -55.19 152.26 8.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 35.6 mt-30 78.31 6.73 2.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.851 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 40.7 p30 -78.11 152.62 32.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.636 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.9 mmp_? -85.78 109.1 18.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.652 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.43 HG13 ' HG3' ' A' ' 177' ' ' GLN . 39.1 mm -68.64 113.14 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.809 0.337 . . . . 0.0 110.441 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.0 t -105.72 -46.09 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.45 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 6.2 pt-20 -136.69 171.68 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 0.0 111.912 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' A' ' 205' ' ' VAL . 17.9 t -147.84 113.09 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.553 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 50.6 t30 70.04 20.66 6.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.934 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 102.53 -15.41 55.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.559 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 202' ' ' VAL . 27.1 m -83.61 91.31 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 117.229 0.514 . . . . 0.0 111.537 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.45 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 51.6 t -82.89 109.59 17.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.737 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.425 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 20.5 mmt -130.5 99.89 5.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -74.9 103.57 5.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.77 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 175' ' ' PRO . . . 122.16 10.38 6.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.939 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.425 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 9.1 mmtt -56.82 147.61 22.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.9 0.381 . . . . 0.0 111.258 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.53 160.51 26.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -47.84 -54.3 12.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.668 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.2 -33.02 85.77 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.802 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.52 -47.21 82.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.849 0.357 . . . . 0.0 110.281 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.468 ' CG1' ' HG2' ' A' ' 177' ' ' GLN . 28.2 t -66.55 -38.41 81.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.181 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.24 -43.3 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.496 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 52.4 m -64.58 -37.64 88.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.409 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.0 -44.3 78.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.898 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.461 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 34.0 mm -61.57 -36.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.696 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 47.7 ttp85 -72.4 -33.98 67.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.04 5.39 29.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.67 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -84.55 12.61 55.49 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.187 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -140.77 17.35 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.88 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.49 -25.18 36.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 111.154 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -115.62 114.87 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.9 m -107.82 94.97 5.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -81.27 94.76 6.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.464 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 155' ' ' CYS . 19.2 mt -101.27 141.51 34.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.657 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.41 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 13.1 tp -117.18 109.66 17.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 26.8 m -116.96 178.35 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.3 t -119.69 165.77 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.495 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -93.91 109.22 20.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.992 0.425 . . . . 0.0 112.016 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.457 ' HD3' ' NH1' ' A' ' 198' ' ' ARG . 24.9 ttp180 -100.94 -21.0 15.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.424 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -44.96 -56.89 4.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.229 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.3 m -69.21 -30.98 69.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.554 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.6 -25.96 66.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.657 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -109.99 -29.6 8.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.988 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -53.5 -52.52 59.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.946 0.403 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -59.78 -31.09 69.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.69 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.875 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -69.98 133.61 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.385 . . . . 0.0 110.924 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.411 ' O ' ' CD1' ' A' ' 144' ' ' ILE . 7.1 t70 -66.53 137.26 95.15 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.424 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.58 -58.03 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.601 2.2 . . . . 0.0 112.77 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.443 ' O ' ' CG2' ' A' ' 148' ' ' THR . 13.9 t80 -106.7 -60.71 1.63 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.665 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 147' ' ' PHE . 2.9 p -168.59 158.79 9.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 22.7 mtm -109.67 -33.34 6.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.491 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.0 tp -74.39 -7.95 54.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.142 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.403 ' HB2' ' HD2' ' A' ' 152' ' ' PRO . 9.9 ptm180 -42.42 159.98 0.19 Allowed Pre-proline 0 CA--C 1.527 0.086 0 CA-C-O 120.899 0.38 . . . . 0.0 111.448 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HB3' ' CG2' ' A' ' 231' ' ' VAL . 19.7 Cg_endo -60.78 140.9 93.08 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.692 2.261 . . . . 0.0 112.422 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -108.41 141.68 39.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.991 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.433 ' HA ' HD11 ' A' ' 229' ' ' LEU . 37.2 tp -76.27 132.61 39.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.222 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 6.1 t -126.93 140.16 52.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.265 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.428 ' N ' ' OG ' ' A' ' 191' ' ' SER . 4.3 m -130.03 104.61 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.655 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -109.88 141.49 42.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.007 0.432 . . . . 0.0 111.379 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -113.09 115.93 29.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.401 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.416 ' HD3' ' CE1' ' A' ' 164' ' ' TYR . 7.6 tptp -61.76 -88.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.804 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.68 -150.15 18.16 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.341 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.9 0.06 10.3 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.68 2.253 . . . . 0.0 112.627 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.7 p -92.31 -30.33 15.89 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.321 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.04 -158.65 21.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.471 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.444 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 30.4 m-85 -87.93 -50.71 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.967 0.413 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.53 14.91 33.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.968 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 164' ' ' TYR . 7.5 p90 -163.72 -179.42 6.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.168 0.509 . . . . 0.0 111.585 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -127.72 165.06 20.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.551 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 166' ' ' PHE . 3.2 mm? -134.37 137.65 44.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -134.82 153.43 52.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.042 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.0 t -155.25 158.09 38.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.768 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -130.09 -77.23 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -81.05 175.14 10.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.666 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -90.41 12.25 19.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.369 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.464 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 26.7 mtmm -105.65 -47.17 0.13 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.904 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.464 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . 76.9 Cg_exo -51.27 -63.56 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.145 1.897 . . . . 0.0 112.462 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.08 -141.15 16.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.434 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -105.31 104.88 14.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.681 0.277 . . . . 0.0 110.972 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.492 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 10.3 m-30 -115.64 148.82 39.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.717 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.0 mt -76.08 133.73 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.583 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.434 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 8.1 ptt180 -104.97 -31.07 9.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.363 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.2 t -150.32 155.67 40.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 111.241 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 24.5 t -132.89 141.65 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -94.4 120.92 64.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.915 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.55 134.17 49.7 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.36 2.04 . . . . 0.0 112.362 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 73.09 14.89 4.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.839 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 36.4 m -94.78 162.51 25.15 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.565 0.221 . . . . 0.0 110.503 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.22 -40.16 34.82 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.367 2.045 . . . . 0.0 112.4 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.79 -44.61 96.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.495 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -65.28 -55.41 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.017 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.19 -25.47 61.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 156' ' ' THR . 26.4 t -78.73 -22.53 46.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 106.89 28.63 4.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.016 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.437 HD11 ' CG ' ' A' ' 166' ' ' PHE . 7.3 tt -85.4 145.18 27.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 0.0 110.935 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -131.53 131.64 43.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -57.37 145.64 31.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.319 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 233' ' ' ARG . 56.5 mt-30 74.81 -0.22 3.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.979 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 49.2 p30 -63.63 158.2 21.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.765 0.317 . . . . 0.0 110.672 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.492 ' HD2' ' CE1' ' A' ' 178' ' ' PHE . 1.8 mmm180 -94.95 112.84 24.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.344 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.7 mm -65.08 117.21 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.853 0.359 . . . . 0.0 110.586 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.61 -46.64 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.61 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 5.2 pt-20 -139.68 176.03 9.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.069 0.461 . . . . 0.0 111.425 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 33.8 t -153.18 105.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.773 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.7 t30 70.35 25.09 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.395 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.47 -19.85 38.56 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.451 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.0 m -82.8 98.16 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.992 0.425 . . . . 0.0 111.319 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 45.8 t -84.93 102.47 13.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.034 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 16.2 mmt -130.14 99.86 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.938 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -69.55 102.61 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.48 22.43 4.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.71 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.93 157.79 3.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.87 160.12 14.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.12 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -50.09 -60.72 2.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.9 -33.58 84.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.236 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.64 -48.62 80.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 110.26 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 23.0 t -68.01 -40.42 83.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.089 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 47.0 t -62.4 -44.81 99.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.281 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 75.0 m -66.84 -39.05 87.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.29 80.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.874 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.5 mm -62.68 -36.43 75.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.653 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -46.93 84.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.536 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.0 5.08 30.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.534 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -92.37 20.18 45.52 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.837 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.26 -143.33 12.47 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.893 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -88.71 -22.9 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.674 0.273 . . . . 0.0 111.342 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -108.42 115.73 30.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 28.0 m -120.19 114.19 21.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.452 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -86.04 99.04 11.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.171 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 23.0 mt -105.39 140.75 38.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.046 0.451 . . . . 0.0 111.961 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.495 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 13.7 tp -115.55 109.47 17.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.467 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 33.3 m -116.63 169.23 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.999 0.428 . . . . 0.0 111.736 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 152' ' ' PRO . 2.6 t -135.62 152.94 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -69.86 109.66 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.77 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.491 ' HG2' ' HG2' ' A' ' 237' ' ' GLU . 26.8 ttp180 -100.4 -18.18 16.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.247 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 238' ' ' PHE . 76.1 mt-10 -49.41 -55.23 13.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.589 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.0 m -90.12 -21.92 22.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.861 0.362 . . . . 0.0 111.213 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -53.8 -54.89 31.97 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.491 ' HG2' ' HG2' ' A' ' 233' ' ' ARG . 5.0 pt-20 -110.21 -41.85 4.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.454 ' CB ' ' O ' ' A' ' 234' ' ' GLU . 4.5 t80 -39.98 -60.38 1.04 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -28.92 65.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.357 . . . . 0.0 110.832 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -94.09 144.37 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.84 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.416 ' N ' ' CD1' ' A' ' 144' ' ' ILE . 4.1 t0 -48.44 104.26 0.41 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.251 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -80.32 -67.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.19 1.927 . . . . 0.0 112.043 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -115.83 -43.76 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.658 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -119.91 162.34 19.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.431 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 35.5 mtm -121.37 -19.84 6.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.62 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 236' ' ' ASP . 10.0 tp -64.92 -17.59 64.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.617 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 150' ' ' LEU . 6.3 ptp180 -28.53 143.97 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 O-C-N 123.355 0.409 . . . . 0.0 112.026 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.415 ' HB3' ' CG2' ' A' ' 231' ' ' VAL . 7.6 Cg_endo -50.45 151.95 9.39 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.063 2.509 . . . . 0.0 112.957 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -127.71 140.94 51.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.575 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 16.6 tp -87.16 132.93 33.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.278 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 39.4 t -130.08 140.1 50.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.757 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -135.1 106.39 6.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.707 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 12.3 ptp -113.78 143.93 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 0.0 111.171 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -102.22 124.3 47.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.792 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 224' ' ' ASP . 6.6 tptm -55.76 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.37 -150.66 40.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.403 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.74 -16.68 14.54 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.72 2.28 . . . . 0.0 112.596 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.5 p -93.12 -30.15 15.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.174 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.418 ' HA2' ' HD2' ' A' ' 159' ' ' LYS . . . 80.05 -131.68 10.73 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.471 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CB ' ' CE1' ' A' ' 166' ' ' PHE . 3.6 m-85 -105.94 -50.36 3.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 110.433 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.06 20.83 52.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.29 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.497 ' CE1' ' CB ' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -124.86 179.11 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.125 0.488 . . . . 0.0 111.728 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.417 ' CB ' ' HG2' ' A' ' 180' ' ' ARG . 8.7 m120 -129.87 159.2 37.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.877 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -136.32 136.02 39.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.191 0.52 . . . . 0.0 112.066 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.426 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -134.53 165.26 25.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.5 178.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.5 t -140.69 148.0 40.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.073 0.463 . . . . 0.0 111.789 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -130.33 -67.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.527 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -90.05 164.63 14.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.733 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 67.0 m -110.15 22.33 15.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.472 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.688 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 25.1 mtpp -116.96 -56.25 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.838 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.688 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 57.4 Cg_exo -53.62 -56.23 2.85 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.139 1.892 . . . . 0.0 112.536 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 137.92 -143.7 14.78 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.358 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -84.22 142.48 30.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 110.776 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.532 ' CD2' ' CZ ' ' A' ' 198' ' ' ARG . 1.7 m-85 -120.98 149.67 42.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.427 ' CG2' ' HA ' ' A' ' 195' ' ' ALA . 9.9 mt -98.46 130.91 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.1 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.426 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 24.2 ptt180 -100.77 -30.57 11.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.5 t -157.73 151.24 23.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.1 0.476 . . . . 0.0 112.009 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 54.6 t -131.85 141.09 46.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.456 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 186' ' ' SER . 56.8 t0 -84.95 125.33 70.92 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.111 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.18 127.53 19.47 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.392 2.061 . . . . 0.0 112.161 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 185' ' ' ASP . 13.7 t0 74.4 23.49 1.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.429 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.5 m -102.56 164.63 15.27 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.606 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 81.1 Cg_exo -44.85 -40.28 14.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.612 2.208 . . . . 0.0 112.747 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -43.01 92.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.077 0.465 . . . . 0.0 110.407 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.56 -51.81 25.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.038 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -49.28 -27.4 3.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.644 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.3 t -85.03 -31.54 23.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 111.056 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 121.19 21.33 3.13 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.991 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.435 ' CD2' ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -83.09 151.59 25.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.613 0.244 . . . . 0.0 110.573 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.435 ' N ' ' CD2' ' A' ' 193' ' ' LEU . 30.5 mtp180 -145.57 129.72 17.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.266 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -52.15 160.78 0.71 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.703 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.627 ' HB3' ' HG3' ' A' ' 234' ' ' GLU . 54.9 mt-30 82.43 -4.82 1.4 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.092 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.414 ' OD1' ' CD1' ' A' ' 179' ' ' ILE . 38.3 p30 -86.13 165.2 16.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 110.593 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.532 ' CZ ' ' CD2' ' A' ' 178' ' ' PHE . 15.5 mmp_? -101.55 125.12 48.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 111.682 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 26.0 mm -69.43 108.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.854 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.18 -50.11 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.367 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 11.2 pt-20 -136.22 173.92 11.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.98 0.419 . . . . 0.0 111.139 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 40.1 t -151.48 107.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.929 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 53.5 t30 70.25 25.22 4.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.437 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.55 -18.67 43.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.5 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 36.0 m -83.74 97.87 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.008 0.432 . . . . 0.0 111.191 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.436 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 48.5 t -85.91 101.66 13.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.061 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 96.6 mmm -130.11 99.66 5.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.856 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -70.89 105.34 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.27 17.85 5.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.743 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.94 150.15 10.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.952 0.406 . . . . 0.0 111.123 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -91.53 160.43 15.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.058 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -47.81 -64.58 0.75 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.67 -33.79 59.9 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.108 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.27 -47.13 83.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.191 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 23.3 t -71.94 -38.95 66.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.116 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.44 -41.63 92.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.193 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 32.4 m -75.05 -40.82 60.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.419 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.26 -46.79 87.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.694 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.479 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 23.3 mm -61.23 -34.08 59.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.534 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -73.89 -36.89 64.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.382 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.75 5.53 28.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.674 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -83.29 16.34 29.65 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.171 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.29 -135.89 26.96 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.055 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.2 m-20 -92.21 -25.08 18.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.668 0.27 . . . . 0.0 111.38 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -102.34 117.94 35.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.592 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 5.7 m -114.69 98.45 6.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.485 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -88.73 97.71 11.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.056 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 54.3 mt -105.38 138.89 40.85 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.418 ' CB ' ' HG2' ' A' ' 201' ' ' GLU . 13.6 tp -117.8 109.91 17.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.082 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 35.4 m -124.43 170.76 14.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 152' ' ' PRO . 2.6 t -141.33 135.44 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.484 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.402 ' O ' ' CD1' ' A' ' 150' ' ' LEU . 22.3 t0 -72.55 119.87 17.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.401 . . . . 0.0 111.408 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -100.82 -25.35 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.81 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.627 ' HG3' ' HB3' ' A' ' 196' ' ' GLN . 27.8 mt-10 -78.66 -44.25 24.2 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.366 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 239' ' ' PHE . 6.4 m -59.81 -24.33 64.07 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.471 ' HB2' HD11 ' A' ' 150' ' ' LEU . 23.4 t0 -63.72 -37.37 87.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.393 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -110.65 -50.86 2.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.805 0.336 . . . . 0.0 111.729 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -66.95 -70.82 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.698 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.466 ' HB3' HG22 ' A' ' 235' ' ' THR . 0.8 OUTLIER -59.94 -17.13 35.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.497 -179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 236' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.02 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -113.74 141.48 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.666 0.269 . . . . 0.0 110.794 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.432 ' N ' ' CD1' ' A' ' 144' ' ' ILE . 16.0 t70 -47.28 137.77 8.48 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.625 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.93 -61.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.492 2.128 . . . . 0.0 113.318 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.652 ' O ' ' CG2' ' A' ' 148' ' ' THR . 43.5 t80 -89.52 -60.97 1.8 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.652 ' CG2' ' O ' ' A' ' 147' ' ' PHE . 2.3 p 161.5 129.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.217 0.607 . . . . 0.0 110.659 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 41.7 mtt -125.6 -57.94 1.44 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.925 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.4 tp -121.46 -23.58 5.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.651 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -49.04 146.47 5.69 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.706 0.288 . . . . 0.0 111.227 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.24 170.77 19.62 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.674 2.249 . . . . 0.0 112.869 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 15.5 mtm105 -135.39 145.13 47.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.611 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.414 ' HA ' ' CD1' ' A' ' 229' ' ' LEU . 59.4 tp -85.76 135.02 33.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.37 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.7 t -130.01 140.07 50.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.814 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -131.53 108.34 9.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 6.7 ptp -119.85 142.1 48.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -102.73 135.63 44.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.085 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.452 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 18.2 tptt -70.14 -78.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.785 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.419 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.87 -159.89 5.62 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.266 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.62 0.21 10.2 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.597 2.198 . . . . 0.0 112.654 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.0 p -101.03 -30.24 11.72 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 89.41 -147.79 19.7 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.26 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.493 ' HB3' ' CE2' ' A' ' 166' ' ' PHE . 13.8 m-85 -110.19 -43.93 3.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.991 0.424 . . . . 0.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.94 40.49 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.507 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.501 ' CE1' HD22 ' A' ' 168' ' ' LEU . 4.2 p90 -124.6 174.08 8.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 117.219 0.509 . . . . 0.0 111.714 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -134.98 152.84 52.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.319 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.501 HD22 ' CE1' ' A' ' 166' ' ' PHE . 4.1 mm? -127.49 142.8 51.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.011 0.434 . . . . 0.0 111.838 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.464 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 1.5 p80 -142.62 144.39 32.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.235 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.9 t -144.05 160.48 40.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.924 0.392 . . . . 0.0 111.273 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -126.39 -71.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -90.09 168.54 11.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.7 m -110.0 21.19 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.233 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.552 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 30.7 mtmm -104.79 -49.1 0.13 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.492 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 13.8 Cg_exo -69.39 -66.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.402 2.068 . . . . 0.0 112.154 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.48 -159.45 28.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -105.52 144.32 32.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.419 ' CG ' ' CZ ' ' A' ' 198' ' ' ARG . 8.7 m-85 -135.8 151.29 49.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.804 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.0 mt -72.96 138.98 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.549 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.464 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 5.8 ptt180 -99.31 -34.13 10.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.583 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.0 t -151.73 152.86 33.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.051 0.453 . . . . 0.0 111.512 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.407 ' CG2' ' CD2' ' A' ' 193' ' ' LEU . 26.8 t -131.17 135.48 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.665 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 186' ' ' SER . 59.0 t0 -81.66 120.72 78.56 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.949 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.94 126.94 20.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.351 2.034 . . . . 0.0 112.38 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 t70 74.25 22.94 2.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.741 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 183' ' ' ASP . 5.6 m -100.86 162.61 20.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.594 0.235 . . . . 0.0 110.638 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -43.49 -40.34 10.16 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.673 2.249 . . . . 0.0 112.721 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.61 89.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.471 . . . . 0.0 110.31 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.54 -51.68 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.887 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -48.12 -29.68 3.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.541 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.6 t -83.5 -30.05 27.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 120.7 29.5 1.54 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.53 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.407 ' CD2' ' CG2' ' A' ' 182' ' ' VAL . 8.2 tt -84.2 149.22 26.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.74 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -141.43 135.93 30.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.08 153.37 9.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.343 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 70.97 7.87 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.774 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -74.02 150.05 40.9 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.419 ' CZ ' ' CG ' ' A' ' 178' ' ' PHE . 1.4 mmp_? -89.87 113.43 25.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 111.231 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 27.8 mm -68.27 125.73 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.75 -44.52 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.499 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.461 ' HG2' ' CB ' ' A' ' 229' ' ' LEU . 10.1 pt-20 -143.61 176.85 8.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 111.389 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 36.0 t -155.65 107.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.946 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 12.5 t30 70.19 24.27 4.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.45 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.79 -19.16 39.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.369 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.7 m -81.87 95.69 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.015 0.436 . . . . 0.0 111.272 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.429 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 50.2 t -86.42 99.17 11.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.938 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 17.6 mmt -130.14 99.83 5.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -68.24 103.91 1.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.748 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.61 21.02 4.83 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.583 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.557 ' HA ' ' HE3' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -54.78 142.18 29.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.972 0.415 . . . . 0.0 111.138 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -85.84 160.39 19.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -45.55 -60.91 1.92 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.02 -31.14 64.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.981 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -43.71 67.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.939 0.4 . . . . 0.0 110.249 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 40.5 t -72.14 -39.13 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.286 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.92 -41.25 89.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.48 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 73.1 m -70.06 -38.47 75.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.566 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.49 -45.15 77.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.004 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.456 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 30.1 mm -63.84 -36.43 76.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.752 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -65.43 -41.32 93.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.649 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.51 5.2 28.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -81.89 5.56 70.08 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.073 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -140.13 18.53 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.852 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.21 -25.18 34.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.71 0.291 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -115.6 114.86 25.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.524 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 17.3 m -111.6 96.48 6.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.445 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -73.58 97.07 2.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.009 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 73.6 mt -105.33 131.59 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.978 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.461 ' CB ' ' HG2' ' A' ' 201' ' ' GLU . 12.2 tp -109.58 109.48 20.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.315 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.19 169.82 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.031 0.443 . . . . 0.0 111.907 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 15.9 t -119.82 156.32 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.697 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -92.41 112.31 24.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.304 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -100.16 -25.43 14.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.804 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -63.92 -60.08 3.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 62.4 m -58.66 -24.4 61.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.5 -46.39 86.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.269 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -110.05 -43.01 4.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.261 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -50.37 -67.11 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.292 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -60.58 -30.64 69.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -118.19 139.8 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.921 0.391 . . . . 0.0 111.0 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.451 ' O ' HD12 ' A' ' 144' ' ' ILE . 15.3 t70 -45.73 137.54 5.72 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.89 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.28 -70.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.663 2.242 . . . . 0.0 112.551 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.63 ' O ' ' CG2' ' A' ' 148' ' ' THR . 1.0 OUTLIER -96.2 -60.72 1.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.454 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.63 ' CG2' ' O ' ' A' ' 147' ' ' PHE . 2.3 p 168.83 128.82 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.204 0.602 . . . . 0.0 110.627 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 41.4 mtt -126.5 -65.57 0.96 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.931 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.0 tp -125.91 -4.83 6.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.106 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.43 ' HD3' ' CG2' ' A' ' 148' ' ' THR . 0.4 OUTLIER -44.88 130.79 5.27 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 120.79 0.329 . . . . 0.0 111.587 -179.048 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.12 -179.91 5.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.794 2.329 . . . . 0.0 112.783 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -137.79 141.47 40.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.735 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 35.1 tp -99.4 131.36 45.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.962 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.9 t -130.01 138.54 50.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.035 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -131.49 104.4 6.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.486 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 5.7 ptm -119.73 140.49 50.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.216 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -96.28 129.42 43.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.41 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 18.9 tptp -59.78 -80.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.802 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.82 -156.7 17.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.262 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.69 0.02 10.33 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.615 2.21 . . . . 0.0 112.798 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.4 p -92.89 -30.36 15.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.574 0.226 . . . . 0.0 111.469 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 159' ' ' LYS . . . 91.33 -124.9 7.79 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.378 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.471 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 2.4 m-85 -108.21 -55.07 2.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 0.0 110.488 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.71 -5.04 61.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.457 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 164' ' ' TYR . 45.1 p90 -128.74 177.45 7.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.403 0.602 . . . . 0.0 111.762 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.43 ' CB ' ' HG2' ' A' ' 180' ' ' ARG . 5.7 m120 -125.5 165.19 18.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.426 HD21 ' CD2' ' A' ' 166' ' ' PHE . 2.4 mm? -133.55 147.66 51.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.011 0.434 . . . . 0.0 112.003 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 2.2 p-80 -134.47 146.23 49.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.708 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.6 t -155.21 150.04 26.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 111.65 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -114.96 -68.93 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.231 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 155.2 19.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.464 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.1 m -96.34 20.27 10.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.177 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.546 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 31.7 mttp -110.9 -49.71 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.994 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 38.2 Cg_exo -57.63 -63.38 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.109 1.873 . . . . 0.0 112.391 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.9 -162.02 29.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.579 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -108.3 136.47 47.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 0.0 110.886 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.432 ' CD1' ' HD2' ' A' ' 198' ' ' ARG . 2.3 m-85 -124.08 158.05 33.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.608 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 15.0 mt -87.14 139.6 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.875 0.369 . . . . 0.0 110.743 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 169' ' ' HIS . 10.2 ptm180 -105.16 -37.79 6.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.516 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.6 t -148.49 154.95 40.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.013 0.435 . . . . 0.0 111.716 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.6 t -132.34 143.04 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.739 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 57.2 t0 -95.03 125.33 51.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.081 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 23.5 Cg_exo -63.96 134.42 43.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.275 1.984 . . . . 0.0 112.084 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 74.24 14.9 3.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.728 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 21.2 m -97.26 163.37 20.0 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.515 0.198 . . . . 0.0 110.537 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.66 -40.35 18.67 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.473 2.115 . . . . 0.0 112.548 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.13 -41.62 94.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 110.687 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -70.13 -50.6 38.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.82 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -47.59 -31.49 4.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.474 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.2 t -81.23 -31.45 33.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.049 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 113.1 31.54 2.42 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.063 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.59 151.37 26.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.733 0.302 . . . . 0.0 110.905 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -137.78 130.02 29.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.645 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -52.82 157.59 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.497 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 47.5 mt-30 82.46 -17.04 0.55 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.326 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.483 ' HB2' ' HB ' ' A' ' 230' ' ' VAL . 20.1 p-10 -61.13 149.58 36.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.727 0.299 . . . . 0.0 110.662 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 4.6 mmm-85 -90.63 118.31 29.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.335 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 24.3 mm -65.28 128.6 28.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.799 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.412 ' CG2' ' CG2' ' A' ' 231' ' ' VAL . 11.8 t -111.23 -43.73 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.636 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.4 pt-20 -142.81 173.74 11.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.477 . . . . 0.0 111.433 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 47.0 t -153.4 107.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.983 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.5 t30 70.37 25.27 4.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.508 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.48 -20.46 37.14 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.452 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.9 m -80.4 95.28 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.09 0.445 . . . . 0.0 111.161 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 44.9 t -89.93 99.73 12.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.012 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 45.6 mmm -130.16 101.38 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -67.1 100.04 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.625 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.23 26.49 3.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.392 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -54.9 156.27 3.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 111.119 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -92.11 160.28 15.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -47.71 -62.69 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.49 -30.3 64.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.284 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.86 -45.78 73.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 110.484 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 28.7 t -70.92 -37.04 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.458 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.2 -42.03 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.658 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 70.3 m -72.15 -33.18 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.78 80.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.139 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.457 ' CG2' ' CE1' ' A' ' 164' ' ' TYR . 26.8 mm -62.24 -38.08 80.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.944 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -68.47 -36.84 79.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.734 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.14 5.2 30.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.645 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -85.1 10.18 64.1 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.039 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.17 -128.68 27.07 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.806 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.33 -25.09 18.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.717 0.294 . . . . 0.0 111.125 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -107.98 117.37 33.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.788 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.0 m -113.24 96.11 5.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -78.5 98.55 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.097 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 28.7 mt -106.46 131.01 54.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.035 0.445 . . . . 0.0 111.906 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.427 ' CB ' ' HG2' ' A' ' 201' ' ' GLU . 11.9 tp -115.98 109.7 17.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.572 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 197' ' ' ASP . 32.0 m -109.77 176.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 112.068 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.412 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 5.4 t -126.49 162.89 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.074 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -80.61 112.9 18.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.252 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -100.06 -27.26 13.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.572 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -50.58 -58.59 5.45 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.626 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 89.7 m -63.12 -30.56 71.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.91 -30.22 67.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -109.51 -28.2 9.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -57.18 -50.14 73.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.02 0.438 . . . . 0.0 110.792 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.76 -26.19 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.933 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.9 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.384 -0.286 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -127.65 133.15 68.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.969 0.414 . . . . 0.0 110.992 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.423 ' O ' ' CD1' ' A' ' 144' ' ' ILE . 22.2 t70 -71.22 138.48 84.41 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.718 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.79 -61.32 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.817 2.345 . . . . 0.0 112.392 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.666 ' O ' ' CG2' ' A' ' 148' ' ' THR . 0.9 OUTLIER -83.75 -61.61 1.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.507 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.666 ' CG2' ' O ' ' A' ' 147' ' ' PHE . 2.2 p 158.83 127.89 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.347 0.659 . . . . 0.0 111.157 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 77.9 mtp -127.16 -66.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.361 0.601 . . . . 0.0 110.449 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 151' ' ' ARG . 13.0 tp -126.25 -4.88 6.71 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.644 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.537 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 3.7 ptm85 -26.77 121.87 0.23 Allowed Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.4 139.13 12.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.567 2.178 . . . . 0.0 112.556 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -94.51 139.89 30.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.383 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.421 ' HA ' ' CD1' ' A' ' 229' ' ' LEU . 18.1 tp -95.99 119.84 35.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.989 0.423 . . . . 0.0 111.026 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 228' ' ' LEU . 45.3 t -116.21 126.94 54.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.53 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.448 ' N ' ' OG ' ' A' ' 191' ' ' SER . 3.0 m -135.48 99.91 4.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.192 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.4 ptp -112.38 142.91 44.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.195 0.522 . . . . 0.0 111.88 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -104.44 119.65 39.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.895 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 224' ' ' ASP . 16.5 tptp -58.08 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.057 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.01 -152.86 12.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.385 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.02 0.17 10.22 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.747 2.298 . . . . 0.0 112.885 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.7 p -87.16 -30.41 21.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.575 0.226 . . . . 0.0 111.544 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 97.27 -146.66 18.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.179 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 7.7 m-85 -109.33 -46.83 3.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.167 0.508 . . . . 0.0 110.259 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 183' ' ' ASP . . . 70.71 28.34 71.01 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.626 -0.715 . . . . 0.0 113.813 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.475 ' CZ ' ' HB3' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -140.84 175.68 9.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.576 0.688 . . . . 0.0 112.163 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.43 ' HB3' ' CG ' ' A' ' 180' ' ' ARG . 10.0 m120 -135.65 155.98 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.66 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 168' ' ' LEU . 2.3 mm? -133.42 143.06 48.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.046 0.451 . . . . 0.0 111.9 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.466 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 2.5 p80 -141.03 136.86 32.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.298 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.6 t -137.15 163.95 29.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.379 . . . . 0.0 111.28 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -130.04 -78.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.665 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -90.14 175.05 7.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.761 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.0 m -109.22 19.65 19.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.208 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.615 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 2.6 mtmp? -110.87 -51.36 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.752 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 38.8 Cg_exo -61.2 -63.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.238 1.959 . . . . 0.0 112.229 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 144.35 -176.4 23.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.53 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.406 ' HB3' ' CG1' ' A' ' 215' ' ' VAL . 9.8 tp-100 -89.27 140.28 29.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.445 ' CD1' ' HD3' ' A' ' 198' ' ' ARG . 3.0 m-85 -127.73 147.84 50.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.654 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 68.0 mt -78.38 135.03 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.209 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.466 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 10.2 ptm180 -98.71 -35.04 10.3 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.9 t -151.58 156.76 41.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 112.076 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.413 ' CG2' ' CD2' ' A' ' 193' ' ' LEU . 23.3 t -132.69 140.6 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.524 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 165' ' ' GLY . 40.7 t0 -95.11 117.1 66.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.199 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.86 140.76 96.56 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.502 2.135 . . . . 0.0 112.185 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.1 t70 66.0 14.87 9.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.511 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.486 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 9.2 m -105.03 166.36 11.58 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.447 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 98.4 Cg_exo -43.98 -40.15 11.63 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.438 2.092 . . . . 0.0 112.437 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.94 93.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.684 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.18 -54.5 12.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -52.79 -26.63 14.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.533 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 156' ' ' THR . 4.4 t -85.09 -24.71 27.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.991 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.09 26.07 6.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.121 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.413 ' CD2' ' CG2' ' A' ' 182' ' ' VAL . 8.3 tt -79.82 149.39 31.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 111.009 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.4 ' N ' ' CD2' ' A' ' 193' ' ' LEU . 50.6 mtt-85 -140.72 129.9 23.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.706 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -58.42 151.1 20.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.324 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 41.5 mt-30 77.55 -3.05 2.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.163 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -67.71 151.83 46.59 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.567 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.445 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 68.1 mmt-85 -90.61 115.67 27.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.25 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.51 124.55 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.117 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.02 -45.19 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.492 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.503 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.9 pt-20 -144.27 173.97 11.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 111.449 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 26.4 t -155.43 112.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.817 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 44.2 t30 70.21 22.93 5.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.385 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.54 -15.96 48.88 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.581 -0.818 . . . . 0.0 113.589 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.59 93.75 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.25 0.525 . . . . 0.0 111.539 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.503 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 50.8 t -92.18 100.92 13.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.668 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.1 mmt -130.63 101.61 5.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.353 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -68.36 99.25 0.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.643 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.5 25.55 3.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.609 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 175.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.767 0.318 . . . . 0.0 110.916 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -91.11 157.23 17.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.986 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -52.44 -64.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.692 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.05 -25.04 61.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.283 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.01 -44.02 55.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.323 . . . . 0.0 110.712 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 177' ' ' GLN . 4.6 t -74.81 -36.82 40.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.565 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 40.7 t -70.13 -38.22 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.71 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.3 m -74.56 -33.51 62.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.627 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.34 82.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.0 mm -61.86 -42.16 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 54.2 ttp85 -75.16 -28.4 60.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.21 5.78 28.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.737 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -66.53 -0.65 8.57 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.564 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 47.43 -132.23 15.16 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.987 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.506 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.1 m-20 -83.86 -25.17 30.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.308 . . . . 0.0 111.217 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -125.48 114.82 19.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.814 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 4.6 m -112.42 96.84 6.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.369 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -84.08 94.8 8.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.031 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 155' ' ' CYS . 8.1 mt -110.07 140.1 44.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.145 0.498 . . . . 0.0 112.283 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.427 ' CB ' ' HG2' ' A' ' 201' ' ' GLU . 10.4 tp -120.0 109.58 15.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.313 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 27.5 m -114.87 179.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 111.766 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 198' ' ' ARG . 2.6 t -119.95 166.08 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.726 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -90.26 111.0 22.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.209 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -100.03 -24.69 14.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -52.33 -59.89 3.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.839 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 46.0 m -66.34 -30.34 70.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.92 -24.73 66.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.995 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -106.2 -34.38 7.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.013 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.1 -64.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -59.99 -34.36 73.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.467 ' CD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -134.91 150.1 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.666 0.269 . . . . 0.0 110.803 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.467 ' N ' ' CD1' ' A' ' 144' ' ' ILE . 10.7 t70 -44.83 137.98 4.23 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.426 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.96 -57.64 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.682 2.254 . . . . 0.0 112.537 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.64 ' O ' ' CG2' ' A' ' 148' ' ' THR . 4.4 t80 -107.3 -60.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.376 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.64 ' CG2' ' O ' ' A' ' 147' ' ' PHE . 2.0 p 164.18 133.48 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.325 0.65 . . . . 0.0 110.246 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 69.5 mtp -125.46 -65.08 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.7 tp -125.82 -8.94 6.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 29.2 ptt85 -50.08 122.11 14.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.685 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.19 176.88 5.76 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.671 2.247 . . . . 0.0 113.075 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.44 158.11 43.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.699 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.418 ' HA ' HD13 ' A' ' 229' ' ' LEU . 36.2 tp -90.01 125.74 35.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.005 0.431 . . . . 0.0 111.369 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 47.7 t -120.52 140.2 51.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.374 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.4 m -134.11 104.1 6.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -109.81 127.02 54.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -90.39 125.53 35.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.981 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.419 ' HE2' ' CZ ' ' A' ' 164' ' ' TYR . 1.7 tppp? -59.66 -80.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.703 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.38 -156.19 12.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.498 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.76 0.02 10.35 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.704 2.269 . . . . 0.0 112.782 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 p -96.85 -30.15 13.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.734 0.302 . . . . 0.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.93 -142.12 15.84 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.439 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.452 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 14.7 m-85 -96.41 -51.33 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.34 30.49 24.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.627 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -151.49 178.65 9.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.238 0.542 . . . . 0.0 112.152 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -135.22 154.63 51.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.054 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 168' ' ' LEU . 0.4 OUTLIER -132.19 148.33 52.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.398 . . . . 0.0 111.655 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -134.21 141.33 46.99 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.314 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.6 t -155.14 149.61 26.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.179 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -121.44 -67.97 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.561 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -90.16 159.73 16.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.6 m -100.8 21.41 13.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.166 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 5.0 mttp -108.73 -48.59 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.792 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 25.5 Cg_exo -63.02 -65.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.216 1.944 . . . . 0.0 112.298 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.09 -152.25 23.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.411 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -125.88 133.96 51.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 111.097 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 2.8 m-85 -122.53 165.11 16.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.412 ' CD1' ' OD1' ' A' ' 197' ' ' ASP . 57.0 mt -91.9 135.91 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 110.66 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.78 -35.63 10.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.879 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.0 t -153.21 158.51 41.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 111.63 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 195' ' ' ALA . 49.0 t -135.29 141.15 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.789 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.4 ' HB3' ' OG ' ' A' ' 186' ' ' SER . 48.7 t0 -90.72 117.28 67.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.799 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.91 136.61 74.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.448 2.099 . . . . 0.0 112.408 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.7 t70 71.21 14.78 6.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.58 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.488 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 48.0 m -99.99 164.78 15.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.583 0.23 . . . . 0.0 110.778 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 99.9 Cg_exo -44.04 -40.25 11.91 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.584 2.19 . . . . 0.0 112.912 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.95 97.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -70.33 -51.65 28.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.007 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.96 -32.19 3.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.574 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.1 t -83.99 -27.5 28.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.063 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 115.11 25.51 3.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.464 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -83.44 149.21 26.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.731 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.406 ' N ' ' CD2' ' A' ' 193' ' ' LEU . 1.4 mtt85 -143.15 138.31 29.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.798 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.404 ' N ' ' CG2' ' A' ' 182' ' ' VAL . . . -55.69 153.97 7.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.573 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 71.39 9.14 6.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.065 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 231' ' ' VAL . 38.9 p30 -75.77 149.53 37.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.029 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 17.4 mmt85 -85.67 112.49 21.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.691 0.281 . . . . 0.0 111.548 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.401 ' CD1' HG12 ' A' ' 230' ' ' VAL . 12.8 mm -68.09 123.9 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.366 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.3 t -110.18 -43.86 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.126 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 10.6 pt-20 -143.19 176.64 8.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.317 0.58 . . . . 0.0 111.936 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.7 t -150.81 107.77 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.517 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.45 23.86 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.368 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.65 -17.01 51.01 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.633 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.43 90.2 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.191 0.495 . . . . 0.0 111.569 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.475 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 53.0 t -80.31 100.57 8.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.754 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.441 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 17.0 mmt -130.74 99.43 4.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.18 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -75.03 115.5 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.2 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 104.21 12.85 28.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.112 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.441 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 0.5 OUTLIER -54.93 166.16 0.54 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.06 0.457 . . . . 0.0 111.398 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -94.46 160.4 14.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -47.49 -56.42 7.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.026 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.05 -29.12 70.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.17 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.94 -44.5 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.55 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 32.9 t -71.84 -35.04 53.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.449 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.25 -41.61 74.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.458 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.8 m -67.14 -38.13 84.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.67 -45.64 77.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.053 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.8 mm -65.45 -33.33 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.793 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -67.68 -41.35 83.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.86 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.09 5.03 31.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.613 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -87.6 10.03 71.33 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.975 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.12 -136.32 25.56 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.854 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.79 -25.13 23.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.74 0.305 . . . . 0.0 111.079 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -104.22 114.89 29.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.682 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 19.9 m -110.55 101.12 9.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.287 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -85.35 94.86 9.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.192 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.6 mt -103.67 137.62 41.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.026 0.441 . . . . 0.0 111.858 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.511 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 13.9 tp -110.56 109.41 19.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 23.8 m -124.62 177.04 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.475 0.655 . . . . 0.0 112.243 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 197' ' ' ASP . 39.9 t -119.2 145.11 25.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.776 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.712 ' O ' ' HB2' ' A' ' 236' ' ' ASP . 21.0 t0 -96.41 112.81 24.42 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.581 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -101.0 -19.58 15.77 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.946 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -85.38 -59.03 2.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 109.965 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.492 ' HB ' ' OD2' ' A' ' 232' ' ' ASP . 11.3 m -68.88 -19.81 64.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.172 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.712 ' HB2' ' O ' ' A' ' 232' ' ' ASP . 16.1 t0 -41.35 -28.6 0.12 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.468 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -108.5 -20.05 13.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.919 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -85.36 -73.0 0.46 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.417 ' HB3' ' CG2' ' A' ' 235' ' ' THR . 0.8 OUTLIER -93.92 -14.04 26.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.64 -178.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.516 ' CB ' ' HA ' ' A' ' 236' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.008 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.42 HD11 HG23 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -135.01 121.33 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.01 0.433 . . . . 0.0 111.013 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -93.28 137.3 23.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.945 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.96 -70.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.299 1.999 . . . . 0.0 112.678 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.642 ' O ' ' CG2' ' A' ' 148' ' ' THR . 83.1 t80 -115.5 -60.83 1.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.642 ' CG2' ' O ' ' A' ' 147' ' ' PHE . 2.2 p 162.83 128.56 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.531 0.732 . . . . 0.0 110.157 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 7.0 mtt -127.15 -52.03 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.412 0.625 . . . . 0.0 110.526 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.505 ' HG ' ' OG1' ' A' ' 235' ' ' THR . 30.6 tp -125.38 -24.31 3.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.037 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.581 ' HB2' ' HD2' ' A' ' 152' ' ' PRO . 5.7 ptm180 -46.12 160.31 0.3 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.931 0.396 . . . . 0.0 111.154 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 151' ' ' ARG . 7.1 Cg_endo -51.52 143.71 35.04 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.979 2.453 . . . . 0.0 112.439 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -125.2 171.81 10.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.354 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.409 ' HA ' HD12 ' A' ' 229' ' ' LEU . 25.2 tp -108.21 139.35 43.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.046 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.453 ' N ' ' O ' ' A' ' 228' ' ' LEU . 54.1 t -126.56 135.83 51.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.51 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 191' ' ' SER . 3.0 m -137.24 99.9 4.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.744 0.307 . . . . 0.0 110.689 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -114.43 141.12 48.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 111.266 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -96.22 121.6 38.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.552 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -46.41 -76.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.126 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.36 -158.05 7.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.314 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.01 0.03 10.32 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.676 2.25 . . . . 0.0 112.69 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.2 p -100.56 -30.19 11.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.517 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.95 -124.79 6.57 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.71 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 8.2 m-85 -91.63 -60.41 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.084 0.469 . . . . 0.0 111.099 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 183' ' ' ASP . . . 96.71 -0.74 61.22 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.555 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 164' ' ' TYR . 1.4 p90 -124.8 -176.89 3.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.06 0.457 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.412 ' CB ' ' HG2' ' A' ' 180' ' ' ARG . 3.3 m120 -124.72 161.96 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.685 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.417 ' CD2' ' N ' ' A' ' 168' ' ' LEU . 0.9 OUTLIER -132.71 135.27 45.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.076 0.465 . . . . 0.0 111.976 -179.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.456 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 0.7 OUTLIER -134.86 143.31 46.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.948 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 t -155.06 166.84 32.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 111.442 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -130.14 -59.5 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.739 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -90.01 167.34 12.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 m -110.08 22.21 15.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.278 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.533 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 14.2 mttt -102.93 -48.6 0.17 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.563 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 14.2 Cg_exo -69.3 -58.0 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.359 2.039 . . . . 0.0 112.331 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 140.33 -146.75 18.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.41 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -103.97 131.58 51.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.765 0.317 . . . . 0.0 110.865 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.535 ' CD1' ' HD3' ' A' ' 198' ' ' ARG . 1.2 m-30 -109.76 165.19 11.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.416 ' CG1' ' OD1' ' A' ' 197' ' ' ASP . 4.0 mt -100.37 131.75 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.166 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.456 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 10.9 ptm180 -104.33 -33.53 8.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.709 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.4 t -150.82 152.53 33.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 111.868 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.67 140.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.761 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 165' ' ' GLY . 47.3 t0 -89.0 123.1 68.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 23.7 Cg_exo -63.59 133.07 37.95 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.233 1.955 . . . . 0.0 112.195 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 185' ' ' ASP . 13.6 t0 76.88 14.84 2.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.26 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.423 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 37.0 m -98.69 163.21 19.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 84.1 Cg_exo -45.56 -40.2 18.05 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.36 2.04 . . . . 0.0 112.345 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.61 -44.85 95.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.764 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -66.64 -54.52 22.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.917 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -55.84 -26.49 46.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.279 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 156' ' ' THR . 11.3 t -82.52 -20.3 36.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.22 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 100.8 36.95 3.81 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.914 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.445 HD12 ' CD2' ' A' ' 166' ' ' PHE . 8.3 tt -100.18 148.68 24.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.83 0.347 . . . . 0.0 111.153 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -147.79 138.78 23.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.758 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -47.69 166.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.613 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.685 ' O ' ' HB2' ' A' ' 233' ' ' ARG . 67.1 mt-30 80.27 -24.36 0.2 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.237 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.713 ' HA ' ' O ' ' A' ' 231' ' ' VAL . 27.2 p-10 -66.92 138.17 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.452 0.644 . . . . 0.0 112.266 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.535 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 0.2 OUTLIER -92.19 130.12 37.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.373 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.2 mm -69.78 116.45 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.764 0.316 . . . . 0.0 110.58 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.21 -46.48 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.736 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 10.2 pt-20 -138.45 174.11 10.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.962 0.41 . . . . 0.0 111.164 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 205' ' ' VAL . 23.7 t -152.74 109.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.144 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 13.0 t30 70.01 24.32 5.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.306 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.33 49.38 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.469 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 202' ' ' VAL . 28.5 m -80.95 95.29 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.205 0.502 . . . . 0.0 111.093 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.42 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 26.5 t -86.8 103.6 15.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.176 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 84.7 mmm -130.16 99.92 5.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.69 103.66 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.705 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 113.95 23.71 4.84 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.337 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -54.9 158.47 2.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.918 0.389 . . . . 0.0 111.157 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.08 160.28 14.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.151 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -48.05 -60.99 2.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.92 -31.15 67.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.212 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -46.15 78.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.261 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.05 -35.41 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.438 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 41.5 t -70.36 -42.69 78.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.649 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 71.6 m -73.46 -33.44 64.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.735 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.04 80.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.143 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.408 ' CG2' ' CE2' ' A' ' 164' ' ' TYR . 17.6 mm -63.81 -40.35 88.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -43.37 89.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.675 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.95 5.06 30.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.526 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -90.81 19.71 43.61 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.895 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.05 -137.7 22.77 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.963 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.85 -24.83 20.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -100.38 117.96 35.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.393 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.0 m -111.38 99.49 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.6 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -87.42 94.93 9.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.947 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 155' ' ' CYS . 18.4 mt -109.12 139.8 43.53 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.446 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 14.2 tp -109.54 111.42 22.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 197' ' ' ASP . 34.8 m -125.39 152.49 32.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 197' ' ' ASP . 2.6 t -119.98 137.79 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 197' ' ' ASP . 20.4 t0 -67.94 143.5 55.62 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.856 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.685 ' HB2' ' O ' ' A' ' 196' ' ' GLN . 38.6 ttp180 -54.67 -25.19 25.47 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.453 ' HG3' ' CG ' ' A' ' 232' ' ' ASP . 27.9 mt-10 -59.36 -29.1 67.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 238' ' ' PHE . 2.9 m -87.57 -23.56 24.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.35 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 233' ' ' ARG . 28.3 t70 -46.78 -31.87 3.29 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -59.89 -40.06 87.48 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 235' ' ' THR . 6.6 t80 -72.37 -55.61 6.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.288 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.45 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 21.9 t80 -59.43 -17.21 28.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.426 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 236' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.798 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -97.14 125.68 50.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.936 0.398 . . . . 0.0 111.125 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.638 ' HB3' ' O ' ' A' ' 148' ' ' THR . 9.1 t70 -105.02 138.44 19.51 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.791 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -80.34 -59.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 122.73 2.287 . . . . 0.0 114.746 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -77.45 -42.21 36.82 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.638 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 2.9 p -119.58 129.64 54.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 10.6 mtt -117.59 -16.93 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.715 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.414 ' O ' ' CG1' ' A' ' 231' ' ' VAL . 54.6 tp -74.29 -5.01 39.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.576 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -36.82 140.12 0.44 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-O 120.658 0.266 . . . . 0.0 111.537 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.68 165.9 30.49 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.621 2.214 . . . . 0.0 112.913 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -129.71 158.43 39.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.774 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.414 ' HA ' HD11 ' A' ' 229' ' ' LEU . 26.3 tp -96.48 129.37 43.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.376 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.4 t -128.25 135.63 49.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.504 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.2 m -131.47 111.26 11.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.03 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 3.6 ptp -118.18 133.11 56.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -92.97 130.54 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' A' ' 160' ' ' GLY . 10.7 tptm -61.56 -80.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.754 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.73 -157.2 6.98 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.299 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.77 0.21 10.19 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.681 2.254 . . . . 0.0 112.686 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.3 p -95.23 -30.14 14.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.428 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.45 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 93.01 -161.2 25.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.46 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.463 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 31.8 m-85 -81.67 -43.29 18.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.336 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.18 27.67 32.91 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.927 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.464 ' CE2' ' CD1' ' A' ' 168' ' ' LEU . 0.0 OUTLIER -164.83 -177.32 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.256 0.55 . . . . 0.0 111.882 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.439 ' CB ' ' HG2' ' A' ' 180' ' ' ARG . 9.8 m120 -136.6 157.29 47.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.028 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.464 ' CD1' ' CE2' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -133.35 130.64 39.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.166 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.528 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.3 OUTLIER -136.04 135.58 39.55 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.018 178.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.0 t -155.32 144.26 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.152 0.501 . . . . 0.0 111.498 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -130.26 -6.45 4.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.309 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.443 ' CB ' ' HD2' ' A' ' 175' ' ' PRO . 0.1 OUTLIER -89.16 146.58 24.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.555 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.1 m -110.21 8.95 23.86 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.707 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 50.4 mtmt -120.68 -58.27 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.707 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 37.1 Cg_exo -56.89 -64.48 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.138 1.892 . . . . 0.0 112.302 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.81 -145.44 12.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.686 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -108.68 151.12 26.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 110.838 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -130.29 151.45 50.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.854 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.418 ' CD1' ' OD1' ' A' ' 197' ' ' ASP . 69.6 mt -82.53 140.79 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.528 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 2.8 ptm180 -103.21 -36.32 8.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.225 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 40.8 t -151.0 153.8 35.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.034 0.445 . . . . 0.0 111.681 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 32.5 t -133.5 141.82 43.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.575 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -91.89 121.23 67.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.973 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.41 132.67 39.38 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.345 2.03 . . . . 0.0 112.33 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.7 t0 69.87 22.62 5.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.259 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 58.6 m -104.9 164.69 14.65 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.725 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 94.5 Cg_exo -43.47 -40.12 9.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.628 2.218 . . . . 0.0 112.792 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.2 96.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 110.293 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -70.02 -52.63 22.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.894 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.6 -31.14 2.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.655 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.2 t -81.97 -30.61 31.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 116.96 25.61 3.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.45 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 166' ' ' PHE . 7.8 tt -78.29 150.32 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.739 0.304 . . . . 0.0 110.743 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -139.6 130.01 25.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -55.05 152.7 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 75.22 2.9 4.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.08 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.418 ' OD1' ' CD1' ' A' ' 179' ' ' ILE . 41.2 p30 -73.74 155.58 38.76 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.307 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.426 ' HB2' ' HB ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -87.72 112.76 22.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.458 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 24.8 mm -66.97 124.17 21.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.913 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 19.3 t -106.78 -44.0 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.912 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.4 pt-20 -145.2 175.15 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.102 0.477 . . . . 0.0 111.688 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 40.1 t -150.56 109.36 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.65 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 49.8 t30 70.38 23.43 4.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.299 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.17 -16.28 53.73 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.564 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.7 m -85.45 96.76 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 117.181 0.49 . . . . 0.0 111.432 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' CYS . . . . . 0.442 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 52.5 t -81.8 103.2 11.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.661 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' MET . . . . . 0.43 ' HB2' ' CG ' ' A' ' 210' ' ' LYS . 21.9 mmt -130.23 99.47 5.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -78.7 101.73 7.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.1 5.34 6.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.135 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.43 ' CG ' ' HB2' ' A' ' 207' ' ' MET . 0.9 OUTLIER -54.85 156.81 3.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.096 0.448 . . . . 0.0 110.97 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -89.34 160.28 16.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.999 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -47.26 -60.92 2.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.91 -31.41 64.65 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.114 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.23 -44.02 69.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.473 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 16.8 t -72.38 -38.9 62.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 49.2 t -65.06 -42.29 94.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.186 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 45.4 m -67.24 -39.67 86.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.411 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.06 73.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.959 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.433 HG21 ' CE1' ' A' ' 164' ' ' TYR . 25.9 mm -61.35 -37.53 77.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -70.48 -33.91 71.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.509 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.15 5.33 30.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.591 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -83.99 13.99 46.08 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.149 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.12 -134.78 27.56 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.868 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.46 -25.18 23.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.722 0.296 . . . . 0.0 111.239 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -112.72 117.5 32.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.706 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 5.8 m -112.85 95.06 5.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.31 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -78.84 97.97 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.251 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 46.3 mt -105.02 135.72 45.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 112.259 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' A' ' 154' ' ' LEU . 14.3 tp -112.06 109.45 19.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.117 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 198' ' ' ARG . 31.9 m -120.78 169.44 12.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.137 0.494 . . . . 0.0 112.114 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 198' ' ' ARG . 39.8 t -119.92 137.54 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.74 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -71.21 110.73 6.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.257 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -100.11 -24.8 14.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.812 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -64.18 -56.63 13.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.956 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 84.0 m -66.64 -24.64 66.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.019 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -67.49 -32.97 74.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -109.96 -48.51 3.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.333 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -64.73 -67.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.058 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -60.38 -33.35 72.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.937 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.11 142.63 42.47 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.548 2.165 . . . . 0.0 111.976 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -107.48 141.22 39.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.085 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.899 ' HA ' HD12 ' A' ' 229' ' ' LEU . 55.3 tp -98.6 134.26 41.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.544 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 41.4 t -129.92 139.99 51.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 19.0 m -131.86 101.99 5.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.157 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.434 ' HE1' ' CE2' ' A' ' 166' ' ' PHE . 6.6 ptp -109.99 137.53 47.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 111.219 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -100.59 119.09 38.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.657 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.406 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 1.0 OUTLIER -51.29 -82.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.95 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.48 -156.42 26.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.23 -0.0 10.38 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.603 2.202 . . . . 0.0 112.841 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.7 p -108.43 -30.03 8.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.724 0.297 . . . . 0.0 111.119 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 83.92 -131.11 10.17 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.423 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CZ ' ' CG2' ' A' ' 219' ' ' ILE . 32.5 m-85 -110.2 -46.56 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.05 17.41 63.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.809 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' A' ' 157' ' ' MET . 0.1 OUTLIER -124.93 -178.62 4.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.092 0.472 . . . . 0.0 111.845 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.82 ' C ' HD22 ' A' ' 168' ' ' LEU . 9.9 m120 -134.83 160.73 37.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.393 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.82 HD22 ' C ' ' A' ' 167' ' ' ASN . 3.3 mm? -138.54 137.25 36.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.313 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.424 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 0.7 OUTLIER -134.76 141.53 46.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.62 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 t -155.09 150.14 26.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.25 -72.95 0.56 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.033 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -64.34 163.97 12.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.044 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.0 m -110.05 20.3 18.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.624 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 23.1 mttp -112.47 -50.56 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.873 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 25.2 Cg_exo -63.15 -64.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.143 1.895 . . . . 0.0 112.248 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 142.58 -148.34 20.04 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.5 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.409 ' HG2' HG11 ' A' ' 215' ' ' VAL . 9.8 tp-100 -114.93 129.09 56.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 0.0 110.973 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.498 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 1.6 m-85 -117.34 165.27 13.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.349 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.617 HD12 ' OD1' ' A' ' 197' ' ' ASP . 5.0 mt -90.18 136.3 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.939 0.399 . . . . 0.0 110.358 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.425 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 9.4 ptm180 -102.38 -34.55 9.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.818 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.9 t -150.36 149.4 30.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 0.0 111.909 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 195' ' ' ALA . 81.9 t -135.32 134.1 52.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.548 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 186' ' ' SER . 47.4 t0 -84.37 122.5 75.33 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.971 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.01 130.22 30.1 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.229 1.953 . . . . 0.0 112.193 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 75.93 18.18 2.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.736 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.6 m -98.23 164.93 16.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.56 0.219 . . . . 0.0 110.632 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 97.5 Cg_exo -43.45 -40.1 9.84 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.607 2.205 . . . . 0.0 112.768 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.77 91.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.039 0.447 . . . . 0.0 110.373 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.03 -50.86 37.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.755 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -47.91 -32.96 6.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.333 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -79.32 -30.0 42.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.04 32.58 1.51 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.241 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -97.59 149.17 22.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.854 0.359 . . . . 0.0 110.995 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.84 ' N ' HD23 ' A' ' 193' ' ' LEU . 76.5 mtt180 -142.51 133.77 26.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -46.59 161.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.576 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 233' ' ' ARG . 56.4 mt-30 82.73 -13.92 0.79 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.042 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.673 ' OD2' HG21 ' A' ' 230' ' ' VAL . 7.9 p-10 -68.18 146.45 53.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.749 0.309 . . . . 0.0 110.566 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.498 ' HD2' ' CE1' ' A' ' 178' ' ' PHE . 15.8 mmt85 -93.1 123.13 36.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.387 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.82 HD13 HG12 ' A' ' 230' ' ' VAL . 22.1 mm -66.52 128.96 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.976 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.81 -42.97 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.785 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.452 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 10.9 pt-20 -144.87 172.63 12.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.024 0.44 . . . . 0.0 111.649 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.87 ' O ' HG22 ' A' ' 205' ' ' VAL . 16.5 t -149.42 105.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.017 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 35.7 t30 70.27 26.39 4.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.538 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.06 -21.85 32.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.486 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 202' ' ' VAL . 27.0 m -80.32 97.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.985 0.422 . . . . 0.0 111.158 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 42.3 t -89.98 98.78 11.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.114 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.418 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 21.7 mmt -130.24 99.68 5.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.817 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -74.48 106.56 6.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.121 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.04 11.93 8.72 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.858 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.418 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 12.3 mmtt -55.76 161.91 1.97 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.887 0.375 . . . . 0.0 111.217 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.621 ' O ' HG23 ' A' ' 215' ' ' VAL . 14.5 mm100 -88.25 160.33 17.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.909 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.841 ' O ' HG23 ' A' ' 216' ' ' VAL . 0.9 OUTLIER -49.89 -57.28 7.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.577 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.97 -34.21 82.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.814 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -44.75 80.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 211' ' ' GLN . 35.5 t -70.65 -37.32 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.342 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 212' ' ' HIS . 59.0 t -68.96 -41.77 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.418 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.8 m -66.24 -40.05 89.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.537 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.625 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -55.39 -39.01 69.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.7 HD11 HD21 ' A' ' 228' ' ' LEU . 25.2 mm -69.75 -32.28 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.716 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -71.57 -36.49 70.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.86 5.16 29.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.619 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.33 14.03 60.43 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.009 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.03 -135.55 26.19 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.906 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.96 -25.13 24.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.793 0.33 . . . . 0.0 111.184 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -108.75 114.93 29.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.632 HG22 ' HG ' ' A' ' 228' ' ' LEU . 24.6 m -109.82 101.56 10.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.715 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -81.19 98.12 7.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.893 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.7 HD21 HD11 ' A' ' 219' ' ' ILE . 32.8 mt -108.19 129.87 55.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.045 0.45 . . . . 0.0 112.17 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.899 HD12 ' HA ' ' A' ' 154' ' ' LEU . 11.8 tp -110.7 109.74 20.12 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.82 HG12 HD13 ' A' ' 199' ' ' ILE . 33.9 m -110.91 -179.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.563 . . . . 0.0 112.305 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 232' ' ' ASP . 17.7 t -119.52 165.66 14.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.116 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.52 ' N ' HG12 ' A' ' 231' ' ' VAL . 32.3 t0 -99.8 109.75 22.15 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 196' ' ' GLN . 25.2 ttm180 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.472 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.777 0.322 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.87 151.46 85.11 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.742 2.295 . . . . 0.0 112.786 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -130.67 145.91 52.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.709 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.901 ' HA ' HD12 ' A' ' 229' ' ' LEU . 21.9 tp -93.08 137.93 31.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.189 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 42.1 t -130.17 140.05 50.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.814 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.1 m -130.17 107.35 9.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.826 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 9.5 ptp -109.98 143.11 40.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.812 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -105.87 127.36 53.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -60.2 -80.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.824 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.68 -156.86 9.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.442 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.77 -1.51 11.68 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.571 2.181 . . . . 0.0 112.671 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.8 p -101.37 -30.15 11.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.126 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.3 -127.93 8.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.433 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.47 ' CZ ' HG22 ' A' ' 219' ' ' ILE . 9.7 m-85 -110.08 -50.21 3.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.863 0.364 . . . . 0.0 110.814 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.24 13.96 69.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.99 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.414 ' CE1' ' CB ' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -124.86 178.39 5.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.223 0.535 . . . . 0.0 111.963 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.805 ' C ' HD22 ' A' ' 168' ' ' LEU . 10.0 m120 -134.35 157.76 45.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.256 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.805 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.3 mm? -133.07 148.32 52.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.965 0.412 . . . . 0.0 111.599 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -134.53 149.18 50.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.103 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 148.02 33.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.011 0.434 . . . . 0.0 111.423 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -130.19 -74.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.612 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -90.08 174.73 7.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.714 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.2 m -110.02 20.22 18.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.252 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.562 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 25.2 mtpt -108.66 -49.25 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.684 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 21.6 Cg_exo -65.28 -56.75 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.269 1.98 . . . . 0.0 112.19 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.73 -156.76 21.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.492 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.602 ' HG2' HG11 ' A' ' 215' ' ' VAL . 4.0 tp-100 -102.5 136.16 42.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.849 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -132.31 152.16 51.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.745 ' HA ' HD13 ' A' ' 168' ' ' LEU . 57.3 mt -74.4 138.08 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.421 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 7.6 ptm180 -103.61 -33.09 9.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.63 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.8 t -149.73 154.66 38.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.95 0.405 . . . . 0.0 111.441 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.884 HG23 ' HB2' ' A' ' 195' ' ' ALA . 37.4 t -135.01 134.99 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 186' ' ' SER . 56.8 t0 -84.37 125.54 71.69 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.24 131.05 30.67 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.341 2.027 . . . . 0.0 112.224 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 73.69 18.71 3.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.78 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.423 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.6 m -97.75 164.36 17.65 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.6 0.238 . . . . 0.0 110.69 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 88.4 Cg_exo -44.4 -40.13 13.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.563 2.175 . . . . 0.0 112.739 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.973 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -63.67 -42.99 98.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 110.639 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.92 -50.89 37.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.966 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -49.1 -30.22 6.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.551 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.5 t -84.97 -26.1 27.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.71 27.89 3.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.175 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.973 HD13 ' HB1' ' A' ' 188' ' ' ALA . 8.3 tt -75.96 149.85 37.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.832 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.822 ' N ' HD23 ' A' ' 193' ' ' LEU . 36.7 mtt85 -134.66 129.86 35.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.794 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.884 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -57.8 150.58 19.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.163 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 73.75 3.07 4.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.766 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.756 ' OD2' HG21 ' A' ' 230' ' ' VAL . 56.0 p30 -66.86 154.84 39.94 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.274 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -89.84 110.25 21.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.767 0.318 . . . . 0.0 111.453 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.74 ' HA ' HG12 ' A' ' 230' ' ' VAL . 24.5 mm -61.99 123.79 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.939 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.88 -45.94 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.448 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.466 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 9.6 pt-20 -143.31 174.16 10.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 111.363 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.884 ' O ' HG22 ' A' ' 205' ' ' VAL . 40.4 t -152.91 106.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.016 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 18.8 t30 70.3 25.97 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.482 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.81 -21.02 35.15 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.372 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 202' ' ' VAL . 28.7 m -81.45 97.27 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.998 0.428 . . . . 0.0 111.232 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.466 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 42.4 t -87.84 98.26 11.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.7 mmt -130.17 99.83 5.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -68.58 101.9 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 113.34 25.37 4.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.543 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.406 ' HD3' ' HB3' ' A' ' 214' ' ' ASP . 0.1 OUTLIER -54.86 164.04 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.843 0.354 . . . . 0.0 111.169 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.645 ' O ' HG23 ' A' ' 215' ' ' VAL . 18.0 mm-40 -99.59 160.21 14.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.037 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.852 ' O ' HG23 ' A' ' 216' ' ' VAL . 10.8 t60 -48.76 -62.56 1.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.87 -32.6 59.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.043 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.406 ' HB3' ' HD3' ' A' ' 210' ' ' LYS . 0.9 OUTLIER -68.37 -44.95 74.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.153 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 211' ' ' GLN . 25.9 t -70.64 -40.01 76.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 212' ' ' HIS . 44.1 t -64.0 -42.83 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.336 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 58.8 m -71.57 -39.04 70.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.575 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.02 81.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.47 HG22 ' CZ ' ' A' ' 164' ' ' TYR . 32.3 mm -61.82 -31.7 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.597 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -73.1 -38.15 66.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.727 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.03 5.32 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.66 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -82.12 9.24 58.08 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.21 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -139.2 20.2 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.017 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -25.12 34.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.663 0.268 . . . . 0.0 111.252 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -116.01 115.34 25.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 110.782 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.9 m -107.32 99.23 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -76.32 98.52 4.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.149 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.455 ' CD2' HG22 ' A' ' 202' ' ' VAL . 34.5 mt -107.36 128.06 54.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.715 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.901 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.5 tp -107.6 109.66 21.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.337 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.756 HG21 ' OD2' ' A' ' 197' ' ' ASP . 29.4 m -123.62 169.93 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 112.187 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.6 t -120.01 138.89 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.393 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -69.85 112.7 6.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.33 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 179.557 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.603 0.24 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 137.87 20.6 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.439 2.093 . . . . 0.0 112.172 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 230' ' ' VAL . 0.8 OUTLIER -93.7 139.37 30.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.786 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 229' ' ' LEU . 14.5 tp -87.62 123.0 32.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 50.5 t -122.33 127.55 49.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.9 m -127.28 103.7 7.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.502 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.629 ' HE1' HD12 ' A' ' 228' ' ' LEU . 2.0 ptt? -110.64 145.04 38.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.02 0.438 . . . . 0.0 111.259 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -104.32 119.36 38.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.578 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.414 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 1.5 tppt? -47.83 -78.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.88 -159.85 26.78 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.228 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.56 0.16 10.24 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.582 2.188 . . . . 0.0 112.91 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.3 p -104.0 -30.27 10.39 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.414 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 93.12 -140.3 15.0 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.079 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 166' ' ' PHE . 7.8 m-85 -110.38 -47.17 3.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.931 0.396 . . . . 0.0 110.762 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.52 24.13 51.54 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.646 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 164' ' ' TYR . 8.5 p90 -124.81 172.87 8.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.216 0.532 . . . . 0.0 111.827 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.695 ' C ' HD22 ' A' ' 168' ' ' LEU . 10.0 m120 -137.95 152.5 49.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.96 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.914 HD12 ' HG3' ' A' ' 177' ' ' GLN . 4.2 mm? -129.78 146.13 51.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.246 0.546 . . . . 0.0 112.299 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -143.59 133.72 24.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.721 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.5 t -129.46 155.5 45.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.033 0.444 . . . . 0.0 111.605 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -130.05 -64.39 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.474 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -90.06 162.52 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -110.12 22.5 15.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.348 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.616 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 52.8 mttm -105.56 -50.22 0.11 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.608 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.616 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 9.0 Cg_exo -72.13 -57.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.426 2.084 . . . . 0.0 112.144 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 145.06 -144.22 12.87 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.369 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.914 ' HG3' HD12 ' A' ' 168' ' ' LEU . 7.0 tp-100 -100.76 150.29 22.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.753 0.311 . . . . 0.0 110.857 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.452 ' CZ ' ' NH1' ' A' ' 198' ' ' ARG . 3.6 m-85 -131.06 138.12 49.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.781 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.81 HD13 HD21 ' A' ' 193' ' ' LEU . 86.9 mt -71.7 133.57 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 110.271 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.424 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 4.5 ptm180 -101.54 -30.88 11.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.723 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.2 t -152.78 145.43 24.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.469 . . . . 0.0 111.731 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 195' ' ' ALA . 18.0 t -128.64 132.31 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.434 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -84.1 120.23 74.44 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.106 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.45 133.44 49.01 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.415 2.076 . . . . 0.0 112.359 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 71.81 15.25 5.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.814 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 44.8 m -97.43 161.8 24.75 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.623 0.249 . . . . 0.0 110.64 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 99.6 Cg_exo -43.99 -40.32 11.78 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.571 2.18 . . . . 0.0 112.753 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.839 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -62.41 -44.3 96.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.444 . . . . 0.0 110.518 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -70.37 -52.27 23.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.027 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.51 -29.39 1.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.609 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.5 t -83.78 -31.98 25.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.959 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.49 7.38 6.32 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.984 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.839 HD13 ' HB1' ' A' ' 188' ' ' ALA . 7.5 tt -57.17 146.45 27.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.744 0.306 . . . . 0.0 110.85 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.703 ' N ' HD23 ' A' ' 193' ' ' LEU . 66.3 mtt-85 -136.54 137.99 40.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -63.46 149.64 45.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.299 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 75.31 2.61 3.91 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.099 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.757 ' OD2' HG21 ' A' ' 230' ' ' VAL . 52.6 p30 -73.1 153.98 40.58 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.435 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.452 ' NH1' ' CZ ' ' A' ' 178' ' ' PHE . 1.3 mmp_? -89.6 115.26 26.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 0.0 111.154 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.88 HD13 HG12 ' A' ' 230' ' ' VAL . 33.8 mm -65.01 125.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.15 -44.29 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.492 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.65 ' OE1' HD22 ' A' ' 229' ' ' LEU . 6.2 pt-20 -144.34 173.35 11.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.024 0.44 . . . . 0.0 111.623 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 205' ' ' VAL . 43.4 t -151.52 107.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.861 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.1 t30 70.27 24.35 4.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.322 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.76 -20.14 37.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.343 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 202' ' ' VAL . 36.0 m -82.48 99.19 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.99 0.424 . . . . 0.0 111.335 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.443 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 45.3 t -84.92 100.62 11.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.986 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.421 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 20.4 mmt -130.13 99.81 5.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -69.73 102.42 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.761 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.81 20.93 4.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.729 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.56 ' HA ' ' CE ' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -54.82 150.67 9.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.918 0.389 . . . . 0.0 111.076 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 215' ' ' VAL . 4.8 mm-40 -94.56 160.25 14.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.1 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.841 ' O ' HG23 ' A' ' 216' ' ' VAL . 85.0 t60 -47.15 -61.64 1.79 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.12 -30.55 60.9 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.151 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -44.26 67.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.407 . . . . 0.0 110.331 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 177' ' ' GLN . 39.2 t -71.96 -38.95 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.312 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 212' ' ' HIS . 46.3 t -66.4 -41.2 88.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.592 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 64.6 m -72.55 -34.64 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.696 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.1 83.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.057 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 32.0 mm -59.55 -41.98 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 ttp-105 -64.21 -41.68 96.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.724 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.06 5.32 30.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.712 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.64 19.21 38.1 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.046 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -145.08 9.61 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.941 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.63 -25.15 28.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.725 0.298 . . . . 0.0 111.158 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -103.98 114.99 29.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.59 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 4.5 m -111.09 108.05 17.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.345 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -91.12 99.89 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.403 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.713 HD21 HG13 ' A' ' 202' ' ' VAL . 12.4 mt -107.06 132.21 53.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.044 0.45 . . . . 0.0 111.717 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.671 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.3 tp -116.46 109.41 17.26 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.88 HG12 HD13 ' A' ' 199' ' ' ILE . 34.3 m -113.86 177.69 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.021 0.439 . . . . 0.0 112.061 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 198' ' ' ARG . 5.2 t -124.48 144.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.778 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -74.1 110.91 8.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.375 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.665 179.364 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.64 142.53 14.44 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.458 ' O ' HD12 ' A' ' 229' ' ' LEU . 16.1 mtm105 -110.38 153.92 24.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.708 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.636 ' HA ' HD12 ' A' ' 229' ' ' LEU . 25.5 tp -104.15 133.1 49.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.028 0.442 . . . . 0.0 111.114 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.488 ' SG ' HD12 ' A' ' 193' ' ' LEU . 38.4 t -129.99 138.55 50.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.736 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.0 m -140.09 101.21 4.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.781 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.704 ' HE1' HD11 ' A' ' 228' ' ' LEU . 3.3 ptt? -109.91 135.8 50.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.954 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -95.12 135.61 36.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.011 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.453 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 18.3 tptp -73.97 -78.03 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.82 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.89 -159.94 5.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.198 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.02 0.17 10.22 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.614 2.209 . . . . 0.0 112.519 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.8 p -103.07 -30.12 10.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.592 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.453 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 95.46 -148.56 19.03 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.398 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.607 ' OH ' HG22 ' A' ' 219' ' ' ILE . 31.7 m-85 -97.73 -44.16 6.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.922 0.392 . . . . 0.0 110.77 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 183' ' ' ASP . . . 88.68 14.83 60.73 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.95 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.584 ' CE1' HD21 ' A' ' 168' ' ' LEU . 0.0 OUTLIER -124.86 -177.46 3.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.139 0.495 . . . . 0.0 111.879 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.813 ' C ' HD22 ' A' ' 168' ' ' LEU . 9.8 m120 -129.7 161.76 29.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.888 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.813 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.8 mm? -135.67 134.63 39.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.22 0.533 . . . . 0.0 112.276 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 6.6 p-80 -134.8 165.29 25.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.808 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.1 t -128.2 142.13 51.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.513 0.673 . . . . 0.0 112.504 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 178' ' ' PHE . 16.1 t0 -105.6 -40.22 5.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.386 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 14.3 mmtm -82.97 175.02 10.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.854 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.7 m -104.4 -26.97 12.22 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.912 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.766 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 32.0 mtmm -122.21 -58.64 0.03 OUTLIER Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.766 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 7.0 Cg_exo -81.28 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.837 2.358 . . . . 0.0 115.702 -175.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -39.07 145.0 0.24 Allowed Glycine 0 N--CA 1.453 -0.21 0 N-CA-C 116.532 1.373 . . . . 0.0 116.532 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.84 ' HG2' HG11 ' A' ' 215' ' ' VAL . 30.5 tp60 -138.35 127.13 23.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 112.867 -1.667 . . . . 0.0 107.159 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.638 ' CD2' ' NH2' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -134.93 135.65 41.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.727 HD12 ' OD2' ' A' ' 197' ' ' ASP . 50.4 mt -80.88 129.91 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' A' ' 169' ' ' HIS . 19.6 ptt180 -95.99 -33.27 12.21 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.0 t -154.74 157.69 38.4 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 195' ' ' ALA . 22.1 t -133.9 139.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.503 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 165' ' ' GLY . 47.1 t0 -87.35 122.44 70.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.176 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 31.2 Cg_exo -61.4 133.87 48.55 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.28 1.987 . . . . 0.0 111.973 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 75.26 14.85 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.625 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 46.6 m -100.62 162.97 19.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.637 0.255 . . . . 0.0 110.532 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 82.4 Cg_exo -45.87 -40.21 19.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.469 2.112 . . . . 0.0 112.797 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.643 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -65.07 -42.53 94.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.07 0.462 . . . . 0.0 110.475 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -70.42 -51.58 28.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.022 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.2 -24.76 11.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.497 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.8 t -85.06 -29.14 25.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 0.0 110.969 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.13 8.72 11.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.506 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -60.41 150.86 29.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.694 0.283 . . . . 0.0 110.557 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.887 ' N ' HD23 ' A' ' 193' ' ' LEU . 48.1 mtt180 -142.87 129.69 20.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.712 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -55.19 152.26 8.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 35.6 mt-30 78.31 6.73 2.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.851 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.727 ' OD2' HD12 ' A' ' 179' ' ' ILE . 40.7 p30 -78.11 152.62 32.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.636 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.638 ' NH2' ' CD2' ' A' ' 178' ' ' PHE . 7.9 mmp_? -85.78 109.1 18.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.652 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.87 ' HA ' HG12 ' A' ' 230' ' ' VAL . 39.1 mm -68.64 113.14 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.809 0.337 . . . . 0.0 110.441 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.0 t -105.72 -46.09 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.458 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 6.2 pt-20 -136.69 171.68 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 0.0 111.912 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 205' ' ' VAL . 17.9 t -147.84 113.09 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.553 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 50.6 t30 70.04 20.66 6.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.934 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 102.53 -15.41 55.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.559 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 202' ' ' VAL . 27.1 m -83.61 91.31 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 117.229 0.514 . . . . 0.0 111.537 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 51.6 t -82.89 109.59 17.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.737 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.444 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 20.5 mmt -130.5 99.89 5.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -74.9 103.57 5.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.77 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 175' ' ' PRO . . . 122.16 10.38 6.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.939 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.444 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 9.1 mmtt -56.82 147.61 22.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.9 0.381 . . . . 0.0 111.258 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.459 ' O ' HG23 ' A' ' 215' ' ' VAL . 29.5 mm-40 -79.53 160.51 26.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.862 ' O ' HG23 ' A' ' 216' ' ' VAL . 0.7 OUTLIER -47.84 -54.3 12.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.668 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.2 -33.02 85.77 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.802 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.52 -47.21 82.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.849 0.357 . . . . 0.0 110.281 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.84 HG11 ' HG2' ' A' ' 177' ' ' GLN . 28.2 t -66.55 -38.41 81.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.181 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 212' ' ' HIS . 57.3 t -68.24 -43.3 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.496 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 52.4 m -64.58 -37.64 88.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.409 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.499 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -56.0 -44.3 78.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.898 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.607 HG22 ' OH ' ' A' ' 164' ' ' TYR . 34.0 mm -61.57 -36.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.696 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 47.7 ttp85 -72.4 -33.98 67.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.04 5.39 29.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.67 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -84.55 12.61 55.49 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.187 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -140.77 17.35 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.88 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.49 -25.18 36.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 111.154 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -115.62 114.87 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.658 HG22 HD21 ' A' ' 228' ' ' LEU . 3.9 m -107.82 94.97 5.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -81.27 94.76 6.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.464 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.887 ' CD2' HG13 ' A' ' 202' ' ' VAL . 19.2 mt -101.27 141.51 34.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.657 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.636 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.1 tp -117.18 109.66 17.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.87 HG12 ' HA ' ' A' ' 199' ' ' ILE . 26.8 m -116.96 178.35 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 232' ' ' ASP . 4.3 t -119.69 165.77 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.495 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.484 ' N ' HG12 ' A' ' 231' ' ' VAL . 66.6 t0 -93.91 109.22 20.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.992 0.425 . . . . 0.0 112.016 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.455 ' HD3' ' NH1' ' A' ' 198' ' ' ARG . 24.9 ttp180 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.424 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.418 ' HB2' ' HD2' ' A' ' 152' ' ' PRO . 9.9 ptm180 . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.899 0.38 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.736 ' HA ' HG22 ' A' ' 231' ' ' VAL . 19.7 Cg_endo -60.78 140.9 93.08 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.692 2.261 . . . . 0.0 112.422 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.582 ' O ' HD12 ' A' ' 229' ' ' LEU . 42.5 mtm180 -108.41 141.68 39.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.991 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 37.2 tp -76.27 132.61 39.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.222 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 6.1 t -126.93 140.16 52.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.265 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.428 ' N ' ' OG ' ' A' ' 191' ' ' SER . 4.3 m -130.03 104.61 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.655 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -109.88 141.49 42.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.007 0.432 . . . . 0.0 111.379 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -113.09 115.93 29.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.401 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.427 ' HD3' ' CE1' ' A' ' 164' ' ' TYR . 7.6 tptp -61.76 -88.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.804 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.68 -150.15 18.16 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.341 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.9 0.06 10.3 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.68 2.253 . . . . 0.0 112.627 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.7 p -92.31 -30.33 15.89 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.321 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.04 -158.65 21.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.471 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.463 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 30.4 m-85 -87.93 -50.71 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.967 0.413 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.53 14.91 33.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.968 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.821 ' CE2' HD21 ' A' ' 168' ' ' LEU . 7.5 p90 -163.72 -179.42 6.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.168 0.509 . . . . 0.0 111.585 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.77 ' C ' HD22 ' A' ' 168' ' ' LEU . 2.9 m120 -127.72 165.06 20.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.551 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.821 HD21 ' CE2' ' A' ' 166' ' ' PHE . 3.2 mm? -134.37 137.65 44.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.456 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -134.82 153.43 52.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.042 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.0 t -155.25 158.09 38.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.768 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -130.09 -77.23 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.407 ' HB2' ' CD ' ' A' ' 175' ' ' PRO . 3.7 mmpt? -81.05 175.14 10.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.666 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -90.41 12.25 19.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.369 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.482 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 26.7 mtmm -105.65 -47.17 0.13 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.904 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 76.9 Cg_exo -51.27 -63.56 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.145 1.897 . . . . 0.0 112.462 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.08 -141.15 16.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.434 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.716 ' CB ' HG21 ' A' ' 215' ' ' VAL . 3.0 tp-100 -105.31 104.88 14.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.681 0.277 . . . . 0.0 110.972 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.512 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 10.3 m-30 -115.64 148.82 39.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.717 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.743 HD13 HD21 ' A' ' 193' ' ' LEU . 65.0 mt -76.08 133.73 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.583 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.456 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 8.1 ptt180 -104.97 -31.07 9.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.363 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.2 t -150.32 155.67 40.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 111.241 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.955 HG23 ' HB2' ' A' ' 195' ' ' ALA . 24.5 t -132.89 141.65 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -94.4 120.92 64.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.915 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.55 134.17 49.7 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.36 2.04 . . . . 0.0 112.362 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 73.09 14.89 4.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.839 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.4 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 36.4 m -94.78 162.51 25.15 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.565 0.221 . . . . 0.0 110.503 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 75.1 Cg_exo -48.22 -40.16 34.82 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.367 2.045 . . . . 0.0 112.4 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.94 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -61.79 -44.61 96.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.495 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -65.28 -55.41 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.017 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.19 -25.47 61.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 156' ' ' THR . 26.4 t -78.73 -22.53 46.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 106.89 28.63 4.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.016 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.94 HD13 ' HB1' ' A' ' 188' ' ' ALA . 7.3 tt -85.4 145.18 27.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 0.0 110.935 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.667 ' N ' HD23 ' A' ' 193' ' ' LEU . 5.3 mtt-85 -131.53 131.64 43.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.955 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -57.37 145.64 31.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.319 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' A' ' 233' ' ' ARG . 56.5 mt-30 74.81 -0.22 3.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.979 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.662 ' CG ' HD12 ' A' ' 179' ' ' ILE . 49.2 p30 -63.63 158.2 21.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.765 0.317 . . . . 0.0 110.672 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.512 ' HD2' ' CE1' ' A' ' 178' ' ' PHE . 1.8 mmm180 -94.95 112.84 24.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.344 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.794 HD13 HG12 ' A' ' 230' ' ' VAL . 32.7 mm -65.08 117.21 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.853 0.359 . . . . 0.0 110.586 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.557 ' CG1' HD23 ' A' ' 229' ' ' LEU . 23.4 t -97.61 -46.64 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.61 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 5.2 pt-20 -139.68 176.03 9.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.069 0.461 . . . . 0.0 111.425 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.893 ' O ' HG22 ' A' ' 205' ' ' VAL . 33.8 t -153.18 105.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.773 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.7 t30 70.35 25.09 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.395 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.47 -19.85 38.56 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.451 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 202' ' ' VAL . 32.0 m -82.8 98.16 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.992 0.425 . . . . 0.0 111.319 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.438 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 45.8 t -84.93 102.47 13.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.034 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.412 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 16.2 mmt -130.14 99.86 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.938 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -69.55 102.61 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.48 22.43 4.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.71 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.412 ' HG2' ' HB2' ' A' ' 207' ' ' MET . 0.0 OUTLIER -54.93 157.79 3.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.533 ' O ' HG23 ' A' ' 215' ' ' VAL . 31.0 mm-40 -94.87 160.12 14.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.12 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.862 ' O ' HG23 ' A' ' 216' ' ' VAL . 1.1 t-80 -50.09 -60.72 2.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.9 -33.58 84.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.236 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.64 -48.62 80.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 110.26 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.716 HG21 ' CB ' ' A' ' 177' ' ' GLN . 23.0 t -68.01 -40.42 83.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.089 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 212' ' ' HIS . 47.0 t -62.4 -44.81 99.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.281 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 75.0 m -66.84 -39.05 87.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.29 80.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.874 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 226' ' ' THR . 36.5 mm -62.68 -36.43 75.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.653 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -46.93 84.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.536 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.0 5.08 30.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.534 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -92.37 20.18 45.52 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.837 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.26 -143.33 12.47 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.893 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -88.71 -22.9 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.674 0.273 . . . . 0.0 111.342 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -108.42 115.73 30.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.753 HG21 ' CD1' ' A' ' 219' ' ' ILE . 28.0 m -120.19 114.19 21.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.452 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -86.04 99.04 11.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.171 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.711 HD23 ' HA ' ' A' ' 202' ' ' VAL . 23.0 mt -105.39 140.75 38.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.046 0.451 . . . . 0.0 111.961 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 153' ' ' ARG . 13.7 tp -115.55 109.47 17.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.467 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.794 HG12 HD13 ' A' ' 199' ' ' ILE . 33.3 m -116.63 169.23 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.999 0.428 . . . . 0.0 111.736 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 152' ' ' PRO . 2.6 t -135.62 152.94 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -69.86 109.66 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.77 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 196' ' ' GLN . 26.8 ttp180 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.247 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.677 ' HA ' HG22 ' A' ' 231' ' ' VAL . 7.6 Cg_endo -50.45 151.95 9.39 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.063 2.509 . . . . 0.0 112.957 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -127.71 140.94 51.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.575 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.818 ' HA ' HD12 ' A' ' 229' ' ' LEU . 16.6 tp -87.16 132.93 33.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.278 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 39.4 t -130.08 140.1 50.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.757 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -135.1 106.39 6.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.707 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' MET . . . . . 1.066 ' HE1' HD12 ' A' ' 228' ' ' LEU . 12.3 ptp -113.78 143.93 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 0.0 111.171 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -102.22 124.3 47.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.792 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 224' ' ' ASP . 6.6 tptm -55.76 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.37 -150.66 40.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.403 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.74 -16.68 14.54 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.72 2.28 . . . . 0.0 112.596 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.5 p -93.12 -30.15 15.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.174 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.435 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 80.05 -131.68 10.73 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.471 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CB ' ' CE1' ' A' ' 166' ' ' PHE . 3.6 m-85 -105.94 -50.36 3.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 110.433 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.06 20.83 52.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.29 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.497 ' CE1' ' CB ' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -124.86 179.11 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.125 0.488 . . . . 0.0 111.728 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.807 ' C ' HD22 ' A' ' 168' ' ' LEU . 8.7 m120 -129.87 159.2 37.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.877 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.807 HD22 ' C ' ' A' ' 167' ' ' ASN . 3.1 mm? -136.32 136.02 39.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.191 0.52 . . . . 0.0 112.066 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -134.53 165.26 25.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.5 178.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.5 t -140.69 148.0 40.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.073 0.463 . . . . 0.0 111.789 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -130.33 -67.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.527 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -90.05 164.63 14.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.733 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 67.0 m -110.15 22.33 15.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.472 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.733 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 25.1 mtpp -116.96 -56.25 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.838 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 57.4 Cg_exo -53.62 -56.23 2.85 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.139 1.892 . . . . 0.0 112.536 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 137.92 -143.7 14.78 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.358 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.869 ' HB2' HG21 ' A' ' 215' ' ' VAL . 10.3 tp-100 -84.22 142.48 30.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 110.776 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.532 ' CD2' ' CZ ' ' A' ' 198' ' ' ARG . 1.7 m-85 -120.98 149.67 42.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.53 HD12 ' OD1' ' A' ' 197' ' ' ASP . 9.9 mt -98.46 130.91 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.1 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.448 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 24.2 ptt180 -100.77 -30.57 11.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.5 t -157.73 151.24 23.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.1 0.476 . . . . 0.0 112.009 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.775 HG23 ' HB2' ' A' ' 195' ' ' ALA . 54.6 t -131.85 141.09 46.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.456 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 186' ' ' SER . 56.8 t0 -84.95 125.33 70.92 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.111 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.18 127.53 19.47 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.392 2.061 . . . . 0.0 112.161 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 185' ' ' ASP . 13.7 t0 74.4 23.49 1.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.5 m -102.56 164.63 15.27 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.606 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 81.1 Cg_exo -44.85 -40.28 14.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.612 2.208 . . . . 0.0 112.747 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -43.01 92.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.077 0.465 . . . . 0.0 110.407 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.56 -51.81 25.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.038 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -49.28 -27.4 3.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.644 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.3 t -85.03 -31.54 23.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 111.056 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 121.19 21.33 3.13 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.991 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.862 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -83.09 151.59 25.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.613 0.244 . . . . 0.0 110.573 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.862 ' N ' HD23 ' A' ' 193' ' ' LEU . 30.5 mtp180 -145.57 129.72 17.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.266 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.775 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -52.15 160.78 0.71 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.703 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 54.9 mt-30 82.43 -4.82 1.4 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.092 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.689 ' OD2' HG21 ' A' ' 230' ' ' VAL . 38.3 p30 -86.13 165.2 16.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 110.593 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.532 ' CZ ' ' CD2' ' A' ' 178' ' ' PHE . 15.5 mmp_? -101.55 125.12 48.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 111.682 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.767 ' HA ' HG12 ' A' ' 230' ' ' VAL . 26.0 mm -69.43 108.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.854 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.18 -50.11 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.367 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.441 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 11.2 pt-20 -136.22 173.92 11.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.98 0.419 . . . . 0.0 111.139 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.873 ' O ' HG22 ' A' ' 205' ' ' VAL . 40.1 t -151.48 107.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.929 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 53.5 t30 70.25 25.22 4.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.437 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.55 -18.67 43.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.5 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 202' ' ' VAL . 36.0 m -83.74 97.87 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.008 0.432 . . . . 0.0 111.191 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 48.5 t -85.91 101.66 13.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.061 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.427 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 96.6 mmm -130.11 99.66 5.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.856 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -70.89 105.34 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.27 17.85 5.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.743 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.427 ' HG2' ' HB2' ' A' ' 207' ' ' MET . 0.7 OUTLIER -54.94 150.15 10.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.952 0.406 . . . . 0.0 111.123 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.509 ' O ' HG23 ' A' ' 215' ' ' VAL . 11.4 mm100 -91.53 160.43 15.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.058 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.872 ' O ' HG23 ' A' ' 216' ' ' VAL . 32.4 t-80 -47.81 -64.58 0.75 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.67 -33.79 59.9 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.108 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.27 -47.13 83.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.191 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.869 HG21 ' HB2' ' A' ' 177' ' ' GLN . 23.3 t -71.94 -38.95 66.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.116 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 212' ' ' HIS . 48.6 t -62.44 -41.63 92.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.193 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 32.4 m -75.05 -40.82 60.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.419 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.26 -46.79 87.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.694 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.479 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 23.3 mm -61.23 -34.08 59.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.534 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -73.89 -36.89 64.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.382 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.75 5.53 28.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.674 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -83.29 16.34 29.65 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.171 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.29 -135.89 26.96 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.055 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.2 m-20 -92.21 -25.08 18.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.668 0.27 . . . . 0.0 111.38 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -102.34 117.94 35.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.592 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 5.7 m -114.69 98.45 6.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.485 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -88.73 97.71 11.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.056 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 1.066 HD12 ' HE1' ' A' ' 157' ' ' MET . 54.3 mt -105.38 138.89 40.85 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.6 tp -117.8 109.91 17.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.082 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 199' ' ' ILE . 35.4 m -124.43 170.76 14.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 152' ' ' PRO . 2.6 t -141.33 135.44 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.484 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -72.55 119.87 17.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.401 . . . . 0.0 111.408 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.445 ' HB3' ' NH1' ' A' ' 198' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.81 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.706 0.288 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.627 ' HB3' HG22 ' A' ' 231' ' ' VAL . 73.9 Cg_endo -75.24 170.77 19.62 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.674 2.249 . . . . 0.0 112.869 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 15.5 mtm105 -135.39 145.13 47.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.611 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.916 ' HA ' HD12 ' A' ' 229' ' ' LEU . 59.4 tp -85.76 135.02 33.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.37 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.7 t -130.01 140.07 50.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.814 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -131.53 108.34 9.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.65 ' CE ' HD12 ' A' ' 228' ' ' LEU . 6.7 ptp -119.85 142.1 48.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -102.73 135.63 44.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.085 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.459 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 18.2 tptt -70.14 -78.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.785 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.87 -159.89 5.62 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.266 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.62 0.21 10.2 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.597 2.198 . . . . 0.0 112.654 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.0 p -101.03 -30.24 11.72 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.459 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 89.41 -147.79 19.7 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.26 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.508 ' HB3' ' CE2' ' A' ' 166' ' ' PHE . 13.8 m-85 -110.19 -43.93 3.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.991 0.424 . . . . 0.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.94 40.49 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.507 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 164' ' ' TYR . 4.2 p90 -124.6 174.08 8.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 117.219 0.509 . . . . 0.0 111.714 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.731 ' O ' HG23 ' A' ' 179' ' ' ILE . 10.0 m120 -134.98 152.84 52.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.319 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 179' ' ' ILE . 4.1 mm? -127.49 142.8 51.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.011 0.434 . . . . 0.0 111.838 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.456 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 7.5 p-80 -142.62 144.39 32.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.235 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.9 t -144.05 160.48 40.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.924 0.392 . . . . 0.0 111.273 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -126.39 -71.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -90.09 168.54 11.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.7 m -110.0 21.19 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.233 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.543 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 30.7 mtmm -104.79 -49.1 0.13 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.492 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.543 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 13.8 Cg_exo -69.39 -66.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.402 2.068 . . . . 0.0 112.154 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.48 -159.45 28.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.609 ' HG3' HD12 ' A' ' 168' ' ' LEU . 8.2 tp-100 -105.52 144.32 32.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.866 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.426 ' CE1' ' HD3' ' A' ' 198' ' ' ARG . 8.7 m-85 -135.8 151.29 49.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.804 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 167' ' ' ASN . 70.0 mt -72.96 138.98 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.549 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.456 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 5.8 ptt180 -99.31 -34.13 10.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.583 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.416 ' N ' ' HG3' ' A' ' 180' ' ' ARG . 23.0 t -151.73 152.86 33.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.051 0.453 . . . . 0.0 111.512 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 195' ' ' ALA . 26.8 t -131.17 135.48 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.665 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 186' ' ' SER . 59.0 t0 -81.66 120.72 78.56 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.949 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.94 126.94 20.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.351 2.034 . . . . 0.0 112.38 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 t70 74.25 22.94 2.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.741 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 183' ' ' ASP . 5.6 m -100.86 162.61 20.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.594 0.235 . . . . 0.0 110.638 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -43.49 -40.34 10.16 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.673 2.249 . . . . 0.0 112.721 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.891 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -66.11 -42.61 89.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.471 . . . . 0.0 110.31 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.54 -51.68 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.887 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -48.12 -29.68 3.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.541 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.6 t -83.5 -30.05 27.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 120.7 29.5 1.54 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.53 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.891 HD13 ' HB1' ' A' ' 188' ' ' ALA . 8.2 tt -84.2 149.22 26.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.74 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.816 ' N ' HD23 ' A' ' 193' ' ' LEU . 5.4 mtt-85 -141.43 135.93 30.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.665 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -56.08 153.37 9.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.343 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 70.97 7.87 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.774 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.622 ' OD2' HD12 ' A' ' 179' ' ' ILE . 58.8 p30 -74.02 150.05 40.9 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.426 ' HD3' ' CE1' ' A' ' 178' ' ' PHE . 1.4 mmp_? -89.87 113.43 25.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 111.231 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.778 HD13 HG12 ' A' ' 230' ' ' VAL . 27.8 mm -68.27 125.73 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.75 -44.52 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.499 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.459 ' HG2' ' CB ' ' A' ' 229' ' ' LEU . 10.1 pt-20 -143.61 176.85 8.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 111.389 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.89 ' O ' HG22 ' A' ' 205' ' ' VAL . 36.0 t -155.65 107.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.946 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 12.5 t30 70.19 24.27 4.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.45 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.79 -19.16 39.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.369 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.89 HG22 ' O ' ' A' ' 202' ' ' VAL . 32.7 m -81.87 95.69 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.015 0.436 . . . . 0.0 111.272 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.436 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 50.2 t -86.42 99.17 11.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.938 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.424 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 17.6 mmt -130.14 99.83 5.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -68.24 103.91 1.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.748 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.61 21.02 4.83 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.583 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -54.78 142.18 29.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.972 0.415 . . . . 0.0 111.138 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.512 ' O ' HG23 ' A' ' 215' ' ' VAL . 7.4 mm-40 -85.84 160.39 19.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.854 ' O ' HG23 ' A' ' 216' ' ' VAL . 77.9 t60 -45.55 -60.91 1.92 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.02 -31.14 64.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.981 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -43.71 67.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.939 0.4 . . . . 0.0 110.249 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 211' ' ' GLN . 40.5 t -72.14 -39.13 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.286 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 212' ' ' HIS . 49.3 t -65.92 -41.25 89.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.48 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 73.1 m -70.06 -38.47 75.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.566 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.469 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -55.49 -45.15 77.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.004 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.456 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 30.1 mm -63.84 -36.43 76.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.752 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -65.43 -41.32 93.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.649 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.51 5.2 28.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -81.89 5.56 70.08 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.073 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -140.13 18.53 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.852 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.21 -25.18 34.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.71 0.291 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -115.6 114.86 25.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.524 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.503 HG22 ' CD2' ' A' ' 228' ' ' LEU . 17.3 m -111.6 96.48 6.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.445 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -73.58 97.07 2.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.009 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.887 HD21 HG13 ' A' ' 202' ' ' VAL . 73.6 mt -105.33 131.59 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.978 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 154' ' ' LEU . 12.2 tp -109.58 109.48 20.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.315 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.778 HG12 HD13 ' A' ' 199' ' ' ILE . 35.9 m -119.19 169.82 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.031 0.443 . . . . 0.0 111.907 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 152' ' ' PRO . 15.9 t -119.82 156.32 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.697 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 231' ' ' VAL . 67.9 t0 -92.41 112.31 24.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.304 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.804 179.586 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 120.79 0.329 . . . . 0.0 111.587 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.12 -179.91 5.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.794 2.329 . . . . 0.0 112.783 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -137.79 141.47 40.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.735 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.868 ' HA ' HD12 ' A' ' 229' ' ' LEU . 35.1 tp -99.4 131.36 45.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.962 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.9 t -130.01 138.54 50.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.035 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -131.49 104.4 6.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.486 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.683 ' HE1' ' HB2' ' A' ' 188' ' ' ALA . 5.7 ptm -119.73 140.49 50.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.216 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -96.28 129.42 43.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.404 ' CE ' ' HA2' ' A' ' 163' ' ' GLY . 18.9 tptp -59.78 -80.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.802 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.82 -156.7 17.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.262 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.69 0.02 10.33 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.615 2.21 . . . . 0.0 112.798 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.4 p -92.89 -30.36 15.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.574 0.226 . . . . 0.0 111.469 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.404 ' HA2' ' CE ' ' A' ' 159' ' ' LYS . . . 91.33 -124.9 7.79 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.378 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.488 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 2.4 m-85 -108.21 -55.07 2.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 0.0 110.488 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.71 -5.04 61.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.457 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.645 ' CE2' HD21 ' A' ' 168' ' ' LEU . 45.1 p90 -128.74 177.45 7.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.403 0.602 . . . . 0.0 111.762 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.806 ' C ' HD22 ' A' ' 168' ' ' LEU . 84.9 m-20 -125.5 165.19 18.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.806 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.4 mm? -133.55 147.66 51.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.011 0.434 . . . . 0.0 112.003 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 2.2 p-80 -134.47 146.23 49.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.708 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.6 t -155.21 150.04 26.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 111.65 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -114.96 -68.93 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.231 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 155.2 19.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.464 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.1 m -96.34 20.27 10.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.177 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.561 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 31.7 mttp -110.9 -49.71 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.994 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 38.2 Cg_exo -57.63 -63.38 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.109 1.873 . . . . 0.0 112.391 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.9 -162.02 29.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.579 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -108.3 136.47 47.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 0.0 110.886 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.434 ' CD1' ' HD2' ' A' ' 198' ' ' ARG . 2.3 m-85 -124.08 158.05 33.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.608 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.64 ' HA ' HD13 ' A' ' 168' ' ' LEU . 15.0 mt -87.14 139.6 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.875 0.369 . . . . 0.0 110.743 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.458 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 10.2 ptm180 -105.16 -37.79 6.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.516 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.6 t -148.49 154.95 40.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.013 0.435 . . . . 0.0 111.716 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.758 HG23 ' HB2' ' A' ' 195' ' ' ALA . 33.6 t -132.34 143.04 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.739 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 57.2 t0 -95.03 125.33 51.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.081 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 23.5 Cg_exo -63.96 134.42 43.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.275 1.984 . . . . 0.0 112.084 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 74.24 14.9 3.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.728 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 21.2 m -97.26 163.37 20.0 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.515 0.198 . . . . 0.0 110.537 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 81.3 Cg_exo -45.66 -40.35 18.67 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.473 2.115 . . . . 0.0 112.548 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.683 ' HB2' ' HE1' ' A' ' 157' ' ' MET . . . -65.13 -41.62 94.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 110.687 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -70.13 -50.6 38.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.82 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -47.59 -31.49 4.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.474 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.2 t -81.23 -31.45 33.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.049 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 113.1 31.54 2.42 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.063 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 194' ' ' ARG . 6.8 tt -82.59 151.37 26.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.733 0.302 . . . . 0.0 110.905 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.745 ' N ' HD23 ' A' ' 193' ' ' LEU . 49.9 mtt180 -137.78 130.02 29.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.645 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.758 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -52.82 157.59 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.497 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 47.5 mt-30 82.46 -17.04 0.55 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.326 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.739 ' OD2' HG21 ' A' ' 230' ' ' VAL . 20.1 p-10 -61.13 149.58 36.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.727 0.299 . . . . 0.0 110.662 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.434 ' HD2' ' CD1' ' A' ' 178' ' ' PHE . 4.6 mmm-85 -90.63 118.31 29.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.335 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.788 HD13 HG12 ' A' ' 230' ' ' VAL . 24.3 mm -65.28 128.6 28.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.799 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.485 ' CG2' HG23 ' A' ' 231' ' ' VAL . 11.8 t -111.23 -43.73 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.636 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.562 ' OE1' HD22 ' A' ' 229' ' ' LEU . 5.4 pt-20 -142.81 173.74 11.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.477 . . . . 0.0 111.433 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.88 ' O ' HG22 ' A' ' 205' ' ' VAL . 47.0 t -153.4 107.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.983 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.5 t30 70.37 25.27 4.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.508 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.48 -20.46 37.14 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.452 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 202' ' ' VAL . 26.9 m -80.4 95.28 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.09 0.445 . . . . 0.0 111.161 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.44 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 44.9 t -89.93 99.73 12.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.012 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.4 ' O ' ' HG2' ' A' ' 210' ' ' LYS . 45.6 mmm -130.16 101.38 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -67.1 100.04 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.625 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.23 26.49 3.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.392 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 207' ' ' MET . 6.5 mmtp -54.9 156.27 3.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 111.119 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.525 ' O ' HG23 ' A' ' 215' ' ' VAL . 3.7 mm-40 -92.11 160.28 15.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.987 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.811 ' O ' HG23 ' A' ' 216' ' ' VAL . 63.8 t-80 -47.71 -62.69 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.49 -30.3 64.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.284 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.86 -45.78 73.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 110.484 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 211' ' ' GLN . 28.7 t -70.92 -37.04 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.458 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 212' ' ' HIS . 45.0 t -69.2 -42.03 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.658 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 70.3 m -72.15 -33.18 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -59.35 -48.78 80.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.479 HD13 HG13 ' A' ' 202' ' ' VAL . 26.8 mm -62.24 -38.08 80.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.944 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -68.47 -36.84 79.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.734 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.14 5.2 30.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.645 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -85.1 10.18 64.1 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.039 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.17 -128.68 27.07 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.806 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.33 -25.09 18.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.717 0.294 . . . . 0.0 111.125 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -107.98 117.37 33.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.788 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.408 HG22 HD21 ' A' ' 228' ' ' LEU . 3.0 m -113.24 96.11 5.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.442 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -78.5 98.55 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.097 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.604 HD12 ' SD ' ' A' ' 157' ' ' MET . 28.7 mt -106.46 131.01 54.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.035 0.445 . . . . 0.0 111.906 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 154' ' ' LEU . 11.9 tp -115.98 109.7 17.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.572 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.788 HG12 HD13 ' A' ' 199' ' ' ILE . 32.0 m -109.77 176.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 112.068 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.485 HG23 ' CG2' ' A' ' 200' ' ' VAL . 5.4 t -126.49 162.89 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.074 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.479 ' N ' HG12 ' A' ' 231' ' ' VAL . 64.9 t0 -80.61 112.9 18.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.252 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.572 179.446 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.548 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 3.7 ptm85 . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.4 139.13 12.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.567 2.178 . . . . 0.0 112.556 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -94.51 139.89 30.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.383 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.917 ' HA ' HD12 ' A' ' 229' ' ' LEU . 18.1 tp -95.99 119.84 35.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.989 0.423 . . . . 0.0 111.026 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 228' ' ' LEU . 45.3 t -116.21 126.94 54.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.53 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.448 ' N ' ' OG ' ' A' ' 191' ' ' SER . 3.0 m -135.48 99.91 4.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.192 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.42 ' HE2' ' HA ' ' A' ' 188' ' ' ALA . 16.4 ptp -112.38 142.91 44.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.195 0.522 . . . . 0.0 111.88 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -104.44 119.65 39.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.895 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 224' ' ' ASP . 16.5 tptp -58.08 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.057 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.01 -152.86 12.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.385 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.02 0.17 10.22 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.747 2.298 . . . . 0.0 112.885 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.7 p -87.16 -30.41 21.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.575 0.226 . . . . 0.0 111.544 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.402 ' HA2' ' CE ' ' A' ' 159' ' ' LYS . . . 97.27 -146.66 18.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.179 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 7.7 m-85 -109.33 -46.83 3.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.167 0.508 . . . . 0.0 110.259 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 183' ' ' ASP . . . 70.71 28.34 71.01 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.626 -0.715 . . . . 0.0 113.813 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -140.84 175.68 9.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.576 0.688 . . . . 0.0 112.163 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.796 ' C ' HD22 ' A' ' 168' ' ' LEU . 10.0 m120 -135.65 155.98 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.66 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.796 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.3 mm? -133.42 143.06 48.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.046 0.451 . . . . 0.0 111.9 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -141.03 136.86 32.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.298 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.6 t -137.15 163.95 29.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.379 . . . . 0.0 111.28 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -130.04 -78.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.665 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -90.14 175.05 7.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.761 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.0 m -109.22 19.65 19.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.208 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.63 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 2.6 mtmp? -110.87 -51.36 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.752 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 38.8 Cg_exo -61.2 -63.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.238 1.959 . . . . 0.0 112.229 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 144.35 -176.4 23.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.53 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.753 ' HB3' HG11 ' A' ' 215' ' ' VAL . 9.8 tp-100 -89.27 140.28 29.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.455 ' CD1' ' HD3' ' A' ' 198' ' ' ARG . 3.0 m-85 -127.73 147.84 50.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.654 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.773 HD12 ' OD2' ' A' ' 197' ' ' ASP . 68.0 mt -78.38 135.03 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.209 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.448 ' CG ' ' HB3' ' A' ' 167' ' ' ASN . 10.2 ptm180 -98.71 -35.04 10.3 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.9 t -151.58 156.76 41.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 112.076 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.76 HG23 ' HB2' ' A' ' 195' ' ' ALA . 23.3 t -132.69 140.6 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.524 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 165' ' ' GLY . 40.7 t0 -95.11 117.1 66.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.199 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.86 140.76 96.56 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.502 2.135 . . . . 0.0 112.185 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.1 t70 66.0 14.87 9.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.511 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 9.2 m -105.03 166.36 11.58 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.447 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 98.4 Cg_exo -43.98 -40.15 11.63 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.438 2.092 . . . . 0.0 112.437 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.42 ' HA ' ' HE2' ' A' ' 157' ' ' MET . . . -59.65 -44.94 93.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.684 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.18 -54.5 12.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -52.79 -26.63 14.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.533 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 156' ' ' THR . 4.4 t -85.09 -24.71 27.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.991 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.09 26.07 6.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.121 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -79.82 149.39 31.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 111.009 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.825 ' N ' HD23 ' A' ' 193' ' ' LEU . 50.6 mtt-85 -140.72 129.9 23.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.706 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.76 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -58.42 151.1 20.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.324 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 41.5 mt-30 77.55 -3.05 2.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.163 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.773 ' OD2' HD12 ' A' ' 179' ' ' ILE . 41.3 p30 -67.71 151.83 46.59 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.567 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.455 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 68.1 mmt-85 -90.61 115.67 27.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.25 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.715 HD13 HG12 ' A' ' 230' ' ' VAL . 22.8 mm -65.51 124.55 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.117 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.583 HG12 ' SG ' ' A' ' 206' ' ' CYS . 17.1 t -109.02 -45.19 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.492 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.9 pt-20 -144.27 173.97 11.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 111.449 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.886 HG13 ' CD2' ' A' ' 228' ' ' LEU . 26.4 t -155.43 112.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.817 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 44.2 t30 70.21 22.93 5.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.385 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.54 -15.96 48.88 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.581 -0.818 . . . . 0.0 113.589 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 202' ' ' VAL . 27.0 m -86.59 93.75 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.25 0.525 . . . . 0.0 111.539 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.583 ' SG ' HG12 ' A' ' 200' ' ' VAL . 50.8 t -92.18 100.92 13.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.668 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.1 mmt -130.63 101.61 5.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.353 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -68.36 99.25 0.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.643 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.5 25.55 3.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.609 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.404 ' HB2' HG22 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -54.96 175.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.767 0.318 . . . . 0.0 110.916 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.912 ' O ' HG23 ' A' ' 215' ' ' VAL . 11.7 mm-40 -91.11 157.23 17.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.986 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.812 ' O ' HG23 ' A' ' 216' ' ' VAL . 67.6 t60 -52.44 -64.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.692 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.05 -25.04 61.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.283 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.01 -44.02 55.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.323 . . . . 0.0 110.712 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 211' ' ' GLN . 4.6 t -74.81 -36.82 40.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.565 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 212' ' ' HIS . 40.7 t -70.13 -38.22 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.71 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.3 m -74.56 -33.51 62.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.627 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.522 ' HB1' HG11 ' A' ' 202' ' ' VAL . . . -59.49 -48.34 82.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.0 mm -61.86 -42.16 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 54.2 ttp85 -75.16 -28.4 60.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.21 5.78 28.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.737 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -66.53 -0.65 8.57 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.564 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 47.43 -132.23 15.16 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.987 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.1 m-20 -83.86 -25.17 30.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.308 . . . . 0.0 111.217 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -125.48 114.82 19.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.814 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.58 HG22 HD21 ' A' ' 228' ' ' LEU . 4.6 m -112.42 96.84 6.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.369 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -84.08 94.8 8.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.031 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.886 ' CD2' HG13 ' A' ' 202' ' ' VAL . 8.1 mt -110.07 140.1 44.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.145 0.498 . . . . 0.0 112.283 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 154' ' ' LEU . 10.4 tp -120.0 109.58 15.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.313 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.715 HG12 HD13 ' A' ' 199' ' ' ILE . 27.5 m -114.87 179.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 111.766 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 232' ' ' ASP . 2.6 t -119.95 166.08 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.726 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.493 ' H ' HG12 ' A' ' 231' ' ' VAL . 46.7 t0 -90.26 111.0 22.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.209 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.617 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 29.2 ptt85 . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.533 ' HB3' HG22 ' A' ' 231' ' ' VAL . 46.4 Cg_endo -69.19 176.88 5.76 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.671 2.247 . . . . 0.0 113.075 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.842 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.3 OUTLIER -143.44 158.11 43.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.699 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.2 tp -90.01 125.74 35.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.005 0.431 . . . . 0.0 111.369 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 47.7 t -120.52 140.2 51.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.374 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.4 m -134.11 104.1 6.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -109.81 127.02 54.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -90.39 125.53 35.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.981 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.445 ' HE2' ' CZ ' ' A' ' 164' ' ' TYR . 1.7 tppp? -59.66 -80.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.703 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.38 -156.19 12.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.498 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.76 0.02 10.35 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.704 2.269 . . . . 0.0 112.782 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 p -96.85 -30.15 13.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.734 0.302 . . . . 0.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.93 -142.12 15.84 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.439 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.464 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 14.7 m-85 -96.41 -51.33 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.34 30.49 24.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.627 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -151.49 178.65 9.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.238 0.542 . . . . 0.0 112.152 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.887 ' O ' HD13 ' A' ' 168' ' ' LEU . 10.0 m120 -135.22 154.63 51.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.054 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.887 HD13 ' O ' ' A' ' 167' ' ' ASN . 0.4 OUTLIER -132.19 148.33 52.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.398 . . . . 0.0 111.655 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -134.21 141.33 46.99 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.314 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.6 t -155.14 149.61 26.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.179 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -121.44 -67.97 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.561 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -90.16 159.73 16.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.6 m -100.8 21.41 13.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.166 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.552 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 5.0 mttp -108.73 -48.59 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.792 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 25.5 Cg_exo -63.02 -65.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.216 1.944 . . . . 0.0 112.298 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.09 -152.25 23.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.411 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -125.88 133.96 51.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 111.097 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 2.8 m-85 -122.53 165.11 16.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.824 HD12 ' OD2' ' A' ' 197' ' ' ASP . 57.0 mt -91.9 135.91 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 110.66 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.401 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 0.3 OUTLIER -98.78 -35.63 10.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.879 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.0 t -153.21 158.51 41.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 111.63 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 195' ' ' ALA . 49.0 t -135.29 141.15 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.789 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -90.72 117.28 67.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.799 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.91 136.61 74.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.448 2.099 . . . . 0.0 112.408 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.7 t70 71.21 14.78 6.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.58 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.524 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 48.0 m -99.99 164.78 15.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.583 0.23 . . . . 0.0 110.778 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 99.9 Cg_exo -44.04 -40.25 11.91 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.584 2.19 . . . . 0.0 112.912 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.456 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -62.78 -43.95 97.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -70.33 -51.65 28.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.007 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.96 -32.19 3.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.574 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.1 t -83.99 -27.5 28.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.063 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 115.11 25.51 3.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.464 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.839 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -83.44 149.21 26.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.731 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.839 ' N ' HD23 ' A' ' 193' ' ' LEU . 1.4 mtt85 -143.15 138.31 29.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.798 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.624 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -55.69 153.97 7.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.573 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 71.39 9.14 6.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.065 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.824 ' OD2' HD12 ' A' ' 179' ' ' ILE . 38.9 p30 -75.77 149.53 37.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.029 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 17.4 mmt85 -85.67 112.49 21.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.691 0.281 . . . . 0.0 111.548 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.933 ' HA ' HG12 ' A' ' 230' ' ' VAL . 12.8 mm -68.09 123.9 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.366 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.3 t -110.18 -43.86 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.126 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.52 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 10.6 pt-20 -143.19 176.64 8.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.317 0.58 . . . . 0.0 111.936 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.891 ' O ' HG22 ' A' ' 205' ' ' VAL . 48.7 t -150.81 107.77 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.517 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.45 23.86 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.368 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.65 -17.01 51.01 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.633 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 202' ' ' VAL . 26.9 m -83.43 90.2 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.191 0.495 . . . . 0.0 111.569 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.483 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 53.0 t -80.31 100.57 8.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.754 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.464 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 17.0 mmt -130.74 99.43 4.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.18 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -75.03 115.5 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.2 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 104.21 12.85 28.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.112 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.464 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 0.5 OUTLIER -54.93 166.16 0.54 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.06 0.457 . . . . 0.0 111.398 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -94.46 160.4 14.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.841 ' O ' HG23 ' A' ' 216' ' ' VAL . 11.2 t60 -47.49 -56.42 7.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.026 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.05 -29.12 70.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.17 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.94 -44.5 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.55 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 32.9 t -71.84 -35.04 53.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.449 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 212' ' ' HIS . 47.9 t -71.25 -41.61 74.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.458 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.8 m -67.14 -38.13 84.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.516 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -55.67 -45.64 77.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.053 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.421 HD13 HG13 ' A' ' 202' ' ' VAL . 25.8 mm -65.45 -33.33 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -67.68 -41.35 83.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.86 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.09 5.03 31.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.613 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -87.6 10.03 71.33 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.975 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.12 -136.32 25.56 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.854 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.79 -25.13 23.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.74 0.305 . . . . 0.0 111.079 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -104.22 114.89 29.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.682 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.6 HG22 ' HG ' ' A' ' 228' ' ' LEU . 19.9 m -110.55 101.12 9.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.287 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -85.35 94.86 9.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.192 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 202' ' ' VAL . 13.6 mt -103.67 137.62 41.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.026 0.441 . . . . 0.0 111.858 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.842 HD12 ' O ' ' A' ' 153' ' ' ARG . 13.9 tp -110.56 109.41 19.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.933 HG12 ' HA ' ' A' ' 199' ' ' ILE . 23.8 m -124.62 177.04 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.475 0.655 . . . . 0.0 112.243 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 152' ' ' PRO . 39.9 t -119.2 145.11 25.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.776 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -96.41 112.81 24.42 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.581 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 . . . . . 0 CA--C 1.531 0.245 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.946 -179.829 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.589 ' HB2' ' HD2' ' A' ' 152' ' ' PRO . 5.7 ptm180 . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.931 0.396 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.645 ' HB3' HG22 ' A' ' 231' ' ' VAL . 7.1 Cg_endo -51.52 143.71 35.04 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.979 2.453 . . . . 0.0 112.439 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.673 ' O ' HD12 ' A' ' 229' ' ' LEU . 81.7 mtt180 -125.2 171.81 10.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.354 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.2 tp -108.21 139.35 43.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.046 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 228' ' ' LEU . 54.1 t -126.56 135.83 51.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.51 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -137.24 99.9 4.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.744 0.307 . . . . 0.0 110.689 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -114.43 141.12 48.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 111.266 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -96.22 121.6 38.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.552 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.42 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 2.0 tppp? -46.41 -76.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.36 -158.05 7.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.314 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.01 0.03 10.32 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.676 2.25 . . . . 0.0 112.69 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.2 p -100.56 -30.19 11.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.517 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.42 ' HA2' ' HD2' ' A' ' 159' ' ' LYS . . . 80.95 -124.79 6.57 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.71 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.96 ' CE2' HG21 ' A' ' 219' ' ' ILE . 8.2 m-85 -91.63 -60.41 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.084 0.469 . . . . 0.0 111.099 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 183' ' ' ASP . . . 96.71 -0.74 61.22 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.555 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CD2' HD13 ' A' ' 193' ' ' LEU . 1.4 p90 -124.8 -176.89 3.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.06 0.457 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.856 ' O ' HD13 ' A' ' 168' ' ' LEU . 60.8 m-20 -124.72 161.96 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.685 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.856 HD13 ' O ' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -132.71 135.27 45.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.076 0.465 . . . . 0.0 111.976 -179.102 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.453 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 4.1 p-80 -134.86 143.31 46.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.948 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 t -155.06 166.84 32.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 111.442 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -130.14 -59.5 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.739 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -90.01 167.34 12.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 m -110.08 22.21 15.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.278 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 14.2 mttt -102.93 -48.6 0.17 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.563 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 14.2 Cg_exo -69.3 -58.0 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.359 2.039 . . . . 0.0 112.331 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 140.33 -146.75 18.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.41 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -103.97 131.58 51.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.765 0.317 . . . . 0.0 110.865 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CD1' ' HD3' ' A' ' 198' ' ' ARG . 1.2 m-30 -109.76 165.19 11.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.559 HD12 ' OD1' ' A' ' 197' ' ' ASP . 4.0 mt -100.37 131.75 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.166 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.453 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 10.9 ptm180 -104.33 -33.53 8.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.709 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.4 t -150.82 152.53 33.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 111.868 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.67 140.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.761 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 47.3 t0 -89.0 123.1 68.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 23.7 Cg_exo -63.59 133.07 37.95 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.233 1.955 . . . . 0.0 112.195 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 185' ' ' ASP . 13.6 t0 76.88 14.84 2.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.26 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 37.0 m -98.69 163.21 19.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 84.1 Cg_exo -45.56 -40.2 18.05 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.36 2.04 . . . . 0.0 112.345 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.61 -44.85 95.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.764 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -66.64 -54.52 22.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.917 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -55.84 -26.49 46.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.279 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.3 t -82.52 -20.3 36.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.22 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 100.8 36.95 3.81 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.914 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -100.18 148.68 24.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.83 0.347 . . . . 0.0 111.153 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.785 ' N ' HD23 ' A' ' 193' ' ' LEU . 53.0 mtp180 -147.79 138.78 23.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.758 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -47.69 166.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.613 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.7 ' O ' ' HB2' ' A' ' 233' ' ' ARG . 67.1 mt-30 80.27 -24.36 0.2 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.237 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.737 ' OD2' HG21 ' A' ' 230' ' ' VAL . 27.2 p-10 -66.92 138.17 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.452 0.644 . . . . 0.0 112.266 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.546 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 0.2 OUTLIER -92.19 130.12 37.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.373 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.79 ' HA ' HG12 ' A' ' 230' ' ' VAL . 22.2 mm -69.78 116.45 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.764 0.316 . . . . 0.0 110.58 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.21 -46.48 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.736 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.457 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 10.2 pt-20 -138.45 174.11 10.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.962 0.41 . . . . 0.0 111.164 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.926 ' O ' HG22 ' A' ' 205' ' ' VAL . 23.7 t -152.74 109.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.144 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 13.0 t30 70.01 24.32 5.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.306 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.33 49.38 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.469 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.926 HG22 ' O ' ' A' ' 202' ' ' VAL . 28.5 m -80.95 95.29 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.205 0.502 . . . . 0.0 111.093 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.426 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 26.5 t -86.8 103.6 15.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.176 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.405 ' O ' ' HG2' ' A' ' 210' ' ' LYS . 84.7 mmm -130.16 99.92 5.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.69 103.66 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.705 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 113.95 23.71 4.84 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.337 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 207' ' ' MET . 9.7 mmmt -54.9 158.47 2.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.918 0.389 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 215' ' ' VAL . 27.4 mm-40 -98.08 160.28 14.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.151 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.872 ' O ' HG23 ' A' ' 216' ' ' VAL . 14.6 t60 -48.05 -60.99 2.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.92 -31.15 67.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.212 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -46.15 78.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.261 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 211' ' ' GLN . 25.5 t -70.05 -35.41 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.438 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 212' ' ' HIS . 41.5 t -70.36 -42.69 78.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.649 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 71.6 m -73.46 -33.44 64.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.735 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.04 80.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.143 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.96 HG21 ' CE2' ' A' ' 164' ' ' TYR . 17.6 mm -63.81 -40.35 88.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -43.37 89.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.675 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.95 5.06 30.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.526 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -90.81 19.71 43.61 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.895 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.05 -137.7 22.77 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.963 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.85 -24.83 20.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -100.38 117.96 35.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.393 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.801 HG22 HD21 ' A' ' 228' ' ' LEU . 3.0 m -111.38 99.49 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.6 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -87.42 94.93 9.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.947 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.801 HD21 HG22 ' A' ' 226' ' ' THR . 18.4 mt -109.12 139.8 43.53 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 153' ' ' ARG . 14.2 tp -109.54 111.42 22.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 199' ' ' ILE . 34.8 m -125.39 152.49 32.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 197' ' ' ASP . 2.6 t -119.98 137.79 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 197' ' ' ASP . 20.4 t0 -67.94 143.5 55.62 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.856 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.7 ' HB2' ' O ' ' A' ' 196' ' ' GLN . 38.6 ttp180 . . . . . 0 CA--C 1.511 -0.534 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.658 0.266 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.471 ' HB3' HG22 ' A' ' 231' ' ' VAL . 56.3 Cg_endo -70.68 165.9 30.49 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.621 2.214 . . . . 0.0 112.913 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.797 ' O ' HD12 ' A' ' 229' ' ' LEU . 70.4 mtm180 -129.71 158.43 39.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.774 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 26.3 tp -96.48 129.37 43.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.376 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.4 t -128.25 135.63 49.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.504 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.2 m -131.47 111.26 11.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.03 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.712 ' HE3' HD12 ' A' ' 228' ' ' LEU . 3.6 ptp -118.18 133.11 56.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -92.97 130.54 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.452 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 10.7 tptm -61.56 -80.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.754 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.441 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.73 -157.2 6.98 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.299 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.77 0.21 10.19 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.681 2.254 . . . . 0.0 112.686 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.3 p -95.23 -30.14 14.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.428 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 93.01 -161.2 25.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.46 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.657 ' CE1' HG22 ' A' ' 219' ' ' ILE . 31.8 m-85 -81.67 -43.29 18.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.336 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 186' ' ' SER . . . 85.18 27.67 32.91 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.927 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.996 ' CE2' HD11 ' A' ' 168' ' ' LEU . 0.0 OUTLIER -164.83 -177.32 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.256 0.55 . . . . 0.0 111.882 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.914 ' O ' HD13 ' A' ' 168' ' ' LEU . 9.8 m120 -136.6 157.29 47.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.028 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.996 HD11 ' CE2' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -133.35 130.64 39.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.166 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.55 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.4 OUTLIER -136.04 135.58 39.55 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.018 178.644 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.0 t -155.32 144.26 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.152 0.501 . . . . 0.0 111.498 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -130.26 -6.45 4.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.309 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.479 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.1 OUTLIER -89.16 146.58 24.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.555 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.1 m -110.21 8.95 23.86 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.735 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 50.4 mtmt -120.68 -58.27 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 37.1 Cg_exo -56.89 -64.48 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.138 1.892 . . . . 0.0 112.302 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.81 -145.44 12.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.686 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.875 ' HB2' HG21 ' A' ' 215' ' ' VAL . 6.2 tp-100 -108.68 151.12 26.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.404 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 5.4 m-85 -130.29 151.45 50.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.854 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.738 HD13 HD21 ' A' ' 193' ' ' LEU . 69.6 mt -82.53 140.79 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.55 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 2.8 ptm180 -103.21 -36.32 8.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.225 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 40.8 t -151.0 153.8 35.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.034 0.445 . . . . 0.0 111.681 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.825 HG23 ' HB2' ' A' ' 195' ' ' ALA . 32.5 t -133.5 141.82 43.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.575 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 46.8 t0 -91.89 121.23 67.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.973 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 26.4 Cg_exo -62.41 132.67 39.38 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.345 2.03 . . . . 0.0 112.33 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.7 t0 69.87 22.62 5.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.259 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.511 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 58.6 m -104.9 164.69 14.65 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.725 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 94.5 Cg_exo -43.47 -40.12 9.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.628 2.218 . . . . 0.0 112.792 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.616 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -63.08 -44.2 96.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 110.293 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -70.02 -52.63 22.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.894 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.6 -31.14 2.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.655 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.2 t -81.97 -30.61 31.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 116.96 25.61 3.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.45 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 194' ' ' ARG . 7.8 tt -78.29 150.32 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.739 0.304 . . . . 0.0 110.743 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.797 ' N ' HD23 ' A' ' 193' ' ' LEU . 57.6 mtt-85 -139.6 130.01 25.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.857 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.825 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -55.05 152.7 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 75.22 2.9 4.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.08 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.609 ' CG ' HD12 ' A' ' 179' ' ' ILE . 41.2 p30 -73.74 155.58 38.76 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.307 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -87.72 112.76 22.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.458 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.789 HD13 HG12 ' A' ' 230' ' ' VAL . 24.8 mm -66.97 124.17 21.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.913 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.568 ' CG1' HD23 ' A' ' 229' ' ' LEU . 19.3 t -106.78 -44.0 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.912 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.4 pt-20 -145.2 175.15 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.102 0.477 . . . . 0.0 111.688 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.877 ' O ' HG22 ' A' ' 205' ' ' VAL . 40.1 t -150.56 109.36 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.65 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 49.8 t30 70.38 23.43 4.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.299 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.17 -16.28 53.73 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.564 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 202' ' ' VAL . 32.7 m -85.45 96.76 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 117.181 0.49 . . . . 0.0 111.432 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' CYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 52.5 t -81.8 103.2 11.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.661 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' MET . . . . . 0.455 ' HB2' ' CG ' ' A' ' 210' ' ' LYS . 21.9 mmt -130.23 99.47 5.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -78.7 101.73 7.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.1 5.34 6.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.135 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.455 ' CG ' ' HB2' ' A' ' 207' ' ' MET . 0.9 OUTLIER -54.85 156.81 3.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.096 0.448 . . . . 0.0 110.97 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.656 ' O ' HG23 ' A' ' 215' ' ' VAL . 10.1 mm100 -89.34 160.28 16.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.999 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.842 ' O ' HG23 ' A' ' 216' ' ' VAL . 0.9 OUTLIER -47.26 -60.92 2.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.91 -31.41 64.65 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.114 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.23 -44.02 69.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.473 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.875 HG21 ' HB2' ' A' ' 177' ' ' GLN . 16.8 t -72.38 -38.9 62.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 212' ' ' HIS . 49.2 t -65.06 -42.29 94.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.186 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 45.4 m -67.24 -39.67 86.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.411 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.06 73.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.959 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.657 HG22 ' CE1' ' A' ' 164' ' ' TYR . 25.9 mm -61.35 -37.53 77.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -70.48 -33.91 71.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.509 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.15 5.33 30.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.591 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -83.99 13.99 46.08 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.149 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.12 -134.78 27.56 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.868 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.4 m-20 -87.46 -25.18 23.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.722 0.296 . . . . 0.0 111.239 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -112.72 117.5 32.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.706 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.695 HG22 HD21 ' A' ' 228' ' ' LEU . 5.8 m -112.85 95.06 5.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.31 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -78.84 97.97 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.251 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.712 HD12 ' HE3' ' A' ' 157' ' ' MET . 46.3 mt -105.02 135.72 45.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 112.259 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 153' ' ' ARG . 14.3 tp -112.06 109.45 19.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.117 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.789 HG12 HD13 ' A' ' 199' ' ' ILE . 31.9 m -120.78 169.44 12.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.137 0.494 . . . . 0.0 112.114 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 152' ' ' PRO . 39.8 t -119.92 137.54 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.74 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -71.21 110.73 6.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.257 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.812 179.511 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.835 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.1 OUTLIER -94.64 133.9 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.837 0.351 . . . . 0.0 110.922 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.835 ' N ' HD13 ' A' ' 144' ' ' ILE . 14.2 t70 -75.21 136.09 72.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.388 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.41 -57.6 1.02 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.545 2.163 . . . . 0.0 112.314 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.032 ' O ' HG23 ' A' ' 148' ' ' THR . 14.1 t80 -86.25 -60.61 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.104 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . 1.032 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.3 p 159.86 157.96 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.428 0.691 . . . . 0.0 110.567 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.426 ' HG3' ' CB ' ' A' ' 145' ' ' ASP . 45.0 mtm -125.56 -55.21 1.54 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.822 0.344 . . . . 0.0 111.798 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.522 HD11 ' CG1' ' A' ' 231' ' ' VAL . 20.7 tp -124.11 -4.61 7.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.239 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.906 ' CD ' HG21 ' A' ' 148' ' ' THR . 1.0 OUTLIER -29.34 143.42 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.11 142.63 42.47 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.548 2.165 . . . . 0.0 111.976 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -107.48 141.22 39.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.085 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.899 ' HA ' HD12 ' A' ' 229' ' ' LEU . 55.3 tp -98.6 134.26 41.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.544 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 41.4 t -129.92 139.99 51.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 19.0 m -131.86 101.99 5.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.157 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.434 ' HE1' ' CE2' ' A' ' 166' ' ' PHE . 6.6 ptp -109.99 137.53 47.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 111.219 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -100.59 119.09 38.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.657 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.406 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 1.0 OUTLIER -51.29 -82.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.95 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.48 -156.42 26.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.23 -0.0 10.38 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.603 2.202 . . . . 0.0 112.841 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.7 p -108.43 -30.03 8.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.724 0.297 . . . . 0.0 111.119 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 83.92 -131.11 10.17 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.423 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CZ ' ' CG2' ' A' ' 219' ' ' ILE . 32.5 m-85 -110.2 -46.56 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.05 17.41 63.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.809 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' A' ' 157' ' ' MET . 0.1 OUTLIER -124.93 -178.62 4.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.092 0.472 . . . . 0.0 111.845 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.82 ' C ' HD22 ' A' ' 168' ' ' LEU . 9.9 m120 -134.83 160.73 37.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.393 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.82 HD22 ' C ' ' A' ' 167' ' ' ASN . 3.3 mm? -138.54 137.25 36.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.313 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.424 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 0.7 OUTLIER -134.76 141.53 46.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.62 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 t -155.09 150.14 26.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.25 -72.95 0.56 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.033 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -64.34 163.97 12.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.044 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.0 m -110.05 20.3 18.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.624 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 23.1 mttp -112.47 -50.56 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.873 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 25.2 Cg_exo -63.15 -64.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.143 1.895 . . . . 0.0 112.248 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 142.58 -148.34 20.04 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.5 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.409 ' HG2' HG11 ' A' ' 215' ' ' VAL . 9.8 tp-100 -114.93 129.09 56.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 0.0 110.973 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.498 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 1.6 m-85 -117.34 165.27 13.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.349 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.617 HD12 ' OD1' ' A' ' 197' ' ' ASP . 5.0 mt -90.18 136.3 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.939 0.399 . . . . 0.0 110.358 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.425 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 9.4 ptm180 -102.38 -34.55 9.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.818 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.9 t -150.36 149.4 30.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 0.0 111.909 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 195' ' ' ALA . 81.9 t -135.32 134.1 52.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.548 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 186' ' ' SER . 47.4 t0 -84.37 122.5 75.33 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.971 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.01 130.22 30.1 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.229 1.953 . . . . 0.0 112.193 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 75.93 18.18 2.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.736 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.6 m -98.23 164.93 16.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.56 0.219 . . . . 0.0 110.632 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 97.5 Cg_exo -43.45 -40.1 9.84 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.607 2.205 . . . . 0.0 112.768 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.77 91.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.039 0.447 . . . . 0.0 110.373 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.03 -50.86 37.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.755 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -47.91 -32.96 6.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.333 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -79.32 -30.0 42.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.04 32.58 1.51 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.241 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -97.59 149.17 22.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.854 0.359 . . . . 0.0 110.995 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.84 ' N ' HD23 ' A' ' 193' ' ' LEU . 76.5 mtt180 -142.51 133.77 26.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -46.59 161.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.576 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 233' ' ' ARG . 56.4 mt-30 82.73 -13.92 0.79 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.042 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.673 ' OD2' HG21 ' A' ' 230' ' ' VAL . 7.9 p-10 -68.18 146.45 53.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.749 0.309 . . . . 0.0 110.566 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.498 ' HD2' ' CE1' ' A' ' 178' ' ' PHE . 15.8 mmt85 -93.1 123.13 36.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.387 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.82 HD13 HG12 ' A' ' 230' ' ' VAL . 22.1 mm -66.52 128.96 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.976 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.81 -42.97 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.785 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.452 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 10.9 pt-20 -144.87 172.63 12.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.024 0.44 . . . . 0.0 111.649 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.87 ' O ' HG22 ' A' ' 205' ' ' VAL . 16.5 t -149.42 105.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.017 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 35.7 t30 70.27 26.39 4.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.538 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.06 -21.85 32.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.486 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 202' ' ' VAL . 27.0 m -80.32 97.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.985 0.422 . . . . 0.0 111.158 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 42.3 t -89.98 98.78 11.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.114 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.418 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 21.7 mmt -130.24 99.68 5.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.817 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -74.48 106.56 6.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.121 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.04 11.93 8.72 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.858 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.418 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 12.3 mmtt -55.76 161.91 1.97 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.887 0.375 . . . . 0.0 111.217 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.621 ' O ' HG23 ' A' ' 215' ' ' VAL . 14.5 mm100 -88.25 160.33 17.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.909 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.841 ' O ' HG23 ' A' ' 216' ' ' VAL . 0.9 OUTLIER -49.89 -57.28 7.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.577 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.97 -34.21 82.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.814 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -44.75 80.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 211' ' ' GLN . 35.5 t -70.65 -37.32 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.342 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 212' ' ' HIS . 59.0 t -68.96 -41.77 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.418 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.8 m -66.24 -40.05 89.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.537 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.625 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -55.39 -39.01 69.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.7 HD11 HD21 ' A' ' 228' ' ' LEU . 25.2 mm -69.75 -32.28 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.716 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -71.57 -36.49 70.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.86 5.16 29.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.619 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.33 14.03 60.43 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.009 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.03 -135.55 26.19 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.906 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.96 -25.13 24.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.793 0.33 . . . . 0.0 111.184 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -108.75 114.93 29.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.632 HG22 ' HG ' ' A' ' 228' ' ' LEU . 24.6 m -109.82 101.56 10.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.715 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -81.19 98.12 7.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.893 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.7 HD21 HD11 ' A' ' 219' ' ' ILE . 32.8 mt -108.19 129.87 55.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.045 0.45 . . . . 0.0 112.17 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.899 HD12 ' HA ' ' A' ' 154' ' ' LEU . 11.8 tp -110.7 109.74 20.12 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.82 HG12 HD13 ' A' ' 199' ' ' ILE . 33.9 m -110.91 -179.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.563 . . . . 0.0 112.305 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.522 ' CG1' HD11 ' A' ' 150' ' ' LEU . 17.7 t -119.52 165.66 14.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.116 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.52 ' N ' HG12 ' A' ' 231' ' ' VAL . 32.3 t0 -99.8 109.75 22.15 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 196' ' ' GLN . 25.2 ttm180 -82.23 -20.08 38.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.472 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -46.51 -37.34 7.78 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.797 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 54.0 m -85.14 -34.46 22.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.553 -0.748 . . . . 0.0 108.986 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.428 ' HB2' ' HA ' ' A' ' 233' ' ' ARG . 10.3 t70 -53.04 -35.71 59.77 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.008 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.07 -31.65 39.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.992 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -59.37 -52.03 67.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.142 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -59.79 -21.05 60.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.823 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.925 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.639 -0.185 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.599 HD13 ' C ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -122.6 121.1 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.043 0.449 . . . . 0.0 111.018 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.408 ' N ' HD13 ' A' ' 144' ' ' ILE . 15.4 t70 -105.27 138.13 19.46 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.65 -54.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.551 2.167 . . . . 0.0 112.891 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 147' ' ' PHE . 1.0 OUTLIER -54.59 -25.72 28.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.24 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.6 p -119.11 129.54 55.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.66 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 38.5 mtp -122.87 -14.74 7.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.086 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.624 HD13 ' CG ' ' A' ' 236' ' ' ASP . 40.9 tp -64.54 -18.4 64.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -36.83 152.31 0.11 Allowed Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.465 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.87 151.46 85.11 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.742 2.295 . . . . 0.0 112.786 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -130.67 145.91 52.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.709 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.901 ' HA ' HD12 ' A' ' 229' ' ' LEU . 21.9 tp -93.08 137.93 31.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.189 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 42.1 t -130.17 140.05 50.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.814 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.1 m -130.17 107.35 9.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.826 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 9.5 ptp -109.98 143.11 40.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.812 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -105.87 127.36 53.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -60.2 -80.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.824 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.68 -156.86 9.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.442 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.77 -1.51 11.68 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.571 2.181 . . . . 0.0 112.671 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.8 p -101.37 -30.15 11.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.126 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.3 -127.93 8.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.433 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.47 ' CZ ' HG22 ' A' ' 219' ' ' ILE . 9.7 m-85 -110.08 -50.21 3.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.863 0.364 . . . . 0.0 110.814 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.24 13.96 69.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.99 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.414 ' CE1' ' CB ' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -124.86 178.39 5.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.223 0.535 . . . . 0.0 111.963 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.805 ' C ' HD22 ' A' ' 168' ' ' LEU . 10.0 m120 -134.35 157.76 45.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.256 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.805 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.3 mm? -133.07 148.32 52.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.965 0.412 . . . . 0.0 111.599 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -134.53 149.18 50.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.103 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 148.02 33.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.011 0.434 . . . . 0.0 111.423 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -130.19 -74.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.612 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -90.08 174.73 7.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.714 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.2 m -110.02 20.22 18.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.252 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.562 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 25.2 mtpt -108.66 -49.25 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.684 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 21.6 Cg_exo -65.28 -56.75 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.269 1.98 . . . . 0.0 112.19 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.73 -156.76 21.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.492 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.602 ' HG2' HG11 ' A' ' 215' ' ' VAL . 4.0 tp-100 -102.5 136.16 42.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.849 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -132.31 152.16 51.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.745 ' HA ' HD13 ' A' ' 168' ' ' LEU . 57.3 mt -74.4 138.08 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.421 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 7.6 ptm180 -103.61 -33.09 9.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.63 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.8 t -149.73 154.66 38.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.95 0.405 . . . . 0.0 111.441 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.884 HG23 ' HB2' ' A' ' 195' ' ' ALA . 37.4 t -135.01 134.99 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 186' ' ' SER . 56.8 t0 -84.37 125.54 71.69 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.24 131.05 30.67 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.341 2.027 . . . . 0.0 112.224 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 73.69 18.71 3.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.78 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.423 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.6 m -97.75 164.36 17.65 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.6 0.238 . . . . 0.0 110.69 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 88.4 Cg_exo -44.4 -40.13 13.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.563 2.175 . . . . 0.0 112.739 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.973 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -63.67 -42.99 98.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 110.639 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.92 -50.89 37.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.966 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -49.1 -30.22 6.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.551 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.5 t -84.97 -26.1 27.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.71 27.89 3.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.175 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.973 HD13 ' HB1' ' A' ' 188' ' ' ALA . 8.3 tt -75.96 149.85 37.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.832 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.822 ' N ' HD23 ' A' ' 193' ' ' LEU . 36.7 mtt85 -134.66 129.86 35.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.794 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.884 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -57.8 150.58 19.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.163 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 73.75 3.07 4.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.766 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.756 ' OD2' HG21 ' A' ' 230' ' ' VAL . 56.0 p30 -66.86 154.84 39.94 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.274 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -89.84 110.25 21.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.767 0.318 . . . . 0.0 111.453 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.74 ' HA ' HG12 ' A' ' 230' ' ' VAL . 24.5 mm -61.99 123.79 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.939 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.88 -45.94 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.448 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.466 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 9.6 pt-20 -143.31 174.16 10.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 111.363 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.884 ' O ' HG22 ' A' ' 205' ' ' VAL . 40.4 t -152.91 106.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.016 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 18.8 t30 70.3 25.97 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.482 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.81 -21.02 35.15 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.372 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 202' ' ' VAL . 28.7 m -81.45 97.27 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.998 0.428 . . . . 0.0 111.232 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.466 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 42.4 t -87.84 98.26 11.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.7 mmt -130.17 99.83 5.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -68.58 101.9 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 113.34 25.37 4.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.543 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.406 ' HD3' ' HB3' ' A' ' 214' ' ' ASP . 0.1 OUTLIER -54.86 164.04 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.843 0.354 . . . . 0.0 111.169 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.645 ' O ' HG23 ' A' ' 215' ' ' VAL . 18.0 mm-40 -99.59 160.21 14.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.037 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.852 ' O ' HG23 ' A' ' 216' ' ' VAL . 10.8 t60 -48.76 -62.56 1.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.87 -32.6 59.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.043 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.406 ' HB3' ' HD3' ' A' ' 210' ' ' LYS . 0.9 OUTLIER -68.37 -44.95 74.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.153 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 211' ' ' GLN . 25.9 t -70.64 -40.01 76.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 212' ' ' HIS . 44.1 t -64.0 -42.83 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.336 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 58.8 m -71.57 -39.04 70.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.575 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.02 81.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.47 HG22 ' CZ ' ' A' ' 164' ' ' TYR . 32.3 mm -61.82 -31.7 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.597 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -73.1 -38.15 66.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.727 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.03 5.32 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.66 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -82.12 9.24 58.08 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.21 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -139.2 20.2 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.017 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -25.12 34.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.663 0.268 . . . . 0.0 111.252 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -116.01 115.34 25.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 110.782 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.9 m -107.32 99.23 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -76.32 98.52 4.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.149 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.455 ' CD2' HG22 ' A' ' 202' ' ' VAL . 34.5 mt -107.36 128.06 54.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.715 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.901 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.5 tp -107.6 109.66 21.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.337 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.756 HG21 ' OD2' ' A' ' 197' ' ' ASP . 29.4 m -123.62 169.93 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 112.187 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.6 t -120.01 138.89 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.393 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -69.85 112.7 6.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.33 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -100.16 -24.75 14.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.03 -60.1 3.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.841 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.3 m -66.53 -28.15 68.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.624 ' CG ' HD13 ' A' ' 150' ' ' LEU . 17.3 t0 -66.96 -22.09 65.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.149 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -102.6 -33.08 9.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.829 0.347 . . . . 0.0 111.103 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -63.43 -62.48 1.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -28.46 67.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.71 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -120.5 131.8 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.396 . . . . 0.0 110.989 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.71 ' N ' HD13 ' A' ' 144' ' ' ILE . 24.8 t70 -45.0 139.25 3.98 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.67 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.85 -56.27 2.76 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.74 2.293 . . . . 0.0 112.223 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.938 ' O ' HG23 ' A' ' 148' ' ' THR . 39.6 t80 -82.55 -61.13 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.857 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.938 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.0 p 158.32 150.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.827 0.851 . . . . 0.0 110.649 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.437 ' HG3' ' CB ' ' A' ' 145' ' ' ASP . 8.4 mtt -125.7 -52.86 1.57 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.55 HD12 ' CG1' ' A' ' 231' ' ' VAL . 13.4 tp -122.31 -10.02 8.53 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.774 ' HD3' HG21 ' A' ' 148' ' ' THR . 5.5 ptm180 -51.53 145.64 14.63 Favored Pre-proline 0 N--CA 1.465 0.288 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.856 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 137.87 20.6 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.439 2.093 . . . . 0.0 112.172 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 230' ' ' VAL . 0.8 OUTLIER -93.7 139.37 30.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.786 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 229' ' ' LEU . 14.5 tp -87.62 123.0 32.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 50.5 t -122.33 127.55 49.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.9 m -127.28 103.7 7.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.502 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.629 ' HE1' HD12 ' A' ' 228' ' ' LEU . 2.0 ptt? -110.64 145.04 38.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.02 0.438 . . . . 0.0 111.259 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -104.32 119.36 38.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.578 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.414 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 1.5 tppt? -47.83 -78.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.88 -159.85 26.78 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.228 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.56 0.16 10.24 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.582 2.188 . . . . 0.0 112.91 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.3 p -104.0 -30.27 10.39 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.414 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 93.12 -140.3 15.0 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.079 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 166' ' ' PHE . 7.8 m-85 -110.38 -47.17 3.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.931 0.396 . . . . 0.0 110.762 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.52 24.13 51.54 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.646 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 164' ' ' TYR . 8.5 p90 -124.81 172.87 8.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.216 0.532 . . . . 0.0 111.827 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.695 ' C ' HD22 ' A' ' 168' ' ' LEU . 10.0 m120 -137.95 152.5 49.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.96 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.914 HD12 ' HG3' ' A' ' 177' ' ' GLN . 4.2 mm? -129.78 146.13 51.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.246 0.546 . . . . 0.0 112.299 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -143.59 133.72 24.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.721 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.5 t -129.46 155.5 45.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.033 0.444 . . . . 0.0 111.605 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -130.05 -64.39 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.474 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -90.06 162.52 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -110.12 22.5 15.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.348 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.616 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 52.8 mttm -105.56 -50.22 0.11 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.608 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.616 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 9.0 Cg_exo -72.13 -57.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.426 2.084 . . . . 0.0 112.144 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 145.06 -144.22 12.87 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.369 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.914 ' HG3' HD12 ' A' ' 168' ' ' LEU . 7.0 tp-100 -100.76 150.29 22.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.753 0.311 . . . . 0.0 110.857 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.452 ' CZ ' ' NH1' ' A' ' 198' ' ' ARG . 3.6 m-85 -131.06 138.12 49.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.781 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.81 HD13 HD21 ' A' ' 193' ' ' LEU . 86.9 mt -71.7 133.57 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 110.271 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.424 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 4.5 ptm180 -101.54 -30.88 11.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.723 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.2 t -152.78 145.43 24.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.469 . . . . 0.0 111.731 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 195' ' ' ALA . 18.0 t -128.64 132.31 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.434 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -84.1 120.23 74.44 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.106 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.45 133.44 49.01 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.415 2.076 . . . . 0.0 112.359 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 71.81 15.25 5.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.814 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 44.8 m -97.43 161.8 24.75 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.623 0.249 . . . . 0.0 110.64 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 99.6 Cg_exo -43.99 -40.32 11.78 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.571 2.18 . . . . 0.0 112.753 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.839 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -62.41 -44.3 96.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.444 . . . . 0.0 110.518 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -70.37 -52.27 23.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.027 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.51 -29.39 1.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.609 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.5 t -83.78 -31.98 25.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.959 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.49 7.38 6.32 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.984 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.839 HD13 ' HB1' ' A' ' 188' ' ' ALA . 7.5 tt -57.17 146.45 27.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.744 0.306 . . . . 0.0 110.85 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.703 ' N ' HD23 ' A' ' 193' ' ' LEU . 66.3 mtt-85 -136.54 137.99 40.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -63.46 149.64 45.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.299 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 75.31 2.61 3.91 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.099 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.757 ' OD2' HG21 ' A' ' 230' ' ' VAL . 52.6 p30 -73.1 153.98 40.58 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.435 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.452 ' NH1' ' CZ ' ' A' ' 178' ' ' PHE . 1.3 mmp_? -89.6 115.26 26.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 0.0 111.154 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.88 HD13 HG12 ' A' ' 230' ' ' VAL . 33.8 mm -65.01 125.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.15 -44.29 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.492 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.65 ' OE1' HD22 ' A' ' 229' ' ' LEU . 6.2 pt-20 -144.34 173.35 11.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.024 0.44 . . . . 0.0 111.623 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 205' ' ' VAL . 43.4 t -151.52 107.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.861 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.1 t30 70.27 24.35 4.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.322 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.76 -20.14 37.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.343 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 202' ' ' VAL . 36.0 m -82.48 99.19 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.99 0.424 . . . . 0.0 111.335 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.443 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 45.3 t -84.92 100.62 11.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.986 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.421 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 20.4 mmt -130.13 99.81 5.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -69.73 102.42 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.761 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.81 20.93 4.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.729 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.56 ' HA ' ' CE ' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -54.82 150.67 9.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.918 0.389 . . . . 0.0 111.076 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 215' ' ' VAL . 4.8 mm-40 -94.56 160.25 14.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.1 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.841 ' O ' HG23 ' A' ' 216' ' ' VAL . 85.0 t60 -47.15 -61.64 1.79 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.12 -30.55 60.9 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.151 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -44.26 67.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.407 . . . . 0.0 110.331 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 177' ' ' GLN . 39.2 t -71.96 -38.95 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.312 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 212' ' ' HIS . 46.3 t -66.4 -41.2 88.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.592 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 64.6 m -72.55 -34.64 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.696 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.1 83.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.057 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 32.0 mm -59.55 -41.98 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 ttp-105 -64.21 -41.68 96.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.724 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.06 5.32 30.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.712 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.64 19.21 38.1 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.046 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -145.08 9.61 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.941 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.63 -25.15 28.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.725 0.298 . . . . 0.0 111.158 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -103.98 114.99 29.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.59 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 4.5 m -111.09 108.05 17.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.345 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -91.12 99.89 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.403 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.713 HD21 HG13 ' A' ' 202' ' ' VAL . 12.4 mt -107.06 132.21 53.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.044 0.45 . . . . 0.0 111.717 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.671 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.3 tp -116.46 109.41 17.26 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.88 HG12 HD13 ' A' ' 199' ' ' ILE . 34.3 m -113.86 177.69 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.021 0.439 . . . . 0.0 112.061 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.55 ' CG1' HD12 ' A' ' 150' ' ' LEU . 5.2 t -124.48 144.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.778 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -74.1 110.91 8.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.375 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 -100.07 -25.28 14.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.665 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -56.63 -60.02 4.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.738 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 23.0 m -58.35 -32.47 68.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.455 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.84 -31.89 68.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.874 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.84 -30.14 11.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -57.65 -58.9 6.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.02 -29.97 68.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.917 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.576 -0.209 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.906 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -135.11 147.76 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.986 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.906 ' N ' HD13 ' A' ' 144' ' ' ILE . 25.7 t70 -44.73 140.84 3.14 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.382 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.5 -63.79 0.26 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.911 2.407 . . . . 0.0 112.172 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.996 ' O ' HG23 ' A' ' 148' ' ' THR . 19.3 t80 -88.03 -61.81 1.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.949 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.996 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.2 p 158.37 132.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.338 0.655 . . . . 0.0 110.818 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.5 mtm -125.39 -57.42 1.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.966 0.413 . . . . 0.0 111.159 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.64 HD12 HG11 ' A' ' 231' ' ' VAL . 20.8 tp -109.88 -4.12 16.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.563 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.461 ' C ' ' O ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -24.73 119.34 0.21 Allowed Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.301 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.64 142.53 14.44 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.458 ' O ' HD12 ' A' ' 229' ' ' LEU . 16.1 mtm105 -110.38 153.92 24.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.708 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.636 ' HA ' HD12 ' A' ' 229' ' ' LEU . 25.5 tp -104.15 133.1 49.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.028 0.442 . . . . 0.0 111.114 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.488 ' SG ' HD12 ' A' ' 193' ' ' LEU . 38.4 t -129.99 138.55 50.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.736 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.0 m -140.09 101.21 4.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.781 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.704 ' HE1' HD11 ' A' ' 228' ' ' LEU . 3.3 ptt? -109.91 135.8 50.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.954 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -95.12 135.61 36.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.011 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.453 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 18.3 tptp -73.97 -78.03 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.82 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.89 -159.94 5.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.198 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.02 0.17 10.22 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.614 2.209 . . . . 0.0 112.519 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.8 p -103.07 -30.12 10.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.592 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.453 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 95.46 -148.56 19.03 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.398 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.607 ' OH ' HG22 ' A' ' 219' ' ' ILE . 31.7 m-85 -97.73 -44.16 6.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.922 0.392 . . . . 0.0 110.77 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 183' ' ' ASP . . . 88.68 14.83 60.73 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.95 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.584 ' CE1' HD21 ' A' ' 168' ' ' LEU . 0.0 OUTLIER -124.86 -177.46 3.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.139 0.495 . . . . 0.0 111.879 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.813 ' C ' HD22 ' A' ' 168' ' ' LEU . 9.8 m120 -129.7 161.76 29.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.888 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.813 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.8 mm? -135.67 134.63 39.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.22 0.533 . . . . 0.0 112.276 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 6.6 p-80 -134.8 165.29 25.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.808 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.1 t -128.2 142.13 51.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.513 0.673 . . . . 0.0 112.504 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 178' ' ' PHE . 16.1 t0 -105.6 -40.22 5.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.386 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 14.3 mmtm -82.97 175.02 10.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.854 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.7 m -104.4 -26.97 12.22 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.912 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.766 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 32.0 mtmm -122.21 -58.64 0.03 OUTLIER Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.766 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 7.0 Cg_exo -81.28 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.837 2.358 . . . . 0.0 115.702 -175.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -39.07 145.0 0.24 Allowed Glycine 0 N--CA 1.453 -0.21 0 N-CA-C 116.532 1.373 . . . . 0.0 116.532 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.84 ' HG2' HG11 ' A' ' 215' ' ' VAL . 30.5 tp60 -138.35 127.13 23.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 112.867 -1.667 . . . . 0.0 107.159 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.638 ' CD2' ' NH2' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -134.93 135.65 41.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.727 HD12 ' OD2' ' A' ' 197' ' ' ASP . 50.4 mt -80.88 129.91 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' A' ' 169' ' ' HIS . 19.6 ptt180 -95.99 -33.27 12.21 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.0 t -154.74 157.69 38.4 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 195' ' ' ALA . 22.1 t -133.9 139.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.503 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 165' ' ' GLY . 47.1 t0 -87.35 122.44 70.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.176 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 31.2 Cg_exo -61.4 133.87 48.55 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.28 1.987 . . . . 0.0 111.973 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 75.26 14.85 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.625 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 46.6 m -100.62 162.97 19.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.637 0.255 . . . . 0.0 110.532 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 82.4 Cg_exo -45.87 -40.21 19.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.469 2.112 . . . . 0.0 112.797 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.643 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -65.07 -42.53 94.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.07 0.462 . . . . 0.0 110.475 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -70.42 -51.58 28.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.022 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.2 -24.76 11.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.497 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.8 t -85.06 -29.14 25.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 0.0 110.969 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.13 8.72 11.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.506 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -60.41 150.86 29.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.694 0.283 . . . . 0.0 110.557 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.887 ' N ' HD23 ' A' ' 193' ' ' LEU . 48.1 mtt180 -142.87 129.69 20.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.712 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -55.19 152.26 8.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 35.6 mt-30 78.31 6.73 2.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.851 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.727 ' OD2' HD12 ' A' ' 179' ' ' ILE . 40.7 p30 -78.11 152.62 32.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.636 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.638 ' NH2' ' CD2' ' A' ' 178' ' ' PHE . 7.9 mmp_? -85.78 109.1 18.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.652 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.87 ' HA ' HG12 ' A' ' 230' ' ' VAL . 39.1 mm -68.64 113.14 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.809 0.337 . . . . 0.0 110.441 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.0 t -105.72 -46.09 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.458 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 6.2 pt-20 -136.69 171.68 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 0.0 111.912 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 205' ' ' VAL . 17.9 t -147.84 113.09 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.553 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 50.6 t30 70.04 20.66 6.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.934 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 102.53 -15.41 55.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.559 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 202' ' ' VAL . 27.1 m -83.61 91.31 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 117.229 0.514 . . . . 0.0 111.537 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 51.6 t -82.89 109.59 17.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.737 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.444 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 20.5 mmt -130.5 99.89 5.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -74.9 103.57 5.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.77 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 175' ' ' PRO . . . 122.16 10.38 6.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.939 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.444 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 9.1 mmtt -56.82 147.61 22.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.9 0.381 . . . . 0.0 111.258 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.459 ' O ' HG23 ' A' ' 215' ' ' VAL . 29.5 mm-40 -79.53 160.51 26.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.862 ' O ' HG23 ' A' ' 216' ' ' VAL . 0.7 OUTLIER -47.84 -54.3 12.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.668 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.2 -33.02 85.77 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.802 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.52 -47.21 82.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.849 0.357 . . . . 0.0 110.281 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.84 HG11 ' HG2' ' A' ' 177' ' ' GLN . 28.2 t -66.55 -38.41 81.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.181 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 212' ' ' HIS . 57.3 t -68.24 -43.3 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.496 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 52.4 m -64.58 -37.64 88.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.409 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.499 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -56.0 -44.3 78.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.898 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.607 HG22 ' OH ' ' A' ' 164' ' ' TYR . 34.0 mm -61.57 -36.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.696 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 47.7 ttp85 -72.4 -33.98 67.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.04 5.39 29.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.67 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -84.55 12.61 55.49 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.187 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -140.77 17.35 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.88 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.49 -25.18 36.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 111.154 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -115.62 114.87 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.658 HG22 HD21 ' A' ' 228' ' ' LEU . 3.9 m -107.82 94.97 5.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -81.27 94.76 6.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.464 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.887 ' CD2' HG13 ' A' ' 202' ' ' VAL . 19.2 mt -101.27 141.51 34.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.657 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.636 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.1 tp -117.18 109.66 17.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.87 HG12 ' HA ' ' A' ' 199' ' ' ILE . 26.8 m -116.96 178.35 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.64 HG11 HD12 ' A' ' 150' ' ' LEU . 4.3 t -119.69 165.77 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.495 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.484 ' N ' HG12 ' A' ' 231' ' ' VAL . 66.6 t0 -93.91 109.22 20.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.992 0.425 . . . . 0.0 112.016 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.455 ' HD3' ' NH1' ' A' ' 198' ' ' ARG . 24.9 ttp180 -100.94 -21.0 15.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.424 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -44.96 -56.89 4.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.229 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.3 m -69.21 -30.98 69.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.554 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.6 -25.96 66.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.657 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -109.99 -29.6 8.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.988 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -53.5 -52.52 59.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.946 0.403 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -59.78 -31.09 69.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.69 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.875 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.798 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.1 OUTLIER -69.98 133.61 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.385 . . . . 0.0 110.924 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.798 ' N ' HD13 ' A' ' 144' ' ' ILE . 7.1 t70 -66.53 137.26 95.15 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.424 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.58 -58.03 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.601 2.2 . . . . 0.0 112.77 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.755 ' O ' HG23 ' A' ' 148' ' ' THR . 13.9 t80 -106.7 -60.71 1.63 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.665 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.9 p -168.59 158.79 9.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 22.7 mtm -109.67 -33.34 6.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.491 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.0 tp -74.39 -7.95 54.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.142 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.418 ' HB2' ' HD2' ' A' ' 152' ' ' PRO . 9.9 ptm180 -42.42 159.98 0.19 Allowed Pre-proline 0 CA--C 1.527 0.086 0 CA-C-O 120.899 0.38 . . . . 0.0 111.448 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.736 ' HA ' HG22 ' A' ' 231' ' ' VAL . 19.7 Cg_endo -60.78 140.9 93.08 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.692 2.261 . . . . 0.0 112.422 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.582 ' O ' HD12 ' A' ' 229' ' ' LEU . 42.5 mtm180 -108.41 141.68 39.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.991 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 37.2 tp -76.27 132.61 39.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.222 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 6.1 t -126.93 140.16 52.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.265 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.428 ' N ' ' OG ' ' A' ' 191' ' ' SER . 4.3 m -130.03 104.61 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.655 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -109.88 141.49 42.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.007 0.432 . . . . 0.0 111.379 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -113.09 115.93 29.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.401 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.427 ' HD3' ' CE1' ' A' ' 164' ' ' TYR . 7.6 tptp -61.76 -88.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.804 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.68 -150.15 18.16 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.341 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.9 0.06 10.3 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.68 2.253 . . . . 0.0 112.627 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.7 p -92.31 -30.33 15.89 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.321 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.04 -158.65 21.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.471 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.463 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 30.4 m-85 -87.93 -50.71 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.967 0.413 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.53 14.91 33.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.968 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.821 ' CE2' HD21 ' A' ' 168' ' ' LEU . 7.5 p90 -163.72 -179.42 6.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.168 0.509 . . . . 0.0 111.585 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.77 ' C ' HD22 ' A' ' 168' ' ' LEU . 2.9 m120 -127.72 165.06 20.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.551 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.821 HD21 ' CE2' ' A' ' 166' ' ' PHE . 3.2 mm? -134.37 137.65 44.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.456 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -134.82 153.43 52.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.042 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.0 t -155.25 158.09 38.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.768 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -130.09 -77.23 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.407 ' HB2' ' CD ' ' A' ' 175' ' ' PRO . 3.7 mmpt? -81.05 175.14 10.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.666 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -90.41 12.25 19.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.369 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.482 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 26.7 mtmm -105.65 -47.17 0.13 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.904 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 76.9 Cg_exo -51.27 -63.56 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.145 1.897 . . . . 0.0 112.462 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.08 -141.15 16.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.434 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.716 ' CB ' HG21 ' A' ' 215' ' ' VAL . 3.0 tp-100 -105.31 104.88 14.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.681 0.277 . . . . 0.0 110.972 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.512 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 10.3 m-30 -115.64 148.82 39.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.717 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.743 HD13 HD21 ' A' ' 193' ' ' LEU . 65.0 mt -76.08 133.73 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.583 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.456 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 8.1 ptt180 -104.97 -31.07 9.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.363 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.2 t -150.32 155.67 40.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 111.241 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.955 HG23 ' HB2' ' A' ' 195' ' ' ALA . 24.5 t -132.89 141.65 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -94.4 120.92 64.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.915 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.55 134.17 49.7 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.36 2.04 . . . . 0.0 112.362 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 73.09 14.89 4.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.839 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.4 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 36.4 m -94.78 162.51 25.15 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.565 0.221 . . . . 0.0 110.503 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 75.1 Cg_exo -48.22 -40.16 34.82 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.367 2.045 . . . . 0.0 112.4 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.94 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -61.79 -44.61 96.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.495 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -65.28 -55.41 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.017 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.19 -25.47 61.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 156' ' ' THR . 26.4 t -78.73 -22.53 46.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 106.89 28.63 4.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.016 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.94 HD13 ' HB1' ' A' ' 188' ' ' ALA . 7.3 tt -85.4 145.18 27.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 0.0 110.935 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.667 ' N ' HD23 ' A' ' 193' ' ' LEU . 5.3 mtt-85 -131.53 131.64 43.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.955 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -57.37 145.64 31.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.319 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' A' ' 233' ' ' ARG . 56.5 mt-30 74.81 -0.22 3.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.979 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.662 ' CG ' HD12 ' A' ' 179' ' ' ILE . 49.2 p30 -63.63 158.2 21.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.765 0.317 . . . . 0.0 110.672 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.512 ' HD2' ' CE1' ' A' ' 178' ' ' PHE . 1.8 mmm180 -94.95 112.84 24.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.344 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.794 HD13 HG12 ' A' ' 230' ' ' VAL . 32.7 mm -65.08 117.21 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.853 0.359 . . . . 0.0 110.586 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.557 ' CG1' HD23 ' A' ' 229' ' ' LEU . 23.4 t -97.61 -46.64 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.61 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 5.2 pt-20 -139.68 176.03 9.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.069 0.461 . . . . 0.0 111.425 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.893 ' O ' HG22 ' A' ' 205' ' ' VAL . 33.8 t -153.18 105.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.773 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.7 t30 70.35 25.09 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.395 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.47 -19.85 38.56 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.451 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 202' ' ' VAL . 32.0 m -82.8 98.16 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.992 0.425 . . . . 0.0 111.319 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.438 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 45.8 t -84.93 102.47 13.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.034 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.412 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 16.2 mmt -130.14 99.86 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.938 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -69.55 102.61 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.48 22.43 4.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.71 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.412 ' HG2' ' HB2' ' A' ' 207' ' ' MET . 0.0 OUTLIER -54.93 157.79 3.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.533 ' O ' HG23 ' A' ' 215' ' ' VAL . 31.0 mm-40 -94.87 160.12 14.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.12 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.862 ' O ' HG23 ' A' ' 216' ' ' VAL . 1.1 t-80 -50.09 -60.72 2.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.9 -33.58 84.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.236 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.64 -48.62 80.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 110.26 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.716 HG21 ' CB ' ' A' ' 177' ' ' GLN . 23.0 t -68.01 -40.42 83.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.089 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 212' ' ' HIS . 47.0 t -62.4 -44.81 99.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.281 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 75.0 m -66.84 -39.05 87.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.29 80.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.874 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 226' ' ' THR . 36.5 mm -62.68 -36.43 75.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.653 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -46.93 84.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.536 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.0 5.08 30.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.534 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -92.37 20.18 45.52 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.837 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.26 -143.33 12.47 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.893 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -88.71 -22.9 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.674 0.273 . . . . 0.0 111.342 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -108.42 115.73 30.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.753 HG21 ' CD1' ' A' ' 219' ' ' ILE . 28.0 m -120.19 114.19 21.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.452 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -86.04 99.04 11.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.171 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.711 HD23 ' HA ' ' A' ' 202' ' ' VAL . 23.0 mt -105.39 140.75 38.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.046 0.451 . . . . 0.0 111.961 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 153' ' ' ARG . 13.7 tp -115.55 109.47 17.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.467 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.794 HG12 HD13 ' A' ' 199' ' ' ILE . 33.3 m -116.63 169.23 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.999 0.428 . . . . 0.0 111.736 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 152' ' ' PRO . 2.6 t -135.62 152.94 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -69.86 109.66 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.77 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 237' ' ' GLU . 26.8 ttp180 -100.4 -18.18 16.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.247 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 238' ' ' PHE . 76.1 mt-10 -49.41 -55.23 13.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.589 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.0 m -90.12 -21.92 22.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.861 0.362 . . . . 0.0 111.213 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -53.8 -54.89 31.97 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 233' ' ' ARG . 5.0 pt-20 -110.21 -41.85 4.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.454 ' CB ' ' O ' ' A' ' 234' ' ' GLU . 4.5 t80 -39.98 -60.38 1.04 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -28.92 65.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.357 . . . . 0.0 110.832 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.82 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -94.09 144.37 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.84 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.82 ' N ' HD13 ' A' ' 144' ' ' ILE . 4.1 t0 -48.44 104.26 0.41 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.251 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -80.32 -67.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.19 1.927 . . . . 0.0 112.043 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -115.83 -43.76 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.658 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -119.91 162.34 19.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.431 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 35.5 mtm -121.37 -19.84 6.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.62 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.787 HD11 ' O ' ' A' ' 232' ' ' ASP . 10.0 tp -64.92 -17.59 64.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.617 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 150' ' ' LEU . 6.3 ptp180 -28.53 143.97 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 O-C-N 123.355 0.409 . . . . 0.0 112.026 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.677 ' HA ' HG22 ' A' ' 231' ' ' VAL . 7.6 Cg_endo -50.45 151.95 9.39 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.063 2.509 . . . . 0.0 112.957 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -127.71 140.94 51.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.575 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.818 ' HA ' HD12 ' A' ' 229' ' ' LEU . 16.6 tp -87.16 132.93 33.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.278 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 39.4 t -130.08 140.1 50.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.757 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -135.1 106.39 6.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.707 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' MET . . . . . 1.066 ' HE1' HD12 ' A' ' 228' ' ' LEU . 12.3 ptp -113.78 143.93 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 0.0 111.171 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -102.22 124.3 47.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.792 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 224' ' ' ASP . 6.6 tptm -55.76 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.37 -150.66 40.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.403 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.74 -16.68 14.54 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.72 2.28 . . . . 0.0 112.596 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.5 p -93.12 -30.15 15.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.174 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.435 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 80.05 -131.68 10.73 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.471 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CB ' ' CE1' ' A' ' 166' ' ' PHE . 3.6 m-85 -105.94 -50.36 3.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 110.433 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.06 20.83 52.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.29 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.497 ' CE1' ' CB ' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -124.86 179.11 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.125 0.488 . . . . 0.0 111.728 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.807 ' C ' HD22 ' A' ' 168' ' ' LEU . 8.7 m120 -129.87 159.2 37.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.877 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.807 HD22 ' C ' ' A' ' 167' ' ' ASN . 3.1 mm? -136.32 136.02 39.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.191 0.52 . . . . 0.0 112.066 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -134.53 165.26 25.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.5 178.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.5 t -140.69 148.0 40.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.073 0.463 . . . . 0.0 111.789 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -130.33 -67.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.527 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -90.05 164.63 14.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.733 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 67.0 m -110.15 22.33 15.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.472 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.733 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 25.1 mtpp -116.96 -56.25 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.838 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 57.4 Cg_exo -53.62 -56.23 2.85 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.139 1.892 . . . . 0.0 112.536 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 137.92 -143.7 14.78 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.358 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.869 ' HB2' HG21 ' A' ' 215' ' ' VAL . 10.3 tp-100 -84.22 142.48 30.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 110.776 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.532 ' CD2' ' CZ ' ' A' ' 198' ' ' ARG . 1.7 m-85 -120.98 149.67 42.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.53 HD12 ' OD1' ' A' ' 197' ' ' ASP . 9.9 mt -98.46 130.91 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.1 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.448 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 24.2 ptt180 -100.77 -30.57 11.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.5 t -157.73 151.24 23.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.1 0.476 . . . . 0.0 112.009 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.775 HG23 ' HB2' ' A' ' 195' ' ' ALA . 54.6 t -131.85 141.09 46.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.456 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 186' ' ' SER . 56.8 t0 -84.95 125.33 70.92 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.111 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.18 127.53 19.47 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.392 2.061 . . . . 0.0 112.161 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 185' ' ' ASP . 13.7 t0 74.4 23.49 1.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.5 m -102.56 164.63 15.27 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.606 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 81.1 Cg_exo -44.85 -40.28 14.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.612 2.208 . . . . 0.0 112.747 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -43.01 92.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.077 0.465 . . . . 0.0 110.407 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.56 -51.81 25.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.038 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -49.28 -27.4 3.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.644 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.3 t -85.03 -31.54 23.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 111.056 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 121.19 21.33 3.13 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.991 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.862 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -83.09 151.59 25.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.613 0.244 . . . . 0.0 110.573 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.862 ' N ' HD23 ' A' ' 193' ' ' LEU . 30.5 mtp180 -145.57 129.72 17.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.266 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.775 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -52.15 160.78 0.71 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.703 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.623 ' HB3' ' HG3' ' A' ' 234' ' ' GLU . 54.9 mt-30 82.43 -4.82 1.4 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.092 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.689 ' OD2' HG21 ' A' ' 230' ' ' VAL . 38.3 p30 -86.13 165.2 16.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 110.593 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.532 ' CZ ' ' CD2' ' A' ' 178' ' ' PHE . 15.5 mmp_? -101.55 125.12 48.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 111.682 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.767 ' HA ' HG12 ' A' ' 230' ' ' VAL . 26.0 mm -69.43 108.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.854 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.18 -50.11 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.367 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.441 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 11.2 pt-20 -136.22 173.92 11.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.98 0.419 . . . . 0.0 111.139 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.873 ' O ' HG22 ' A' ' 205' ' ' VAL . 40.1 t -151.48 107.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.929 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 53.5 t30 70.25 25.22 4.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.437 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.55 -18.67 43.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.5 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 202' ' ' VAL . 36.0 m -83.74 97.87 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.008 0.432 . . . . 0.0 111.191 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 48.5 t -85.91 101.66 13.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.061 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.427 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 96.6 mmm -130.11 99.66 5.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.856 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -70.89 105.34 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.27 17.85 5.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.743 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.427 ' HG2' ' HB2' ' A' ' 207' ' ' MET . 0.7 OUTLIER -54.94 150.15 10.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.952 0.406 . . . . 0.0 111.123 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.509 ' O ' HG23 ' A' ' 215' ' ' VAL . 11.4 mm100 -91.53 160.43 15.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.058 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.872 ' O ' HG23 ' A' ' 216' ' ' VAL . 32.4 t-80 -47.81 -64.58 0.75 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.67 -33.79 59.9 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.108 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.27 -47.13 83.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.191 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.869 HG21 ' HB2' ' A' ' 177' ' ' GLN . 23.3 t -71.94 -38.95 66.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.116 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 212' ' ' HIS . 48.6 t -62.44 -41.63 92.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.193 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 32.4 m -75.05 -40.82 60.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.419 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.26 -46.79 87.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.694 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.479 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 23.3 mm -61.23 -34.08 59.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.534 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -73.89 -36.89 64.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.382 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.75 5.53 28.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.674 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -83.29 16.34 29.65 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.171 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.29 -135.89 26.96 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.055 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.2 m-20 -92.21 -25.08 18.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.668 0.27 . . . . 0.0 111.38 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -102.34 117.94 35.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.592 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 5.7 m -114.69 98.45 6.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.485 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -88.73 97.71 11.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.056 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 1.066 HD12 ' HE1' ' A' ' 157' ' ' MET . 54.3 mt -105.38 138.89 40.85 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.6 tp -117.8 109.91 17.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.082 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 199' ' ' ILE . 35.4 m -124.43 170.76 14.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 152' ' ' PRO . 2.6 t -141.33 135.44 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.484 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.787 ' O ' HD11 ' A' ' 150' ' ' LEU . 22.3 t0 -72.55 119.87 17.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.401 . . . . 0.0 111.408 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.445 ' HB3' ' NH1' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -100.82 -25.35 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.81 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.623 ' HG3' ' HB3' ' A' ' 196' ' ' GLN . 27.8 mt-10 -78.66 -44.25 24.2 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.366 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.696 HG23 ' HB3' ' A' ' 239' ' ' PHE . 6.4 m -59.81 -24.33 64.07 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.457 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . 23.4 t0 -63.72 -37.37 87.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.393 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -110.65 -50.86 2.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.805 0.336 . . . . 0.0 111.729 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -66.95 -70.82 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.698 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.696 ' HB3' HG23 ' A' ' 235' ' ' THR . 0.8 OUTLIER -59.94 -17.13 35.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.497 -179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 236' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.02 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.915 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -113.74 141.48 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.666 0.269 . . . . 0.0 110.794 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.915 ' N ' HD13 ' A' ' 144' ' ' ILE . 16.0 t70 -47.28 137.77 8.48 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.625 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.93 -61.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.492 2.128 . . . . 0.0 113.318 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.021 ' O ' HG23 ' A' ' 148' ' ' THR . 43.5 t80 -89.52 -60.97 1.8 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . 1.021 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.3 p 161.5 129.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.217 0.607 . . . . 0.0 110.659 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 41.7 mtt -125.6 -57.94 1.44 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.925 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.4 tp -121.46 -23.58 5.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.651 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.776 ' CD ' HG22 ' A' ' 148' ' ' THR . 4.8 ptp180 -49.04 146.47 5.69 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.706 0.288 . . . . 0.0 111.227 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.627 ' HB3' HG22 ' A' ' 231' ' ' VAL . 73.9 Cg_endo -75.24 170.77 19.62 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.674 2.249 . . . . 0.0 112.869 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 15.5 mtm105 -135.39 145.13 47.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.611 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.916 ' HA ' HD12 ' A' ' 229' ' ' LEU . 59.4 tp -85.76 135.02 33.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.37 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.7 t -130.01 140.07 50.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.814 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -131.53 108.34 9.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.65 ' CE ' HD12 ' A' ' 228' ' ' LEU . 6.7 ptp -119.85 142.1 48.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -102.73 135.63 44.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.085 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.459 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 18.2 tptt -70.14 -78.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.785 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.87 -159.89 5.62 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.266 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.62 0.21 10.2 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.597 2.198 . . . . 0.0 112.654 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.0 p -101.03 -30.24 11.72 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.459 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 89.41 -147.79 19.7 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.26 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.508 ' HB3' ' CE2' ' A' ' 166' ' ' PHE . 13.8 m-85 -110.19 -43.93 3.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.991 0.424 . . . . 0.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.94 40.49 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.507 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 164' ' ' TYR . 4.2 p90 -124.6 174.08 8.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 117.219 0.509 . . . . 0.0 111.714 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.731 ' O ' HG23 ' A' ' 179' ' ' ILE . 10.0 m120 -134.98 152.84 52.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.319 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 179' ' ' ILE . 4.1 mm? -127.49 142.8 51.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.011 0.434 . . . . 0.0 111.838 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.456 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 7.5 p-80 -142.62 144.39 32.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.235 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.9 t -144.05 160.48 40.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.924 0.392 . . . . 0.0 111.273 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -126.39 -71.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -90.09 168.54 11.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.7 m -110.0 21.19 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.233 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.543 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 30.7 mtmm -104.79 -49.1 0.13 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.492 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.543 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 13.8 Cg_exo -69.39 -66.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.402 2.068 . . . . 0.0 112.154 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.48 -159.45 28.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.609 ' HG3' HD12 ' A' ' 168' ' ' LEU . 8.2 tp-100 -105.52 144.32 32.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.866 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.426 ' CE1' ' HD3' ' A' ' 198' ' ' ARG . 8.7 m-85 -135.8 151.29 49.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.804 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 167' ' ' ASN . 70.0 mt -72.96 138.98 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.549 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.456 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 5.8 ptt180 -99.31 -34.13 10.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.583 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.416 ' N ' ' HG3' ' A' ' 180' ' ' ARG . 23.0 t -151.73 152.86 33.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.051 0.453 . . . . 0.0 111.512 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 195' ' ' ALA . 26.8 t -131.17 135.48 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.665 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 186' ' ' SER . 59.0 t0 -81.66 120.72 78.56 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.949 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.94 126.94 20.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.351 2.034 . . . . 0.0 112.38 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 t70 74.25 22.94 2.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.741 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 183' ' ' ASP . 5.6 m -100.86 162.61 20.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.594 0.235 . . . . 0.0 110.638 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -43.49 -40.34 10.16 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.673 2.249 . . . . 0.0 112.721 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.891 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -66.11 -42.61 89.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.471 . . . . 0.0 110.31 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.54 -51.68 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.887 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -48.12 -29.68 3.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.541 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.6 t -83.5 -30.05 27.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 120.7 29.5 1.54 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.53 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.891 HD13 ' HB1' ' A' ' 188' ' ' ALA . 8.2 tt -84.2 149.22 26.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.74 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.816 ' N ' HD23 ' A' ' 193' ' ' LEU . 5.4 mtt-85 -141.43 135.93 30.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.665 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -56.08 153.37 9.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.343 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 70.97 7.87 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.774 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.622 ' OD2' HD12 ' A' ' 179' ' ' ILE . 58.8 p30 -74.02 150.05 40.9 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.426 ' HD3' ' CE1' ' A' ' 178' ' ' PHE . 1.4 mmp_? -89.87 113.43 25.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 111.231 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.778 HD13 HG12 ' A' ' 230' ' ' VAL . 27.8 mm -68.27 125.73 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.75 -44.52 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.499 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.459 ' HG2' ' CB ' ' A' ' 229' ' ' LEU . 10.1 pt-20 -143.61 176.85 8.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 111.389 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.89 ' O ' HG22 ' A' ' 205' ' ' VAL . 36.0 t -155.65 107.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.946 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 12.5 t30 70.19 24.27 4.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.45 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.79 -19.16 39.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.369 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.89 HG22 ' O ' ' A' ' 202' ' ' VAL . 32.7 m -81.87 95.69 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.015 0.436 . . . . 0.0 111.272 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.436 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 50.2 t -86.42 99.17 11.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.938 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.424 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 17.6 mmt -130.14 99.83 5.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -68.24 103.91 1.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.748 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.61 21.02 4.83 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.583 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -54.78 142.18 29.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.972 0.415 . . . . 0.0 111.138 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.512 ' O ' HG23 ' A' ' 215' ' ' VAL . 7.4 mm-40 -85.84 160.39 19.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.854 ' O ' HG23 ' A' ' 216' ' ' VAL . 77.9 t60 -45.55 -60.91 1.92 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.02 -31.14 64.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.981 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -43.71 67.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.939 0.4 . . . . 0.0 110.249 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 211' ' ' GLN . 40.5 t -72.14 -39.13 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.286 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 212' ' ' HIS . 49.3 t -65.92 -41.25 89.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.48 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 73.1 m -70.06 -38.47 75.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.566 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.469 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -55.49 -45.15 77.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.004 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.456 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 30.1 mm -63.84 -36.43 76.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.752 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -65.43 -41.32 93.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.649 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.51 5.2 28.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -81.89 5.56 70.08 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.073 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -140.13 18.53 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.852 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.21 -25.18 34.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.71 0.291 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -115.6 114.86 25.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.524 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.503 HG22 ' CD2' ' A' ' 228' ' ' LEU . 17.3 m -111.6 96.48 6.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.445 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -73.58 97.07 2.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.009 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.887 HD21 HG13 ' A' ' 202' ' ' VAL . 73.6 mt -105.33 131.59 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.978 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 154' ' ' LEU . 12.2 tp -109.58 109.48 20.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.315 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.778 HG12 HD13 ' A' ' 199' ' ' ILE . 35.9 m -119.19 169.82 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.031 0.443 . . . . 0.0 111.907 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 152' ' ' PRO . 15.9 t -119.82 156.32 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.697 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 231' ' ' VAL . 67.9 t0 -92.41 112.31 24.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.304 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -100.16 -25.43 14.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.804 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -63.92 -60.08 3.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 62.4 m -58.66 -24.4 61.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.5 -46.39 86.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.269 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -110.05 -43.01 4.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.261 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -50.37 -67.11 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.292 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -60.58 -30.64 69.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.822 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -118.19 139.8 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.921 0.391 . . . . 0.0 111.0 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.822 ' N ' HD13 ' A' ' 144' ' ' ILE . 15.3 t70 -45.73 137.54 5.72 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.89 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.28 -70.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.663 2.242 . . . . 0.0 112.551 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.027 ' O ' HG23 ' A' ' 148' ' ' THR . 1.0 OUTLIER -96.2 -60.72 1.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.454 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . 1.027 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.3 p 168.83 128.82 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.204 0.602 . . . . 0.0 110.627 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 41.4 mtt -126.5 -65.57 0.96 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.931 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 150' ' ' LEU . 11.0 tp -125.91 -4.83 6.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.106 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.784 ' HD3' HG22 ' A' ' 148' ' ' THR . 0.4 OUTLIER -44.88 130.79 5.27 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 120.79 0.329 . . . . 0.0 111.587 -179.048 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.12 -179.91 5.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.794 2.329 . . . . 0.0 112.783 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -137.79 141.47 40.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.735 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.868 ' HA ' HD12 ' A' ' 229' ' ' LEU . 35.1 tp -99.4 131.36 45.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.962 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.9 t -130.01 138.54 50.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.035 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -131.49 104.4 6.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.486 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.683 ' HE1' ' HB2' ' A' ' 188' ' ' ALA . 5.7 ptm -119.73 140.49 50.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.216 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -96.28 129.42 43.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.404 ' CE ' ' HA2' ' A' ' 163' ' ' GLY . 18.9 tptp -59.78 -80.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.802 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.82 -156.7 17.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.262 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.69 0.02 10.33 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.615 2.21 . . . . 0.0 112.798 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.4 p -92.89 -30.36 15.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.574 0.226 . . . . 0.0 111.469 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.404 ' HA2' ' CE ' ' A' ' 159' ' ' LYS . . . 91.33 -124.9 7.79 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.378 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.488 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 2.4 m-85 -108.21 -55.07 2.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 0.0 110.488 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.71 -5.04 61.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.457 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.645 ' CE2' HD21 ' A' ' 168' ' ' LEU . 45.1 p90 -128.74 177.45 7.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.403 0.602 . . . . 0.0 111.762 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.806 ' C ' HD22 ' A' ' 168' ' ' LEU . 84.9 m-20 -125.5 165.19 18.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.806 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.4 mm? -133.55 147.66 51.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.011 0.434 . . . . 0.0 112.003 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 2.2 p-80 -134.47 146.23 49.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.708 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.6 t -155.21 150.04 26.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 111.65 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -114.96 -68.93 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.231 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 155.2 19.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.464 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.1 m -96.34 20.27 10.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.177 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.561 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 31.7 mttp -110.9 -49.71 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.994 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 38.2 Cg_exo -57.63 -63.38 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.109 1.873 . . . . 0.0 112.391 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.9 -162.02 29.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.579 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -108.3 136.47 47.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 0.0 110.886 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.434 ' CD1' ' HD2' ' A' ' 198' ' ' ARG . 2.3 m-85 -124.08 158.05 33.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.608 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.64 ' HA ' HD13 ' A' ' 168' ' ' LEU . 15.0 mt -87.14 139.6 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.875 0.369 . . . . 0.0 110.743 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.458 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 10.2 ptm180 -105.16 -37.79 6.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.516 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.6 t -148.49 154.95 40.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.013 0.435 . . . . 0.0 111.716 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.758 HG23 ' HB2' ' A' ' 195' ' ' ALA . 33.6 t -132.34 143.04 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.739 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 57.2 t0 -95.03 125.33 51.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.081 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 23.5 Cg_exo -63.96 134.42 43.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.275 1.984 . . . . 0.0 112.084 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 74.24 14.9 3.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.728 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 21.2 m -97.26 163.37 20.0 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.515 0.198 . . . . 0.0 110.537 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 81.3 Cg_exo -45.66 -40.35 18.67 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.473 2.115 . . . . 0.0 112.548 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.683 ' HB2' ' HE1' ' A' ' 157' ' ' MET . . . -65.13 -41.62 94.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 110.687 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -70.13 -50.6 38.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.82 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -47.59 -31.49 4.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.474 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.2 t -81.23 -31.45 33.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.049 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 113.1 31.54 2.42 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.063 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 194' ' ' ARG . 6.8 tt -82.59 151.37 26.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.733 0.302 . . . . 0.0 110.905 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.745 ' N ' HD23 ' A' ' 193' ' ' LEU . 49.9 mtt180 -137.78 130.02 29.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.645 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.758 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -52.82 157.59 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.497 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 47.5 mt-30 82.46 -17.04 0.55 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.326 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.739 ' OD2' HG21 ' A' ' 230' ' ' VAL . 20.1 p-10 -61.13 149.58 36.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.727 0.299 . . . . 0.0 110.662 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.434 ' HD2' ' CD1' ' A' ' 178' ' ' PHE . 4.6 mmm-85 -90.63 118.31 29.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.335 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.788 HD13 HG12 ' A' ' 230' ' ' VAL . 24.3 mm -65.28 128.6 28.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.799 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.485 ' CG2' HG23 ' A' ' 231' ' ' VAL . 11.8 t -111.23 -43.73 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.636 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.562 ' OE1' HD22 ' A' ' 229' ' ' LEU . 5.4 pt-20 -142.81 173.74 11.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.477 . . . . 0.0 111.433 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.88 ' O ' HG22 ' A' ' 205' ' ' VAL . 47.0 t -153.4 107.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.983 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.5 t30 70.37 25.27 4.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.508 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.48 -20.46 37.14 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.452 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 202' ' ' VAL . 26.9 m -80.4 95.28 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.09 0.445 . . . . 0.0 111.161 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.44 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 44.9 t -89.93 99.73 12.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.012 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.4 ' O ' ' HG2' ' A' ' 210' ' ' LYS . 45.6 mmm -130.16 101.38 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -67.1 100.04 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.625 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.23 26.49 3.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.392 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 207' ' ' MET . 6.5 mmtp -54.9 156.27 3.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 111.119 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.525 ' O ' HG23 ' A' ' 215' ' ' VAL . 3.7 mm-40 -92.11 160.28 15.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.987 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.811 ' O ' HG23 ' A' ' 216' ' ' VAL . 63.8 t-80 -47.71 -62.69 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.49 -30.3 64.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.284 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.86 -45.78 73.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 110.484 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 211' ' ' GLN . 28.7 t -70.92 -37.04 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.458 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 212' ' ' HIS . 45.0 t -69.2 -42.03 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.658 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 70.3 m -72.15 -33.18 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -59.35 -48.78 80.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.479 HD13 HG13 ' A' ' 202' ' ' VAL . 26.8 mm -62.24 -38.08 80.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.944 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -68.47 -36.84 79.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.734 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.14 5.2 30.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.645 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -85.1 10.18 64.1 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.039 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.17 -128.68 27.07 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.806 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.33 -25.09 18.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.717 0.294 . . . . 0.0 111.125 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -107.98 117.37 33.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.788 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.408 HG22 HD21 ' A' ' 228' ' ' LEU . 3.0 m -113.24 96.11 5.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.442 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -78.5 98.55 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.097 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.604 HD12 ' SD ' ' A' ' 157' ' ' MET . 28.7 mt -106.46 131.01 54.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.035 0.445 . . . . 0.0 111.906 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 154' ' ' LEU . 11.9 tp -115.98 109.7 17.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.572 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.788 HG12 HD13 ' A' ' 199' ' ' ILE . 32.0 m -109.77 176.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 112.068 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.485 HG23 ' CG2' ' A' ' 200' ' ' VAL . 5.4 t -126.49 162.89 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.074 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.479 ' N ' HG12 ' A' ' 231' ' ' VAL . 64.9 t0 -80.61 112.9 18.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.252 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -100.06 -27.26 13.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.572 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -50.58 -58.59 5.45 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.626 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 89.7 m -63.12 -30.56 71.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.91 -30.22 67.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -109.51 -28.2 9.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -57.18 -50.14 73.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.02 0.438 . . . . 0.0 110.792 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.76 -26.19 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.933 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.9 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.384 -0.286 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.827 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.1 OUTLIER -127.65 133.15 68.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.969 0.414 . . . . 0.0 110.992 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.827 ' N ' HD13 ' A' ' 144' ' ' ILE . 22.2 t70 -71.22 138.48 84.41 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.718 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.79 -61.32 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.817 2.345 . . . . 0.0 112.392 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.033 ' O ' HG23 ' A' ' 148' ' ' THR . 0.9 OUTLIER -83.75 -61.61 1.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.507 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . 1.033 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.2 p 158.83 127.89 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.347 0.659 . . . . 0.0 111.157 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 77.9 mtp -127.16 -66.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.361 0.601 . . . . 0.0 110.449 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.541 HD12 HG11 ' A' ' 231' ' ' VAL . 13.0 tp -126.25 -4.88 6.71 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.644 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.724 ' HD2' HG22 ' A' ' 148' ' ' THR . 3.7 ptm85 -26.77 121.87 0.23 Allowed Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.4 139.13 12.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.567 2.178 . . . . 0.0 112.556 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -94.51 139.89 30.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.383 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.917 ' HA ' HD12 ' A' ' 229' ' ' LEU . 18.1 tp -95.99 119.84 35.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.989 0.423 . . . . 0.0 111.026 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 228' ' ' LEU . 45.3 t -116.21 126.94 54.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.53 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.448 ' N ' ' OG ' ' A' ' 191' ' ' SER . 3.0 m -135.48 99.91 4.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.192 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.42 ' HE2' ' HA ' ' A' ' 188' ' ' ALA . 16.4 ptp -112.38 142.91 44.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.195 0.522 . . . . 0.0 111.88 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -104.44 119.65 39.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.895 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 224' ' ' ASP . 16.5 tptp -58.08 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.057 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.01 -152.86 12.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.385 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.02 0.17 10.22 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.747 2.298 . . . . 0.0 112.885 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.7 p -87.16 -30.41 21.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.575 0.226 . . . . 0.0 111.544 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.402 ' HA2' ' CE ' ' A' ' 159' ' ' LYS . . . 97.27 -146.66 18.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.179 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 7.7 m-85 -109.33 -46.83 3.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.167 0.508 . . . . 0.0 110.259 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 183' ' ' ASP . . . 70.71 28.34 71.01 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.626 -0.715 . . . . 0.0 113.813 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -140.84 175.68 9.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.576 0.688 . . . . 0.0 112.163 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.796 ' C ' HD22 ' A' ' 168' ' ' LEU . 10.0 m120 -135.65 155.98 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.66 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.796 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.3 mm? -133.42 143.06 48.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.046 0.451 . . . . 0.0 111.9 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -141.03 136.86 32.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.298 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.6 t -137.15 163.95 29.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.379 . . . . 0.0 111.28 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -130.04 -78.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.665 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -90.14 175.05 7.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.761 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.0 m -109.22 19.65 19.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.208 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.63 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 2.6 mtmp? -110.87 -51.36 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.752 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 38.8 Cg_exo -61.2 -63.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.238 1.959 . . . . 0.0 112.229 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 144.35 -176.4 23.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.53 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.753 ' HB3' HG11 ' A' ' 215' ' ' VAL . 9.8 tp-100 -89.27 140.28 29.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.455 ' CD1' ' HD3' ' A' ' 198' ' ' ARG . 3.0 m-85 -127.73 147.84 50.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.654 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.773 HD12 ' OD2' ' A' ' 197' ' ' ASP . 68.0 mt -78.38 135.03 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.209 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.448 ' CG ' ' HB3' ' A' ' 167' ' ' ASN . 10.2 ptm180 -98.71 -35.04 10.3 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.9 t -151.58 156.76 41.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 112.076 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.76 HG23 ' HB2' ' A' ' 195' ' ' ALA . 23.3 t -132.69 140.6 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.524 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 165' ' ' GLY . 40.7 t0 -95.11 117.1 66.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.199 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.86 140.76 96.56 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.502 2.135 . . . . 0.0 112.185 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.1 t70 66.0 14.87 9.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.511 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 9.2 m -105.03 166.36 11.58 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.447 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 98.4 Cg_exo -43.98 -40.15 11.63 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.438 2.092 . . . . 0.0 112.437 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.42 ' HA ' ' HE2' ' A' ' 157' ' ' MET . . . -59.65 -44.94 93.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.684 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.18 -54.5 12.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -52.79 -26.63 14.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.533 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 156' ' ' THR . 4.4 t -85.09 -24.71 27.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.991 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.09 26.07 6.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.121 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -79.82 149.39 31.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 111.009 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.825 ' N ' HD23 ' A' ' 193' ' ' LEU . 50.6 mtt-85 -140.72 129.9 23.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.706 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.76 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -58.42 151.1 20.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.324 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 41.5 mt-30 77.55 -3.05 2.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.163 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.773 ' OD2' HD12 ' A' ' 179' ' ' ILE . 41.3 p30 -67.71 151.83 46.59 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.567 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.455 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 68.1 mmt-85 -90.61 115.67 27.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.25 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.715 HD13 HG12 ' A' ' 230' ' ' VAL . 22.8 mm -65.51 124.55 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.117 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.583 HG12 ' SG ' ' A' ' 206' ' ' CYS . 17.1 t -109.02 -45.19 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.492 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.9 pt-20 -144.27 173.97 11.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 111.449 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.886 HG13 ' CD2' ' A' ' 228' ' ' LEU . 26.4 t -155.43 112.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.817 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 44.2 t30 70.21 22.93 5.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.385 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.54 -15.96 48.88 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.581 -0.818 . . . . 0.0 113.589 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 202' ' ' VAL . 27.0 m -86.59 93.75 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.25 0.525 . . . . 0.0 111.539 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.583 ' SG ' HG12 ' A' ' 200' ' ' VAL . 50.8 t -92.18 100.92 13.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.668 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.1 mmt -130.63 101.61 5.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.353 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -68.36 99.25 0.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.643 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.5 25.55 3.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.609 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.404 ' HB2' HG22 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -54.96 175.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.767 0.318 . . . . 0.0 110.916 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.912 ' O ' HG23 ' A' ' 215' ' ' VAL . 11.7 mm-40 -91.11 157.23 17.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.986 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.812 ' O ' HG23 ' A' ' 216' ' ' VAL . 67.6 t60 -52.44 -64.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.692 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.05 -25.04 61.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.283 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.01 -44.02 55.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.323 . . . . 0.0 110.712 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 211' ' ' GLN . 4.6 t -74.81 -36.82 40.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.565 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 212' ' ' HIS . 40.7 t -70.13 -38.22 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.71 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.3 m -74.56 -33.51 62.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.627 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.522 ' HB1' HG11 ' A' ' 202' ' ' VAL . . . -59.49 -48.34 82.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.0 mm -61.86 -42.16 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 54.2 ttp85 -75.16 -28.4 60.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.21 5.78 28.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.737 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -66.53 -0.65 8.57 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.564 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 47.43 -132.23 15.16 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.987 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.1 m-20 -83.86 -25.17 30.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.308 . . . . 0.0 111.217 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -125.48 114.82 19.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.814 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.58 HG22 HD21 ' A' ' 228' ' ' LEU . 4.6 m -112.42 96.84 6.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.369 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -84.08 94.8 8.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.031 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.886 ' CD2' HG13 ' A' ' 202' ' ' VAL . 8.1 mt -110.07 140.1 44.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.145 0.498 . . . . 0.0 112.283 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 154' ' ' LEU . 10.4 tp -120.0 109.58 15.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.313 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.715 HG12 HD13 ' A' ' 199' ' ' ILE . 27.5 m -114.87 179.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 111.766 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.541 HG11 HD12 ' A' ' 150' ' ' LEU . 2.6 t -119.95 166.08 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.726 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.493 ' H ' HG12 ' A' ' 231' ' ' VAL . 46.7 t0 -90.26 111.0 22.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.209 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -100.03 -24.69 14.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -52.33 -59.89 3.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.839 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 46.0 m -66.34 -30.34 70.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.92 -24.73 66.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.995 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -106.2 -34.38 7.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.013 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.1 -64.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -59.99 -34.36 73.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.926 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -134.91 150.1 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.666 0.269 . . . . 0.0 110.803 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.926 ' N ' HD13 ' A' ' 144' ' ' ILE . 10.7 t70 -44.83 137.98 4.23 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.426 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.96 -57.64 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.682 2.254 . . . . 0.0 112.537 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.025 ' O ' HG23 ' A' ' 148' ' ' THR . 4.4 t80 -107.3 -60.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.376 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . 1.025 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.0 p 164.18 133.48 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.325 0.65 . . . . 0.0 110.246 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 69.5 mtp -125.46 -65.08 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.965 HD12 HG11 ' A' ' 231' ' ' VAL . 12.7 tp -125.82 -8.94 6.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.572 ' NE ' HG22 ' A' ' 148' ' ' THR . 29.2 ptt85 -50.08 122.11 14.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.685 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.533 ' HB3' HG22 ' A' ' 231' ' ' VAL . 46.4 Cg_endo -69.19 176.88 5.76 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.671 2.247 . . . . 0.0 113.075 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.842 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.3 OUTLIER -143.44 158.11 43.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.699 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.2 tp -90.01 125.74 35.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.005 0.431 . . . . 0.0 111.369 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 47.7 t -120.52 140.2 51.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.374 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.4 m -134.11 104.1 6.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -109.81 127.02 54.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -90.39 125.53 35.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.981 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.445 ' HE2' ' CZ ' ' A' ' 164' ' ' TYR . 1.7 tppp? -59.66 -80.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.703 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.38 -156.19 12.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.498 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.76 0.02 10.35 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.704 2.269 . . . . 0.0 112.782 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 p -96.85 -30.15 13.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.734 0.302 . . . . 0.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.93 -142.12 15.84 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.439 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.464 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 14.7 m-85 -96.41 -51.33 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.34 30.49 24.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.627 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -151.49 178.65 9.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.238 0.542 . . . . 0.0 112.152 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.887 ' O ' HD13 ' A' ' 168' ' ' LEU . 10.0 m120 -135.22 154.63 51.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.054 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.887 HD13 ' O ' ' A' ' 167' ' ' ASN . 0.4 OUTLIER -132.19 148.33 52.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.398 . . . . 0.0 111.655 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -134.21 141.33 46.99 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.314 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.6 t -155.14 149.61 26.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.179 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -121.44 -67.97 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.561 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -90.16 159.73 16.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.6 m -100.8 21.41 13.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.166 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.552 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 5.0 mttp -108.73 -48.59 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.792 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 25.5 Cg_exo -63.02 -65.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.216 1.944 . . . . 0.0 112.298 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.09 -152.25 23.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.411 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -125.88 133.96 51.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 111.097 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 2.8 m-85 -122.53 165.11 16.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.824 HD12 ' OD2' ' A' ' 197' ' ' ASP . 57.0 mt -91.9 135.91 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 110.66 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.401 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 0.3 OUTLIER -98.78 -35.63 10.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.879 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.0 t -153.21 158.51 41.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 111.63 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 195' ' ' ALA . 49.0 t -135.29 141.15 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.789 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -90.72 117.28 67.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.799 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.91 136.61 74.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.448 2.099 . . . . 0.0 112.408 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.7 t70 71.21 14.78 6.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.58 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.524 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 48.0 m -99.99 164.78 15.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.583 0.23 . . . . 0.0 110.778 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 99.9 Cg_exo -44.04 -40.25 11.91 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.584 2.19 . . . . 0.0 112.912 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.456 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -62.78 -43.95 97.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -70.33 -51.65 28.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.007 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.96 -32.19 3.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.574 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.1 t -83.99 -27.5 28.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.063 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 115.11 25.51 3.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.464 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.839 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -83.44 149.21 26.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.731 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.839 ' N ' HD23 ' A' ' 193' ' ' LEU . 1.4 mtt85 -143.15 138.31 29.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.798 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.624 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -55.69 153.97 7.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.573 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 71.39 9.14 6.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.065 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.824 ' OD2' HD12 ' A' ' 179' ' ' ILE . 38.9 p30 -75.77 149.53 37.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.029 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 17.4 mmt85 -85.67 112.49 21.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.691 0.281 . . . . 0.0 111.548 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.933 ' HA ' HG12 ' A' ' 230' ' ' VAL . 12.8 mm -68.09 123.9 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.366 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.3 t -110.18 -43.86 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.126 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.52 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 10.6 pt-20 -143.19 176.64 8.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.317 0.58 . . . . 0.0 111.936 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.891 ' O ' HG22 ' A' ' 205' ' ' VAL . 48.7 t -150.81 107.77 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.517 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.45 23.86 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.368 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.65 -17.01 51.01 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.633 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 202' ' ' VAL . 26.9 m -83.43 90.2 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.191 0.495 . . . . 0.0 111.569 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.483 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 53.0 t -80.31 100.57 8.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.754 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.464 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 17.0 mmt -130.74 99.43 4.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.18 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -75.03 115.5 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.2 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 104.21 12.85 28.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.112 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.464 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 0.5 OUTLIER -54.93 166.16 0.54 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.06 0.457 . . . . 0.0 111.398 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -94.46 160.4 14.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.841 ' O ' HG23 ' A' ' 216' ' ' VAL . 11.2 t60 -47.49 -56.42 7.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.026 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.05 -29.12 70.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.17 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.94 -44.5 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.55 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 32.9 t -71.84 -35.04 53.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.449 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 212' ' ' HIS . 47.9 t -71.25 -41.61 74.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.458 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.8 m -67.14 -38.13 84.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.516 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -55.67 -45.64 77.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.053 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.421 HD13 HG13 ' A' ' 202' ' ' VAL . 25.8 mm -65.45 -33.33 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -67.68 -41.35 83.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.86 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.09 5.03 31.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.613 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -87.6 10.03 71.33 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.975 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.12 -136.32 25.56 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.854 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.79 -25.13 23.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.74 0.305 . . . . 0.0 111.079 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -104.22 114.89 29.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.682 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.6 HG22 ' HG ' ' A' ' 228' ' ' LEU . 19.9 m -110.55 101.12 9.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.287 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -85.35 94.86 9.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.192 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 202' ' ' VAL . 13.6 mt -103.67 137.62 41.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.026 0.441 . . . . 0.0 111.858 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.842 HD12 ' O ' ' A' ' 153' ' ' ARG . 13.9 tp -110.56 109.41 19.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.933 HG12 ' HA ' ' A' ' 199' ' ' ILE . 23.8 m -124.62 177.04 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.475 0.655 . . . . 0.0 112.243 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.965 HG11 HD12 ' A' ' 150' ' ' LEU . 39.9 t -119.2 145.11 25.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.776 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.711 ' O ' ' HB2' ' A' ' 236' ' ' ASP . 21.0 t0 -96.41 112.81 24.42 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.581 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -101.0 -19.58 15.77 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.946 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -85.38 -59.03 2.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 109.965 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.462 ' HB ' ' OD2' ' A' ' 232' ' ' ASP . 11.3 m -68.88 -19.81 64.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.172 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.711 ' HB2' ' O ' ' A' ' 232' ' ' ASP . 16.1 t0 -41.35 -28.6 0.12 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.468 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -108.5 -20.05 13.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.919 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -85.36 -73.0 0.46 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.442 ' HB3' ' CG2' ' A' ' 235' ' ' THR . 0.8 OUTLIER -93.92 -14.04 26.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.64 -178.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 236' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.008 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.586 HD13 ' C ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -135.01 121.33 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.01 0.433 . . . . 0.0 111.013 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -93.28 137.3 23.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.945 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.96 -70.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.299 1.999 . . . . 0.0 112.678 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.002 ' O ' HG23 ' A' ' 148' ' ' THR . 83.1 t80 -115.5 -60.83 1.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . 1.002 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.2 p 162.83 128.56 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.531 0.732 . . . . 0.0 110.157 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 7.0 mtt -127.15 -52.03 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.412 0.625 . . . . 0.0 110.526 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.765 HD21 ' HA ' ' A' ' 235' ' ' THR . 30.6 tp -125.38 -24.31 3.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.037 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.789 ' CD ' HG22 ' A' ' 148' ' ' THR . 5.7 ptm180 -46.12 160.31 0.3 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.931 0.396 . . . . 0.0 111.154 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.645 ' HB3' HG22 ' A' ' 231' ' ' VAL . 7.1 Cg_endo -51.52 143.71 35.04 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.979 2.453 . . . . 0.0 112.439 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.673 ' O ' HD12 ' A' ' 229' ' ' LEU . 81.7 mtt180 -125.2 171.81 10.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.354 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.2 tp -108.21 139.35 43.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.046 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 228' ' ' LEU . 54.1 t -126.56 135.83 51.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.51 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -137.24 99.9 4.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.744 0.307 . . . . 0.0 110.689 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -114.43 141.12 48.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 111.266 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -96.22 121.6 38.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.552 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.42 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 2.0 tppp? -46.41 -76.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.36 -158.05 7.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.314 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.01 0.03 10.32 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.676 2.25 . . . . 0.0 112.69 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.2 p -100.56 -30.19 11.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.517 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.42 ' HA2' ' HD2' ' A' ' 159' ' ' LYS . . . 80.95 -124.79 6.57 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.71 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.96 ' CE2' HG21 ' A' ' 219' ' ' ILE . 8.2 m-85 -91.63 -60.41 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.084 0.469 . . . . 0.0 111.099 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 183' ' ' ASP . . . 96.71 -0.74 61.22 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.555 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CD2' HD13 ' A' ' 193' ' ' LEU . 1.4 p90 -124.8 -176.89 3.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.06 0.457 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.856 ' O ' HD13 ' A' ' 168' ' ' LEU . 60.8 m-20 -124.72 161.96 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.685 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.856 HD13 ' O ' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -132.71 135.27 45.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.076 0.465 . . . . 0.0 111.976 -179.102 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.453 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 4.1 p-80 -134.86 143.31 46.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.948 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 t -155.06 166.84 32.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 111.442 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -130.14 -59.5 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.739 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -90.01 167.34 12.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 m -110.08 22.21 15.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.278 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 14.2 mttt -102.93 -48.6 0.17 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.563 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 14.2 Cg_exo -69.3 -58.0 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.359 2.039 . . . . 0.0 112.331 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 140.33 -146.75 18.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.41 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -103.97 131.58 51.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.765 0.317 . . . . 0.0 110.865 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CD1' ' HD3' ' A' ' 198' ' ' ARG . 1.2 m-30 -109.76 165.19 11.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.559 HD12 ' OD1' ' A' ' 197' ' ' ASP . 4.0 mt -100.37 131.75 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.166 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.453 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 10.9 ptm180 -104.33 -33.53 8.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.709 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.4 t -150.82 152.53 33.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 111.868 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.67 140.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.761 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 47.3 t0 -89.0 123.1 68.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 23.7 Cg_exo -63.59 133.07 37.95 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.233 1.955 . . . . 0.0 112.195 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 185' ' ' ASP . 13.6 t0 76.88 14.84 2.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.26 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 37.0 m -98.69 163.21 19.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 84.1 Cg_exo -45.56 -40.2 18.05 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.36 2.04 . . . . 0.0 112.345 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.61 -44.85 95.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.764 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -66.64 -54.52 22.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.917 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -55.84 -26.49 46.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.279 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.3 t -82.52 -20.3 36.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.22 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 100.8 36.95 3.81 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.914 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -100.18 148.68 24.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.83 0.347 . . . . 0.0 111.153 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.785 ' N ' HD23 ' A' ' 193' ' ' LEU . 53.0 mtp180 -147.79 138.78 23.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.758 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -47.69 166.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.613 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.7 ' O ' ' HB2' ' A' ' 233' ' ' ARG . 67.1 mt-30 80.27 -24.36 0.2 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.237 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.737 ' OD2' HG21 ' A' ' 230' ' ' VAL . 27.2 p-10 -66.92 138.17 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.452 0.644 . . . . 0.0 112.266 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.546 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 0.2 OUTLIER -92.19 130.12 37.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.373 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.79 ' HA ' HG12 ' A' ' 230' ' ' VAL . 22.2 mm -69.78 116.45 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.764 0.316 . . . . 0.0 110.58 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.21 -46.48 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.736 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.457 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 10.2 pt-20 -138.45 174.11 10.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.962 0.41 . . . . 0.0 111.164 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.926 ' O ' HG22 ' A' ' 205' ' ' VAL . 23.7 t -152.74 109.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.144 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 13.0 t30 70.01 24.32 5.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.306 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.33 49.38 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.469 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.926 HG22 ' O ' ' A' ' 202' ' ' VAL . 28.5 m -80.95 95.29 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.205 0.502 . . . . 0.0 111.093 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.426 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 26.5 t -86.8 103.6 15.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.176 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.405 ' O ' ' HG2' ' A' ' 210' ' ' LYS . 84.7 mmm -130.16 99.92 5.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.69 103.66 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.705 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 113.95 23.71 4.84 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.337 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 207' ' ' MET . 9.7 mmmt -54.9 158.47 2.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.918 0.389 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 215' ' ' VAL . 27.4 mm-40 -98.08 160.28 14.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.151 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.872 ' O ' HG23 ' A' ' 216' ' ' VAL . 14.6 t60 -48.05 -60.99 2.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.92 -31.15 67.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.212 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -46.15 78.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.261 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 211' ' ' GLN . 25.5 t -70.05 -35.41 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.438 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 212' ' ' HIS . 41.5 t -70.36 -42.69 78.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.649 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 71.6 m -73.46 -33.44 64.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.735 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.04 80.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.143 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.96 HG21 ' CE2' ' A' ' 164' ' ' TYR . 17.6 mm -63.81 -40.35 88.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -43.37 89.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.675 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.95 5.06 30.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.526 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -90.81 19.71 43.61 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.895 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.05 -137.7 22.77 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.963 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.85 -24.83 20.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -100.38 117.96 35.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.393 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.801 HG22 HD21 ' A' ' 228' ' ' LEU . 3.0 m -111.38 99.49 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.6 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -87.42 94.93 9.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.947 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.801 HD21 HG22 ' A' ' 226' ' ' THR . 18.4 mt -109.12 139.8 43.53 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 153' ' ' ARG . 14.2 tp -109.54 111.42 22.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 199' ' ' ILE . 34.8 m -125.39 152.49 32.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 197' ' ' ASP . 2.6 t -119.98 137.79 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 197' ' ' ASP . 20.4 t0 -67.94 143.5 55.62 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.856 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.7 ' HB2' ' O ' ' A' ' 196' ' ' GLN . 38.6 ttp180 -54.67 -25.19 25.47 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.447 ' HG3' ' CG ' ' A' ' 232' ' ' ASP . 27.9 mt-10 -59.36 -29.1 67.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.765 ' HA ' HD21 ' A' ' 150' ' ' LEU . 2.9 m -87.57 -23.56 24.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.35 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 233' ' ' ARG . 28.3 t70 -46.78 -31.87 3.29 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -59.89 -40.06 87.48 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 235' ' ' THR . 6.6 t80 -72.37 -55.61 6.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.288 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 21.9 t80 -59.43 -17.21 28.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.426 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 236' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.798 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.576 HD13 ' C ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -97.14 125.68 50.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.936 0.398 . . . . 0.0 111.125 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.641 ' HB3' ' O ' ' A' ' 148' ' ' THR . 9.1 t70 -105.02 138.44 19.51 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.791 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -80.34 -59.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 122.73 2.287 . . . . 0.0 114.746 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -77.45 -42.21 36.82 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.641 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 2.9 p -119.58 129.64 54.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 10.6 mtt -117.59 -16.93 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.715 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.517 ' O ' HG13 ' A' ' 231' ' ' VAL . 54.6 tp -74.29 -5.01 39.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.576 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -36.82 140.12 0.44 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-O 120.658 0.266 . . . . 0.0 111.537 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.471 ' HB3' HG22 ' A' ' 231' ' ' VAL . 56.3 Cg_endo -70.68 165.9 30.49 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.621 2.214 . . . . 0.0 112.913 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.797 ' O ' HD12 ' A' ' 229' ' ' LEU . 70.4 mtm180 -129.71 158.43 39.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.774 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 26.3 tp -96.48 129.37 43.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.376 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.4 t -128.25 135.63 49.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.504 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.2 m -131.47 111.26 11.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.03 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.712 ' HE3' HD12 ' A' ' 228' ' ' LEU . 3.6 ptp -118.18 133.11 56.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -92.97 130.54 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.452 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 10.7 tptm -61.56 -80.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.754 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.441 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.73 -157.2 6.98 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.299 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.77 0.21 10.19 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.681 2.254 . . . . 0.0 112.686 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.3 p -95.23 -30.14 14.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.428 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 93.01 -161.2 25.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.46 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.657 ' CE1' HG22 ' A' ' 219' ' ' ILE . 31.8 m-85 -81.67 -43.29 18.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.336 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 186' ' ' SER . . . 85.18 27.67 32.91 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.927 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.996 ' CE2' HD11 ' A' ' 168' ' ' LEU . 0.0 OUTLIER -164.83 -177.32 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.256 0.55 . . . . 0.0 111.882 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.914 ' O ' HD13 ' A' ' 168' ' ' LEU . 9.8 m120 -136.6 157.29 47.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.028 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.996 HD11 ' CE2' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -133.35 130.64 39.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.166 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.55 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.4 OUTLIER -136.04 135.58 39.55 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.018 178.644 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.0 t -155.32 144.26 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.152 0.501 . . . . 0.0 111.498 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -130.26 -6.45 4.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.309 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.479 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.1 OUTLIER -89.16 146.58 24.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.555 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.1 m -110.21 8.95 23.86 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.735 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 50.4 mtmt -120.68 -58.27 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 37.1 Cg_exo -56.89 -64.48 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.138 1.892 . . . . 0.0 112.302 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.81 -145.44 12.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.686 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.875 ' HB2' HG21 ' A' ' 215' ' ' VAL . 6.2 tp-100 -108.68 151.12 26.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.404 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 5.4 m-85 -130.29 151.45 50.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.854 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.738 HD13 HD21 ' A' ' 193' ' ' LEU . 69.6 mt -82.53 140.79 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.55 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 2.8 ptm180 -103.21 -36.32 8.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.225 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 40.8 t -151.0 153.8 35.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.034 0.445 . . . . 0.0 111.681 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.825 HG23 ' HB2' ' A' ' 195' ' ' ALA . 32.5 t -133.5 141.82 43.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.575 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 46.8 t0 -91.89 121.23 67.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.973 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 26.4 Cg_exo -62.41 132.67 39.38 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.345 2.03 . . . . 0.0 112.33 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.7 t0 69.87 22.62 5.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.259 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.511 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 58.6 m -104.9 164.69 14.65 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.725 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 94.5 Cg_exo -43.47 -40.12 9.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.628 2.218 . . . . 0.0 112.792 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.616 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -63.08 -44.2 96.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 110.293 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -70.02 -52.63 22.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.894 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.6 -31.14 2.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.655 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.2 t -81.97 -30.61 31.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 116.96 25.61 3.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.45 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 194' ' ' ARG . 7.8 tt -78.29 150.32 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.739 0.304 . . . . 0.0 110.743 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.797 ' N ' HD23 ' A' ' 193' ' ' LEU . 57.6 mtt-85 -139.6 130.01 25.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.857 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.825 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -55.05 152.7 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 75.22 2.9 4.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.08 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.609 ' CG ' HD12 ' A' ' 179' ' ' ILE . 41.2 p30 -73.74 155.58 38.76 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.307 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -87.72 112.76 22.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.458 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.789 HD13 HG12 ' A' ' 230' ' ' VAL . 24.8 mm -66.97 124.17 21.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.913 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.568 ' CG1' HD23 ' A' ' 229' ' ' LEU . 19.3 t -106.78 -44.0 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.912 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.4 pt-20 -145.2 175.15 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.102 0.477 . . . . 0.0 111.688 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.877 ' O ' HG22 ' A' ' 205' ' ' VAL . 40.1 t -150.56 109.36 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.65 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 49.8 t30 70.38 23.43 4.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.299 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.17 -16.28 53.73 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.564 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 202' ' ' VAL . 32.7 m -85.45 96.76 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 117.181 0.49 . . . . 0.0 111.432 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' CYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 52.5 t -81.8 103.2 11.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.661 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.455 ' HB2' ' CG ' ' A' ' 210' ' ' LYS . 21.9 mmt -130.23 99.47 5.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -78.7 101.73 7.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.1 5.34 6.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.135 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.455 ' CG ' ' HB2' ' A' ' 207' ' ' MET . 0.9 OUTLIER -54.85 156.81 3.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.096 0.448 . . . . 0.0 110.97 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.656 ' O ' HG23 ' A' ' 215' ' ' VAL . 10.1 mm100 -89.34 160.28 16.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.999 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.842 ' O ' HG23 ' A' ' 216' ' ' VAL . 0.9 OUTLIER -47.26 -60.92 2.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.91 -31.41 64.65 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.114 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.23 -44.02 69.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.473 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.875 HG21 ' HB2' ' A' ' 177' ' ' GLN . 16.8 t -72.38 -38.9 62.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 212' ' ' HIS . 49.2 t -65.06 -42.29 94.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.186 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 45.4 m -67.24 -39.67 86.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.411 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.06 73.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.959 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.657 HG22 ' CE1' ' A' ' 164' ' ' TYR . 25.9 mm -61.35 -37.53 77.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -70.48 -33.91 71.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.509 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.15 5.33 30.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.591 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -83.99 13.99 46.08 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.149 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.12 -134.78 27.56 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.868 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.4 m-20 -87.46 -25.18 23.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.722 0.296 . . . . 0.0 111.239 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -112.72 117.5 32.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.706 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.695 HG22 HD21 ' A' ' 228' ' ' LEU . 5.8 m -112.85 95.06 5.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.31 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -78.84 97.97 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.251 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.712 HD12 ' HE3' ' A' ' 157' ' ' MET . 46.3 mt -105.02 135.72 45.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 112.259 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 153' ' ' ARG . 14.3 tp -112.06 109.45 19.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.117 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.789 HG12 HD13 ' A' ' 199' ' ' ILE . 31.9 m -120.78 169.44 12.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.137 0.494 . . . . 0.0 112.114 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 150' ' ' LEU . 39.8 t -119.92 137.54 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.74 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -71.21 110.73 6.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.257 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -100.11 -24.8 14.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.812 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -64.18 -56.63 13.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.956 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.652 HG23 ' CB ' ' A' ' 239' ' ' PHE . 84.0 m -66.64 -24.64 66.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.019 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -67.49 -32.97 74.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -109.96 -48.51 3.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.333 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -64.73 -67.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.058 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.652 ' CB ' HG23 ' A' ' 235' ' ' THR . 8.3 t80 -60.38 -33.35 72.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.937 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.11 142.63 42.47 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.548 2.165 . . . . 0.0 111.976 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -107.48 141.22 39.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.085 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.899 ' HA ' HD12 ' A' ' 229' ' ' LEU . 55.3 tp -98.6 134.26 41.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.544 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 41.4 t -129.92 139.99 51.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 19.0 m -131.86 101.99 5.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.157 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.434 ' HE1' ' CE2' ' A' ' 166' ' ' PHE . 6.6 ptp -109.99 137.53 47.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 111.219 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -100.59 119.09 38.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.657 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.406 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 1.0 OUTLIER -51.29 -82.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.95 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.48 -156.42 26.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.23 -0.0 10.38 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.603 2.202 . . . . 0.0 112.841 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.7 p -108.43 -30.03 8.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.724 0.297 . . . . 0.0 111.119 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 83.92 -131.11 10.17 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.423 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CZ ' ' CG2' ' A' ' 219' ' ' ILE . 32.5 m-85 -110.2 -46.56 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.05 17.41 63.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.809 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' A' ' 157' ' ' MET . 0.1 OUTLIER -124.93 -178.62 4.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.092 0.472 . . . . 0.0 111.845 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.82 ' C ' HD22 ' A' ' 168' ' ' LEU . 9.9 m120 -134.83 160.73 37.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.393 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.82 HD22 ' C ' ' A' ' 167' ' ' ASN . 3.3 mm? -138.54 137.25 36.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.313 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.424 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 0.7 OUTLIER -134.76 141.53 46.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.62 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 t -155.09 150.14 26.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.25 -72.95 0.56 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.033 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -64.34 163.97 12.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.044 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.0 m -110.05 20.3 18.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.624 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 23.1 mttp -112.47 -50.56 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.873 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 25.2 Cg_exo -63.15 -64.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.143 1.895 . . . . 0.0 112.248 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 142.58 -148.34 20.04 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.5 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.409 ' HG2' HG11 ' A' ' 215' ' ' VAL . 9.8 tp-100 -114.93 129.09 56.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 0.0 110.973 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.498 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 1.6 m-85 -117.34 165.27 13.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.349 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.617 HD12 ' OD1' ' A' ' 197' ' ' ASP . 5.0 mt -90.18 136.3 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.939 0.399 . . . . 0.0 110.358 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.425 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 9.4 ptm180 -102.38 -34.55 9.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.818 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.9 t -150.36 149.4 30.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 0.0 111.909 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 195' ' ' ALA . 81.9 t -135.32 134.1 52.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.548 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 186' ' ' SER . 47.4 t0 -84.37 122.5 75.33 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.971 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.01 130.22 30.1 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.229 1.953 . . . . 0.0 112.193 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 75.93 18.18 2.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.736 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.6 m -98.23 164.93 16.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.56 0.219 . . . . 0.0 110.632 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 97.5 Cg_exo -43.45 -40.1 9.84 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.607 2.205 . . . . 0.0 112.768 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.77 91.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.039 0.447 . . . . 0.0 110.373 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.03 -50.86 37.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.755 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -47.91 -32.96 6.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.333 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -79.32 -30.0 42.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.04 32.58 1.51 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.241 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -97.59 149.17 22.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.854 0.359 . . . . 0.0 110.995 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.84 ' N ' HD23 ' A' ' 193' ' ' LEU . 76.5 mtt180 -142.51 133.77 26.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -46.59 161.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.576 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 233' ' ' ARG . 56.4 mt-30 82.73 -13.92 0.79 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.042 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.673 ' OD2' HG21 ' A' ' 230' ' ' VAL . 7.9 p-10 -68.18 146.45 53.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.749 0.309 . . . . 0.0 110.566 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.498 ' HD2' ' CE1' ' A' ' 178' ' ' PHE . 15.8 mmt85 -93.1 123.13 36.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.387 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.82 HD13 HG12 ' A' ' 230' ' ' VAL . 22.1 mm -66.52 128.96 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.976 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.81 -42.97 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.785 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.452 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 10.9 pt-20 -144.87 172.63 12.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.024 0.44 . . . . 0.0 111.649 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.87 ' O ' HG22 ' A' ' 205' ' ' VAL . 16.5 t -149.42 105.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.017 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 35.7 t30 70.27 26.39 4.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.538 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.06 -21.85 32.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.486 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 202' ' ' VAL . 27.0 m -80.32 97.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.985 0.422 . . . . 0.0 111.158 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 42.3 t -89.98 98.78 11.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.114 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.418 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 21.7 mmt -130.24 99.68 5.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.817 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -74.48 106.56 6.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.121 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.04 11.93 8.72 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.858 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.418 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 12.3 mmtt -55.76 161.91 1.97 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.887 0.375 . . . . 0.0 111.217 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.621 ' O ' HG23 ' A' ' 215' ' ' VAL . 8.5 mm-40 -88.25 160.33 17.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.909 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.841 ' O ' HG23 ' A' ' 216' ' ' VAL . 0.9 OUTLIER -49.89 -57.28 7.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.577 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.97 -34.21 82.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.814 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -44.75 80.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 211' ' ' GLN . 35.5 t -70.65 -37.32 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.342 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 212' ' ' HIS . 59.0 t -68.96 -41.77 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.418 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.8 m -66.24 -40.05 89.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.537 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.625 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -55.39 -39.01 69.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.7 HD11 HD21 ' A' ' 228' ' ' LEU . 25.2 mm -69.75 -32.28 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.716 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -71.57 -36.49 70.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.86 5.16 29.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.619 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.33 14.03 60.43 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.009 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.03 -135.55 26.19 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.906 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.96 -25.13 24.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.793 0.33 . . . . 0.0 111.184 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -108.75 114.93 29.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.632 HG22 ' HG ' ' A' ' 228' ' ' LEU . 24.6 m -109.82 101.56 10.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.715 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -81.19 98.12 7.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.893 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.7 HD21 HD11 ' A' ' 219' ' ' ILE . 32.8 mt -108.19 129.87 55.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.045 0.45 . . . . 0.0 112.17 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.899 HD12 ' HA ' ' A' ' 154' ' ' LEU . 11.8 tp -110.7 109.74 20.12 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.82 HG12 HD13 ' A' ' 199' ' ' ILE . 33.9 m -110.91 -179.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.563 . . . . 0.0 112.305 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 232' ' ' ASP . 17.7 t -119.52 165.66 14.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.116 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.52 ' N ' HG12 ' A' ' 231' ' ' VAL . 32.3 t0 -99.8 109.75 22.15 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 196' ' ' GLN . 25.2 ttm180 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.472 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.777 0.322 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.87 151.46 85.11 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.742 2.295 . . . . 0.0 112.786 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -130.67 145.91 52.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.709 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.901 ' HA ' HD12 ' A' ' 229' ' ' LEU . 21.9 tp -93.08 137.93 31.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.189 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 42.1 t -130.17 140.05 50.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.814 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.1 m -130.17 107.35 9.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.826 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 9.5 ptp -109.98 143.11 40.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.812 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -105.87 127.36 53.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -60.2 -80.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.824 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.68 -156.86 9.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.442 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.77 -1.51 11.68 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.571 2.181 . . . . 0.0 112.671 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.8 p -101.37 -30.15 11.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.126 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.3 -127.93 8.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.433 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.47 ' CZ ' HG22 ' A' ' 219' ' ' ILE . 9.7 m-85 -110.08 -50.21 3.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.863 0.364 . . . . 0.0 110.814 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.24 13.96 69.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.99 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.414 ' CE1' ' CB ' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -124.86 178.39 5.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.223 0.535 . . . . 0.0 111.963 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.805 ' C ' HD22 ' A' ' 168' ' ' LEU . 10.0 m120 -134.35 157.76 45.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.256 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.805 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.3 mm? -133.07 148.32 52.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.965 0.412 . . . . 0.0 111.599 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -134.53 149.18 50.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.103 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 148.02 33.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.011 0.434 . . . . 0.0 111.423 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -130.19 -74.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.612 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -90.08 174.73 7.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.714 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.2 m -110.02 20.22 18.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.252 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.562 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 25.2 mtpt -108.66 -49.25 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.684 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 21.6 Cg_exo -65.28 -56.75 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.269 1.98 . . . . 0.0 112.19 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.73 -156.76 21.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.492 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.602 ' HG2' HG11 ' A' ' 215' ' ' VAL . 4.0 tp-100 -102.5 136.16 42.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.849 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -132.31 152.16 51.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.745 ' HA ' HD13 ' A' ' 168' ' ' LEU . 57.3 mt -74.4 138.08 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.421 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 7.6 ptm180 -103.61 -33.09 9.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.63 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.8 t -149.73 154.66 38.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.95 0.405 . . . . 0.0 111.441 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.884 HG23 ' HB2' ' A' ' 195' ' ' ALA . 37.4 t -135.01 134.99 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 186' ' ' SER . 56.8 t0 -84.37 125.54 71.69 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.24 131.05 30.67 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.341 2.027 . . . . 0.0 112.224 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 73.69 18.71 3.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.78 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.423 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.6 m -97.75 164.36 17.65 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.6 0.238 . . . . 0.0 110.69 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 88.4 Cg_exo -44.4 -40.13 13.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.563 2.175 . . . . 0.0 112.739 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.973 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -63.67 -42.99 98.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 110.639 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.92 -50.89 37.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.966 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -49.1 -30.22 6.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.551 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.5 t -84.97 -26.1 27.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.71 27.89 3.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.175 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.973 HD13 ' HB1' ' A' ' 188' ' ' ALA . 8.3 tt -75.96 149.85 37.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.832 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.822 ' N ' HD23 ' A' ' 193' ' ' LEU . 36.7 mtt85 -134.66 129.86 35.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.794 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.884 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -57.8 150.58 19.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.163 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 73.75 3.07 4.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.766 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.756 ' OD2' HG21 ' A' ' 230' ' ' VAL . 56.0 p30 -66.86 154.84 39.94 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.274 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -89.84 110.25 21.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.767 0.318 . . . . 0.0 111.453 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.74 ' HA ' HG12 ' A' ' 230' ' ' VAL . 24.5 mm -61.99 123.79 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.939 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.88 -45.94 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.448 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.466 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 9.6 pt-20 -143.31 174.16 10.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 111.363 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.884 ' O ' HG22 ' A' ' 205' ' ' VAL . 40.4 t -152.91 106.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.016 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 18.8 t30 70.3 25.97 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.482 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.81 -21.02 35.15 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.372 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 202' ' ' VAL . 28.7 m -81.45 97.27 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.998 0.428 . . . . 0.0 111.232 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.466 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 42.4 t -87.84 98.26 11.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.7 mmt -130.17 99.83 5.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -68.58 101.9 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 113.34 25.37 4.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.543 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.406 ' HD3' ' HB3' ' A' ' 214' ' ' ASP . 0.1 OUTLIER -54.86 164.04 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.843 0.354 . . . . 0.0 111.169 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.645 ' O ' HG23 ' A' ' 215' ' ' VAL . 18.0 mm-40 -99.59 160.21 14.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.037 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.852 ' O ' HG23 ' A' ' 216' ' ' VAL . 10.8 t60 -48.76 -62.56 1.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.87 -32.6 59.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.043 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.406 ' HB3' ' HD3' ' A' ' 210' ' ' LYS . 0.9 OUTLIER -68.37 -44.95 74.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.153 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 211' ' ' GLN . 25.9 t -70.64 -40.01 76.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 212' ' ' HIS . 44.1 t -64.0 -42.83 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.336 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 58.8 m -71.57 -39.04 70.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.575 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.02 81.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.47 HG22 ' CZ ' ' A' ' 164' ' ' TYR . 32.3 mm -61.82 -31.7 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.597 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -73.1 -38.15 66.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.727 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.03 5.32 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.66 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -82.12 9.24 58.08 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.21 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -139.2 20.2 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.017 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -25.12 34.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.663 0.268 . . . . 0.0 111.252 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -116.01 115.34 25.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 110.782 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.9 m -107.32 99.23 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -76.32 98.52 4.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.149 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.455 ' CD2' HG22 ' A' ' 202' ' ' VAL . 34.5 mt -107.36 128.06 54.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.715 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.901 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.5 tp -107.6 109.66 21.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.337 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.756 HG21 ' OD2' ' A' ' 197' ' ' ASP . 29.4 m -123.62 169.93 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 112.187 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.6 t -120.01 138.89 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.393 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -69.85 112.7 6.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.33 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 179.557 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.603 0.24 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 137.87 20.6 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.439 2.093 . . . . 0.0 112.172 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 230' ' ' VAL . 0.8 OUTLIER -93.7 139.37 30.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.786 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 229' ' ' LEU . 14.5 tp -87.62 123.0 32.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 50.5 t -122.33 127.55 49.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.9 m -127.28 103.7 7.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.502 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.629 ' HE1' HD12 ' A' ' 228' ' ' LEU . 2.0 ptt? -110.64 145.04 38.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.02 0.438 . . . . 0.0 111.259 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -104.32 119.36 38.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.578 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.414 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 1.5 tppt? -47.83 -78.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.88 -159.85 26.78 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.228 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.56 0.16 10.24 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.582 2.188 . . . . 0.0 112.91 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.3 p -104.0 -30.27 10.39 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.414 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 93.12 -140.3 15.0 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.079 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 166' ' ' PHE . 7.8 m-85 -110.38 -47.17 3.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.931 0.396 . . . . 0.0 110.762 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.52 24.13 51.54 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.646 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 164' ' ' TYR . 8.5 p90 -124.81 172.87 8.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.216 0.532 . . . . 0.0 111.827 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.695 ' C ' HD22 ' A' ' 168' ' ' LEU . 10.0 m120 -137.95 152.5 49.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.96 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.914 HD12 ' HG3' ' A' ' 177' ' ' GLN . 4.2 mm? -129.78 146.13 51.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.246 0.546 . . . . 0.0 112.299 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.496 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 2.8 p80 -143.59 133.72 24.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.721 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.5 t -129.46 155.5 45.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.033 0.444 . . . . 0.0 111.605 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -130.05 -64.39 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.474 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -90.06 162.52 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -110.12 22.5 15.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.348 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.616 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 52.8 mttm -105.56 -50.22 0.11 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.608 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.616 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 9.0 Cg_exo -72.13 -57.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.426 2.084 . . . . 0.0 112.144 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 145.06 -144.22 12.87 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.369 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.914 ' HG3' HD12 ' A' ' 168' ' ' LEU . 7.0 tp-100 -100.76 150.29 22.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.753 0.311 . . . . 0.0 110.857 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.452 ' CZ ' ' NH1' ' A' ' 198' ' ' ARG . 3.6 m-85 -131.06 138.12 49.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.781 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.81 HD13 HD21 ' A' ' 193' ' ' LEU . 86.9 mt -71.7 133.57 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 110.271 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.496 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 4.5 ptm180 -101.54 -30.88 11.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.723 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.2 t -152.78 145.43 24.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.469 . . . . 0.0 111.731 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 195' ' ' ALA . 18.0 t -128.64 132.31 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.434 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -84.1 120.23 74.44 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.106 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.45 133.44 49.01 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.415 2.076 . . . . 0.0 112.359 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 71.81 15.25 5.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.814 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 44.8 m -97.43 161.8 24.75 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.623 0.249 . . . . 0.0 110.64 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 99.6 Cg_exo -43.99 -40.32 11.78 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.571 2.18 . . . . 0.0 112.753 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.839 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -62.41 -44.3 96.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.444 . . . . 0.0 110.518 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -70.37 -52.27 23.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.027 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.51 -29.39 1.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.609 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.5 t -83.78 -31.98 25.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.959 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.49 7.38 6.32 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.984 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.839 HD13 ' HB1' ' A' ' 188' ' ' ALA . 7.5 tt -57.17 146.45 27.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.744 0.306 . . . . 0.0 110.85 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.703 ' N ' HD23 ' A' ' 193' ' ' LEU . 66.3 mtt-85 -136.54 137.99 40.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -63.46 149.64 45.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.299 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 75.31 2.61 3.91 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.099 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.757 ' OD2' HG21 ' A' ' 230' ' ' VAL . 52.6 p30 -73.1 153.98 40.58 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.435 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.452 ' NH1' ' CZ ' ' A' ' 178' ' ' PHE . 1.3 mmp_? -89.6 115.26 26.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 0.0 111.154 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.88 HD13 HG12 ' A' ' 230' ' ' VAL . 33.8 mm -65.01 125.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.15 -44.29 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.492 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.65 ' OE1' HD22 ' A' ' 229' ' ' LEU . 6.2 pt-20 -144.34 173.35 11.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.024 0.44 . . . . 0.0 111.623 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 205' ' ' VAL . 43.4 t -151.52 107.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.861 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.1 t30 70.27 24.35 4.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.322 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.76 -20.14 37.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.343 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 202' ' ' VAL . 36.0 m -82.48 99.19 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.99 0.424 . . . . 0.0 111.335 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.443 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 45.3 t -84.92 100.62 11.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.986 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.421 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 20.4 mmt -130.13 99.81 5.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -69.73 102.42 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.761 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.81 20.93 4.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.729 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.56 ' HA ' ' CE ' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -54.82 150.67 9.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.918 0.389 . . . . 0.0 111.076 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 215' ' ' VAL . 4.8 mm-40 -94.56 160.25 14.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.1 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.841 ' O ' HG23 ' A' ' 216' ' ' VAL . 85.0 t60 -47.15 -61.64 1.79 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.12 -30.55 60.9 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.151 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -44.26 67.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.407 . . . . 0.0 110.331 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 177' ' ' GLN . 39.2 t -71.96 -38.95 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.312 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 212' ' ' HIS . 46.3 t -66.4 -41.2 88.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.592 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 64.6 m -72.55 -34.64 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.696 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.1 83.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.057 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 32.0 mm -59.55 -41.98 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 ttp-105 -64.21 -41.68 96.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.724 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.06 5.32 30.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.712 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.64 19.21 38.1 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.046 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -145.08 9.61 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.941 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.63 -25.15 28.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.725 0.298 . . . . 0.0 111.158 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -103.98 114.99 29.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.59 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 4.5 m -111.09 108.05 17.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.345 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -91.12 99.89 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.403 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.713 HD21 HG13 ' A' ' 202' ' ' VAL . 12.4 mt -107.06 132.21 53.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.044 0.45 . . . . 0.0 111.717 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.671 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.3 tp -116.46 109.41 17.26 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.88 HG12 HD13 ' A' ' 199' ' ' ILE . 34.3 m -113.86 177.69 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.021 0.439 . . . . 0.0 112.061 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 198' ' ' ARG . 5.2 t -124.48 144.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.778 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -74.1 110.91 8.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.375 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.665 179.364 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.64 142.53 14.44 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.458 ' O ' HD12 ' A' ' 229' ' ' LEU . 16.1 mtm105 -110.38 153.92 24.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.708 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.636 ' HA ' HD12 ' A' ' 229' ' ' LEU . 25.5 tp -104.15 133.1 49.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.028 0.442 . . . . 0.0 111.114 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.488 ' SG ' HD12 ' A' ' 193' ' ' LEU . 38.4 t -129.99 138.55 50.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.736 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.0 m -140.09 101.21 4.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.781 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.704 ' HE1' HD11 ' A' ' 228' ' ' LEU . 3.3 ptt? -109.91 135.8 50.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.954 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -95.12 135.61 36.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.011 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.453 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 18.3 tptp -73.97 -78.03 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.82 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.89 -159.94 5.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.198 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.02 0.17 10.22 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.614 2.209 . . . . 0.0 112.519 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.8 p -103.07 -30.12 10.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.592 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.453 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 95.46 -148.56 19.03 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.398 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.607 ' OH ' HG22 ' A' ' 219' ' ' ILE . 31.7 m-85 -97.73 -44.16 6.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.922 0.392 . . . . 0.0 110.77 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 183' ' ' ASP . . . 88.68 14.83 60.73 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.95 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.584 ' CE1' HD21 ' A' ' 168' ' ' LEU . 0.0 OUTLIER -124.86 -177.46 3.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.139 0.495 . . . . 0.0 111.879 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.813 ' C ' HD22 ' A' ' 168' ' ' LEU . 9.8 m120 -129.7 161.76 29.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.888 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.813 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.8 mm? -135.67 134.63 39.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.22 0.533 . . . . 0.0 112.276 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 6.6 p-80 -134.8 165.29 25.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.808 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.1 t -128.2 142.13 51.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.513 0.673 . . . . 0.0 112.504 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 178' ' ' PHE . 16.1 t0 -105.6 -40.22 5.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.386 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 14.3 mmtm -82.97 175.02 10.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.854 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.7 m -104.4 -26.97 12.22 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.912 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.766 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 32.0 mtmm -122.21 -58.64 0.03 OUTLIER Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.766 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 7.0 Cg_exo -81.28 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.837 2.358 . . . . 0.0 115.702 -175.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -39.07 145.0 0.24 Allowed Glycine 0 N--CA 1.453 -0.21 0 N-CA-C 116.532 1.373 . . . . 0.0 116.532 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.84 ' HG2' HG11 ' A' ' 215' ' ' VAL . 2.0 tp-100 -138.35 127.13 23.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 112.867 -1.667 . . . . 0.0 107.159 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.638 ' CD2' ' NH2' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -134.93 135.65 41.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.727 HD12 ' OD2' ' A' ' 197' ' ' ASP . 50.4 mt -80.88 129.91 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' A' ' 169' ' ' HIS . 19.6 ptt180 -95.99 -33.27 12.21 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.0 t -154.74 157.69 38.4 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 195' ' ' ALA . 22.1 t -133.9 139.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.503 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 165' ' ' GLY . 47.1 t0 -87.35 122.44 70.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.176 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 31.2 Cg_exo -61.4 133.87 48.55 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.28 1.987 . . . . 0.0 111.973 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 75.26 14.85 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.625 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 46.6 m -100.62 162.97 19.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.637 0.255 . . . . 0.0 110.532 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 82.4 Cg_exo -45.87 -40.21 19.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.469 2.112 . . . . 0.0 112.797 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.643 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -65.07 -42.53 94.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.07 0.462 . . . . 0.0 110.475 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -70.42 -51.58 28.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.022 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.2 -24.76 11.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.497 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.8 t -85.06 -29.14 25.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 0.0 110.969 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.13 8.72 11.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.506 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -60.41 150.86 29.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.694 0.283 . . . . 0.0 110.557 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.887 ' N ' HD23 ' A' ' 193' ' ' LEU . 48.1 mtt180 -142.87 129.69 20.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.712 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -55.19 152.26 8.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 35.6 mt-30 78.31 6.73 2.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.851 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.727 ' OD2' HD12 ' A' ' 179' ' ' ILE . 40.7 p30 -78.11 152.62 32.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.636 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.638 ' NH2' ' CD2' ' A' ' 178' ' ' PHE . 7.9 mmp_? -85.78 109.1 18.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.652 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.87 ' HA ' HG12 ' A' ' 230' ' ' VAL . 39.1 mm -68.64 113.14 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.809 0.337 . . . . 0.0 110.441 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.0 t -105.72 -46.09 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.458 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 6.2 pt-20 -136.69 171.68 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 0.0 111.912 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 205' ' ' VAL . 17.9 t -147.84 113.09 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.553 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 50.6 t30 70.04 20.66 6.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.934 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 102.53 -15.41 55.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.559 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 202' ' ' VAL . 27.1 m -83.61 91.31 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 117.229 0.514 . . . . 0.0 111.537 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 51.6 t -82.89 109.59 17.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.737 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.444 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 20.5 mmt -130.5 99.89 5.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -74.9 103.57 5.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.77 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 175' ' ' PRO . . . 122.16 10.38 6.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.939 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.444 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 9.1 mmtt -56.82 147.61 22.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.9 0.381 . . . . 0.0 111.258 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.459 ' O ' HG23 ' A' ' 215' ' ' VAL . 0.6 OUTLIER -79.53 160.51 26.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.862 ' O ' HG23 ' A' ' 216' ' ' VAL . 9.3 t-160 -47.84 -54.3 12.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.668 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.2 -33.02 85.77 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.802 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.52 -47.21 82.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.849 0.357 . . . . 0.0 110.281 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.84 HG11 ' HG2' ' A' ' 177' ' ' GLN . 28.2 t -66.55 -38.41 81.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.181 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 212' ' ' HIS . 57.3 t -68.24 -43.3 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.496 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 52.4 m -64.58 -37.64 88.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.409 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.499 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -56.0 -44.3 78.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.898 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.607 HG22 ' OH ' ' A' ' 164' ' ' TYR . 34.0 mm -61.57 -36.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.696 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 47.7 ttp85 -72.4 -33.98 67.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.04 5.39 29.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.67 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -84.55 12.61 55.49 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.187 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -140.77 17.35 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.88 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.49 -25.18 36.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 111.154 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -115.62 114.87 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.658 HG22 HD21 ' A' ' 228' ' ' LEU . 3.9 m -107.82 94.97 5.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -81.27 94.76 6.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.464 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.887 ' CD2' HG13 ' A' ' 202' ' ' VAL . 19.2 mt -101.27 141.51 34.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.657 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.636 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.1 tp -117.18 109.66 17.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.87 HG12 ' HA ' ' A' ' 199' ' ' ILE . 26.8 m -116.96 178.35 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 232' ' ' ASP . 4.3 t -119.69 165.77 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.495 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.484 ' N ' HG12 ' A' ' 231' ' ' VAL . 66.6 t0 -93.91 109.22 20.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.992 0.425 . . . . 0.0 112.016 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.455 ' HD3' ' NH1' ' A' ' 198' ' ' ARG . 24.9 ttp180 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.424 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.418 ' HB2' ' HD2' ' A' ' 152' ' ' PRO . 9.9 ptm180 . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.899 0.38 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.736 ' HA ' HG22 ' A' ' 231' ' ' VAL . 19.7 Cg_endo -60.78 140.9 93.08 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.692 2.261 . . . . 0.0 112.422 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.582 ' O ' HD12 ' A' ' 229' ' ' LEU . 42.5 mtm180 -108.41 141.68 39.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.991 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 37.2 tp -76.27 132.61 39.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.222 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 6.1 t -126.93 140.16 52.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.265 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.428 ' N ' ' OG ' ' A' ' 191' ' ' SER . 4.3 m -130.03 104.61 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.655 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -109.88 141.49 42.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.007 0.432 . . . . 0.0 111.379 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -113.09 115.93 29.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.401 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.427 ' HD3' ' CE1' ' A' ' 164' ' ' TYR . 7.6 tptp -61.76 -88.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.804 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.68 -150.15 18.16 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.341 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.9 0.06 10.3 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.68 2.253 . . . . 0.0 112.627 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.7 p -92.31 -30.33 15.89 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.321 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.04 -158.65 21.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.471 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.463 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 30.4 m-85 -87.93 -50.71 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.967 0.413 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.53 14.91 33.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.968 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.821 ' CE2' HD21 ' A' ' 168' ' ' LEU . 7.5 p90 -163.72 -179.42 6.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.168 0.509 . . . . 0.0 111.585 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.77 ' C ' HD22 ' A' ' 168' ' ' LEU . 2.9 m120 -127.72 165.06 20.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.551 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.821 HD21 ' CE2' ' A' ' 166' ' ' PHE . 3.2 mm? -134.37 137.65 44.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.456 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -134.82 153.43 52.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.042 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.0 t -155.25 158.09 38.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.768 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -130.09 -77.23 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.407 ' HB2' ' CD ' ' A' ' 175' ' ' PRO . 3.7 mmpt? -81.05 175.14 10.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.666 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -90.41 12.25 19.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.369 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.482 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 26.7 mtmm -105.65 -47.17 0.13 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.904 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 76.9 Cg_exo -51.27 -63.56 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.145 1.897 . . . . 0.0 112.462 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.08 -141.15 16.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.434 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.716 ' CB ' HG21 ' A' ' 215' ' ' VAL . 3.3 tp60 -105.31 104.88 14.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.681 0.277 . . . . 0.0 110.972 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.512 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 10.3 m-30 -115.64 148.82 39.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.717 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.743 HD13 HD21 ' A' ' 193' ' ' LEU . 65.0 mt -76.08 133.73 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.583 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.456 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 8.1 ptt180 -104.97 -31.07 9.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.363 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.2 t -150.32 155.67 40.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 111.241 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.955 HG23 ' HB2' ' A' ' 195' ' ' ALA . 24.5 t -132.89 141.65 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -94.4 120.92 64.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.915 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.55 134.17 49.7 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.36 2.04 . . . . 0.0 112.362 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 73.09 14.89 4.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.839 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.4 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 36.4 m -94.78 162.51 25.15 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.565 0.221 . . . . 0.0 110.503 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 75.1 Cg_exo -48.22 -40.16 34.82 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.367 2.045 . . . . 0.0 112.4 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.94 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -61.79 -44.61 96.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.495 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -65.28 -55.41 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.017 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.19 -25.47 61.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 156' ' ' THR . 26.4 t -78.73 -22.53 46.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 106.89 28.63 4.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.016 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.94 HD13 ' HB1' ' A' ' 188' ' ' ALA . 7.3 tt -85.4 145.18 27.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 0.0 110.935 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.667 ' N ' HD23 ' A' ' 193' ' ' LEU . 5.3 mtt-85 -131.53 131.64 43.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.955 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -57.37 145.64 31.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.319 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' A' ' 233' ' ' ARG . 56.5 mt-30 74.81 -0.22 3.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.979 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.662 ' CG ' HD12 ' A' ' 179' ' ' ILE . 49.2 p30 -63.63 158.2 21.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.765 0.317 . . . . 0.0 110.672 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.512 ' HD2' ' CE1' ' A' ' 178' ' ' PHE . 1.8 mmm180 -94.95 112.84 24.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.344 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.794 HD13 HG12 ' A' ' 230' ' ' VAL . 32.7 mm -65.08 117.21 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.853 0.359 . . . . 0.0 110.586 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.557 ' CG1' HD23 ' A' ' 229' ' ' LEU . 23.4 t -97.61 -46.64 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.61 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 5.2 pt-20 -139.68 176.03 9.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.069 0.461 . . . . 0.0 111.425 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.893 ' O ' HG22 ' A' ' 205' ' ' VAL . 33.8 t -153.18 105.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.773 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.7 t30 70.35 25.09 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.395 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.47 -19.85 38.56 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.451 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 202' ' ' VAL . 32.0 m -82.8 98.16 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.992 0.425 . . . . 0.0 111.319 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.438 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 45.8 t -84.93 102.47 13.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.034 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.412 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 16.2 mmt -130.14 99.86 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.938 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -69.55 102.61 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.48 22.43 4.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.71 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.412 ' HG2' ' HB2' ' A' ' 207' ' ' MET . 0.0 OUTLIER -54.93 157.79 3.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.533 ' O ' HG23 ' A' ' 215' ' ' VAL . 0.8 OUTLIER -94.87 160.12 14.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.12 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.862 ' O ' HG23 ' A' ' 216' ' ' VAL . 7.0 t-160 -50.09 -60.72 2.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.9 -33.58 84.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.236 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.64 -48.62 80.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 110.26 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.716 HG21 ' CB ' ' A' ' 177' ' ' GLN . 23.0 t -68.01 -40.42 83.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.089 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 212' ' ' HIS . 47.0 t -62.4 -44.81 99.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.281 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 75.0 m -66.84 -39.05 87.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.29 80.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.874 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 226' ' ' THR . 36.5 mm -62.68 -36.43 75.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.653 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -46.93 84.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.536 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.0 5.08 30.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.534 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -92.37 20.18 45.52 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.837 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.26 -143.33 12.47 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.893 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -88.71 -22.9 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.674 0.273 . . . . 0.0 111.342 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -108.42 115.73 30.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.753 HG21 ' CD1' ' A' ' 219' ' ' ILE . 28.0 m -120.19 114.19 21.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.452 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -86.04 99.04 11.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.171 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.711 HD23 ' HA ' ' A' ' 202' ' ' VAL . 23.0 mt -105.39 140.75 38.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.046 0.451 . . . . 0.0 111.961 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 153' ' ' ARG . 13.7 tp -115.55 109.47 17.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.467 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.794 HG12 HD13 ' A' ' 199' ' ' ILE . 33.3 m -116.63 169.23 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.999 0.428 . . . . 0.0 111.736 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 152' ' ' PRO . 2.6 t -135.62 152.94 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -69.86 109.66 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.77 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 196' ' ' GLN . 26.8 ttp180 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.247 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.677 ' HA ' HG22 ' A' ' 231' ' ' VAL . 7.6 Cg_endo -50.45 151.95 9.39 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.063 2.509 . . . . 0.0 112.957 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -127.71 140.94 51.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.575 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.818 ' HA ' HD12 ' A' ' 229' ' ' LEU . 16.6 tp -87.16 132.93 33.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.278 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 39.4 t -130.08 140.1 50.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.757 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -135.1 106.39 6.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.707 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 1.066 ' HE1' HD12 ' A' ' 228' ' ' LEU . 12.3 ptp -113.78 143.93 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 0.0 111.171 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -102.22 124.3 47.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.792 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 224' ' ' ASP . 6.6 tptm -55.76 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.37 -150.66 40.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.403 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.74 -16.68 14.54 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.72 2.28 . . . . 0.0 112.596 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.5 p -93.12 -30.15 15.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.174 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.435 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 80.05 -131.68 10.73 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.471 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CB ' ' CE1' ' A' ' 166' ' ' PHE . 3.6 m-85 -105.94 -50.36 3.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 110.433 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.06 20.83 52.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.29 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.497 ' CE1' ' CB ' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -124.86 179.11 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.125 0.488 . . . . 0.0 111.728 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.807 ' C ' HD22 ' A' ' 168' ' ' LEU . 8.7 m120 -129.87 159.2 37.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.877 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.807 HD22 ' C ' ' A' ' 167' ' ' ASN . 3.1 mm? -136.32 136.02 39.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.191 0.52 . . . . 0.0 112.066 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -134.53 165.26 25.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.5 178.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.5 t -140.69 148.0 40.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.073 0.463 . . . . 0.0 111.789 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -130.33 -67.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.527 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -90.05 164.63 14.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.733 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 67.0 m -110.15 22.33 15.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.472 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.733 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 25.1 mtpp -116.96 -56.25 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.838 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 57.4 Cg_exo -53.62 -56.23 2.85 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.139 1.892 . . . . 0.0 112.536 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 137.92 -143.7 14.78 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.358 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.869 ' HB2' HG21 ' A' ' 215' ' ' VAL . 10.3 tp-100 -84.22 142.48 30.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 110.776 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.532 ' CD2' ' CZ ' ' A' ' 198' ' ' ARG . 1.7 m-85 -120.98 149.67 42.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.53 HD12 ' OD1' ' A' ' 197' ' ' ASP . 9.9 mt -98.46 130.91 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.1 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.448 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 24.2 ptt180 -100.77 -30.57 11.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.5 t -157.73 151.24 23.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.1 0.476 . . . . 0.0 112.009 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.775 HG23 ' HB2' ' A' ' 195' ' ' ALA . 54.6 t -131.85 141.09 46.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.456 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 186' ' ' SER . 56.8 t0 -84.95 125.33 70.92 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.111 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.18 127.53 19.47 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.392 2.061 . . . . 0.0 112.161 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 185' ' ' ASP . 13.7 t0 74.4 23.49 1.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.5 m -102.56 164.63 15.27 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.606 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 81.1 Cg_exo -44.85 -40.28 14.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.612 2.208 . . . . 0.0 112.747 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -43.01 92.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.077 0.465 . . . . 0.0 110.407 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.56 -51.81 25.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.038 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -49.28 -27.4 3.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.644 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.3 t -85.03 -31.54 23.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 111.056 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 121.19 21.33 3.13 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.991 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.862 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -83.09 151.59 25.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.613 0.244 . . . . 0.0 110.573 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.862 ' N ' HD23 ' A' ' 193' ' ' LEU . 30.5 mtp180 -145.57 129.72 17.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.266 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.775 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -52.15 160.78 0.71 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.703 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 54.9 mt-30 82.43 -4.82 1.4 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.092 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.689 ' OD2' HG21 ' A' ' 230' ' ' VAL . 38.3 p30 -86.13 165.2 16.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 110.593 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.532 ' CZ ' ' CD2' ' A' ' 178' ' ' PHE . 15.5 mmp_? -101.55 125.12 48.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 111.682 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.767 ' HA ' HG12 ' A' ' 230' ' ' VAL . 26.0 mm -69.43 108.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.854 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.18 -50.11 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.367 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.441 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 11.2 pt-20 -136.22 173.92 11.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.98 0.419 . . . . 0.0 111.139 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.873 ' O ' HG22 ' A' ' 205' ' ' VAL . 40.1 t -151.48 107.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.929 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 53.5 t30 70.25 25.22 4.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.437 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.55 -18.67 43.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.5 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 202' ' ' VAL . 36.0 m -83.74 97.87 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.008 0.432 . . . . 0.0 111.191 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 48.5 t -85.91 101.66 13.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.061 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.427 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 96.6 mmm -130.11 99.66 5.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.856 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -70.89 105.34 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.27 17.85 5.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.743 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.427 ' HG2' ' HB2' ' A' ' 207' ' ' MET . 0.7 OUTLIER -54.94 150.15 10.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.952 0.406 . . . . 0.0 111.123 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.509 ' O ' HG23 ' A' ' 215' ' ' VAL . 8.1 mm-40 -91.53 160.43 15.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.058 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.872 ' O ' HG23 ' A' ' 216' ' ' VAL . 32.4 t-80 -47.81 -64.58 0.75 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.67 -33.79 59.9 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.108 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.27 -47.13 83.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.191 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.869 HG21 ' HB2' ' A' ' 177' ' ' GLN . 23.3 t -71.94 -38.95 66.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.116 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 212' ' ' HIS . 48.6 t -62.44 -41.63 92.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.193 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 32.4 m -75.05 -40.82 60.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.419 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.26 -46.79 87.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.694 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.479 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 23.3 mm -61.23 -34.08 59.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.534 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -73.89 -36.89 64.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.382 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.75 5.53 28.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.674 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -83.29 16.34 29.65 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.171 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.29 -135.89 26.96 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.055 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.2 m-20 -92.21 -25.08 18.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.668 0.27 . . . . 0.0 111.38 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -102.34 117.94 35.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.592 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 5.7 m -114.69 98.45 6.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.485 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -88.73 97.71 11.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.056 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 1.066 HD12 ' HE1' ' A' ' 157' ' ' MET . 54.3 mt -105.38 138.89 40.85 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.6 tp -117.8 109.91 17.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.082 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 199' ' ' ILE . 35.4 m -124.43 170.76 14.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 152' ' ' PRO . 2.6 t -141.33 135.44 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.484 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -72.55 119.87 17.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.401 . . . . 0.0 111.408 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.445 ' HB3' ' NH1' ' A' ' 198' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.81 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.706 0.288 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.627 ' HB3' HG22 ' A' ' 231' ' ' VAL . 73.9 Cg_endo -75.24 170.77 19.62 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.674 2.249 . . . . 0.0 112.869 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 15.5 mtm105 -135.39 145.13 47.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.611 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.916 ' HA ' HD12 ' A' ' 229' ' ' LEU . 59.4 tp -85.76 135.02 33.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.37 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.7 t -130.01 140.07 50.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.814 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -131.53 108.34 9.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.65 ' CE ' HD12 ' A' ' 228' ' ' LEU . 6.7 ptp -119.85 142.1 48.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -102.73 135.63 44.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.085 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.459 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 18.2 tptt -70.14 -78.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.785 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.87 -159.89 5.62 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.266 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.62 0.21 10.2 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.597 2.198 . . . . 0.0 112.654 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.0 p -101.03 -30.24 11.72 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.459 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 89.41 -147.79 19.7 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.26 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.508 ' HB3' ' CE2' ' A' ' 166' ' ' PHE . 13.8 m-85 -110.19 -43.93 3.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.991 0.424 . . . . 0.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.94 40.49 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.507 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 164' ' ' TYR . 4.2 p90 -124.6 174.08 8.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 117.219 0.509 . . . . 0.0 111.714 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.731 ' O ' HG23 ' A' ' 179' ' ' ILE . 10.0 m120 -134.98 152.84 52.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.319 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 179' ' ' ILE . 4.1 mm? -127.49 142.8 51.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.011 0.434 . . . . 0.0 111.838 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.48 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 1.5 p80 -142.62 144.39 32.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.235 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.9 t -144.05 160.48 40.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.924 0.392 . . . . 0.0 111.273 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -126.39 -71.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -90.09 168.54 11.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.7 m -110.0 21.19 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.233 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.543 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 30.7 mtmm -104.79 -49.1 0.13 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.492 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.543 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 13.8 Cg_exo -69.39 -66.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.402 2.068 . . . . 0.0 112.154 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.48 -159.45 28.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.609 ' HG3' HD12 ' A' ' 168' ' ' LEU . 8.2 tp-100 -105.52 144.32 32.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.866 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.426 ' CE1' ' HD3' ' A' ' 198' ' ' ARG . 8.7 m-85 -135.8 151.29 49.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.804 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 167' ' ' ASN . 70.0 mt -72.96 138.98 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.549 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.48 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 5.8 ptt180 -99.31 -34.13 10.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.583 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.416 ' N ' ' HG3' ' A' ' 180' ' ' ARG . 23.0 t -151.73 152.86 33.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.051 0.453 . . . . 0.0 111.512 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 195' ' ' ALA . 26.8 t -131.17 135.48 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.665 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 186' ' ' SER . 59.0 t0 -81.66 120.72 78.56 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.949 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.94 126.94 20.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.351 2.034 . . . . 0.0 112.38 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 t70 74.25 22.94 2.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.741 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 183' ' ' ASP . 5.6 m -100.86 162.61 20.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.594 0.235 . . . . 0.0 110.638 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -43.49 -40.34 10.16 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.673 2.249 . . . . 0.0 112.721 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.891 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -66.11 -42.61 89.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.471 . . . . 0.0 110.31 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.54 -51.68 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.887 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -48.12 -29.68 3.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.541 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.6 t -83.5 -30.05 27.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 120.7 29.5 1.54 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.53 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.891 HD13 ' HB1' ' A' ' 188' ' ' ALA . 8.2 tt -84.2 149.22 26.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.74 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.816 ' N ' HD23 ' A' ' 193' ' ' LEU . 5.4 mtt-85 -141.43 135.93 30.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.665 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -56.08 153.37 9.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.343 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 70.97 7.87 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.774 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.622 ' OD2' HD12 ' A' ' 179' ' ' ILE . 58.8 p30 -74.02 150.05 40.9 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.426 ' HD3' ' CE1' ' A' ' 178' ' ' PHE . 1.4 mmp_? -89.87 113.43 25.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 111.231 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.778 HD13 HG12 ' A' ' 230' ' ' VAL . 27.8 mm -68.27 125.73 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.75 -44.52 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.499 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.459 ' HG2' ' CB ' ' A' ' 229' ' ' LEU . 10.1 pt-20 -143.61 176.85 8.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 111.389 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.89 ' O ' HG22 ' A' ' 205' ' ' VAL . 36.0 t -155.65 107.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.946 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 12.5 t30 70.19 24.27 4.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.45 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.79 -19.16 39.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.369 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.89 HG22 ' O ' ' A' ' 202' ' ' VAL . 32.7 m -81.87 95.69 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.015 0.436 . . . . 0.0 111.272 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.436 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 50.2 t -86.42 99.17 11.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.938 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.424 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 17.6 mmt -130.14 99.83 5.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -68.24 103.91 1.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.748 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.61 21.02 4.83 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.583 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -54.78 142.18 29.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.972 0.415 . . . . 0.0 111.138 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.512 ' O ' HG23 ' A' ' 215' ' ' VAL . 7.4 mm-40 -85.84 160.39 19.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.854 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.7 t-80 -45.55 -60.91 1.92 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.02 -31.14 64.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.981 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -43.71 67.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.939 0.4 . . . . 0.0 110.249 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 211' ' ' GLN . 40.5 t -72.14 -39.13 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.286 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 212' ' ' HIS . 49.3 t -65.92 -41.25 89.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.48 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 73.1 m -70.06 -38.47 75.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.566 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.469 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -55.49 -45.15 77.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.004 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.456 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 30.1 mm -63.84 -36.43 76.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.752 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -65.43 -41.32 93.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.649 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.51 5.2 28.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -81.89 5.56 70.08 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.073 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -140.13 18.53 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.852 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.21 -25.18 34.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.71 0.291 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -115.6 114.86 25.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.524 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.503 HG22 ' CD2' ' A' ' 228' ' ' LEU . 17.3 m -111.6 96.48 6.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.445 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -73.58 97.07 2.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.009 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.887 HD21 HG13 ' A' ' 202' ' ' VAL . 73.6 mt -105.33 131.59 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.978 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 154' ' ' LEU . 12.2 tp -109.58 109.48 20.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.315 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.778 HG12 HD13 ' A' ' 199' ' ' ILE . 35.9 m -119.19 169.82 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.031 0.443 . . . . 0.0 111.907 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 152' ' ' PRO . 15.9 t -119.82 156.32 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.697 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 231' ' ' VAL . 67.9 t0 -92.41 112.31 24.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.304 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.804 179.586 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 120.79 0.329 . . . . 0.0 111.587 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.12 -179.91 5.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.794 2.329 . . . . 0.0 112.783 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -137.79 141.47 40.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.735 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.868 ' HA ' HD12 ' A' ' 229' ' ' LEU . 35.1 tp -99.4 131.36 45.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.962 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.9 t -130.01 138.54 50.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.035 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -131.49 104.4 6.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.486 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.683 ' HE1' ' HB2' ' A' ' 188' ' ' ALA . 5.7 ptm -119.73 140.49 50.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.216 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -96.28 129.42 43.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.404 ' CE ' ' HA2' ' A' ' 163' ' ' GLY . 18.9 tptp -59.78 -80.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.802 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.82 -156.7 17.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.262 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.69 0.02 10.33 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.615 2.21 . . . . 0.0 112.798 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.4 p -92.89 -30.36 15.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.574 0.226 . . . . 0.0 111.469 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.404 ' HA2' ' CE ' ' A' ' 159' ' ' LYS . . . 91.33 -124.9 7.79 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.378 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.488 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 2.4 m-85 -108.21 -55.07 2.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 0.0 110.488 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.71 -5.04 61.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.457 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.645 ' CE2' HD21 ' A' ' 168' ' ' LEU . 45.1 p90 -128.74 177.45 7.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.403 0.602 . . . . 0.0 111.762 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.806 ' C ' HD22 ' A' ' 168' ' ' LEU . 5.7 m120 -125.5 165.19 18.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.806 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.4 mm? -133.55 147.66 51.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.011 0.434 . . . . 0.0 112.003 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 2.2 p-80 -134.47 146.23 49.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.708 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.6 t -155.21 150.04 26.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 111.65 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -114.96 -68.93 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.231 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 155.2 19.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.464 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.1 m -96.34 20.27 10.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.177 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.561 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 31.7 mttp -110.9 -49.71 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.994 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 38.2 Cg_exo -57.63 -63.38 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.109 1.873 . . . . 0.0 112.391 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.9 -162.02 29.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.579 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -108.3 136.47 47.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 0.0 110.886 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.434 ' CD1' ' HD2' ' A' ' 198' ' ' ARG . 2.3 m-85 -124.08 158.05 33.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.608 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.64 ' HA ' HD13 ' A' ' 168' ' ' LEU . 15.0 mt -87.14 139.6 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.875 0.369 . . . . 0.0 110.743 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.458 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 10.2 ptm180 -105.16 -37.79 6.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.516 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.6 t -148.49 154.95 40.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.013 0.435 . . . . 0.0 111.716 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.758 HG23 ' HB2' ' A' ' 195' ' ' ALA . 33.6 t -132.34 143.04 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.739 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 57.2 t0 -95.03 125.33 51.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.081 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 23.5 Cg_exo -63.96 134.42 43.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.275 1.984 . . . . 0.0 112.084 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 74.24 14.9 3.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.728 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 21.2 m -97.26 163.37 20.0 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.515 0.198 . . . . 0.0 110.537 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 81.3 Cg_exo -45.66 -40.35 18.67 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.473 2.115 . . . . 0.0 112.548 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.683 ' HB2' ' HE1' ' A' ' 157' ' ' MET . . . -65.13 -41.62 94.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 110.687 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -70.13 -50.6 38.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.82 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -47.59 -31.49 4.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.474 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.2 t -81.23 -31.45 33.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.049 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 113.1 31.54 2.42 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.063 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 194' ' ' ARG . 6.8 tt -82.59 151.37 26.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.733 0.302 . . . . 0.0 110.905 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.745 ' N ' HD23 ' A' ' 193' ' ' LEU . 49.9 mtt180 -137.78 130.02 29.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.645 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.758 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -52.82 157.59 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.497 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 47.5 mt-30 82.46 -17.04 0.55 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.326 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.739 ' OD2' HG21 ' A' ' 230' ' ' VAL . 20.1 p-10 -61.13 149.58 36.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.727 0.299 . . . . 0.0 110.662 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.434 ' HD2' ' CD1' ' A' ' 178' ' ' PHE . 4.6 mmm-85 -90.63 118.31 29.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.335 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.788 HD13 HG12 ' A' ' 230' ' ' VAL . 24.3 mm -65.28 128.6 28.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.799 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.485 ' CG2' HG23 ' A' ' 231' ' ' VAL . 11.8 t -111.23 -43.73 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.636 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.562 ' OE1' HD22 ' A' ' 229' ' ' LEU . 5.4 pt-20 -142.81 173.74 11.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.477 . . . . 0.0 111.433 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.88 ' O ' HG22 ' A' ' 205' ' ' VAL . 47.0 t -153.4 107.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.983 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.5 t30 70.37 25.27 4.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.508 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.48 -20.46 37.14 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.452 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 202' ' ' VAL . 26.9 m -80.4 95.28 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.09 0.445 . . . . 0.0 111.161 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.44 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 44.9 t -89.93 99.73 12.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.012 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.4 ' O ' ' HG2' ' A' ' 210' ' ' LYS . 45.6 mmm -130.16 101.38 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -67.1 100.04 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.625 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.23 26.49 3.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.392 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 207' ' ' MET . 6.5 mmtp -54.9 156.27 3.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 111.119 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.525 ' O ' HG23 ' A' ' 215' ' ' VAL . 3.7 mm-40 -92.11 160.28 15.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.987 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.811 ' O ' HG23 ' A' ' 216' ' ' VAL . 63.8 t-80 -47.71 -62.69 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.49 -30.3 64.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.284 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.86 -45.78 73.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 110.484 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 211' ' ' GLN . 28.7 t -70.92 -37.04 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.458 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 212' ' ' HIS . 45.0 t -69.2 -42.03 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.658 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 70.3 m -72.15 -33.18 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -59.35 -48.78 80.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.479 HD13 HG13 ' A' ' 202' ' ' VAL . 26.8 mm -62.24 -38.08 80.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.944 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -68.47 -36.84 79.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.734 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.14 5.2 30.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.645 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -85.1 10.18 64.1 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.039 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.17 -128.68 27.07 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.806 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.33 -25.09 18.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.717 0.294 . . . . 0.0 111.125 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -107.98 117.37 33.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.788 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.408 HG22 HD21 ' A' ' 228' ' ' LEU . 3.0 m -113.24 96.11 5.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.442 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -78.5 98.55 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.097 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.604 HD12 ' SD ' ' A' ' 157' ' ' MET . 28.7 mt -106.46 131.01 54.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.035 0.445 . . . . 0.0 111.906 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 154' ' ' LEU . 11.9 tp -115.98 109.7 17.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.572 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.788 HG12 HD13 ' A' ' 199' ' ' ILE . 32.0 m -109.77 176.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 112.068 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.485 HG23 ' CG2' ' A' ' 200' ' ' VAL . 5.4 t -126.49 162.89 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.074 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.479 ' N ' HG12 ' A' ' 231' ' ' VAL . 64.9 t0 -80.61 112.9 18.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.252 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.572 179.446 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.548 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 3.7 ptm85 . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.4 139.13 12.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.567 2.178 . . . . 0.0 112.556 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -94.51 139.89 30.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.383 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.917 ' HA ' HD12 ' A' ' 229' ' ' LEU . 18.1 tp -95.99 119.84 35.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.989 0.423 . . . . 0.0 111.026 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 228' ' ' LEU . 45.3 t -116.21 126.94 54.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.53 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.448 ' N ' ' OG ' ' A' ' 191' ' ' SER . 3.0 m -135.48 99.91 4.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.192 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.42 ' HE2' ' HA ' ' A' ' 188' ' ' ALA . 16.4 ptp -112.38 142.91 44.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.195 0.522 . . . . 0.0 111.88 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -104.44 119.65 39.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.895 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 224' ' ' ASP . 16.5 tptp -58.08 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.057 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.01 -152.86 12.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.385 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.02 0.17 10.22 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.747 2.298 . . . . 0.0 112.885 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.7 p -87.16 -30.41 21.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.575 0.226 . . . . 0.0 111.544 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.402 ' HA2' ' CE ' ' A' ' 159' ' ' LYS . . . 97.27 -146.66 18.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.179 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 7.7 m-85 -109.33 -46.83 3.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.167 0.508 . . . . 0.0 110.259 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 183' ' ' ASP . . . 70.71 28.34 71.01 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.626 -0.715 . . . . 0.0 113.813 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -140.84 175.68 9.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.576 0.688 . . . . 0.0 112.163 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.796 ' C ' HD22 ' A' ' 168' ' ' LEU . 10.0 m120 -135.65 155.98 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.66 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.796 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.3 mm? -133.42 143.06 48.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.046 0.451 . . . . 0.0 111.9 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.481 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 2.5 p80 -141.03 136.86 32.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.298 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.6 t -137.15 163.95 29.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.379 . . . . 0.0 111.28 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -130.04 -78.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.665 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -90.14 175.05 7.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.761 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.0 m -109.22 19.65 19.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.208 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.63 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 2.6 mtmp? -110.87 -51.36 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.752 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 38.8 Cg_exo -61.2 -63.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.238 1.959 . . . . 0.0 112.229 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 144.35 -176.4 23.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.53 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.753 ' HB3' HG11 ' A' ' 215' ' ' VAL . 9.8 tp-100 -89.27 140.28 29.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.455 ' CD1' ' HD3' ' A' ' 198' ' ' ARG . 3.0 m-85 -127.73 147.84 50.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.654 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.773 HD12 ' OD2' ' A' ' 197' ' ' ASP . 68.0 mt -78.38 135.03 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.209 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.481 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 10.2 ptm180 -98.71 -35.04 10.3 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.9 t -151.58 156.76 41.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 112.076 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.76 HG23 ' HB2' ' A' ' 195' ' ' ALA . 23.3 t -132.69 140.6 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.524 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 165' ' ' GLY . 40.7 t0 -95.11 117.1 66.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.199 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.86 140.76 96.56 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.502 2.135 . . . . 0.0 112.185 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.1 t70 66.0 14.87 9.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.511 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 9.2 m -105.03 166.36 11.58 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.447 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 98.4 Cg_exo -43.98 -40.15 11.63 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.438 2.092 . . . . 0.0 112.437 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.42 ' HA ' ' HE2' ' A' ' 157' ' ' MET . . . -59.65 -44.94 93.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.684 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.18 -54.5 12.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -52.79 -26.63 14.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.533 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 156' ' ' THR . 4.4 t -85.09 -24.71 27.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.991 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.09 26.07 6.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.121 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -79.82 149.39 31.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 111.009 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.825 ' N ' HD23 ' A' ' 193' ' ' LEU . 50.6 mtt-85 -140.72 129.9 23.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.706 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.76 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -58.42 151.1 20.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.324 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 41.5 mt-30 77.55 -3.05 2.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.163 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.773 ' OD2' HD12 ' A' ' 179' ' ' ILE . 41.3 p30 -67.71 151.83 46.59 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.567 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.455 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 68.1 mmt-85 -90.61 115.67 27.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.25 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.715 HD13 HG12 ' A' ' 230' ' ' VAL . 22.8 mm -65.51 124.55 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.117 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.583 HG12 ' SG ' ' A' ' 206' ' ' CYS . 17.1 t -109.02 -45.19 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.492 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.9 pt-20 -144.27 173.97 11.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 111.449 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.886 HG13 ' CD2' ' A' ' 228' ' ' LEU . 26.4 t -155.43 112.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.817 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 44.2 t30 70.21 22.93 5.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.385 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.54 -15.96 48.88 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.581 -0.818 . . . . 0.0 113.589 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 202' ' ' VAL . 27.0 m -86.59 93.75 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.25 0.525 . . . . 0.0 111.539 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.583 ' SG ' HG12 ' A' ' 200' ' ' VAL . 50.8 t -92.18 100.92 13.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.668 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.1 mmt -130.63 101.61 5.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.353 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -68.36 99.25 0.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.643 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.5 25.55 3.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.609 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.404 ' HB2' HG22 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -54.96 175.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.767 0.318 . . . . 0.0 110.916 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.912 ' O ' HG23 ' A' ' 215' ' ' VAL . 11.7 mm-40 -91.11 157.23 17.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.986 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.812 ' O ' HG23 ' A' ' 216' ' ' VAL . 67.6 t60 -52.44 -64.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.692 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.05 -25.04 61.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.283 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.01 -44.02 55.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.323 . . . . 0.0 110.712 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 211' ' ' GLN . 4.6 t -74.81 -36.82 40.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.565 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 212' ' ' HIS . 40.7 t -70.13 -38.22 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.71 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.3 m -74.56 -33.51 62.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.627 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.522 ' HB1' HG11 ' A' ' 202' ' ' VAL . . . -59.49 -48.34 82.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.0 mm -61.86 -42.16 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 54.2 ttp85 -75.16 -28.4 60.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.21 5.78 28.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.737 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -66.53 -0.65 8.57 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.564 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 47.43 -132.23 15.16 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.987 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.1 m-20 -83.86 -25.17 30.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.308 . . . . 0.0 111.217 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -125.48 114.82 19.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.814 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.58 HG22 HD21 ' A' ' 228' ' ' LEU . 4.6 m -112.42 96.84 6.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.369 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -84.08 94.8 8.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.031 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.886 ' CD2' HG13 ' A' ' 202' ' ' VAL . 8.1 mt -110.07 140.1 44.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.145 0.498 . . . . 0.0 112.283 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 154' ' ' LEU . 10.4 tp -120.0 109.58 15.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.313 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.715 HG12 HD13 ' A' ' 199' ' ' ILE . 27.5 m -114.87 179.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 111.766 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 232' ' ' ASP . 2.6 t -119.95 166.08 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.726 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.493 ' H ' HG12 ' A' ' 231' ' ' VAL . 46.7 t0 -90.26 111.0 22.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.209 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.617 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 29.2 ptt85 . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.533 ' HB3' HG22 ' A' ' 231' ' ' VAL . 46.4 Cg_endo -69.19 176.88 5.76 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.671 2.247 . . . . 0.0 113.075 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.842 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.3 OUTLIER -143.44 158.11 43.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.699 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.2 tp -90.01 125.74 35.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.005 0.431 . . . . 0.0 111.369 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 47.7 t -120.52 140.2 51.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.374 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.4 m -134.11 104.1 6.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -109.81 127.02 54.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -90.39 125.53 35.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.981 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.445 ' HE2' ' CZ ' ' A' ' 164' ' ' TYR . 1.7 tppp? -59.66 -80.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.703 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.38 -156.19 12.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.498 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.76 0.02 10.35 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.704 2.269 . . . . 0.0 112.782 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 p -96.85 -30.15 13.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.734 0.302 . . . . 0.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.93 -142.12 15.84 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.439 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.464 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 14.7 m-85 -96.41 -51.33 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.34 30.49 24.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.627 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -151.49 178.65 9.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.238 0.542 . . . . 0.0 112.152 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.887 ' O ' HD13 ' A' ' 168' ' ' LEU . 10.0 m120 -135.22 154.63 51.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.054 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.887 HD13 ' O ' ' A' ' 167' ' ' ASN . 0.4 OUTLIER -132.19 148.33 52.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.398 . . . . 0.0 111.655 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -134.21 141.33 46.99 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.314 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.6 t -155.14 149.61 26.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.179 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -121.44 -67.97 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.561 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -90.16 159.73 16.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.6 m -100.8 21.41 13.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.166 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.552 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 5.0 mttp -108.73 -48.59 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.792 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 25.5 Cg_exo -63.02 -65.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.216 1.944 . . . . 0.0 112.298 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.09 -152.25 23.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.411 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -125.88 133.96 51.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 111.097 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 2.8 m-85 -122.53 165.11 16.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.824 HD12 ' OD2' ' A' ' 197' ' ' ASP . 57.0 mt -91.9 135.91 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 110.66 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.401 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 0.3 OUTLIER -98.78 -35.63 10.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.879 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.0 t -153.21 158.51 41.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 111.63 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 195' ' ' ALA . 49.0 t -135.29 141.15 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.789 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -90.72 117.28 67.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.799 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.91 136.61 74.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.448 2.099 . . . . 0.0 112.408 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.7 t70 71.21 14.78 6.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.58 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.524 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 48.0 m -99.99 164.78 15.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.583 0.23 . . . . 0.0 110.778 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 99.9 Cg_exo -44.04 -40.25 11.91 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.584 2.19 . . . . 0.0 112.912 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.456 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -62.78 -43.95 97.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -70.33 -51.65 28.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.007 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.96 -32.19 3.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.574 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.1 t -83.99 -27.5 28.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.063 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 115.11 25.51 3.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.464 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.839 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -83.44 149.21 26.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.731 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.839 ' N ' HD23 ' A' ' 193' ' ' LEU . 1.4 mtt85 -143.15 138.31 29.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.798 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.624 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -55.69 153.97 7.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.573 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 71.39 9.14 6.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.065 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.824 ' OD2' HD12 ' A' ' 179' ' ' ILE . 38.9 p30 -75.77 149.53 37.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.029 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 17.4 mmt85 -85.67 112.49 21.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.691 0.281 . . . . 0.0 111.548 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.933 ' HA ' HG12 ' A' ' 230' ' ' VAL . 12.8 mm -68.09 123.9 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.366 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.3 t -110.18 -43.86 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.126 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.52 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 10.6 pt-20 -143.19 176.64 8.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.317 0.58 . . . . 0.0 111.936 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.891 ' O ' HG22 ' A' ' 205' ' ' VAL . 48.7 t -150.81 107.77 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.517 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.45 23.86 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.368 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.65 -17.01 51.01 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.633 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 202' ' ' VAL . 26.9 m -83.43 90.2 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.191 0.495 . . . . 0.0 111.569 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.483 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 53.0 t -80.31 100.57 8.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.754 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.464 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 17.0 mmt -130.74 99.43 4.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.18 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -75.03 115.5 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.2 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 104.21 12.85 28.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.112 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.464 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 0.5 OUTLIER -54.93 166.16 0.54 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.06 0.457 . . . . 0.0 111.398 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -94.46 160.4 14.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.841 ' O ' HG23 ' A' ' 216' ' ' VAL . 11.2 t60 -47.49 -56.42 7.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.026 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.05 -29.12 70.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.17 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.94 -44.5 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.55 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 32.9 t -71.84 -35.04 53.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.449 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 212' ' ' HIS . 47.9 t -71.25 -41.61 74.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.458 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.8 m -67.14 -38.13 84.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.516 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -55.67 -45.64 77.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.053 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.421 HD13 HG13 ' A' ' 202' ' ' VAL . 25.8 mm -65.45 -33.33 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -67.68 -41.35 83.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.86 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.09 5.03 31.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.613 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -87.6 10.03 71.33 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.975 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.12 -136.32 25.56 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.854 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.79 -25.13 23.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.74 0.305 . . . . 0.0 111.079 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -104.22 114.89 29.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.682 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.6 HG22 ' HG ' ' A' ' 228' ' ' LEU . 19.9 m -110.55 101.12 9.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.287 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -85.35 94.86 9.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.192 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 202' ' ' VAL . 13.6 mt -103.67 137.62 41.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.026 0.441 . . . . 0.0 111.858 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.842 HD12 ' O ' ' A' ' 153' ' ' ARG . 13.9 tp -110.56 109.41 19.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.933 HG12 ' HA ' ' A' ' 199' ' ' ILE . 23.8 m -124.62 177.04 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.475 0.655 . . . . 0.0 112.243 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 152' ' ' PRO . 39.9 t -119.2 145.11 25.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.776 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -96.41 112.81 24.42 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.581 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 . . . . . 0 CA--C 1.531 0.245 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.946 -179.829 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.589 ' HB2' ' HD2' ' A' ' 152' ' ' PRO . 5.7 ptm180 . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.931 0.396 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.645 ' HB3' HG22 ' A' ' 231' ' ' VAL . 7.1 Cg_endo -51.52 143.71 35.04 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.979 2.453 . . . . 0.0 112.439 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.673 ' O ' HD12 ' A' ' 229' ' ' LEU . 81.7 mtt180 -125.2 171.81 10.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.354 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.2 tp -108.21 139.35 43.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.046 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 228' ' ' LEU . 54.1 t -126.56 135.83 51.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.51 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -137.24 99.9 4.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.744 0.307 . . . . 0.0 110.689 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -114.43 141.12 48.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 111.266 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -96.22 121.6 38.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.552 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.42 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 2.0 tppp? -46.41 -76.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.36 -158.05 7.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.314 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.01 0.03 10.32 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.676 2.25 . . . . 0.0 112.69 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.2 p -100.56 -30.19 11.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.517 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.42 ' HA2' ' HD2' ' A' ' 159' ' ' LYS . . . 80.95 -124.79 6.57 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.71 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.96 ' CE2' HG21 ' A' ' 219' ' ' ILE . 8.2 m-85 -91.63 -60.41 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.084 0.469 . . . . 0.0 111.099 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 183' ' ' ASP . . . 96.71 -0.74 61.22 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.555 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CD2' HD13 ' A' ' 193' ' ' LEU . 1.4 p90 -124.8 -176.89 3.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.06 0.457 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.856 ' O ' HD13 ' A' ' 168' ' ' LEU . 3.3 m120 -124.72 161.96 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.685 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.856 HD13 ' O ' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -132.71 135.27 45.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.076 0.465 . . . . 0.0 111.976 -179.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 0.7 OUTLIER -134.86 143.31 46.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.948 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 t -155.06 166.84 32.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 111.442 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -130.14 -59.5 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.739 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -90.01 167.34 12.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 m -110.08 22.21 15.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.278 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 14.2 mttt -102.93 -48.6 0.17 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.563 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 14.2 Cg_exo -69.3 -58.0 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.359 2.039 . . . . 0.0 112.331 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 140.33 -146.75 18.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.41 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -103.97 131.58 51.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.765 0.317 . . . . 0.0 110.865 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CD1' ' HD3' ' A' ' 198' ' ' ARG . 1.2 m-30 -109.76 165.19 11.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.559 HD12 ' OD1' ' A' ' 197' ' ' ASP . 4.0 mt -100.37 131.75 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.166 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.47 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 10.9 ptm180 -104.33 -33.53 8.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.709 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.4 t -150.82 152.53 33.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 111.868 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.67 140.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.761 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 47.3 t0 -89.0 123.1 68.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 23.7 Cg_exo -63.59 133.07 37.95 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.233 1.955 . . . . 0.0 112.195 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 185' ' ' ASP . 13.6 t0 76.88 14.84 2.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.26 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 37.0 m -98.69 163.21 19.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 84.1 Cg_exo -45.56 -40.2 18.05 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.36 2.04 . . . . 0.0 112.345 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.61 -44.85 95.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.764 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -66.64 -54.52 22.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.917 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -55.84 -26.49 46.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.279 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.3 t -82.52 -20.3 36.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.22 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 100.8 36.95 3.81 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.914 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -100.18 148.68 24.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.83 0.347 . . . . 0.0 111.153 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.785 ' N ' HD23 ' A' ' 193' ' ' LEU . 53.0 mtp180 -147.79 138.78 23.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.758 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -47.69 166.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.613 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.7 ' O ' ' HB2' ' A' ' 233' ' ' ARG . 67.1 mt-30 80.27 -24.36 0.2 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.237 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.737 ' OD2' HG21 ' A' ' 230' ' ' VAL . 27.2 p-10 -66.92 138.17 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.452 0.644 . . . . 0.0 112.266 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.546 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 0.2 OUTLIER -92.19 130.12 37.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.373 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.79 ' HA ' HG12 ' A' ' 230' ' ' VAL . 22.2 mm -69.78 116.45 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.764 0.316 . . . . 0.0 110.58 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.21 -46.48 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.736 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.457 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 10.2 pt-20 -138.45 174.11 10.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.962 0.41 . . . . 0.0 111.164 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.926 ' O ' HG22 ' A' ' 205' ' ' VAL . 23.7 t -152.74 109.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.144 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 13.0 t30 70.01 24.32 5.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.306 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.33 49.38 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.469 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.926 HG22 ' O ' ' A' ' 202' ' ' VAL . 28.5 m -80.95 95.29 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.205 0.502 . . . . 0.0 111.093 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.426 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 26.5 t -86.8 103.6 15.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.176 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.405 ' O ' ' HG2' ' A' ' 210' ' ' LYS . 84.7 mmm -130.16 99.92 5.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.69 103.66 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.705 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 113.95 23.71 4.84 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.337 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 207' ' ' MET . 9.7 mmmt -54.9 158.47 2.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.918 0.389 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 215' ' ' VAL . 0.7 OUTLIER -98.08 160.28 14.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.151 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.872 ' O ' HG23 ' A' ' 216' ' ' VAL . 14.6 t60 -48.05 -60.99 2.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.92 -31.15 67.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.212 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -46.15 78.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.261 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 211' ' ' GLN . 25.5 t -70.05 -35.41 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.438 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 212' ' ' HIS . 41.5 t -70.36 -42.69 78.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.649 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 71.6 m -73.46 -33.44 64.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.735 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.04 80.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.143 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.96 HG21 ' CE2' ' A' ' 164' ' ' TYR . 17.6 mm -63.81 -40.35 88.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -43.37 89.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.675 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.95 5.06 30.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.526 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -90.81 19.71 43.61 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.895 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.05 -137.7 22.77 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.963 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.85 -24.83 20.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -100.38 117.96 35.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.393 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.801 HG22 HD21 ' A' ' 228' ' ' LEU . 3.0 m -111.38 99.49 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.6 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -87.42 94.93 9.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.947 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.801 HD21 HG22 ' A' ' 226' ' ' THR . 18.4 mt -109.12 139.8 43.53 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 153' ' ' ARG . 14.2 tp -109.54 111.42 22.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 199' ' ' ILE . 34.8 m -125.39 152.49 32.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 197' ' ' ASP . 2.6 t -119.98 137.79 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 197' ' ' ASP . 20.4 t0 -67.94 143.5 55.62 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.856 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.7 ' HB2' ' O ' ' A' ' 196' ' ' GLN . 38.6 ttp180 . . . . . 0 CA--C 1.511 -0.534 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.658 0.266 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.471 ' HB3' HG22 ' A' ' 231' ' ' VAL . 56.3 Cg_endo -70.68 165.9 30.49 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.621 2.214 . . . . 0.0 112.913 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.797 ' O ' HD12 ' A' ' 229' ' ' LEU . 70.4 mtm180 -129.71 158.43 39.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.774 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 26.3 tp -96.48 129.37 43.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.376 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.4 t -128.25 135.63 49.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.504 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.2 m -131.47 111.26 11.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.03 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.712 ' HE3' HD12 ' A' ' 228' ' ' LEU . 3.6 ptp -118.18 133.11 56.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -92.97 130.54 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.452 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 10.7 tptm -61.56 -80.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.754 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.441 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.73 -157.2 6.98 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.299 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.77 0.21 10.19 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.681 2.254 . . . . 0.0 112.686 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.3 p -95.23 -30.14 14.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.428 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 93.01 -161.2 25.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.46 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.657 ' CE1' HG22 ' A' ' 219' ' ' ILE . 31.8 m-85 -81.67 -43.29 18.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.336 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 186' ' ' SER . . . 85.18 27.67 32.91 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.927 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.996 ' CE2' HD11 ' A' ' 168' ' ' LEU . 0.0 OUTLIER -164.83 -177.32 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.256 0.55 . . . . 0.0 111.882 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.914 ' O ' HD13 ' A' ' 168' ' ' LEU . 9.8 m120 -136.6 157.29 47.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.028 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.996 HD11 ' CE2' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -133.35 130.64 39.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.55 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.3 OUTLIER -136.04 135.58 39.55 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.018 178.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.0 t -155.32 144.26 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.152 0.501 . . . . 0.0 111.498 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -130.26 -6.45 4.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.309 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.479 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.1 OUTLIER -89.16 146.58 24.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.555 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.1 m -110.21 8.95 23.86 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.735 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 50.4 mtmt -120.68 -58.27 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 37.1 Cg_exo -56.89 -64.48 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.138 1.892 . . . . 0.0 112.302 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.81 -145.44 12.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.686 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.875 ' HB2' HG21 ' A' ' 215' ' ' VAL . 6.2 tp-100 -108.68 151.12 26.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.404 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 5.4 m-85 -130.29 151.45 50.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.854 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.738 HD13 HD21 ' A' ' 193' ' ' LEU . 69.6 mt -82.53 140.79 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.55 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 2.8 ptm180 -103.21 -36.32 8.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.225 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 40.8 t -151.0 153.8 35.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.034 0.445 . . . . 0.0 111.681 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.825 HG23 ' HB2' ' A' ' 195' ' ' ALA . 32.5 t -133.5 141.82 43.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.575 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 46.8 t0 -91.89 121.23 67.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.973 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 26.4 Cg_exo -62.41 132.67 39.38 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.345 2.03 . . . . 0.0 112.33 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.7 t0 69.87 22.62 5.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.259 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.511 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 58.6 m -104.9 164.69 14.65 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.725 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 94.5 Cg_exo -43.47 -40.12 9.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.628 2.218 . . . . 0.0 112.792 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.616 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -63.08 -44.2 96.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 110.293 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -70.02 -52.63 22.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.894 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.6 -31.14 2.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.655 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.2 t -81.97 -30.61 31.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 116.96 25.61 3.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.45 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 194' ' ' ARG . 7.8 tt -78.29 150.32 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.739 0.304 . . . . 0.0 110.743 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.797 ' N ' HD23 ' A' ' 193' ' ' LEU . 57.6 mtt-85 -139.6 130.01 25.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.857 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.825 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -55.05 152.7 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 75.22 2.9 4.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.08 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.609 ' CG ' HD12 ' A' ' 179' ' ' ILE . 41.2 p30 -73.74 155.58 38.76 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.307 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -87.72 112.76 22.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.458 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.789 HD13 HG12 ' A' ' 230' ' ' VAL . 24.8 mm -66.97 124.17 21.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.913 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.568 ' CG1' HD23 ' A' ' 229' ' ' LEU . 19.3 t -106.78 -44.0 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.912 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.4 pt-20 -145.2 175.15 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.102 0.477 . . . . 0.0 111.688 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.877 ' O ' HG22 ' A' ' 205' ' ' VAL . 40.1 t -150.56 109.36 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.65 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 49.8 t30 70.38 23.43 4.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.299 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.17 -16.28 53.73 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.564 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 202' ' ' VAL . 32.7 m -85.45 96.76 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 117.181 0.49 . . . . 0.0 111.432 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' CYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 52.5 t -81.8 103.2 11.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.661 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' MET . . . . . 0.455 ' HB2' ' CG ' ' A' ' 210' ' ' LYS . 21.9 mmt -130.23 99.47 5.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -78.7 101.73 7.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.1 5.34 6.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.135 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.455 ' CG ' ' HB2' ' A' ' 207' ' ' MET . 0.9 OUTLIER -54.85 156.81 3.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.096 0.448 . . . . 0.0 110.97 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.656 ' O ' HG23 ' A' ' 215' ' ' VAL . 18.0 mm-40 -89.34 160.28 16.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.999 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.842 ' O ' HG23 ' A' ' 216' ' ' VAL . 0.9 OUTLIER -47.26 -60.92 2.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.91 -31.41 64.65 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.114 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.23 -44.02 69.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.473 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.875 HG21 ' HB2' ' A' ' 177' ' ' GLN . 16.8 t -72.38 -38.9 62.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 212' ' ' HIS . 49.2 t -65.06 -42.29 94.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.186 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 45.4 m -67.24 -39.67 86.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.411 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.06 73.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.959 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.657 HG22 ' CE1' ' A' ' 164' ' ' TYR . 25.9 mm -61.35 -37.53 77.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -70.48 -33.91 71.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.509 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.15 5.33 30.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.591 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -83.99 13.99 46.08 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.149 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.12 -134.78 27.56 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.868 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.4 m-20 -87.46 -25.18 23.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.722 0.296 . . . . 0.0 111.239 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -112.72 117.5 32.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.706 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.695 HG22 HD21 ' A' ' 228' ' ' LEU . 5.8 m -112.85 95.06 5.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.31 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -78.84 97.97 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.251 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.712 HD12 ' HE3' ' A' ' 157' ' ' MET . 46.3 mt -105.02 135.72 45.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 112.259 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 153' ' ' ARG . 14.3 tp -112.06 109.45 19.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.117 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.789 HG12 HD13 ' A' ' 199' ' ' ILE . 31.9 m -120.78 169.44 12.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.137 0.494 . . . . 0.0 112.114 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 152' ' ' PRO . 39.8 t -119.92 137.54 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.74 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -71.21 110.73 6.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.257 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.812 179.511 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.835 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.1 OUTLIER -94.64 133.9 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.837 0.351 . . . . 0.0 110.922 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.835 ' N ' HD13 ' A' ' 144' ' ' ILE . 14.2 t70 -75.21 136.09 72.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.388 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.41 -57.6 1.02 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.545 2.163 . . . . 0.0 112.314 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.032 ' O ' HG23 ' A' ' 148' ' ' THR . 14.1 t80 -86.25 -60.61 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.104 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 1.032 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.3 p 159.86 157.96 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.428 0.691 . . . . 0.0 110.567 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.426 ' HG3' ' CB ' ' A' ' 145' ' ' ASP . 45.0 mtm -125.56 -55.21 1.54 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.822 0.344 . . . . 0.0 111.798 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.522 HD11 ' CG1' ' A' ' 231' ' ' VAL . 20.7 tp -124.11 -4.61 7.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.239 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.906 ' CD ' HG21 ' A' ' 148' ' ' THR . 1.0 OUTLIER -29.34 143.42 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.11 142.63 42.47 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.548 2.165 . . . . 0.0 111.976 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -107.48 141.22 39.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.085 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.899 ' HA ' HD12 ' A' ' 229' ' ' LEU . 55.3 tp -98.6 134.26 41.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.544 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 41.4 t -129.92 139.99 51.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 19.0 m -131.86 101.99 5.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.157 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.434 ' HE1' ' CE2' ' A' ' 166' ' ' PHE . 6.6 ptp -109.99 137.53 47.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 111.219 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -100.59 119.09 38.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.657 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.406 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 1.0 OUTLIER -51.29 -82.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.95 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.48 -156.42 26.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.23 -0.0 10.38 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.603 2.202 . . . . 0.0 112.841 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.7 p -108.43 -30.03 8.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.724 0.297 . . . . 0.0 111.119 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 83.92 -131.11 10.17 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.423 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CZ ' ' CG2' ' A' ' 219' ' ' ILE . 32.5 m-85 -110.2 -46.56 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.05 17.41 63.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.809 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' A' ' 157' ' ' MET . 0.1 OUTLIER -124.93 -178.62 4.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.092 0.472 . . . . 0.0 111.845 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.82 ' C ' HD22 ' A' ' 168' ' ' LEU . 9.9 m120 -134.83 160.73 37.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.393 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.82 HD22 ' C ' ' A' ' 167' ' ' ASN . 3.3 mm? -138.54 137.25 36.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 111.313 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.424 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 0.7 OUTLIER -134.76 141.53 46.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.62 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 t -155.09 150.14 26.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.25 -72.95 0.56 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.033 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -64.34 163.97 12.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.044 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.0 m -110.05 20.3 18.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.624 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 23.1 mttp -112.47 -50.56 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.873 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 25.2 Cg_exo -63.15 -64.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.143 1.895 . . . . 0.0 112.248 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 142.58 -148.34 20.04 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.5 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.409 ' HG2' HG11 ' A' ' 215' ' ' VAL . 9.8 tp-100 -114.93 129.09 56.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 0.0 110.973 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.498 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 1.6 m-85 -117.34 165.27 13.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.349 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.617 HD12 ' OD1' ' A' ' 197' ' ' ASP . 5.0 mt -90.18 136.3 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.939 0.399 . . . . 0.0 110.358 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.425 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 9.4 ptm180 -102.38 -34.55 9.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.818 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.9 t -150.36 149.4 30.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 0.0 111.909 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 195' ' ' ALA . 81.9 t -135.32 134.1 52.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.548 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 186' ' ' SER . 47.4 t0 -84.37 122.5 75.33 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.971 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.01 130.22 30.1 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.229 1.953 . . . . 0.0 112.193 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 75.93 18.18 2.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.736 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.6 m -98.23 164.93 16.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.56 0.219 . . . . 0.0 110.632 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 97.5 Cg_exo -43.45 -40.1 9.84 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.607 2.205 . . . . 0.0 112.768 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.77 91.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.039 0.447 . . . . 0.0 110.373 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.03 -50.86 37.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.755 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -47.91 -32.96 6.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.333 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -79.32 -30.0 42.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.04 32.58 1.51 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.241 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -97.59 149.17 22.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.854 0.359 . . . . 0.0 110.995 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.84 ' N ' HD23 ' A' ' 193' ' ' LEU . 76.5 mtt180 -142.51 133.77 26.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -46.59 161.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.576 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 233' ' ' ARG . 56.4 mt-30 82.73 -13.92 0.79 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.042 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.673 ' OD2' HG21 ' A' ' 230' ' ' VAL . 7.9 p-10 -68.18 146.45 53.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.749 0.309 . . . . 0.0 110.566 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.498 ' HD2' ' CE1' ' A' ' 178' ' ' PHE . 15.8 mmt85 -93.1 123.13 36.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.387 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.82 HD13 HG12 ' A' ' 230' ' ' VAL . 22.1 mm -66.52 128.96 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.976 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.81 -42.97 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.785 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.452 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 10.9 pt-20 -144.87 172.63 12.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.024 0.44 . . . . 0.0 111.649 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.87 ' O ' HG22 ' A' ' 205' ' ' VAL . 16.5 t -149.42 105.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.017 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 35.7 t30 70.27 26.39 4.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.538 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.06 -21.85 32.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.486 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 202' ' ' VAL . 27.0 m -80.32 97.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.985 0.422 . . . . 0.0 111.158 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 42.3 t -89.98 98.78 11.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.114 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.418 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 21.7 mmt -130.24 99.68 5.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.817 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -74.48 106.56 6.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.121 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.04 11.93 8.72 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.858 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.418 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 12.3 mmtt -55.76 161.91 1.97 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.887 0.375 . . . . 0.0 111.217 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.621 ' O ' HG23 ' A' ' 215' ' ' VAL . 8.5 mm-40 -88.25 160.33 17.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.909 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.841 ' O ' HG23 ' A' ' 216' ' ' VAL . 0.9 OUTLIER -49.89 -57.28 7.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.577 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.97 -34.21 82.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.814 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -44.75 80.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 211' ' ' GLN . 35.5 t -70.65 -37.32 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.342 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 212' ' ' HIS . 59.0 t -68.96 -41.77 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.418 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.8 m -66.24 -40.05 89.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.537 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.625 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -55.39 -39.01 69.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.7 HD11 HD21 ' A' ' 228' ' ' LEU . 25.2 mm -69.75 -32.28 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.716 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -71.57 -36.49 70.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.86 5.16 29.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.619 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.33 14.03 60.43 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.009 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.03 -135.55 26.19 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.906 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.96 -25.13 24.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.793 0.33 . . . . 0.0 111.184 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -108.75 114.93 29.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.632 HG22 ' HG ' ' A' ' 228' ' ' LEU . 24.6 m -109.82 101.56 10.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.715 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -81.19 98.12 7.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.893 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.7 HD21 HD11 ' A' ' 219' ' ' ILE . 32.8 mt -108.19 129.87 55.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.045 0.45 . . . . 0.0 112.17 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.899 HD12 ' HA ' ' A' ' 154' ' ' LEU . 11.8 tp -110.7 109.74 20.12 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.82 HG12 HD13 ' A' ' 199' ' ' ILE . 33.9 m -110.91 -179.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.563 . . . . 0.0 112.305 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.522 ' CG1' HD11 ' A' ' 150' ' ' LEU . 17.7 t -119.52 165.66 14.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.116 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.52 ' N ' HG12 ' A' ' 231' ' ' VAL . 32.3 t0 -99.8 109.75 22.15 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 196' ' ' GLN . 25.2 ttm180 -82.23 -20.08 38.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.472 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -46.51 -37.34 7.78 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.797 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 54.0 m -85.14 -34.46 22.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.553 -0.748 . . . . 0.0 108.986 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.428 ' HB2' ' HA ' ' A' ' 233' ' ' ARG . 10.3 t70 -53.04 -35.71 59.77 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.008 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.07 -31.65 39.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.992 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -59.37 -52.03 67.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.142 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -59.79 -21.05 60.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.823 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.925 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.639 -0.185 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.599 HD13 ' C ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -122.6 121.1 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.043 0.449 . . . . 0.0 111.018 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.408 ' N ' HD13 ' A' ' 144' ' ' ILE . 15.4 t70 -105.27 138.13 19.46 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.65 -54.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.551 2.167 . . . . 0.0 112.891 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 147' ' ' PHE . 1.0 OUTLIER -54.59 -25.72 28.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.24 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.6 p -119.11 129.54 55.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.66 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 38.5 mtp -122.87 -14.74 7.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.086 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.624 HD13 ' CG ' ' A' ' 236' ' ' ASP . 40.9 tp -64.54 -18.4 64.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -36.83 152.31 0.11 Allowed Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.465 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.87 151.46 85.11 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.742 2.295 . . . . 0.0 112.786 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -130.67 145.91 52.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.709 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.901 ' HA ' HD12 ' A' ' 229' ' ' LEU . 21.9 tp -93.08 137.93 31.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.189 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 42.1 t -130.17 140.05 50.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.814 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.1 m -130.17 107.35 9.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.826 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 9.5 ptp -109.98 143.11 40.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.812 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -105.87 127.36 53.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -60.2 -80.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.824 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.68 -156.86 9.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.442 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.77 -1.51 11.68 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.571 2.181 . . . . 0.0 112.671 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.8 p -101.37 -30.15 11.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.126 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.3 -127.93 8.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.433 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.47 ' CZ ' HG22 ' A' ' 219' ' ' ILE . 9.7 m-85 -110.08 -50.21 3.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.863 0.364 . . . . 0.0 110.814 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.24 13.96 69.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.99 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.414 ' CE1' ' CB ' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -124.86 178.39 5.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.223 0.535 . . . . 0.0 111.963 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.805 ' C ' HD22 ' A' ' 168' ' ' LEU . 10.0 m120 -134.35 157.76 45.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.256 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.805 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.3 mm? -133.07 148.32 52.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.965 0.412 . . . . 0.0 111.599 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -134.53 149.18 50.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.103 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 148.02 33.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.011 0.434 . . . . 0.0 111.423 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -130.19 -74.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.612 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -90.08 174.73 7.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.714 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.2 m -110.02 20.22 18.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.252 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.562 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 25.2 mtpt -108.66 -49.25 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.684 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 21.6 Cg_exo -65.28 -56.75 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.269 1.98 . . . . 0.0 112.19 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.73 -156.76 21.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.492 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.602 ' HG2' HG11 ' A' ' 215' ' ' VAL . 4.0 tp-100 -102.5 136.16 42.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.849 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -132.31 152.16 51.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.745 ' HA ' HD13 ' A' ' 168' ' ' LEU . 57.3 mt -74.4 138.08 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.421 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 7.6 ptm180 -103.61 -33.09 9.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.63 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.8 t -149.73 154.66 38.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.95 0.405 . . . . 0.0 111.441 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.884 HG23 ' HB2' ' A' ' 195' ' ' ALA . 37.4 t -135.01 134.99 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 186' ' ' SER . 56.8 t0 -84.37 125.54 71.69 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.24 131.05 30.67 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.341 2.027 . . . . 0.0 112.224 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 73.69 18.71 3.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.78 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.423 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.6 m -97.75 164.36 17.65 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.6 0.238 . . . . 0.0 110.69 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 88.4 Cg_exo -44.4 -40.13 13.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.563 2.175 . . . . 0.0 112.739 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.973 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -63.67 -42.99 98.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 110.639 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.92 -50.89 37.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.966 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -49.1 -30.22 6.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.551 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.5 t -84.97 -26.1 27.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.71 27.89 3.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.175 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.973 HD13 ' HB1' ' A' ' 188' ' ' ALA . 8.3 tt -75.96 149.85 37.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.832 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.822 ' N ' HD23 ' A' ' 193' ' ' LEU . 36.7 mtt85 -134.66 129.86 35.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.794 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.884 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -57.8 150.58 19.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.163 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 73.75 3.07 4.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.766 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.756 ' OD2' HG21 ' A' ' 230' ' ' VAL . 56.0 p30 -66.86 154.84 39.94 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.274 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -89.84 110.25 21.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.767 0.318 . . . . 0.0 111.453 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.74 ' HA ' HG12 ' A' ' 230' ' ' VAL . 24.5 mm -61.99 123.79 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.939 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.88 -45.94 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.448 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.466 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 9.6 pt-20 -143.31 174.16 10.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 111.363 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.884 ' O ' HG22 ' A' ' 205' ' ' VAL . 40.4 t -152.91 106.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.016 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 18.8 t30 70.3 25.97 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.482 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.81 -21.02 35.15 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.372 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 202' ' ' VAL . 28.7 m -81.45 97.27 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.998 0.428 . . . . 0.0 111.232 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.466 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 42.4 t -87.84 98.26 11.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.7 mmt -130.17 99.83 5.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -68.58 101.9 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 113.34 25.37 4.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.543 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.406 ' HD3' ' HB3' ' A' ' 214' ' ' ASP . 0.1 OUTLIER -54.86 164.04 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.843 0.354 . . . . 0.0 111.169 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.645 ' O ' HG23 ' A' ' 215' ' ' VAL . 18.0 mm-40 -99.59 160.21 14.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.037 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.852 ' O ' HG23 ' A' ' 216' ' ' VAL . 10.8 t60 -48.76 -62.56 1.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.87 -32.6 59.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.043 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.406 ' HB3' ' HD3' ' A' ' 210' ' ' LYS . 0.9 OUTLIER -68.37 -44.95 74.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.153 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 211' ' ' GLN . 25.9 t -70.64 -40.01 76.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 212' ' ' HIS . 44.1 t -64.0 -42.83 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.336 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 58.8 m -71.57 -39.04 70.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.575 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.02 81.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.47 HG22 ' CZ ' ' A' ' 164' ' ' TYR . 32.3 mm -61.82 -31.7 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.597 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -73.1 -38.15 66.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.727 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.03 5.32 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.66 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -82.12 9.24 58.08 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.21 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -139.2 20.2 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.017 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -25.12 34.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.663 0.268 . . . . 0.0 111.252 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -116.01 115.34 25.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 110.782 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.9 m -107.32 99.23 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -76.32 98.52 4.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.149 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.455 ' CD2' HG22 ' A' ' 202' ' ' VAL . 34.5 mt -107.36 128.06 54.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.715 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.901 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.5 tp -107.6 109.66 21.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.337 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.756 HG21 ' OD2' ' A' ' 197' ' ' ASP . 29.4 m -123.62 169.93 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.199 0.523 . . . . 0.0 112.187 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.6 t -120.01 138.89 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.393 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -69.85 112.7 6.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.33 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -100.16 -24.75 14.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.03 -60.1 3.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.841 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.3 m -66.53 -28.15 68.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.624 ' CG ' HD13 ' A' ' 150' ' ' LEU . 17.3 t0 -66.96 -22.09 65.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.149 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -102.6 -33.08 9.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.829 0.347 . . . . 0.0 111.103 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -63.43 -62.48 1.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -28.46 67.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.71 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -120.5 131.8 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.396 . . . . 0.0 110.989 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.71 ' N ' HD13 ' A' ' 144' ' ' ILE . 24.8 t70 -45.0 139.25 3.98 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.67 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.85 -56.27 2.76 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.74 2.293 . . . . 0.0 112.223 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.938 ' O ' HG23 ' A' ' 148' ' ' THR . 39.6 t80 -82.55 -61.13 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.857 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.938 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.0 p 158.32 150.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.827 0.851 . . . . 0.0 110.649 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.437 ' HG3' ' CB ' ' A' ' 145' ' ' ASP . 8.4 mtt -125.7 -52.86 1.57 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.55 HD12 ' CG1' ' A' ' 231' ' ' VAL . 13.4 tp -122.31 -10.02 8.53 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.774 ' HD3' HG21 ' A' ' 148' ' ' THR . 5.5 ptm180 -51.53 145.64 14.63 Favored Pre-proline 0 N--CA 1.465 0.288 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.856 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 137.87 20.6 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.439 2.093 . . . . 0.0 112.172 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 230' ' ' VAL . 0.8 OUTLIER -93.7 139.37 30.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.786 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 229' ' ' LEU . 14.5 tp -87.62 123.0 32.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 50.5 t -122.33 127.55 49.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.9 m -127.28 103.7 7.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.502 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.629 ' HE1' HD12 ' A' ' 228' ' ' LEU . 2.0 ptt? -110.64 145.04 38.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.02 0.438 . . . . 0.0 111.259 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -104.32 119.36 38.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.578 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.414 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 1.5 tppt? -47.83 -78.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.88 -159.85 26.78 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.228 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.56 0.16 10.24 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.582 2.188 . . . . 0.0 112.91 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 86.3 p -104.0 -30.27 10.39 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.414 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 93.12 -140.3 15.0 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.079 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 166' ' ' PHE . 7.8 m-85 -110.38 -47.17 3.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.931 0.396 . . . . 0.0 110.762 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.52 24.13 51.54 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.646 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 164' ' ' TYR . 8.5 p90 -124.81 172.87 8.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.216 0.532 . . . . 0.0 111.827 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.695 ' C ' HD22 ' A' ' 168' ' ' LEU . 10.0 m120 -137.95 152.5 49.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.96 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.914 HD12 ' HG3' ' A' ' 177' ' ' GLN . 4.2 mm? -129.78 146.13 51.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.246 0.546 . . . . 0.0 112.299 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.496 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 2.8 p80 -143.59 133.72 24.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.721 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.5 t -129.46 155.5 45.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.033 0.444 . . . . 0.0 111.605 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -130.05 -64.39 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.474 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -90.06 162.52 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -110.12 22.5 15.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.348 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.616 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 52.8 mttm -105.56 -50.22 0.11 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.608 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.616 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 9.0 Cg_exo -72.13 -57.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.426 2.084 . . . . 0.0 112.144 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 145.06 -144.22 12.87 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.369 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.914 ' HG3' HD12 ' A' ' 168' ' ' LEU . 7.0 tp-100 -100.76 150.29 22.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.753 0.311 . . . . 0.0 110.857 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.452 ' CZ ' ' NH1' ' A' ' 198' ' ' ARG . 3.6 m-85 -131.06 138.12 49.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.781 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.81 HD13 HD21 ' A' ' 193' ' ' LEU . 86.9 mt -71.7 133.57 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 110.271 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.496 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 4.5 ptm180 -101.54 -30.88 11.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.723 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.2 t -152.78 145.43 24.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.469 . . . . 0.0 111.731 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 195' ' ' ALA . 18.0 t -128.64 132.31 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.434 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -84.1 120.23 74.44 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.106 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.45 133.44 49.01 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.415 2.076 . . . . 0.0 112.359 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 71.81 15.25 5.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.814 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 44.8 m -97.43 161.8 24.75 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.623 0.249 . . . . 0.0 110.64 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 99.6 Cg_exo -43.99 -40.32 11.78 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.571 2.18 . . . . 0.0 112.753 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.839 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -62.41 -44.3 96.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.031 0.444 . . . . 0.0 110.518 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -70.37 -52.27 23.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.027 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.51 -29.39 1.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.609 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.5 t -83.78 -31.98 25.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.959 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.49 7.38 6.32 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.984 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.839 HD13 ' HB1' ' A' ' 188' ' ' ALA . 7.5 tt -57.17 146.45 27.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.744 0.306 . . . . 0.0 110.85 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.703 ' N ' HD23 ' A' ' 193' ' ' LEU . 66.3 mtt-85 -136.54 137.99 40.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -63.46 149.64 45.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.299 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 75.31 2.61 3.91 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.099 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.757 ' OD2' HG21 ' A' ' 230' ' ' VAL . 52.6 p30 -73.1 153.98 40.58 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.435 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.452 ' NH1' ' CZ ' ' A' ' 178' ' ' PHE . 1.3 mmp_? -89.6 115.26 26.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 0.0 111.154 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.88 HD13 HG12 ' A' ' 230' ' ' VAL . 33.8 mm -65.01 125.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.15 -44.29 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.492 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.65 ' OE1' HD22 ' A' ' 229' ' ' LEU . 6.2 pt-20 -144.34 173.35 11.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.024 0.44 . . . . 0.0 111.623 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 205' ' ' VAL . 43.4 t -151.52 107.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.861 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.1 t30 70.27 24.35 4.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.322 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.76 -20.14 37.16 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.343 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 202' ' ' VAL . 36.0 m -82.48 99.19 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.99 0.424 . . . . 0.0 111.335 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.443 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 45.3 t -84.92 100.62 11.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.986 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.421 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 20.4 mmt -130.13 99.81 5.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -69.73 102.42 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.761 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.81 20.93 4.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.729 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.56 ' HA ' ' CE ' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -54.82 150.67 9.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.918 0.389 . . . . 0.0 111.076 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 215' ' ' VAL . 4.8 mm-40 -94.56 160.25 14.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.1 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.841 ' O ' HG23 ' A' ' 216' ' ' VAL . 85.0 t60 -47.15 -61.64 1.79 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.12 -30.55 60.9 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.151 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -44.26 67.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.407 . . . . 0.0 110.331 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 177' ' ' GLN . 39.2 t -71.96 -38.95 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.312 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 212' ' ' HIS . 46.3 t -66.4 -41.2 88.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.592 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 64.6 m -72.55 -34.64 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.696 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.1 83.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.057 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 32.0 mm -59.55 -41.98 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 ttp-105 -64.21 -41.68 96.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.724 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.06 5.32 30.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.712 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.64 19.21 38.1 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.046 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -145.08 9.61 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.941 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.63 -25.15 28.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.725 0.298 . . . . 0.0 111.158 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -103.98 114.99 29.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.59 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 4.5 m -111.09 108.05 17.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.345 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -91.12 99.89 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.403 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.713 HD21 HG13 ' A' ' 202' ' ' VAL . 12.4 mt -107.06 132.21 53.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.044 0.45 . . . . 0.0 111.717 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.671 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.3 tp -116.46 109.41 17.26 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.88 HG12 HD13 ' A' ' 199' ' ' ILE . 34.3 m -113.86 177.69 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.021 0.439 . . . . 0.0 112.061 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.55 ' CG1' HD12 ' A' ' 150' ' ' LEU . 5.2 t -124.48 144.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.778 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -74.1 110.91 8.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.375 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 -100.07 -25.28 14.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.665 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -56.63 -60.02 4.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.738 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 23.0 m -58.35 -32.47 68.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.455 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.84 -31.89 68.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.874 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.84 -30.14 11.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -57.65 -58.9 6.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.02 -29.97 68.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.917 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.576 -0.209 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.906 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -135.11 147.76 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.986 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.906 ' N ' HD13 ' A' ' 144' ' ' ILE . 25.7 t70 -44.73 140.84 3.14 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.382 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.5 -63.79 0.26 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.911 2.407 . . . . 0.0 112.172 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.996 ' O ' HG23 ' A' ' 148' ' ' THR . 19.3 t80 -88.03 -61.81 1.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.949 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.996 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.2 p 158.37 132.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.338 0.655 . . . . 0.0 110.818 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.5 mtm -125.39 -57.42 1.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.966 0.413 . . . . 0.0 111.159 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.64 HD12 HG11 ' A' ' 231' ' ' VAL . 20.8 tp -109.88 -4.12 16.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.563 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.461 ' C ' ' O ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -24.73 119.34 0.21 Allowed Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.301 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.64 142.53 14.44 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.508 2.139 . . . . 0.0 112.41 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.458 ' O ' HD12 ' A' ' 229' ' ' LEU . 16.1 mtm105 -110.38 153.92 24.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.708 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.636 ' HA ' HD12 ' A' ' 229' ' ' LEU . 25.5 tp -104.15 133.1 49.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.028 0.442 . . . . 0.0 111.114 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.488 ' SG ' HD12 ' A' ' 193' ' ' LEU . 38.4 t -129.99 138.55 50.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.736 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 23.0 m -140.09 101.21 4.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.781 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.704 ' HE1' HD11 ' A' ' 228' ' ' LEU . 3.3 ptt? -109.91 135.8 50.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.954 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -95.12 135.61 36.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.011 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.453 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 18.3 tptp -73.97 -78.03 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.82 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.89 -159.94 5.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.198 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.02 0.17 10.22 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.614 2.209 . . . . 0.0 112.519 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.8 p -103.07 -30.12 10.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.592 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.453 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 95.46 -148.56 19.03 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.398 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.607 ' OH ' HG22 ' A' ' 219' ' ' ILE . 31.7 m-85 -97.73 -44.16 6.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.922 0.392 . . . . 0.0 110.77 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 183' ' ' ASP . . . 88.68 14.83 60.73 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.95 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.584 ' CE1' HD21 ' A' ' 168' ' ' LEU . 0.0 OUTLIER -124.86 -177.46 3.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.139 0.495 . . . . 0.0 111.879 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.813 ' C ' HD22 ' A' ' 168' ' ' LEU . 9.8 m120 -129.7 161.76 29.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.888 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.813 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.8 mm? -135.67 134.63 39.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.22 0.533 . . . . 0.0 112.276 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 6.6 p-80 -134.8 165.29 25.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.808 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.1 t -128.2 142.13 51.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.513 0.673 . . . . 0.0 112.504 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 178' ' ' PHE . 16.1 t0 -105.6 -40.22 5.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.386 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 14.3 mmtm -82.97 175.02 10.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.854 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.7 m -104.4 -26.97 12.22 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.912 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.766 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 32.0 mtmm -122.21 -58.64 0.03 OUTLIER Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.766 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 7.0 Cg_exo -81.28 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.837 2.358 . . . . 0.0 115.702 -175.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -39.07 145.0 0.24 Allowed Glycine 0 N--CA 1.453 -0.21 0 N-CA-C 116.532 1.373 . . . . 0.0 116.532 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.84 ' HG2' HG11 ' A' ' 215' ' ' VAL . 2.0 tp-100 -138.35 127.13 23.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 112.867 -1.667 . . . . 0.0 107.159 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.638 ' CD2' ' NH2' ' A' ' 198' ' ' ARG . 0.2 OUTLIER -134.93 135.65 41.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.727 HD12 ' OD2' ' A' ' 197' ' ' ASP . 50.4 mt -80.88 129.91 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' A' ' 169' ' ' HIS . 19.6 ptt180 -95.99 -33.27 12.21 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.0 t -154.74 157.69 38.4 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 195' ' ' ALA . 22.1 t -133.9 139.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.503 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 165' ' ' GLY . 47.1 t0 -87.35 122.44 70.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.176 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 31.2 Cg_exo -61.4 133.87 48.55 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.28 1.987 . . . . 0.0 111.973 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 75.26 14.85 2.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.625 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 46.6 m -100.62 162.97 19.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.637 0.255 . . . . 0.0 110.532 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 82.4 Cg_exo -45.87 -40.21 19.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.469 2.112 . . . . 0.0 112.797 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.643 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -65.07 -42.53 94.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.07 0.462 . . . . 0.0 110.475 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -70.42 -51.58 28.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.022 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.2 -24.76 11.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.497 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.8 t -85.06 -29.14 25.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 0.0 110.969 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.13 8.72 11.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.506 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -60.41 150.86 29.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.694 0.283 . . . . 0.0 110.557 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.887 ' N ' HD23 ' A' ' 193' ' ' LEU . 48.1 mtt180 -142.87 129.69 20.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.712 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -55.19 152.26 8.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 35.6 mt-30 78.31 6.73 2.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.851 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.727 ' OD2' HD12 ' A' ' 179' ' ' ILE . 40.7 p30 -78.11 152.62 32.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.636 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.638 ' NH2' ' CD2' ' A' ' 178' ' ' PHE . 7.9 mmp_? -85.78 109.1 18.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.652 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.87 ' HA ' HG12 ' A' ' 230' ' ' VAL . 39.1 mm -68.64 113.14 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.809 0.337 . . . . 0.0 110.441 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.0 t -105.72 -46.09 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.458 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 6.2 pt-20 -136.69 171.68 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 0.0 111.912 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 205' ' ' VAL . 17.9 t -147.84 113.09 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.553 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 50.6 t30 70.04 20.66 6.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.934 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 102.53 -15.41 55.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.559 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 202' ' ' VAL . 27.1 m -83.61 91.31 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 117.229 0.514 . . . . 0.0 111.537 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 51.6 t -82.89 109.59 17.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.737 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.444 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 20.5 mmt -130.5 99.89 5.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -74.9 103.57 5.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.77 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 175' ' ' PRO . . . 122.16 10.38 6.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.939 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.444 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 9.1 mmtt -56.82 147.61 22.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.9 0.381 . . . . 0.0 111.258 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.459 ' O ' HG23 ' A' ' 215' ' ' VAL . 0.6 OUTLIER -79.53 160.51 26.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.862 ' O ' HG23 ' A' ' 216' ' ' VAL . 9.3 t-160 -47.84 -54.3 12.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.668 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.2 -33.02 85.77 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.802 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.52 -47.21 82.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.849 0.357 . . . . 0.0 110.281 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.84 HG11 ' HG2' ' A' ' 177' ' ' GLN . 28.2 t -66.55 -38.41 81.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.181 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 212' ' ' HIS . 57.3 t -68.24 -43.3 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.496 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 52.4 m -64.58 -37.64 88.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.409 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.499 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -56.0 -44.3 78.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.898 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.607 HG22 ' OH ' ' A' ' 164' ' ' TYR . 34.0 mm -61.57 -36.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.696 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 47.7 ttp85 -72.4 -33.98 67.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.04 5.39 29.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.67 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -84.55 12.61 55.49 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.187 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -140.77 17.35 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.88 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.49 -25.18 36.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 111.154 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -115.62 114.87 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.658 HG22 HD21 ' A' ' 228' ' ' LEU . 3.9 m -107.82 94.97 5.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -81.27 94.76 6.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.464 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.887 ' CD2' HG13 ' A' ' 202' ' ' VAL . 19.2 mt -101.27 141.51 34.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.657 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.636 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.1 tp -117.18 109.66 17.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.87 HG12 ' HA ' ' A' ' 199' ' ' ILE . 26.8 m -116.96 178.35 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.64 HG11 HD12 ' A' ' 150' ' ' LEU . 4.3 t -119.69 165.77 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.495 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.484 ' N ' HG12 ' A' ' 231' ' ' VAL . 66.6 t0 -93.91 109.22 20.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.992 0.425 . . . . 0.0 112.016 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.455 ' HD3' ' NH1' ' A' ' 198' ' ' ARG . 24.9 ttp180 -100.94 -21.0 15.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.424 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -44.96 -56.89 4.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.229 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.3 m -69.21 -30.98 69.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.554 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.6 -25.96 66.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.657 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -109.99 -29.6 8.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.988 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -53.5 -52.52 59.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.946 0.403 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -59.78 -31.09 69.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.69 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.875 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.798 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.1 OUTLIER -69.98 133.61 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.385 . . . . 0.0 110.924 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.798 ' N ' HD13 ' A' ' 144' ' ' ILE . 7.1 t70 -66.53 137.26 95.15 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.424 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.58 -58.03 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.601 2.2 . . . . 0.0 112.77 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.755 ' O ' HG23 ' A' ' 148' ' ' THR . 13.9 t80 -106.7 -60.71 1.63 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.665 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.9 p -168.59 158.79 9.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 22.7 mtm -109.67 -33.34 6.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.491 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.0 tp -74.39 -7.95 54.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.142 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.418 ' HB2' ' HD2' ' A' ' 152' ' ' PRO . 9.9 ptm180 -42.42 159.98 0.19 Allowed Pre-proline 0 CA--C 1.527 0.086 0 CA-C-O 120.899 0.38 . . . . 0.0 111.448 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.736 ' HA ' HG22 ' A' ' 231' ' ' VAL . 19.7 Cg_endo -60.78 140.9 93.08 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.692 2.261 . . . . 0.0 112.422 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.582 ' O ' HD12 ' A' ' 229' ' ' LEU . 42.5 mtm180 -108.41 141.68 39.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.991 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 37.2 tp -76.27 132.61 39.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.222 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 6.1 t -126.93 140.16 52.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.265 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.428 ' N ' ' OG ' ' A' ' 191' ' ' SER . 4.3 m -130.03 104.61 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.655 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -109.88 141.49 42.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.007 0.432 . . . . 0.0 111.379 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -113.09 115.93 29.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.401 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.427 ' HD3' ' CE1' ' A' ' 164' ' ' TYR . 7.6 tptp -61.76 -88.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.804 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.68 -150.15 18.16 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.341 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.9 0.06 10.3 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.68 2.253 . . . . 0.0 112.627 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.7 p -92.31 -30.33 15.89 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.321 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.04 -158.65 21.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.471 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.463 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 30.4 m-85 -87.93 -50.71 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.967 0.413 . . . . 0.0 110.904 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.53 14.91 33.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.968 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.821 ' CE2' HD21 ' A' ' 168' ' ' LEU . 7.5 p90 -163.72 -179.42 6.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.168 0.509 . . . . 0.0 111.585 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.77 ' C ' HD22 ' A' ' 168' ' ' LEU . 2.9 m120 -127.72 165.06 20.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.551 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.821 HD21 ' CE2' ' A' ' 166' ' ' PHE . 3.2 mm? -134.37 137.65 44.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 111.275 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.456 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -134.82 153.43 52.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.042 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.0 t -155.25 158.09 38.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.768 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -130.09 -77.23 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.407 ' HB2' ' CD ' ' A' ' 175' ' ' PRO . 3.7 mmpt? -81.05 175.14 10.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.666 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -90.41 12.25 19.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.369 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.482 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 26.7 mtmm -105.65 -47.17 0.13 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.904 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 76.9 Cg_exo -51.27 -63.56 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.145 1.897 . . . . 0.0 112.462 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.08 -141.15 16.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.434 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.716 ' CB ' HG21 ' A' ' 215' ' ' VAL . 3.3 tp60 -105.31 104.88 14.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.681 0.277 . . . . 0.0 110.972 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.512 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 10.3 m-30 -115.64 148.82 39.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.717 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.743 HD13 HD21 ' A' ' 193' ' ' LEU . 65.0 mt -76.08 133.73 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.583 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.456 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 8.1 ptt180 -104.97 -31.07 9.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.363 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.2 t -150.32 155.67 40.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 111.241 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.955 HG23 ' HB2' ' A' ' 195' ' ' ALA . 24.5 t -132.89 141.65 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -94.4 120.92 64.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.915 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.55 134.17 49.7 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.36 2.04 . . . . 0.0 112.362 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 73.09 14.89 4.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.839 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.4 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 36.4 m -94.78 162.51 25.15 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.565 0.221 . . . . 0.0 110.503 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 75.1 Cg_exo -48.22 -40.16 34.82 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.367 2.045 . . . . 0.0 112.4 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.94 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -61.79 -44.61 96.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.495 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -65.28 -55.41 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.017 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.19 -25.47 61.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 156' ' ' THR . 26.4 t -78.73 -22.53 46.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 106.89 28.63 4.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.016 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.94 HD13 ' HB1' ' A' ' 188' ' ' ALA . 7.3 tt -85.4 145.18 27.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 0.0 110.935 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.667 ' N ' HD23 ' A' ' 193' ' ' LEU . 5.3 mtt-85 -131.53 131.64 43.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.955 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -57.37 145.64 31.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.319 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' A' ' 233' ' ' ARG . 56.5 mt-30 74.81 -0.22 3.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.979 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.662 ' CG ' HD12 ' A' ' 179' ' ' ILE . 49.2 p30 -63.63 158.2 21.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.765 0.317 . . . . 0.0 110.672 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.512 ' HD2' ' CE1' ' A' ' 178' ' ' PHE . 1.8 mmm180 -94.95 112.84 24.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.344 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.794 HD13 HG12 ' A' ' 230' ' ' VAL . 32.7 mm -65.08 117.21 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.853 0.359 . . . . 0.0 110.586 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.557 ' CG1' HD23 ' A' ' 229' ' ' LEU . 23.4 t -97.61 -46.64 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.61 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 5.2 pt-20 -139.68 176.03 9.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.069 0.461 . . . . 0.0 111.425 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.893 ' O ' HG22 ' A' ' 205' ' ' VAL . 33.8 t -153.18 105.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.773 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.7 t30 70.35 25.09 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.395 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.47 -19.85 38.56 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.451 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 202' ' ' VAL . 32.0 m -82.8 98.16 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.992 0.425 . . . . 0.0 111.319 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.438 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 45.8 t -84.93 102.47 13.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.034 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.412 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 16.2 mmt -130.14 99.86 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.938 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -69.55 102.61 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.48 22.43 4.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.71 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.412 ' HG2' ' HB2' ' A' ' 207' ' ' MET . 0.0 OUTLIER -54.93 157.79 3.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.533 ' O ' HG23 ' A' ' 215' ' ' VAL . 0.8 OUTLIER -94.87 160.12 14.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.12 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.862 ' O ' HG23 ' A' ' 216' ' ' VAL . 7.0 t-160 -50.09 -60.72 2.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.9 -33.58 84.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.236 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.64 -48.62 80.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 110.26 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.716 HG21 ' CB ' ' A' ' 177' ' ' GLN . 23.0 t -68.01 -40.42 83.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.089 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 212' ' ' HIS . 47.0 t -62.4 -44.81 99.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.281 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 75.0 m -66.84 -39.05 87.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.415 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.29 80.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.874 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 226' ' ' THR . 36.5 mm -62.68 -36.43 75.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.653 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -46.93 84.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.536 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.0 5.08 30.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.534 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -92.37 20.18 45.52 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.837 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.26 -143.33 12.47 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.893 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -88.71 -22.9 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.674 0.273 . . . . 0.0 111.342 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -108.42 115.73 30.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.753 HG21 ' CD1' ' A' ' 219' ' ' ILE . 28.0 m -120.19 114.19 21.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.452 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -86.04 99.04 11.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.171 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.711 HD23 ' HA ' ' A' ' 202' ' ' VAL . 23.0 mt -105.39 140.75 38.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.046 0.451 . . . . 0.0 111.961 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 153' ' ' ARG . 13.7 tp -115.55 109.47 17.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.467 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.794 HG12 HD13 ' A' ' 199' ' ' ILE . 33.3 m -116.63 169.23 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.999 0.428 . . . . 0.0 111.736 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 152' ' ' PRO . 2.6 t -135.62 152.94 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -69.86 109.66 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.77 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 237' ' ' GLU . 26.8 ttp180 -100.4 -18.18 16.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.247 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 238' ' ' PHE . 76.1 mt-10 -49.41 -55.23 13.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.589 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.0 m -90.12 -21.92 22.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.861 0.362 . . . . 0.0 111.213 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -53.8 -54.89 31.97 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 233' ' ' ARG . 5.0 pt-20 -110.21 -41.85 4.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.454 ' CB ' ' O ' ' A' ' 234' ' ' GLU . 4.5 t80 -39.98 -60.38 1.04 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -28.92 65.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.357 . . . . 0.0 110.832 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.82 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -94.09 144.37 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.84 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.82 ' N ' HD13 ' A' ' 144' ' ' ILE . 4.1 t0 -48.44 104.26 0.41 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.251 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -80.32 -67.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.19 1.927 . . . . 0.0 112.043 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -115.83 -43.76 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.658 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -119.91 162.34 19.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.431 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 35.5 mtm -121.37 -19.84 6.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.62 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.787 HD11 ' O ' ' A' ' 232' ' ' ASP . 10.0 tp -64.92 -17.59 64.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.617 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 150' ' ' LEU . 6.3 ptp180 -28.53 143.97 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 O-C-N 123.355 0.409 . . . . 0.0 112.026 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.677 ' HA ' HG22 ' A' ' 231' ' ' VAL . 7.6 Cg_endo -50.45 151.95 9.39 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.063 2.509 . . . . 0.0 112.957 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -127.71 140.94 51.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.575 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.818 ' HA ' HD12 ' A' ' 229' ' ' LEU . 16.6 tp -87.16 132.93 33.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.278 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 39.4 t -130.08 140.1 50.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.757 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -135.1 106.39 6.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.707 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 1.066 ' HE1' HD12 ' A' ' 228' ' ' LEU . 12.3 ptp -113.78 143.93 43.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 0.0 111.171 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -102.22 124.3 47.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.792 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 224' ' ' ASP . 6.6 tptm -55.76 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.37 -150.66 40.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.403 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.74 -16.68 14.54 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.72 2.28 . . . . 0.0 112.596 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.5 p -93.12 -30.15 15.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.174 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.435 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 80.05 -131.68 10.73 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.471 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CB ' ' CE1' ' A' ' 166' ' ' PHE . 3.6 m-85 -105.94 -50.36 3.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 110.433 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.06 20.83 52.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.29 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.497 ' CE1' ' CB ' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -124.86 179.11 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.125 0.488 . . . . 0.0 111.728 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.807 ' C ' HD22 ' A' ' 168' ' ' LEU . 8.7 m120 -129.87 159.2 37.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.877 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.807 HD22 ' C ' ' A' ' 167' ' ' ASN . 3.1 mm? -136.32 136.02 39.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.191 0.52 . . . . 0.0 112.066 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -134.53 165.26 25.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.5 178.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.5 t -140.69 148.0 40.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.073 0.463 . . . . 0.0 111.789 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -130.33 -67.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.527 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -90.05 164.63 14.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.733 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 67.0 m -110.15 22.33 15.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.472 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.733 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 25.1 mtpp -116.96 -56.25 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.838 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 57.4 Cg_exo -53.62 -56.23 2.85 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.139 1.892 . . . . 0.0 112.536 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 137.92 -143.7 14.78 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.358 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.869 ' HB2' HG21 ' A' ' 215' ' ' VAL . 10.3 tp-100 -84.22 142.48 30.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 110.776 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.532 ' CD2' ' CZ ' ' A' ' 198' ' ' ARG . 1.7 m-85 -120.98 149.67 42.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.84 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.53 HD12 ' OD1' ' A' ' 197' ' ' ASP . 9.9 mt -98.46 130.91 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.1 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.448 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 24.2 ptt180 -100.77 -30.57 11.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.5 t -157.73 151.24 23.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.1 0.476 . . . . 0.0 112.009 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.775 HG23 ' HB2' ' A' ' 195' ' ' ALA . 54.6 t -131.85 141.09 46.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.456 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 186' ' ' SER . 56.8 t0 -84.95 125.33 70.92 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.111 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.18 127.53 19.47 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.392 2.061 . . . . 0.0 112.161 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 185' ' ' ASP . 13.7 t0 74.4 23.49 1.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 5.5 m -102.56 164.63 15.27 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.606 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 81.1 Cg_exo -44.85 -40.28 14.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.612 2.208 . . . . 0.0 112.747 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.24 -43.01 92.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.077 0.465 . . . . 0.0 110.407 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -70.56 -51.81 25.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.038 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -49.28 -27.4 3.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.644 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.3 t -85.03 -31.54 23.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 111.056 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 121.19 21.33 3.13 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.991 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.862 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -83.09 151.59 25.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.613 0.244 . . . . 0.0 110.573 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.862 ' N ' HD23 ' A' ' 193' ' ' LEU . 30.5 mtp180 -145.57 129.72 17.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.266 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.775 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -52.15 160.78 0.71 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.703 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.623 ' HB3' ' HG3' ' A' ' 234' ' ' GLU . 54.9 mt-30 82.43 -4.82 1.4 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.092 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.689 ' OD2' HG21 ' A' ' 230' ' ' VAL . 38.3 p30 -86.13 165.2 16.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 110.593 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.532 ' CZ ' ' CD2' ' A' ' 178' ' ' PHE . 15.5 mmp_? -101.55 125.12 48.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 111.682 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.767 ' HA ' HG12 ' A' ' 230' ' ' VAL . 26.0 mm -69.43 108.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.854 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.18 -50.11 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.367 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.441 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 11.2 pt-20 -136.22 173.92 11.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.98 0.419 . . . . 0.0 111.139 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.873 ' O ' HG22 ' A' ' 205' ' ' VAL . 40.1 t -151.48 107.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.929 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 53.5 t30 70.25 25.22 4.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.437 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.55 -18.67 43.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.5 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 202' ' ' VAL . 36.0 m -83.74 97.87 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.008 0.432 . . . . 0.0 111.191 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 48.5 t -85.91 101.66 13.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.061 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.427 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 96.6 mmm -130.11 99.66 5.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.856 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -70.89 105.34 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.27 17.85 5.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.743 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.427 ' HG2' ' HB2' ' A' ' 207' ' ' MET . 0.7 OUTLIER -54.94 150.15 10.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.952 0.406 . . . . 0.0 111.123 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.509 ' O ' HG23 ' A' ' 215' ' ' VAL . 8.1 mm-40 -91.53 160.43 15.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.058 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.872 ' O ' HG23 ' A' ' 216' ' ' VAL . 32.4 t-80 -47.81 -64.58 0.75 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -55.67 -33.79 59.9 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.108 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.27 -47.13 83.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.191 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.869 HG21 ' HB2' ' A' ' 177' ' ' GLN . 23.3 t -71.94 -38.95 66.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.116 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 212' ' ' HIS . 48.6 t -62.44 -41.63 92.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.193 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 32.4 m -75.05 -40.82 60.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.419 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.26 -46.79 87.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.694 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.479 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 23.3 mm -61.23 -34.08 59.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.534 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -73.89 -36.89 64.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.382 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.75 5.53 28.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.674 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -83.29 16.34 29.65 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.171 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.29 -135.89 26.96 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.055 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.2 m-20 -92.21 -25.08 18.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.668 0.27 . . . . 0.0 111.38 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -102.34 117.94 35.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.592 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 5.7 m -114.69 98.45 6.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.485 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -88.73 97.71 11.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.056 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 1.066 HD12 ' HE1' ' A' ' 157' ' ' MET . 54.3 mt -105.38 138.89 40.85 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 154' ' ' LEU . 13.6 tp -117.8 109.91 17.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.082 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 199' ' ' ILE . 35.4 m -124.43 170.76 14.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 152' ' ' PRO . 2.6 t -141.33 135.44 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.484 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.787 ' O ' HD11 ' A' ' 150' ' ' LEU . 22.3 t0 -72.55 119.87 17.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.941 0.401 . . . . 0.0 111.408 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.445 ' HB3' ' NH1' ' A' ' 198' ' ' ARG . 0.0 OUTLIER -100.82 -25.35 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.81 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.623 ' HG3' ' HB3' ' A' ' 196' ' ' GLN . 27.8 mt-10 -78.66 -44.25 24.2 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.366 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.696 HG23 ' HB3' ' A' ' 239' ' ' PHE . 6.4 m -59.81 -24.33 64.07 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.457 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . 23.4 t0 -63.72 -37.37 87.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.393 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -110.65 -50.86 2.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.805 0.336 . . . . 0.0 111.729 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -66.95 -70.82 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.698 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.696 ' HB3' HG23 ' A' ' 235' ' ' THR . 0.8 OUTLIER -59.94 -17.13 35.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.497 -179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 236' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.02 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.915 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -113.74 141.48 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.666 0.269 . . . . 0.0 110.794 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.915 ' N ' HD13 ' A' ' 144' ' ' ILE . 16.0 t70 -47.28 137.77 8.48 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.625 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.93 -61.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.492 2.128 . . . . 0.0 113.318 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.021 ' O ' HG23 ' A' ' 148' ' ' THR . 43.5 t80 -89.52 -60.97 1.8 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 1.021 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.3 p 161.5 129.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.217 0.607 . . . . 0.0 110.659 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 41.7 mtt -125.6 -57.94 1.44 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.925 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.4 tp -121.46 -23.58 5.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.651 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.776 ' CD ' HG22 ' A' ' 148' ' ' THR . 4.8 ptp180 -49.04 146.47 5.69 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.706 0.288 . . . . 0.0 111.227 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.627 ' HB3' HG22 ' A' ' 231' ' ' VAL . 73.9 Cg_endo -75.24 170.77 19.62 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.674 2.249 . . . . 0.0 112.869 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 15.5 mtm105 -135.39 145.13 47.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.611 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.916 ' HA ' HD12 ' A' ' 229' ' ' LEU . 59.4 tp -85.76 135.02 33.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.37 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.7 t -130.01 140.07 50.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.814 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -131.53 108.34 9.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.65 ' CE ' HD12 ' A' ' 228' ' ' LEU . 6.7 ptp -119.85 142.1 48.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -102.73 135.63 44.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.085 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.459 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 18.2 tptt -70.14 -78.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.785 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.87 -159.89 5.62 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.266 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.62 0.21 10.2 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.597 2.198 . . . . 0.0 112.654 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.0 p -101.03 -30.24 11.72 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.459 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 89.41 -147.79 19.7 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.26 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.508 ' HB3' ' CE2' ' A' ' 166' ' ' PHE . 13.8 m-85 -110.19 -43.93 3.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.991 0.424 . . . . 0.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.94 40.49 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.507 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 164' ' ' TYR . 4.2 p90 -124.6 174.08 8.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 117.219 0.509 . . . . 0.0 111.714 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.731 ' O ' HG23 ' A' ' 179' ' ' ILE . 10.0 m120 -134.98 152.84 52.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.319 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 179' ' ' ILE . 4.1 mm? -127.49 142.8 51.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.011 0.434 . . . . 0.0 111.838 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.48 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 1.5 p80 -142.62 144.39 32.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.235 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.9 t -144.05 160.48 40.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.924 0.392 . . . . 0.0 111.273 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -126.39 -71.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -90.09 168.54 11.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.7 m -110.0 21.19 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.233 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.543 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 30.7 mtmm -104.79 -49.1 0.13 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.492 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.543 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 13.8 Cg_exo -69.39 -66.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.402 2.068 . . . . 0.0 112.154 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.48 -159.45 28.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.609 ' HG3' HD12 ' A' ' 168' ' ' LEU . 8.2 tp-100 -105.52 144.32 32.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.866 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.426 ' CE1' ' HD3' ' A' ' 198' ' ' ARG . 8.7 m-85 -135.8 151.29 49.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.804 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 167' ' ' ASN . 70.0 mt -72.96 138.98 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.549 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.48 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 5.8 ptt180 -99.31 -34.13 10.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.583 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.416 ' N ' ' HG3' ' A' ' 180' ' ' ARG . 23.0 t -151.73 152.86 33.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.051 0.453 . . . . 0.0 111.512 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 195' ' ' ALA . 26.8 t -131.17 135.48 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.665 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 186' ' ' SER . 59.0 t0 -81.66 120.72 78.56 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.949 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.94 126.94 20.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.351 2.034 . . . . 0.0 112.38 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 t70 74.25 22.94 2.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.741 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 183' ' ' ASP . 5.6 m -100.86 162.61 20.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.594 0.235 . . . . 0.0 110.638 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -43.49 -40.34 10.16 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.673 2.249 . . . . 0.0 112.721 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.891 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -66.11 -42.61 89.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.471 . . . . 0.0 110.31 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.54 -51.68 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.887 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -48.12 -29.68 3.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.541 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.6 t -83.5 -30.05 27.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 120.7 29.5 1.54 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.53 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.891 HD13 ' HB1' ' A' ' 188' ' ' ALA . 8.2 tt -84.2 149.22 26.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.74 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.816 ' N ' HD23 ' A' ' 193' ' ' LEU . 5.4 mtt-85 -141.43 135.93 30.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.665 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -56.08 153.37 9.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.343 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 70.97 7.87 6.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.774 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.622 ' OD2' HD12 ' A' ' 179' ' ' ILE . 58.8 p30 -74.02 150.05 40.9 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.426 ' HD3' ' CE1' ' A' ' 178' ' ' PHE . 1.4 mmp_? -89.87 113.43 25.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 111.231 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.778 HD13 HG12 ' A' ' 230' ' ' VAL . 27.8 mm -68.27 125.73 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.75 -44.52 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.499 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.459 ' HG2' ' CB ' ' A' ' 229' ' ' LEU . 10.1 pt-20 -143.61 176.85 8.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 111.389 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.89 ' O ' HG22 ' A' ' 205' ' ' VAL . 36.0 t -155.65 107.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.946 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 12.5 t30 70.19 24.27 4.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.45 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.79 -19.16 39.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.369 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.89 HG22 ' O ' ' A' ' 202' ' ' VAL . 32.7 m -81.87 95.69 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.015 0.436 . . . . 0.0 111.272 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.436 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 50.2 t -86.42 99.17 11.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.938 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.424 ' HB2' ' HG2' ' A' ' 210' ' ' LYS . 17.6 mmt -130.14 99.83 5.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -68.24 103.91 1.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.748 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.61 21.02 4.83 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.583 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 210' ' ' LYS . 0.0 OUTLIER -54.78 142.18 29.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.972 0.415 . . . . 0.0 111.138 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.512 ' O ' HG23 ' A' ' 215' ' ' VAL . 7.4 mm-40 -85.84 160.39 19.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.854 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.7 t-80 -45.55 -60.91 1.92 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.052 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.02 -31.14 64.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.981 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -43.71 67.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.939 0.4 . . . . 0.0 110.249 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 211' ' ' GLN . 40.5 t -72.14 -39.13 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.286 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 212' ' ' HIS . 49.3 t -65.92 -41.25 89.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.48 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 73.1 m -70.06 -38.47 75.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.566 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.469 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -55.49 -45.15 77.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.004 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.456 ' CG2' ' CZ ' ' A' ' 164' ' ' TYR . 30.1 mm -63.84 -36.43 76.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.752 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -65.43 -41.32 93.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.649 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.51 5.2 28.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -81.89 5.56 70.08 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.073 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.16 -140.13 18.53 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.852 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.21 -25.18 34.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.71 0.291 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -115.6 114.86 25.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.524 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.503 HG22 ' CD2' ' A' ' 228' ' ' LEU . 17.3 m -111.6 96.48 6.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.445 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -73.58 97.07 2.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.009 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.887 HD21 HG13 ' A' ' 202' ' ' VAL . 73.6 mt -105.33 131.59 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.978 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 154' ' ' LEU . 12.2 tp -109.58 109.48 20.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.315 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.778 HG12 HD13 ' A' ' 199' ' ' ILE . 35.9 m -119.19 169.82 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.031 0.443 . . . . 0.0 111.907 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 152' ' ' PRO . 15.9 t -119.82 156.32 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.697 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 231' ' ' VAL . 67.9 t0 -92.41 112.31 24.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.304 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -100.16 -25.43 14.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.804 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -63.92 -60.08 3.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 62.4 m -58.66 -24.4 61.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.5 -46.39 86.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.269 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -110.05 -43.01 4.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.261 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -50.37 -67.11 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.292 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -60.58 -30.64 69.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.822 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -118.19 139.8 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.921 0.391 . . . . 0.0 111.0 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.822 ' N ' HD13 ' A' ' 144' ' ' ILE . 15.3 t70 -45.73 137.54 5.72 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.89 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.28 -70.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.663 2.242 . . . . 0.0 112.551 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.027 ' O ' HG23 ' A' ' 148' ' ' THR . 1.0 OUTLIER -96.2 -60.72 1.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.454 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 1.027 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.3 p 168.83 128.82 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.204 0.602 . . . . 0.0 110.627 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 41.4 mtt -126.5 -65.57 0.96 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.931 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 150' ' ' LEU . 11.0 tp -125.91 -4.83 6.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.106 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.784 ' HD3' HG22 ' A' ' 148' ' ' THR . 0.4 OUTLIER -44.88 130.79 5.27 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 120.79 0.329 . . . . 0.0 111.587 -179.048 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.12 -179.91 5.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.794 2.329 . . . . 0.0 112.783 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -137.79 141.47 40.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.735 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.868 ' HA ' HD12 ' A' ' 229' ' ' LEU . 35.1 tp -99.4 131.36 45.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.962 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.9 t -130.01 138.54 50.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.035 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -131.49 104.4 6.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.486 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.683 ' HE1' ' HB2' ' A' ' 188' ' ' ALA . 5.7 ptm -119.73 140.49 50.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.216 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -96.28 129.42 43.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.404 ' CE ' ' HA2' ' A' ' 163' ' ' GLY . 18.9 tptp -59.78 -80.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.802 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.82 -156.7 17.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.262 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.69 0.02 10.33 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.615 2.21 . . . . 0.0 112.798 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.4 p -92.89 -30.36 15.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.574 0.226 . . . . 0.0 111.469 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.404 ' HA2' ' CE ' ' A' ' 159' ' ' LYS . . . 91.33 -124.9 7.79 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.378 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.488 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 2.4 m-85 -108.21 -55.07 2.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 0.0 110.488 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.71 -5.04 61.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.457 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.645 ' CE2' HD21 ' A' ' 168' ' ' LEU . 45.1 p90 -128.74 177.45 7.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.403 0.602 . . . . 0.0 111.762 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.806 ' C ' HD22 ' A' ' 168' ' ' LEU . 5.7 m120 -125.5 165.19 18.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.806 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.4 mm? -133.55 147.66 51.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.011 0.434 . . . . 0.0 112.003 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 2.2 p-80 -134.47 146.23 49.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.708 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.6 t -155.21 150.04 26.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 111.65 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -114.96 -68.93 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.231 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 155.2 19.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.464 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.1 m -96.34 20.27 10.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.177 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.561 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 31.7 mttp -110.9 -49.71 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.994 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 38.2 Cg_exo -57.63 -63.38 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.109 1.873 . . . . 0.0 112.391 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.9 -162.02 29.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.579 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -108.3 136.47 47.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 0.0 110.886 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.434 ' CD1' ' HD2' ' A' ' 198' ' ' ARG . 2.3 m-85 -124.08 158.05 33.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.608 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.64 ' HA ' HD13 ' A' ' 168' ' ' LEU . 15.0 mt -87.14 139.6 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.875 0.369 . . . . 0.0 110.743 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.458 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 10.2 ptm180 -105.16 -37.79 6.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.516 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.6 t -148.49 154.95 40.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.013 0.435 . . . . 0.0 111.716 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.758 HG23 ' HB2' ' A' ' 195' ' ' ALA . 33.6 t -132.34 143.04 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.739 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 57.2 t0 -95.03 125.33 51.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.081 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 23.5 Cg_exo -63.96 134.42 43.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.275 1.984 . . . . 0.0 112.084 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.6 t70 74.24 14.9 3.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.728 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 21.2 m -97.26 163.37 20.0 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.515 0.198 . . . . 0.0 110.537 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 81.3 Cg_exo -45.66 -40.35 18.67 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.473 2.115 . . . . 0.0 112.548 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.683 ' HB2' ' HE1' ' A' ' 157' ' ' MET . . . -65.13 -41.62 94.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 110.687 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -70.13 -50.6 38.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.82 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -47.59 -31.49 4.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.474 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.2 t -81.23 -31.45 33.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.049 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 113.1 31.54 2.42 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.063 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 194' ' ' ARG . 6.8 tt -82.59 151.37 26.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.733 0.302 . . . . 0.0 110.905 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.745 ' N ' HD23 ' A' ' 193' ' ' LEU . 49.9 mtt180 -137.78 130.02 29.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.645 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.758 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -52.82 157.59 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.497 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 47.5 mt-30 82.46 -17.04 0.55 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.326 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.739 ' OD2' HG21 ' A' ' 230' ' ' VAL . 20.1 p-10 -61.13 149.58 36.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.727 0.299 . . . . 0.0 110.662 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.434 ' HD2' ' CD1' ' A' ' 178' ' ' PHE . 4.6 mmm-85 -90.63 118.31 29.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.335 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.788 HD13 HG12 ' A' ' 230' ' ' VAL . 24.3 mm -65.28 128.6 28.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.799 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.485 ' CG2' HG23 ' A' ' 231' ' ' VAL . 11.8 t -111.23 -43.73 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.636 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.562 ' OE1' HD22 ' A' ' 229' ' ' LEU . 5.4 pt-20 -142.81 173.74 11.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.477 . . . . 0.0 111.433 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.88 ' O ' HG22 ' A' ' 205' ' ' VAL . 47.0 t -153.4 107.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.983 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.5 t30 70.37 25.27 4.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.508 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.48 -20.46 37.14 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.452 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 202' ' ' VAL . 26.9 m -80.4 95.28 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.09 0.445 . . . . 0.0 111.161 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.44 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 44.9 t -89.93 99.73 12.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.012 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.4 ' O ' ' HG2' ' A' ' 210' ' ' LYS . 45.6 mmm -130.16 101.38 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -67.1 100.04 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.625 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.23 26.49 3.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.392 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 207' ' ' MET . 6.5 mmtp -54.9 156.27 3.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 111.119 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.525 ' O ' HG23 ' A' ' 215' ' ' VAL . 3.7 mm-40 -92.11 160.28 15.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.987 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.811 ' O ' HG23 ' A' ' 216' ' ' VAL . 63.8 t-80 -47.71 -62.69 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.49 -30.3 64.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.284 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.86 -45.78 73.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 110.484 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 211' ' ' GLN . 28.7 t -70.92 -37.04 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.458 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 212' ' ' HIS . 45.0 t -69.2 -42.03 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.658 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 70.3 m -72.15 -33.18 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -59.35 -48.78 80.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.479 HD13 HG13 ' A' ' 202' ' ' VAL . 26.8 mm -62.24 -38.08 80.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.944 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -68.47 -36.84 79.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.734 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.14 5.2 30.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.645 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -85.1 10.18 64.1 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.039 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.17 -128.68 27.07 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.806 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.33 -25.09 18.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.717 0.294 . . . . 0.0 111.125 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -107.98 117.37 33.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.788 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.408 HG22 HD21 ' A' ' 228' ' ' LEU . 3.0 m -113.24 96.11 5.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.442 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -78.5 98.55 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.097 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.604 HD12 ' SD ' ' A' ' 157' ' ' MET . 28.7 mt -106.46 131.01 54.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.035 0.445 . . . . 0.0 111.906 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 154' ' ' LEU . 11.9 tp -115.98 109.7 17.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.572 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.788 HG12 HD13 ' A' ' 199' ' ' ILE . 32.0 m -109.77 176.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.0 112.068 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.485 HG23 ' CG2' ' A' ' 200' ' ' VAL . 5.4 t -126.49 162.89 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.074 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.479 ' N ' HG12 ' A' ' 231' ' ' VAL . 64.9 t0 -80.61 112.9 18.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.252 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -100.06 -27.26 13.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.572 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -50.58 -58.59 5.45 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.626 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 89.7 m -63.12 -30.56 71.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.91 -30.22 67.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -109.51 -28.2 9.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -57.18 -50.14 73.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.02 0.438 . . . . 0.0 110.792 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.76 -26.19 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.933 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.9 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.384 -0.286 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.827 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.1 OUTLIER -127.65 133.15 68.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.969 0.414 . . . . 0.0 110.992 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.827 ' N ' HD13 ' A' ' 144' ' ' ILE . 22.2 t70 -71.22 138.48 84.41 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.718 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.79 -61.32 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.817 2.345 . . . . 0.0 112.392 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.033 ' O ' HG23 ' A' ' 148' ' ' THR . 0.9 OUTLIER -83.75 -61.61 1.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.507 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 1.033 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.2 p 158.83 127.89 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.347 0.659 . . . . 0.0 111.157 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 77.9 mtp -127.16 -66.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.361 0.601 . . . . 0.0 110.449 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.541 HD12 HG11 ' A' ' 231' ' ' VAL . 13.0 tp -126.25 -4.88 6.71 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.644 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.724 ' HD2' HG22 ' A' ' 148' ' ' THR . 3.7 ptm85 -26.77 121.87 0.23 Allowed Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.4 139.13 12.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.567 2.178 . . . . 0.0 112.556 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -94.51 139.89 30.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.383 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.917 ' HA ' HD12 ' A' ' 229' ' ' LEU . 18.1 tp -95.99 119.84 35.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.989 0.423 . . . . 0.0 111.026 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 228' ' ' LEU . 45.3 t -116.21 126.94 54.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.53 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.448 ' N ' ' OG ' ' A' ' 191' ' ' SER . 3.0 m -135.48 99.91 4.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.192 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.42 ' HE2' ' HA ' ' A' ' 188' ' ' ALA . 16.4 ptp -112.38 142.91 44.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.195 0.522 . . . . 0.0 111.88 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -104.44 119.65 39.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.895 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 224' ' ' ASP . 16.5 tptp -58.08 -78.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.057 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.01 -152.86 12.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.385 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.02 0.17 10.22 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.747 2.298 . . . . 0.0 112.885 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.7 p -87.16 -30.41 21.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.575 0.226 . . . . 0.0 111.544 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.402 ' HA2' ' CE ' ' A' ' 159' ' ' LYS . . . 97.27 -146.66 18.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.179 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 7.7 m-85 -109.33 -46.83 3.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.167 0.508 . . . . 0.0 110.259 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 183' ' ' ASP . . . 70.71 28.34 71.01 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.626 -0.715 . . . . 0.0 113.813 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -140.84 175.68 9.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.576 0.688 . . . . 0.0 112.163 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.796 ' C ' HD22 ' A' ' 168' ' ' LEU . 10.0 m120 -135.65 155.98 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.66 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.796 HD22 ' C ' ' A' ' 167' ' ' ASN . 2.3 mm? -133.42 143.06 48.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.046 0.451 . . . . 0.0 111.9 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.481 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 2.5 p80 -141.03 136.86 32.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.298 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.6 t -137.15 163.95 29.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.379 . . . . 0.0 111.28 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -130.04 -78.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.665 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -90.14 175.05 7.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.761 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.0 m -109.22 19.65 19.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.208 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.63 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 2.6 mtmp? -110.87 -51.36 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.752 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 38.8 Cg_exo -61.2 -63.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.238 1.959 . . . . 0.0 112.229 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 144.35 -176.4 23.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.53 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.753 ' HB3' HG11 ' A' ' 215' ' ' VAL . 9.8 tp-100 -89.27 140.28 29.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.455 ' CD1' ' HD3' ' A' ' 198' ' ' ARG . 3.0 m-85 -127.73 147.84 50.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.654 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.773 HD12 ' OD2' ' A' ' 197' ' ' ASP . 68.0 mt -78.38 135.03 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.209 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.481 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 10.2 ptm180 -98.71 -35.04 10.3 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.9 t -151.58 156.76 41.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 112.076 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.76 HG23 ' HB2' ' A' ' 195' ' ' ALA . 23.3 t -132.69 140.6 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.524 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 165' ' ' GLY . 40.7 t0 -95.11 117.1 66.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.199 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.86 140.76 96.56 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.502 2.135 . . . . 0.0 112.185 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 8.1 t70 66.0 14.87 9.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.511 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 9.2 m -105.03 166.36 11.58 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.447 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 98.4 Cg_exo -43.98 -40.15 11.63 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.438 2.092 . . . . 0.0 112.437 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.42 ' HA ' ' HE2' ' A' ' 157' ' ' MET . . . -59.65 -44.94 93.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.684 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.18 -54.5 12.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -52.79 -26.63 14.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.533 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 156' ' ' THR . 4.4 t -85.09 -24.71 27.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.991 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.09 26.07 6.47 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.121 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -79.82 149.39 31.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 111.009 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.825 ' N ' HD23 ' A' ' 193' ' ' LEU . 50.6 mtt-85 -140.72 129.9 23.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.706 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.76 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -58.42 151.1 20.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.324 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 41.5 mt-30 77.55 -3.05 2.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.163 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.773 ' OD2' HD12 ' A' ' 179' ' ' ILE . 41.3 p30 -67.71 151.83 46.59 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.567 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.455 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 68.1 mmt-85 -90.61 115.67 27.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.25 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.715 HD13 HG12 ' A' ' 230' ' ' VAL . 22.8 mm -65.51 124.55 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.117 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.583 HG12 ' SG ' ' A' ' 206' ' ' CYS . 17.1 t -109.02 -45.19 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.492 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.9 pt-20 -144.27 173.97 11.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 111.449 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.886 HG13 ' CD2' ' A' ' 228' ' ' LEU . 26.4 t -155.43 112.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.817 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 44.2 t30 70.21 22.93 5.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.385 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.54 -15.96 48.88 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.581 -0.818 . . . . 0.0 113.589 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 202' ' ' VAL . 27.0 m -86.59 93.75 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 117.25 0.525 . . . . 0.0 111.539 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.583 ' SG ' HG12 ' A' ' 200' ' ' VAL . 50.8 t -92.18 100.92 13.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.668 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.1 mmt -130.63 101.61 5.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.353 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -68.36 99.25 0.91 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.643 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.5 25.55 3.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.609 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.404 ' HB2' HG22 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -54.96 175.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.767 0.318 . . . . 0.0 110.916 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.912 ' O ' HG23 ' A' ' 215' ' ' VAL . 11.7 mm-40 -91.11 157.23 17.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.986 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.812 ' O ' HG23 ' A' ' 216' ' ' VAL . 67.6 t60 -52.44 -64.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.692 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.05 -25.04 61.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.283 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.01 -44.02 55.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.323 . . . . 0.0 110.712 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.912 HG23 ' O ' ' A' ' 211' ' ' GLN . 4.6 t -74.81 -36.82 40.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.565 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 212' ' ' HIS . 40.7 t -70.13 -38.22 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.71 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.3 m -74.56 -33.51 62.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.627 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.522 ' HB1' HG11 ' A' ' 202' ' ' VAL . . . -59.49 -48.34 82.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.0 mm -61.86 -42.16 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 54.2 ttp85 -75.16 -28.4 60.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.21 5.78 28.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.737 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -66.53 -0.65 8.57 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.564 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 47.43 -132.23 15.16 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.987 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.1 m-20 -83.86 -25.17 30.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.308 . . . . 0.0 111.217 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -125.48 114.82 19.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.814 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.58 HG22 HD21 ' A' ' 228' ' ' LEU . 4.6 m -112.42 96.84 6.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.369 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -84.08 94.8 8.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.031 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.886 ' CD2' HG13 ' A' ' 202' ' ' VAL . 8.1 mt -110.07 140.1 44.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.145 0.498 . . . . 0.0 112.283 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 154' ' ' LEU . 10.4 tp -120.0 109.58 15.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.313 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.715 HG12 HD13 ' A' ' 199' ' ' ILE . 27.5 m -114.87 179.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 111.766 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.541 HG11 HD12 ' A' ' 150' ' ' LEU . 2.6 t -119.95 166.08 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.726 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.493 ' H ' HG12 ' A' ' 231' ' ' VAL . 46.7 t0 -90.26 111.0 22.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.209 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -100.03 -24.69 14.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -52.33 -59.89 3.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.839 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 46.0 m -66.34 -30.34 70.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.92 -24.73 66.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.995 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -106.2 -34.38 7.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.013 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.1 -64.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -59.99 -34.36 73.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.926 HD13 ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -134.91 150.1 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.666 0.269 . . . . 0.0 110.803 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.926 ' N ' HD13 ' A' ' 144' ' ' ILE . 10.7 t70 -44.83 137.98 4.23 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.426 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.96 -57.64 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.682 2.254 . . . . 0.0 112.537 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.025 ' O ' HG23 ' A' ' 148' ' ' THR . 4.4 t80 -107.3 -60.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.376 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 1.025 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.0 p 164.18 133.48 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.325 0.65 . . . . 0.0 110.246 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 69.5 mtp -125.46 -65.08 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.965 HD12 HG11 ' A' ' 231' ' ' VAL . 12.7 tp -125.82 -8.94 6.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.572 ' NE ' HG22 ' A' ' 148' ' ' THR . 29.2 ptt85 -50.08 122.11 14.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.685 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.533 ' HB3' HG22 ' A' ' 231' ' ' VAL . 46.4 Cg_endo -69.19 176.88 5.76 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.671 2.247 . . . . 0.0 113.075 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.842 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.3 OUTLIER -143.44 158.11 43.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.699 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.2 tp -90.01 125.74 35.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.005 0.431 . . . . 0.0 111.369 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 47.7 t -120.52 140.2 51.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.374 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 11.4 m -134.11 104.1 6.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -109.81 127.02 54.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -90.39 125.53 35.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.981 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.445 ' HE2' ' CZ ' ' A' ' 164' ' ' TYR . 1.7 tppp? -59.66 -80.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.703 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.38 -156.19 12.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.498 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.76 0.02 10.35 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.704 2.269 . . . . 0.0 112.782 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 p -96.85 -30.15 13.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.734 0.302 . . . . 0.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.93 -142.12 15.84 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.439 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.464 ' HB3' ' CE1' ' A' ' 166' ' ' PHE . 14.7 m-85 -96.41 -51.33 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 85.34 30.49 24.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.627 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 164' ' ' TYR . 0.0 OUTLIER -151.49 178.65 9.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.238 0.542 . . . . 0.0 112.152 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.887 ' O ' HD13 ' A' ' 168' ' ' LEU . 10.0 m120 -135.22 154.63 51.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.054 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.887 HD13 ' O ' ' A' ' 167' ' ' ASN . 0.4 OUTLIER -132.19 148.33 52.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.398 . . . . 0.0 111.655 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -134.21 141.33 46.99 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.314 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.6 t -155.14 149.61 26.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.179 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -121.44 -67.97 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.561 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -90.16 159.73 16.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.6 m -100.8 21.41 13.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.166 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.552 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 5.0 mttp -108.73 -48.59 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.792 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 25.5 Cg_exo -63.02 -65.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.216 1.944 . . . . 0.0 112.298 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.09 -152.25 23.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.411 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -125.88 133.96 51.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 111.097 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 2.8 m-85 -122.53 165.11 16.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.824 HD12 ' OD2' ' A' ' 197' ' ' ASP . 57.0 mt -91.9 135.91 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 110.66 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.401 ' HG2' ' CB ' ' A' ' 167' ' ' ASN . 0.3 OUTLIER -98.78 -35.63 10.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.879 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.0 t -153.21 158.51 41.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 111.63 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 195' ' ' ALA . 49.0 t -135.29 141.15 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.789 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -90.72 117.28 67.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.799 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.91 136.61 74.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.448 2.099 . . . . 0.0 112.408 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.7 t70 71.21 14.78 6.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.58 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.524 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 48.0 m -99.99 164.78 15.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.583 0.23 . . . . 0.0 110.778 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 99.9 Cg_exo -44.04 -40.25 11.91 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.584 2.19 . . . . 0.0 112.912 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.456 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -62.78 -43.95 97.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -70.33 -51.65 28.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.007 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.96 -32.19 3.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.574 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.1 t -83.99 -27.5 28.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.063 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 115.11 25.51 3.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.464 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.839 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -83.44 149.21 26.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.332 . . . . 0.0 110.731 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.839 ' N ' HD23 ' A' ' 193' ' ' LEU . 1.4 mtt85 -143.15 138.31 29.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.798 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.624 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -55.69 153.97 7.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.573 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 71.39 9.14 6.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.065 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.824 ' OD2' HD12 ' A' ' 179' ' ' ILE . 38.9 p30 -75.77 149.53 37.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.029 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 17.4 mmt85 -85.67 112.49 21.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.691 0.281 . . . . 0.0 111.548 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.933 ' HA ' HG12 ' A' ' 230' ' ' VAL . 12.8 mm -68.09 123.9 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.366 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.3 t -110.18 -43.86 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.126 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.52 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 10.6 pt-20 -143.19 176.64 8.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.317 0.58 . . . . 0.0 111.936 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.891 ' O ' HG22 ' A' ' 205' ' ' VAL . 48.7 t -150.81 107.77 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.517 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.45 23.86 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.368 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.65 -17.01 51.01 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.633 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 202' ' ' VAL . 26.9 m -83.43 90.2 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.191 0.495 . . . . 0.0 111.569 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.483 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 53.0 t -80.31 100.57 8.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.754 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.464 ' CB ' ' HG2' ' A' ' 210' ' ' LYS . 17.0 mmt -130.74 99.43 4.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.18 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -75.03 115.5 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.2 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 104.21 12.85 28.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.112 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.464 ' HG2' ' CB ' ' A' ' 207' ' ' MET . 0.5 OUTLIER -54.93 166.16 0.54 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.06 0.457 . . . . 0.0 111.398 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -94.46 160.4 14.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.841 ' O ' HG23 ' A' ' 216' ' ' VAL . 11.2 t60 -47.49 -56.42 7.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.026 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.05 -29.12 70.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.17 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.94 -44.5 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.55 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 32.9 t -71.84 -35.04 53.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.449 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 212' ' ' HIS . 47.9 t -71.25 -41.61 74.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.458 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.8 m -67.14 -38.13 84.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.516 ' HB1' ' HB ' ' A' ' 202' ' ' VAL . . . -55.67 -45.64 77.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.053 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.421 HD13 HG13 ' A' ' 202' ' ' VAL . 25.8 mm -65.45 -33.33 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -67.68 -41.35 83.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.86 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.09 5.03 31.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.613 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -87.6 10.03 71.33 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.975 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.12 -136.32 25.56 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.854 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.79 -25.13 23.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.74 0.305 . . . . 0.0 111.079 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -104.22 114.89 29.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.682 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.6 HG22 ' HG ' ' A' ' 228' ' ' LEU . 19.9 m -110.55 101.12 9.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.287 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -85.35 94.86 9.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.192 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 202' ' ' VAL . 13.6 mt -103.67 137.62 41.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.026 0.441 . . . . 0.0 111.858 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.842 HD12 ' O ' ' A' ' 153' ' ' ARG . 13.9 tp -110.56 109.41 19.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.933 HG12 ' HA ' ' A' ' 199' ' ' ILE . 23.8 m -124.62 177.04 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.475 0.655 . . . . 0.0 112.243 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.965 HG11 HD12 ' A' ' 150' ' ' LEU . 39.9 t -119.2 145.11 25.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.776 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.711 ' O ' ' HB2' ' A' ' 236' ' ' ASP . 21.0 t0 -96.41 112.81 24.42 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.581 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -101.0 -19.58 15.77 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.946 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -85.38 -59.03 2.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 109.965 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.462 ' HB ' ' OD2' ' A' ' 232' ' ' ASP . 11.3 m -68.88 -19.81 64.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.172 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.711 ' HB2' ' O ' ' A' ' 232' ' ' ASP . 16.1 t0 -41.35 -28.6 0.12 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.468 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -108.5 -20.05 13.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.919 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -85.36 -73.0 0.46 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.442 ' HB3' ' CG2' ' A' ' 235' ' ' THR . 0.8 OUTLIER -93.92 -14.04 26.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.64 -178.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 236' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.008 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.586 HD13 ' C ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -135.01 121.33 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.01 0.433 . . . . 0.0 111.013 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -93.28 137.3 23.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.945 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.96 -70.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.299 1.999 . . . . 0.0 112.678 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.002 ' O ' HG23 ' A' ' 148' ' ' THR . 83.1 t80 -115.5 -60.83 1.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 1.002 HG23 ' O ' ' A' ' 147' ' ' PHE . 2.2 p 162.83 128.56 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.531 0.732 . . . . 0.0 110.157 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 7.0 mtt -127.15 -52.03 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.412 0.625 . . . . 0.0 110.526 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.765 HD21 ' HA ' ' A' ' 235' ' ' THR . 30.6 tp -125.38 -24.31 3.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.037 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.789 ' CD ' HG22 ' A' ' 148' ' ' THR . 5.7 ptm180 -46.12 160.31 0.3 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.931 0.396 . . . . 0.0 111.154 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.645 ' HB3' HG22 ' A' ' 231' ' ' VAL . 7.1 Cg_endo -51.52 143.71 35.04 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.979 2.453 . . . . 0.0 112.439 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.673 ' O ' HD12 ' A' ' 229' ' ' LEU . 81.7 mtt180 -125.2 171.81 10.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.354 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.2 tp -108.21 139.35 43.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.046 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 228' ' ' LEU . 54.1 t -126.56 135.83 51.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.51 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.0 m -137.24 99.9 4.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.744 0.307 . . . . 0.0 110.689 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -114.43 141.12 48.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 111.266 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -96.22 121.6 38.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.552 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.42 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 2.0 tppp? -46.41 -76.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.36 -158.05 7.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.314 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.01 0.03 10.32 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.676 2.25 . . . . 0.0 112.69 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.2 p -100.56 -30.19 11.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.517 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.42 ' HA2' ' HD2' ' A' ' 159' ' ' LYS . . . 80.95 -124.79 6.57 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.71 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.96 ' CE2' HG21 ' A' ' 219' ' ' ILE . 8.2 m-85 -91.63 -60.41 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.084 0.469 . . . . 0.0 111.099 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 183' ' ' ASP . . . 96.71 -0.74 61.22 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.555 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CD2' HD13 ' A' ' 193' ' ' LEU . 1.4 p90 -124.8 -176.89 3.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.06 0.457 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.856 ' O ' HD13 ' A' ' 168' ' ' LEU . 3.3 m120 -124.72 161.96 25.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.685 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.856 HD13 ' O ' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -132.71 135.27 45.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.076 0.465 . . . . 0.0 111.976 -179.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' A' ' 180' ' ' ARG . 0.7 OUTLIER -134.86 143.31 46.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.948 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 7.7 t -155.06 166.84 32.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 111.442 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -130.14 -59.5 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.739 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -90.01 167.34 12.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 m -110.08 22.21 15.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.278 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 14.2 mttt -102.93 -48.6 0.17 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.563 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 14.2 Cg_exo -69.3 -58.0 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.359 2.039 . . . . 0.0 112.331 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 140.33 -146.75 18.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.41 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -103.97 131.58 51.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.765 0.317 . . . . 0.0 110.865 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CD1' ' HD3' ' A' ' 198' ' ' ARG . 1.2 m-30 -109.76 165.19 11.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.559 HD12 ' OD1' ' A' ' 197' ' ' ASP . 4.0 mt -100.37 131.75 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.166 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.47 ' HB3' ' CD2' ' A' ' 169' ' ' HIS . 10.9 ptm180 -104.33 -33.53 8.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.709 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.4 t -150.82 152.53 33.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 111.868 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.67 140.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.761 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 47.3 t0 -89.0 123.1 68.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 23.7 Cg_exo -63.59 133.07 37.95 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.233 1.955 . . . . 0.0 112.195 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 185' ' ' ASP . 13.6 t0 76.88 14.84 2.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.26 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 37.0 m -98.69 163.21 19.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 84.1 Cg_exo -45.56 -40.2 18.05 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.36 2.04 . . . . 0.0 112.345 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.61 -44.85 95.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.764 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -66.64 -54.52 22.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.917 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -55.84 -26.49 46.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.279 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.3 t -82.52 -20.3 36.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.22 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 100.8 36.95 3.81 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.914 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 194' ' ' ARG . 8.3 tt -100.18 148.68 24.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.83 0.347 . . . . 0.0 111.153 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.785 ' N ' HD23 ' A' ' 193' ' ' LEU . 53.0 mtp180 -147.79 138.78 23.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.758 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 196' ' ' GLN . . . -47.69 166.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.613 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.7 ' O ' ' HB2' ' A' ' 233' ' ' ARG . 67.1 mt-30 80.27 -24.36 0.2 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.237 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.737 ' OD2' HG21 ' A' ' 230' ' ' VAL . 27.2 p-10 -66.92 138.17 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.452 0.644 . . . . 0.0 112.266 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.546 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 0.2 OUTLIER -92.19 130.12 37.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.373 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.79 ' HA ' HG12 ' A' ' 230' ' ' VAL . 22.2 mm -69.78 116.45 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.764 0.316 . . . . 0.0 110.58 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.21 -46.48 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.736 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.457 ' HG2' ' HB3' ' A' ' 229' ' ' LEU . 10.2 pt-20 -138.45 174.11 10.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.962 0.41 . . . . 0.0 111.164 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.926 ' O ' HG22 ' A' ' 205' ' ' VAL . 23.7 t -152.74 109.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.144 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 13.0 t30 70.01 24.32 5.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.306 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.33 49.38 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.469 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.926 HG22 ' O ' ' A' ' 202' ' ' VAL . 28.5 m -80.95 95.29 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.205 0.502 . . . . 0.0 111.093 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.426 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 26.5 t -86.8 103.6 15.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.176 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.405 ' O ' ' HG2' ' A' ' 210' ' ' LYS . 84.7 mmm -130.16 99.92 5.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.69 103.66 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.705 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 113.95 23.71 4.84 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.337 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 207' ' ' MET . 9.7 mmmt -54.9 158.47 2.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.918 0.389 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 215' ' ' VAL . 0.7 OUTLIER -98.08 160.28 14.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.151 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.872 ' O ' HG23 ' A' ' 216' ' ' VAL . 14.6 t60 -48.05 -60.99 2.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.92 -31.15 67.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.212 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.17 -46.15 78.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.261 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 211' ' ' GLN . 25.5 t -70.05 -35.41 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.438 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 212' ' ' HIS . 41.5 t -70.36 -42.69 78.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.649 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 71.6 m -73.46 -33.44 64.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.735 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.04 80.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.143 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.96 HG21 ' CE2' ' A' ' 164' ' ' TYR . 17.6 mm -63.81 -40.35 88.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -43.37 89.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.675 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.95 5.06 30.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.526 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -90.81 19.71 43.61 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.895 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.05 -137.7 22.77 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.963 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.85 -24.83 20.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -100.38 117.96 35.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.393 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.801 HG22 HD21 ' A' ' 228' ' ' LEU . 3.0 m -111.38 99.49 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.6 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -87.42 94.93 9.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.947 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.801 HD21 HG22 ' A' ' 226' ' ' THR . 18.4 mt -109.12 139.8 43.53 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 153' ' ' ARG . 14.2 tp -109.54 111.42 22.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 199' ' ' ILE . 34.8 m -125.39 152.49 32.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 197' ' ' ASP . 2.6 t -119.98 137.79 52.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 197' ' ' ASP . 20.4 t0 -67.94 143.5 55.62 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.856 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.7 ' HB2' ' O ' ' A' ' 196' ' ' GLN . 38.6 ttp180 -54.67 -25.19 25.47 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.447 ' HG3' ' CG ' ' A' ' 232' ' ' ASP . 27.9 mt-10 -59.36 -29.1 67.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.765 ' HA ' HD21 ' A' ' 150' ' ' LEU . 2.9 m -87.57 -23.56 24.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.35 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 233' ' ' ARG . 28.3 t70 -46.78 -31.87 3.29 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -59.89 -40.06 87.48 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 235' ' ' THR . 6.6 t80 -72.37 -55.61 6.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.288 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.45 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 21.9 t80 -59.43 -17.21 28.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.426 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 236' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.798 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.576 HD13 ' C ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -97.14 125.68 50.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.936 0.398 . . . . 0.0 111.125 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.641 ' HB3' ' O ' ' A' ' 148' ' ' THR . 9.1 t70 -105.02 138.44 19.51 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.791 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -80.34 -59.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 122.73 2.287 . . . . 0.0 114.746 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -77.45 -42.21 36.82 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.641 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 2.9 p -119.58 129.64 54.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 10.6 mtt -117.59 -16.93 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.715 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.517 ' O ' HG13 ' A' ' 231' ' ' VAL . 54.6 tp -74.29 -5.01 39.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.576 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -36.82 140.12 0.44 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-O 120.658 0.266 . . . . 0.0 111.537 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.471 ' HB3' HG22 ' A' ' 231' ' ' VAL . 56.3 Cg_endo -70.68 165.9 30.49 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.621 2.214 . . . . 0.0 112.913 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.797 ' O ' HD12 ' A' ' 229' ' ' LEU . 70.4 mtm180 -129.71 158.43 39.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.774 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 26.3 tp -96.48 129.37 43.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.376 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 52.4 t -128.25 135.63 49.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.504 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.2 m -131.47 111.26 11.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.03 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.712 ' HE3' HD12 ' A' ' 228' ' ' LEU . 3.6 ptp -118.18 133.11 56.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -92.97 130.54 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.452 ' CD ' ' HA2' ' A' ' 163' ' ' GLY . 10.7 tptm -61.56 -80.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.754 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.441 ' N ' ' HG3' ' A' ' 159' ' ' LYS . . . 54.73 -157.2 6.98 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.299 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.77 0.21 10.19 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.681 2.254 . . . . 0.0 112.686 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.3 p -95.23 -30.14 14.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.428 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.452 ' HA2' ' CD ' ' A' ' 159' ' ' LYS . . . 93.01 -161.2 25.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.46 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.657 ' CE1' HG22 ' A' ' 219' ' ' ILE . 31.8 m-85 -81.67 -43.29 18.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.336 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 186' ' ' SER . . . 85.18 27.67 32.91 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.927 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.996 ' CE2' HD11 ' A' ' 168' ' ' LEU . 0.0 OUTLIER -164.83 -177.32 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.256 0.55 . . . . 0.0 111.882 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.914 ' O ' HD13 ' A' ' 168' ' ' LEU . 9.8 m120 -136.6 157.29 47.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.028 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.996 HD11 ' CE2' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -133.35 130.64 39.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.55 ' CG ' ' HB3' ' A' ' 180' ' ' ARG . 0.3 OUTLIER -136.04 135.58 39.55 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.018 178.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.0 t -155.32 144.26 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.152 0.501 . . . . 0.0 111.498 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -130.26 -6.45 4.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.309 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.479 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.1 OUTLIER -89.16 146.58 24.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.555 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.1 m -110.21 8.95 23.86 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.735 ' HB2' ' HD3' ' A' ' 175' ' ' PRO . 50.4 mtmt -120.68 -58.27 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 174' ' ' LYS . 37.1 Cg_exo -56.89 -64.48 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.138 1.892 . . . . 0.0 112.302 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.81 -145.44 12.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.686 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.875 ' HB2' HG21 ' A' ' 215' ' ' VAL . 6.2 tp-100 -108.68 151.12 26.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.404 ' CE1' ' HD2' ' A' ' 198' ' ' ARG . 5.4 m-85 -130.29 151.45 50.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.854 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.738 HD13 HD21 ' A' ' 193' ' ' LEU . 69.6 mt -82.53 140.79 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.55 ' HB3' ' CG ' ' A' ' 169' ' ' HIS . 2.8 ptm180 -103.21 -36.32 8.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.225 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 40.8 t -151.0 153.8 35.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.034 0.445 . . . . 0.0 111.681 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.825 HG23 ' HB2' ' A' ' 195' ' ' ALA . 32.5 t -133.5 141.82 43.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.575 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 46.8 t0 -91.89 121.23 67.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.973 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 183' ' ' ASP . 26.4 Cg_exo -62.41 132.67 39.38 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.345 2.03 . . . . 0.0 112.33 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.7 t0 69.87 22.62 5.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.259 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.511 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 58.6 m -104.9 164.69 14.65 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.725 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 186' ' ' SER . 94.5 Cg_exo -43.47 -40.12 9.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.628 2.218 . . . . 0.0 112.792 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.616 ' HB1' HD13 ' A' ' 193' ' ' LEU . . . -63.08 -44.2 96.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 110.293 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -70.02 -52.63 22.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.894 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.6 -31.14 2.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.655 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.2 t -81.97 -30.61 31.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 116.96 25.61 3.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.45 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 194' ' ' ARG . 7.8 tt -78.29 150.32 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.739 0.304 . . . . 0.0 110.743 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.797 ' N ' HD23 ' A' ' 193' ' ' LEU . 57.6 mtt-85 -139.6 130.01 25.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.857 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.825 ' HB2' HG23 ' A' ' 182' ' ' VAL . . . -55.05 152.7 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 75.22 2.9 4.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.08 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.609 ' CG ' HD12 ' A' ' 179' ' ' ILE . 41.2 p30 -73.74 155.58 38.76 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.307 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -87.72 112.76 22.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.458 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.789 HD13 HG12 ' A' ' 230' ' ' VAL . 24.8 mm -66.97 124.17 21.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.913 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.568 ' CG1' HD23 ' A' ' 229' ' ' LEU . 19.3 t -106.78 -44.0 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.912 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 206' ' ' CYS . 5.4 pt-20 -145.2 175.15 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.102 0.477 . . . . 0.0 111.688 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.877 ' O ' HG22 ' A' ' 205' ' ' VAL . 40.1 t -150.56 109.36 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.65 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 49.8 t30 70.38 23.43 4.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.299 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.17 -16.28 53.73 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.564 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 202' ' ' VAL . 32.7 m -85.45 96.76 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 117.181 0.49 . . . . 0.0 111.432 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' CYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 52.5 t -81.8 103.2 11.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.661 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.455 ' HB2' ' CG ' ' A' ' 210' ' ' LYS . 21.9 mmt -130.23 99.47 5.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -78.7 101.73 7.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.1 5.34 6.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.135 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.455 ' CG ' ' HB2' ' A' ' 207' ' ' MET . 0.9 OUTLIER -54.85 156.81 3.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.096 0.448 . . . . 0.0 110.97 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.656 ' O ' HG23 ' A' ' 215' ' ' VAL . 18.0 mm-40 -89.34 160.28 16.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.999 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.842 ' O ' HG23 ' A' ' 216' ' ' VAL . 0.9 OUTLIER -47.26 -60.92 2.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -57.91 -31.41 64.65 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.114 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.23 -44.02 69.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.473 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.875 HG21 ' HB2' ' A' ' 177' ' ' GLN . 16.8 t -72.38 -38.9 62.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 212' ' ' HIS . 49.2 t -65.06 -42.29 94.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.186 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 45.4 m -67.24 -39.67 86.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.411 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.06 73.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.959 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.657 HG22 ' CE1' ' A' ' 164' ' ' TYR . 25.9 mm -61.35 -37.53 77.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.548 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -70.48 -33.91 71.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.509 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.15 5.33 30.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.591 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -83.99 13.99 46.08 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.149 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 50.12 -134.78 27.56 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.868 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 1.4 m-20 -87.46 -25.18 23.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.722 0.296 . . . . 0.0 111.239 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -112.72 117.5 32.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.706 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.695 HG22 HD21 ' A' ' 228' ' ' LEU . 5.8 m -112.85 95.06 5.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.31 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -78.84 97.97 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.251 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.712 HD12 ' HE3' ' A' ' 157' ' ' MET . 46.3 mt -105.02 135.72 45.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 112.259 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 153' ' ' ARG . 14.3 tp -112.06 109.45 19.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.117 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.789 HG12 HD13 ' A' ' 199' ' ' ILE . 31.9 m -120.78 169.44 12.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.137 0.494 . . . . 0.0 112.114 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 150' ' ' LEU . 39.8 t -119.92 137.54 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.74 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -71.21 110.73 6.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.257 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -100.11 -24.8 14.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.812 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -64.18 -56.63 13.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.956 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.652 HG23 ' CB ' ' A' ' 239' ' ' PHE . 84.0 m -66.64 -24.64 66.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.019 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -67.49 -32.97 74.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -109.96 -48.51 3.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.333 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -64.73 -67.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.058 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.652 ' CB ' HG23 ' A' ' 235' ' ' THR . 8.3 t80 -60.38 -33.35 72.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.937 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 stop_ save_